1	JACC	NN	O	jacc	_	0	SENT_1	[p1l194t81r261b96],
2	:	:	O	:	_	0	SENT_1	[p1l194t81r261b96],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_1	[p1l278t81r500b96],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_1	[p1l518t81r710b96],
5	VOL	NNP	O	VOL	dep	4	SENT_1	[p1l1714t81r1767b96],
6	.	.	O	.	_	0	SENT_1	[p1l1714t81r1767b96],

1	1	CD	NUMBER	1	dep	9	SENT_2	[p1l1786t81r1803b98],
2	,	,	O	,	_	0	SENT_2	[p1l1786t81r1803b98],
3	NO.	NNP	O	NO.	appos	1	SENT_2	[p1l1821t81r1861b96],
4	6	CD	NUMBER	6	num	3	SENT_2	[p1l1878t81r1896b98],
5	,	,	O	,	_	0	SENT_2	[p1l1878t81r1896b98],
6	2008	CD	DATE	2008	num	7	SENT_2	[p1l1914t81r1969b96],
7	©	CD	DATE	©	appos	1	SENT_2	[p1l195t115r208b128],
8	2008	CD	DATE	2008	dep	9	SENT_2	[p1l225t114r280b129],
9	BY	NNP	O	BY	dep	18	SENT_2	[p1l298t114r324b129],
10	THE	DT	O	the	det	12	SENT_2	[p1l340t114r383b129],
11	AMERICAN	NNP	MISC	AMERICAN	nn	12	SENT_2	[p1l400t114r525b129],
12	COLLEGE	NNP	O	COLLEGE	dep	9	SENT_2	[p1l543t114r649b129],
13	OF	IN	O	of	_	0	SENT_2	[p1l667t114r694b129],
14	CARDIOLOGY	NNP	O	CARDIOLOGY	nn	16	SENT_2	[p1l712t114r870b129],
15	FOUNDATION	NNP	O	FOUNDATION	nn	16	SENT_2	[p1l888t114r1048b129],
16	lSSN1936-8798	NN	O	lssn1936-8798	prep_of	12	SENT_2	[p1l1634t113r1969b131],
17	/	:	O	/	punct	18	SENT_2	[p1l1634t113r1969b131],
18	08	CD	NUMBER	08	_	0	SENT_2	[p1l1634t113r1969b131],
19	/	:	O	/	punct	20	SENT_2	[p1l1634t113r1969b131],
20	$	$	MONEY	$	dep	18	SENT_2	[p1l1634t113r1969b131],
21	34.00	CD	MONEY	34.00	num	20	SENT_2	[p1l1634t113r1969b131],
22	PUBLISHED	VBN	O	publish	partmod	18	SENT_2	[p1l196t147r329b162],
23	BY	IN	O	by	_	0	SENT_2	[p1l347t147r373b162],
24	ELSEVIER	NNP	ORGANIZATION	ELSEVIER	nn	25	SENT_2	[p1l390t147r499b162],
25	INC.	NNP	ORGANIZATION	INC.	agent	22	SENT_2	[p1l517t147r564b162],
26	.	.	O	.	_	0	SENT_2	[p1l517t147r564b162],

1	DOI	NNP	O	DOI	_	0	SENT_3	[p1l1564t147r1969b166],
2	:10.1016	CD	NUMBER	:10.1016	num	1	SENT_3	[p1l1564t147r1969b166],
3	/	:	O	/	punct	7	SENT_3	[p1l1564t147r1969b166],
4	j.	NN	O	j.	nn	5	SENT_3	[p1l1564t147r1969b166],
5	jcin	NN	O	jcin	dep	7	SENT_3	[p1l1564t147r1969b166],
6	.2008.09,008	CD	NUMBER	.2008.09,008	num	7	SENT_3	[p1l1564t147r1969b166],
7	(	NN	O	(	dep	1	SENT_3	[p1l1888t176r1925b195],
8	4	CD	NUMBER	4	number	9	SENT_3	[p1l1888t176r1925b195],
9	C	NN	O	c	amod	7	SENT_3	[p1l1889t196r1968b251],
10	!	.	O	!	_	0	SENT_3	[p1l1889t196r1968b251],

1	The	DT	O	the	det	2	SENT_4	[p1l193t304r307b362],
2	Pharmacogenetics	NNS	MISC	pharmacogenetic	_	0	SENT_4	[p1l338t304r921b373],
3	and	CC	O	and	_	0	SENT_4	[p1l949t304r1061b362],
4	Pharmacodynamics	NNS	O	pharmacodynamic	conj_and	2	SENT_4	[p1l198t404r812b473],
5	of	IN	O	of	_	0	SENT_4	[p1l840t403r902b462],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_4	[p1l928t403r1283b473],
7	Response	NN	O	response	prep_of	2	SENT_4	[p1l1316t404r1614b473],

1	An	DT	O	a	det	2	SENT_5	[p1l195t530r246b562],
2	Analysis	NN	O	analysis	_	0	SENT_5	[p1l264t529r433b570],
3	From	IN	O	from	dep	2	SENT_5	[p1l452t530r550b562],
4	the	DT	O	the	det	8	SENT_5	[p1l567t530r633b562],
5	PRINC	NNP	O	PRINC	nn	8	SENT_5	[p1l652t529r780b562],
6	(	CD	NUMBER	(	num	8	SENT_5	[p1l799t529r938b570],
7	Plavix	NNP	O	Plavix	nn	8	SENT_5	[p1l799t529r938b570],
8	Response	NN	O	response	pobj	3	SENT_5	[p1l957t530r1153b570],
9	in	IN	O	in	dep	2	SENT_5	[p1l1171t529r1204b562],
10	Coronary	JJ	O	coronary	amod	13	SENT_5	[p1l1222t529r1403b570],
11	Intervention	NN	O	intervention	nn	13	SENT_5	[p1l1421t529r1679b570],
12	)	CD	NUMBER	)	num	13	SENT_5	[p1l1421t529r1679b570],
13	Trial	NN	O	trial	pobj	9	SENT_5	[p1l1698t529r1784b562],

1	Patrick	NNP	PERSON	Patrick	nn	2	SENT_6	[p1l195t638r315b669],
2	Gladding	NNP	PERSON	Gladding	dep	47	SENT_6	[p1l329t638r496b680],
3	,	,	O	,	_	0	SENT_6	[p1l329t638r496b680],
4	FRACP	NNP	O	FRACP	appos	2	SENT_6	[p1l513t637r677b676],
5	,	,	O	,	_	0	SENT_6	[p1l513t637r677b676],
6	*	CD	NUMBER	*	num	8	SENT_6	[p1l513t637r677b676],
7	Mark	NNP	PERSON	Mark	nn	8	SENT_6	[p1l691t638r786b669],
8	Webster	NNP	PERSON	Webster	appos	2	SENT_6	[p1l797t638r949b676],
9	,	,	O	,	_	0	SENT_6	[p1l797t638r949b676],
10	FRACP	NNP	O	FRACP	appos	2	SENT_6	[p1l966t637r1130b676],
11	,	,	O	,	_	0	SENT_6	[p1l966t637r1130b676],
12	*	NNP	O	*	nn	14	SENT_6	[p1l966t637r1130b676],
13	Irene	NNP	PERSON	Irene	nn	14	SENT_6	[p1l1145t638r1231b669],
14	Zeng	NNP	PERSON	Zeng	appos	2	SENT_6	[p1l1248t638r1344b680],
15	,	,	O	,	_	0	SENT_6	[p1l1248t638r1344b680],
16	MSC	NNP	ORGANIZATION	MSC	appos	2	SENT_6	[p1l1360t638r1469b676],
17	,	,	O	,	_	0	SENT_6	[p1l1360t638r1469b676],
18	*	NNP	O	*	nn	20	SENT_6	[p1l1360t638r1469b676],
19	Helen	NNP	PERSON	Helen	nn	20	SENT_6	[p1l195t696r297b726],
20	Farrell	NNP	PERSON	Farrell	appos	2	SENT_6	[p1l313t696r431b733],
21	,	,	O	,	_	0	SENT_6	[p1l313t696r431b733],
22	BHSC	NNP	O	BHSC	appos	2	SENT_6	[p1l448t696r578b733],
23	,	,	O	,	_	0	SENT_6	[p1l448t696r578b733],
24	*	CD	NUMBER	*	num	26	SENT_6	[p1l448t696r578b733],
25	Jim	NNP	PERSON	Jim	nn	26	SENT_6	[p1l589t696r650b735],
26	Stewart	NNP	PERSON	Stewart	appos	2	SENT_6	[p1l667t696r801b733],
27	,	,	O	,	_	0	SENT_6	[p1l667t696r801b733],
28	FRACP	NNP	LOCATION	FRACP	appos	2	SENT_6	[p1l818t695r982b733],
29	,	,	O	,	_	0	SENT_6	[p1l818t695r982b733],
30	*	NNP	O	*	nn	32	SENT_6	[p1l818t695r982b733],
31	Peter	NNP	PERSON	Peter	nn	32	SENT_6	[p1l998t696r1085b726],
32	Ruygrok	NNP	PERSON	Ruygrok	appos	2	SENT_6	[p1l1101t696r1251b737],
33	,	,	O	,	_	0	SENT_6	[p1l1101t696r1251b737],
34	FRACP	NNP	O	FRACP	appos	2	SENT_6	[p1l1268t695r1432b733],
35	,	,	O	,	_	0	SENT_6	[p1l1268t695r1432b733],
36	*	CD	NUMBER	*	num	38	SENT_6	[p1l1268t695r1432b733],
37	John	NNP	PERSON	John	nn	38	SENT_6	[p1l191t753r273b793],
38	Ormiston	NNP	PERSON	Ormiston	appos	2	SENT_6	[p1l289t753r460b791],
39	,	,	O	,	_	0	SENT_6	[p1l289t753r460b791],
40	FRACP	NNP	O	FRACP	appos	2	SENT_6	[p1l477t752r641b791],
41	,	,	O	,	_	0	SENT_6	[p1l477t752r641b791],
42	*	NNP	O	*	nn	44	SENT_6	[p1l477t752r641b791],
43	Seif	NNP	O	Seif	nn	44	SENT_6	[p1l658t753r725b784],
44	El	NNP	O	El	appos	2	SENT_6	[p1l735t753r868b793],
45	—	CD	NUMBER	—	dep	47	SENT_6	[p1l735t753r868b793],
46	]	CD	NUMBER	]	num	47	SENT_6	[p1l735t753r868b793],
47	ack	NN	O	ack	_	0	SENT_6	[p1l735t753r868b793],
48	,	,	O	,	_	0	SENT_6	[p1l735t753r868b793],
49	FRACP	NN	LOCATION	fracp	appos	47	SENT_6	[p1l885t752r1049b791],
50	,	,	O	,	_	0	SENT_6	[p1l885t752r1049b791],
51	*	CD	NUMBER	*	num	53	SENT_6	[p1l885t752r1049b791],
52	Guy	NNP	PERSON	Guy	nn	53	SENT_6	[p1l1065t753r1138b795],
53	Armstrong	NNP	PERSON	Armstrong	appos	47	SENT_6	[p1l1150t752r1343b795],
54	,	,	O	,	_	0	SENT_6	[p1l1150t752r1343b795],
55	FRACP	NNP	O	FRACP	appos	47	SENT_6	[p1l1360t752r1524b791],
56	,	,	O	,	_	0	SENT_6	[p1l1360t752r1524b791],
57	*	NNP	O	*	nn	59	SENT_6	[p1l1360t752r1524b791],
58	Patrick	NNP	PERSON	Patrick	nn	59	SENT_6	[p1l195t812r315b843],
59	Kay	NNP	PERSON	Kay	appos	47	SENT_6	[p1l330t812r402b854],
60	,	,	O	,	_	0	SENT_6	[p1l330t812r402b854],
61	FRACP	NNP	LOCATION	FRACP	appos	47	SENT_6	[p1l419t811r583b850],
62	,	,	O	,	_	0	SENT_6	[p1l419t811r583b850],
63	*	NNP	O	*	nn	65	SENT_6	[p1l419t811r583b850],
64	Douglas	NNP	PERSON	Douglas	nn	65	SENT_6	[p1l598t812r735b854],
65	Scott	NNP	PERSON	Scott	appos	47	SENT_6	[p1l753t812r846b850],
66	,	,	O	,	_	0	SENT_6	[p1l753t812r846b850],
67	FRACP	NNP	O	FRACP	appos	47	SENT_6	[p1l863t811r1027b850],
68	,	,	O	,	_	0	SENT_6	[p1l863t811r1027b850],
69	*	CD	NUMBER	*	num	72	SENT_6	[p1l863t811r1027b850],
70	Arzu	NNP	PERSON	Arzu	nn	72	SENT_6	[p1l1041t811r1125b843],
71	Gunes	NNP	PERSON	Gunes	nn	72	SENT_6	[p1l1141t812r1248b843],
72	MD	NNP	O	MD	appos	47	SENT_6	[p1l1263t812r1347b850],
73	,	,	O	,	_	0	SENT_6	[p1l1263t812r1347b850],
74	PHD	NNP	O	PHD	appos	47	SENT_6	[p1l1364t812r1477b850],
75	,	,	O	,	_	0	SENT_6	[p1l1364t812r1477b850],
76	l'	NNP	O	l'	nn	78	SENT_6	[p1l1364t812r1477b850],
77	Marja-Liisa	NNP	PERSON	Marja-Liisa	nn	78	SENT_6	[p1l194t870r394b912],
78	Dahl	NNP	PERSON	Dahl	appos	47	SENT_6	[p1l409t870r502b908],
79	,	,	O	,	_	0	SENT_6	[p1l409t870r502b908],
80	MD	NNP	O	MD	appos	78	SENT_6	[p1l518t870r601b908],
81	,	,	O	,	_	0	SENT_6	[p1l518t870r601b908],
82	PHDT	NNP	O	PHDT	nn	83	SENT_6	[p1l618t870r721b907],
83	ﬂuckland	NN	O	ﬂuckland	appos	78	SENT_6	[p1l191t955r348b989],
84	,	,	O	,	_	0	SENT_6	[p1l191t955r348b989],
85	New	NNP	LOCATION	New	nn	86	SENT_6	[p1l365t955r442b984],
86	Zealand	NNP	LOCATION	Zealand	appos	83	SENT_6	[p1l459t955r598b989],
87	;	:	O	;	_	0	SENT_6	[p1l459t955r598b989],
88	and	CC	O	and	_	0	SENT_6	[p1l614t955r677b984],
89	Uppsala	NNP	LOCATION	Uppsala	appos	47	SENT_6	[p1l692t955r823b996],
90	,	,	O	,	_	0	SENT_6	[p1l692t955r823b996],
91	Sweden	NNP	LOCATION	Sweden	appos	47	SENT_6	[p1l843t955r962b984],

1	Objectives	NNS	O	objective	nsubj	4	SENT_7	[p1l195t1099r369b1133],
2	This	DT	O	this	det	3	SENT_7	[p1l389t1098r451b1126],
3	study	NN	O	study	dep	1	SENT_7	[p1l466t1098r551b1134],
4	assessed	VBD	O	assess	_	0	SENT_7	[p1l565t1098r698b1126],
5	the	DT	O	the	det	6	SENT_7	[p1l713t1098r763b1126],
6	effect	NN	O	effect	dobj	4	SENT_7	[p1l778t1098r865b1126],
7	of	IN	O	of	_	0	SENT_7	[p1l880t1098r911b1126],
8	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	6	SENT_7	[p1l925t1098r1212b1134],
9	on	IN	O	on	_	0	SENT_7	[p1l1228t1107r1265b1126],
10	the	DT	O	the	det	12	SENT_7	[p1l1281t1098r1331b1126],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_7	[p1l1346t1098r1523b1133],
12	effect	NN	O	effect	prep_on	4	SENT_7	[p1l1538t1098r1625b1126],
13	of	IN	O	of	_	0	SENT_7	[p1l1639t1098r1671b1126],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_7	[p1l195t1148r380b1183],
15	.	.	O	.	_	0	SENT_7	[p1l195t1148r380b1183],

1	Background	NN	O	background	nn	2	SENT_8	[p1l197t1236r393b1270],
2	Variability	NN	O	variability	nsubjpass	8	SENT_8	[p1l414t1235r570b1271],
3	in	IN	O	in	_	0	SENT_8	[p1l585t1237r609b1263],
4	clopidogrel	NN	O	clopidogrel	nn	5	SENT_8	[p1l626t1235r801b1271],
5	response	NN	O	response	prep_in	2	SENT_8	[p1l818t1244r957b1270],
6	might	MD	O	might	aux	8	SENT_8	[p1l973t1235r1064b1271],
7	be	VB	O	be	auxpass	8	SENT_8	[p1l1080t1235r1116b1263],
8	inﬂuenced	VBN	O	inﬂuenced	dep	18	SENT_8	[p1l1132t1235r1294b1263],
9	by	IN	O	by	_	0	SENT_8	[p1l1311t1235r1347b1271],
10	polymorphisms	NNS	O	polymorphism	agent	8	SENT_8	[p1l1363t1235r1603b1271],
11	in	IN	O	in	_	0	SENT_8	[p1l1619t1237r1644b1263],
12	genes	NNS	O	gene	prep_in	10	SENT_8	[p1l1660t1244r1752b1271],
13	coding	VBG	O	code	partmod	12	SENT_8	[p1l195t1285r301b1321],
14	for	IN	O	for	_	0	SENT_8	[p1l316t1285r359b1313],
15	drug	NN	O	drug	nn	17	SENT_8	[p1l373t1285r445b1321],
16	metabolism	NN	O	metabolism	nn	17	SENT_8	[p1l462t1285r643b1313],
17	enzymes	NNS	O	enzyme	prep_for	13	SENT_8	[p1l660t1294r795b1321],
18	(	VBP	O	(	_	0	SENT_8	[p1l811t1285r1006b1321],
19	cytochrome	NN	O	cytochrome	nn	20	SENT_8	[p1l811t1285r1006b1321],
20	P450	NN	O	p450	dobj	18	SENT_8	[p1l1023t1287r1097b1313],
21	[	CD	NUMBER	[	num	20	SENT_8	[p1l1113t1286r1191b1317],
22	CYP	NN	O	cyp	nn	25	SENT_8	[p1l1113t1286r1191b1317],
23	]	NN	O	]	nn	25	SENT_8	[p1l1113t1286r1191b1317],
24	family	NN	O	family	nn	25	SENT_8	[p1l1206t1285r1319b1321],
25	)	NN	O	)	nsubj	18	SENT_8	[p1l1206t1285r1319b1321],
26	,	,	O	,	_	0	SENT_8	[p1l1206t1285r1319b1321],
27	transport	NN	O	transport	nn	28	SENT_8	[p1l1333t1290r1477b1320],
28	proteins	NNS	O	protein	appos	25	SENT_8	[p1l1492t1287r1619b1320],
29	(	VBP	O	(	rcmod	28	SENT_8	[p1l1635t1286r1673b1318, p1l195t1335r402b1371],
30	Pglycoprotein	NN	O	pglycoprotein	nsubj	34	SENT_8	[p1l1635t1286r1673b1318, p1l195t1335r402b1371],
31	)	CD	NUMBER	)	num	34	SENT_8	[p1l1635t1286r1673b1318, p1l195t1335r402b1371],
32	and/or	NN	O	and/or	nn	34	SENT_8	[p1l418t1335r522b1364],
33	target	NN	O	target	nn	34	SENT_8	[p1l536t1340r630b1371],
34	proteins	NNS	O	protein	xcomp	29	SENT_8	[p1l645t1337r771b1370],
35	for	IN	O	for	_	0	SENT_8	[p1l785t1335r828b1363],
36	the	DT	O	the	det	44	SENT_8	[p1l842t1335r892b1363],
37	drug	NN	O	drug	nn	44	SENT_8	[p1l907t1335r979b1371],
38	(	NN	O	(	nn	44	SENT_8	[p1l996t1335r1166b1368],
39	adenosine	NN	O	adenosine	nn	44	SENT_8	[p1l996t1335r1166b1368],
40	diphosphate	NN	O	diphosphate	nn	44	SENT_8	[p1l1180t1335r1530b1370],
41	—	NN	O	—	nn	44	SENT_8	[p1l1180t1335r1530b1370],
42	receptor	NN	O	receptor	nn	44	SENT_8	[p1l1180t1335r1530b1370],
43	P2Y12	NN	O	p2y12	nn	44	SENT_8	[p1l1545t1336r1658b1368],
44	)	NN	O	)	prep_for	34	SENT_8	[p1l1545t1336r1658b1368],
45	.	.	O	.	_	0	SENT_8	[p1l1545t1336r1658b1368],

1	Methods	NNS	O	method	_	0	SENT_9	[p1l196t1424r340b1450],
2	Sixty	CD	NUMBER	sixty	num	3	SENT_9	[p1l361t1424r434b1458],
3	patients	NNS	O	patient	dep	1	SENT_9	[p1l449t1424r573b1457],
4	undergoing	VBG	O	undergo	partmod	1	SENT_9	[p1l590t1423r770b1458],
5	elective	JJ	O	elective	amod	8	SENT_9	[p1l787t1423r905b1450],
6	percutaneous	JJ	O	percutaneous	amod	8	SENT_9	[p1l921t1427r1134b1457],
7	coronary	JJ	O	coronary	amod	8	SENT_9	[p1l1149t1431r1286b1458],
8	intervention	NN	O	intervention	dobj	4	SENT_9	[p1l1301t1424r1490b1450],
9	in	IN	O	in	_	0	SENT_9	[p1l1507t1424r1532b1450],
10	the	DT	O	the	det	47	SENT_9	[p1l1547t1423r1598b1450],
11	randomized	VBN	O	randomize	dep	47	SENT_9	[p1l1614t1423r1798b1450],
12	PRINC	NNP	O	PRINC	dobj	11	SENT_9	[p1l197t1472r288b1499],
13	(	CD	NUMBER	(	num	15	SENT_9	[p1l304t1471r403b1503],
14	Plavix	NNP	O	Plavix	nn	15	SENT_9	[p1l304t1471r403b1503],
15	Response	NN	O	response	nsubj	21	SENT_9	[p1l419t1473r565b1506],
16	in	IN	O	in	_	0	SENT_9	[p1l581t1473r606b1499],
17	Coronary	JJ	O	coronary	amod	20	SENT_9	[p1l622t1472r765b1507],
18	Intervention	NN	O	intervention	nn	20	SENT_9	[p1l780t1472r979b1503],
19	)	NN	O	)	nn	20	SENT_9	[p1l780t1472r979b1503],
20	trial	NN	O	trial	prep_in	15	SENT_9	[p1l995t1471r1052b1499],
21	had	VBD	O	have	rcmod	12	SENT_9	[p1l1070t1471r1125b1499],
22	platelet	NN	O	platelet	nn	23	SENT_9	[p1l1142t1471r1258b1506],
23	function	NN	O	function	dobj	21	SENT_9	[p1l1272t1471r1401b1499],
24	measured	VBN	O	measure	partmod	23	SENT_9	[p1l1418t1471r1569b1499],
25	using	VBG	O	use	xcomp	24	SENT_9	[p1l1587t1473r1668b1507],
26	the	DT	O	the	det	29	SENT_9	[p1l1683t1471r1734b1499],
27	VerifyNow	NNP	O	VerifyNow	nn	29	SENT_9	[p1l1747t1473r1819b1499, p1l195t1520r295b1556],
28	P2Y12	NN	O	p2y12	nn	29	SENT_9	[p1l311t1522r404b1548],
29	analyzer	NN	O	analyzer	dobj	25	SENT_9	[p1l420t1520r549b1556],
30	after	IN	O	after	_	0	SENT_9	[p1l563t1520r634b1548],
31	a	DT	O	a	det	37	SENT_9	[p1l648t1529r662b1548],
32	600-mg	JJ	O	600-mg	amod	37	SENT_9	[p1l678t1522r796b1556],
33	or	CC	O	or	_	0	SENT_9	[p1l812t1529r844b1548],
34	split	JJ	O	split	conj_or	32	SENT_9	[p1l858t1520r922b1555],
35	1,200-mg	JJ	O	1,200-mg	amod	37	SENT_9	[p1l939t1522r1081b1556],
36	loading	NN	O	loading	nn	37	SENT_9	[p1l1099t1520r1213b1556],
37	dose	NN	O	dose	prep_after	25	SENT_9	[p1l1229t1520r1302b1548],
38	and	CC	O	and	_	0	SENT_9	[p1l1317t1520r1373b1548],
39	after	IN	O	after	conj_and	11	SENT_9	[p1l1389t1520r1460b1548],
40	a	DT	O	a	det	41	SENT_9	[p1l1474t1529r1489b1548],
41	75	CD	NUMBER	75	pobj	39	SENT_9	[p1l1506t1523r1553b1548],
42	-	:	O	-	_	0	SENT_9	[p1l1506t1523r1553b1548],
43	or	CC	O	or	_	0	SENT_9	[p1l1567t1529r1599b1548],
44	150-mg	JJ	O	150-mg	amod	46	SENT_9	[p1l1615t1522r1731b1556],
45	daily	JJ	SET	daily	amod	46	SENT_9	[p1l1747t1520r1820b1556],
46	maintenance	NN	O	maintenance	conj_or	41	SENT_9	[p1l197t1571r398b1597],
47	dosage	NN	O	dosage	prep_in	8	SENT_9	[p1l413t1570r533b1605],
48	.	.	O	.	_	0	SENT_9	[p1l413t1570r533b1605],

1	Polymerase	NN	MISC	polymerase	nn	4	SENT_10	[p1l549t1570r727b1605],
2	chain	NN	O	chain	nn	4	SENT_10	[p1l742t1570r823b1597],
3	reaction	NN	O	reaction	nn	4	SENT_10	[p1l841t1571r984b1597],
4	—	NN	O	—	nsubj	7	SENT_10	[p1l841t1571r984b1597],
5	based	VBN	O	base	partmod	4	SENT_10	[p1l992t1570r1082b1597],
6	genotyping	VBG	O	genotype	xcomp	5	SENT_10	[p1l1098t1571r1277b1605],
7	evaluated	VBN	O	evaluate	_	0	SENT_10	[p1l1293t1570r1445b1597],
8	polymorphisms	NNS	O	polymorphism	dobj	7	SENT_10	[p1l1462t1570r1703b1605],
9	in	IN	O	in	_	0	SENT_10	[p1l1719t1571r1744b1597],
10	the	DT	O	the	det	21	SENT_10	[p1l1759t1570r1809b1597],
11	CYP2C19	NN	O	cyp2c19	nn	21	SENT_10	[p1l196t1620r336b1651],
12	,	,	O	,	_	0	SENT_10	[p1l196t1620r336b1651],
13	CYPZC9	NN	O	cypzc9	dep	21	SENT_10	[p1l351t1620r473b1651],
14	,	,	O	,	_	0	SENT_10	[p1l351t1620r473b1651],
15	CYP3A4	NN	O	cyp3a4	dep	21	SENT_10	[p1l489t1620r610b1651],
16	,	,	O	,	_	0	SENT_10	[p1l489t1620r610b1651],
17	CYP3A5	NN	O	cyp3a5	dep	21	SENT_10	[p1l626t1620r749b1651],
18	,	,	O	,	_	0	SENT_10	[p1l626t1620r749b1651],
19	ABCB1	NN	O	abcb1	dep	21	SENT_10	[p1l762t1620r868b1651],
20	,	,	O	,	_	0	SENT_10	[p1l762t1620r868b1651],
21	P2Y72	NN	O	p2y72	prep_in	8	SENT_10	[p1l883t1620r982b1651],
22	,	,	O	,	_	0	SENT_10	[p1l883t1620r982b1651],
23	and	CC	O	and	_	0	SENT_10	[p1l998t1619r1054b1647],
24	CES	NN	O	ce	nn	25	SENT_10	[p1l1071t1620r1125b1647],
25	genes	NNS	O	gene	prep_in	8	SENT_10	[p1l1139t1627r1238b1654],
26	.	.	O	.	_	0	SENT_10	[p1l1139t1627r1238b1654],

1	Results	NNS	O	result	nn	2	SENT_11	[p1l197t1707r320b1734],
2	CYP2C79	NNS	O	cyp2c79	nsubj	3	SENT_11	[p1l341t1707r540b1734],
3	*	VBP	O	*	dep	66	SENT_11	[p1l341t1707r540b1734],
4	1	CD	NUMBER	1	num	7	SENT_11	[p1l341t1707r540b1734],
5	*	CD	NUMBER	*	num	7	SENT_11	[p1l341t1707r540b1734],
6	1	CD	NUMBER	1	num	7	SENT_11	[p1l341t1707r540b1734],
7	carriers	NNS	O	carrier	dobj	3	SENT_11	[p1l558t1708r669b1734],
8	had	VBD	O	have	rcmod	7	SENT_11	[p1l686t1706r741b1734],
9	greater	JJR	O	greater	amod	11	SENT_11	[p1l757t1711r869b1741],
10	platelet	NN	O	platelet	nn	11	SENT_11	[p1l884t1706r1000b1741],
11	inhibition	NN	O	inhibition	dobj	8	SENT_11	[p1l1016t1706r1163b1734],
12	2	CD	NUMBER	2	number	13	SENT_11	[p1l1179t1708r1195b1733],
13	h	NN	O	h	amod	11	SENT_11	[p1l1212t1706r1228b1733],
14	after	IN	O	after	_	0	SENT_11	[p1l1244t1706r1315b1734],
15	a	DT	O	a	det	21	SENT_11	[p1l1329t1714r1344b1734],
16	600	CD	NUMBER	600	number	17	SENT_11	[p1l1360t1708r1478b1741],
17	—	CD	NUMBER	—	num	21	SENT_11	[p1l1360t1708r1478b1741],
18	mg	NN	O	mg	nn	21	SENT_11	[p1l1360t1708r1478b1741],
19	dose	NN	O	dose	nn	21	SENT_11	[p1l1494t1706r1567b1734],
20	(	NN	O	(	nn	21	SENT_11	[p1l1583t1706r1716b1738],
21	median	NN	O	median	prep_after	8	SENT_11	[p1l1583t1706r1716b1738],
22	:	:	O	:	_	0	SENT_11	[p1l1583t1706r1716b1738],
23	23	CD	PERCENT	23	num	24	SENT_11	[p1l1731t1708r1805b1738],
24	%	NN	PERCENT	%	dep	21	SENT_11	[p1l1731t1708r1805b1738],
25	,	,	O	,	_	0	SENT_11	[p1l1731t1708r1805b1738],
26	range	NN	O	range	appos	24	SENT_11	[p1l197t1763r292b1790],
27	:	:	O	:	_	0	SENT_11	[p1l197t1763r292b1790],
28	o	NN	PERCENT	o	nn	29	SENT_11	[p1l307t1757r353b1783],
29	%	NN	PERCENT	%	dep	24	SENT_11	[p1l307t1757r353b1783],
30	to	TO	O	to	_	0	SENT_11	[p1l367t1759r399b1783],
31	66	CD	PERCENT	66	num	32	SENT_11	[p1l413t1755r498b1787],
32	%	NN	PERCENT	%	prep_to	29	SENT_11	[p1l413t1755r498b1787],
33	)	CD	NUMBER	)	advmod	8	SENT_11	[p1l413t1755r498b1787],
34	,	,	O	,	_	0	SENT_11	[p1l413t1755r498b1787],
35	compared	VBN	O	compare	_	0	SENT_11	[p1l513t1755r669b1790],
36	with	IN	O	with	prepc_compared_with	8	SENT_11	[p1l685t1755r751b1783],
37	platelet	NN	O	platelet	nn	38	SENT_11	[p1l769t1755r885b1790],
38	inhibition	NN	O	inhibition	pobj	8	SENT_11	[p1l900t1755r1048b1783],
39	in	IN	O	in	_	0	SENT_11	[p1l1065t1756r1090b1782],
40	CYP2C19	NN	O	cyp2c19	nn	41	SENT_11	[p1l1106t1756r1273b1783],
41	*	NN	O	*	prep_in	38	SENT_11	[p1l1106t1756r1273b1783],
42	2	CD	NUMBER	2	number	45	SENT_11	[p1l1106t1756r1273b1783],
43	or	CC	O	or	_	0	SENT_11	[p1l1287t1763r1319b1783],
44	*	CD	NUMBER	*	num	46	SENT_11	[p1l1333t1756r1363b1782],
45	4	CD	NUMBER	4	num	46	SENT_11	[p1l1333t1756r1363b1782],
46	carriers	NNS	O	carrier	nsubj	47	SENT_11	[p1l1378t1756r1489b1783],
47	(	VBP	O	(	rcmod	41	SENT_11	[p1l1506t1755r1589b1787],
48	10	CD	PERCENT	10	num	49	SENT_11	[p1l1506t1755r1589b1787],
49	%	NN	PERCENT	%	dobj	47	SENT_11	[p1l1506t1755r1589b1787],
50	,	,	O	,	_	0	SENT_11	[p1l1506t1755r1589b1787],
51	o	NN	PERCENT	o	nn	52	SENT_11	[p1l1604t1757r1650b1783],
52	%	NN	PERCENT	%	appos	49	SENT_11	[p1l1604t1757r1650b1783],
53	to	TO	O	to	_	0	SENT_11	[p1l1664t1759r1696b1783],
54	56	CD	PERCENT	56	num	55	SENT_11	[p1l1711t1757r1784b1787],
55	%	NN	PERCENT	%	prep_to	52	SENT_11	[p1l1711t1757r1784b1787],
56	,	,	O	,	_	0	SENT_11	[p1l1711t1757r1784b1787],
57	p	NN	O	p	dobj	47	SENT_11	[p1l197t1812r214b1838],
58	=	JJ	O	=	amod	60	SENT_11	[p1l232t1814r255b1823],
59	0.029	CD	NUMBER	0.029	tmod	58	SENT_11	[p1l273t1804r365b1835],
60	)	NN	O	)	dep	57	SENT_11	[p1l273t1804r365b1835],
61	and	CC	O	and	_	0	SENT_11	[p1l381t1804r437b1831],
62	CYP2C19	NN	O	cyp2c19	dobj	47	SENT_11	[p1l454t1805r641b1831],
63	*	CD	NUMBER	*	number	64	SENT_11	[p1l454t1805r641b1831],
64	17	CD	NUMBER	17	num	65	SENT_11	[p1l454t1805r641b1831],
65	carriers	NNS	O	carrier	dep	62	SENT_11	[p1l654t1805r765b1831],
66	(	VBP	O	(	_	0	SENT_11	[p1l781t1804r845b1835],
67	9	CD	PERCENT	9	num	68	SENT_11	[p1l781t1804r845b1835],
68	%	NN	PERCENT	%	nsubj	66	SENT_11	[p1l781t1804r845b1835],
69	,	,	O	,	_	0	SENT_11	[p1l781t1804r845b1835],
70	o	NN	PERCENT	o	nn	71	SENT_11	[p1l860t1806r907b1831],
71	%	NN	PERCENT	%	appos	68	SENT_11	[p1l860t1806r907b1831],
72	to	TO	O	to	_	0	SENT_11	[p1l921t1808r952b1831],
73	98	CD	PERCENT	98	num	74	SENT_11	[p1l967t1806r1040b1835],
74	%	NN	PERCENT	%	prep_to	71	SENT_11	[p1l967t1806r1040b1835],
75	,	,	O	,	_	0	SENT_11	[p1l967t1806r1040b1835],
76	p	NN	O	p	appos	74	SENT_11	[p1l1057t1812r1074b1838],
77	=	JJ	O	=	amod	79	SENT_11	[p1l1092t1814r1115b1823],
78	0.026	CD	NUMBER	0.026	tmod	77	SENT_11	[p1l1133t1804r1233b1835],
79	)	NN	O	)	dep	76	SENT_11	[p1l1133t1804r1233b1835],
80	.	.	O	.	_	0	SENT_11	[p1l1133t1804r1233b1835],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_12	[p1l1249t1805r1416b1831],
2	*	NN	O	*	nsubj	8	SENT_12	[p1l1249t1805r1416b1831],
3	2	CD	NUMBER	2	dep	2	SENT_12	[p1l1249t1805r1416b1831],
4	or	CC	O	or	_	0	SENT_12	[p1l1430t1812r1462b1831],
5	*	CD	NUMBER	*	number	6	SENT_12	[p1l1476t1805r1506b1831],
6	4	CD	NUMBER	4	num	7	SENT_12	[p1l1476t1805r1506b1831],
7	carriers	NNS	O	carrier	nsubj	8	SENT_12	[p1l1521t1805r1632b1831],
8	had	VBD	O	have	_	0	SENT_12	[p1l1649t1804r1704b1831],
9	greater	JJR	O	greater	amod	11	SENT_12	[p1l196t1857r307b1888],
10	platelet	NN	O	platelet	nn	11	SENT_12	[p1l323t1853r439b1888],
11	inhibition	NN	O	inhibition	dobj	8	SENT_12	[p1l454t1853r602b1881],
12	with	IN	O	with	_	0	SENT_12	[p1l617t1853r684b1881],
13	the	DT	O	the	det	79	SENT_12	[p1l699t1853r750b1881],
14	higher	JJR	O	higher	amod	79	SENT_12	[p1l766t1853r865b1888],
15	loading	VBG	O	load	dep	14	SENT_12	[p1l881t1853r995b1888],
16	dose	NN	O	dose	dobj	15	SENT_12	[p1l1011t1853r1084b1881],
17	than	IN	O	than	dep	15	SENT_12	[p1l1098t1853r1167b1881],
18	with	IN	O	with	_	0	SENT_12	[p1l1183t1853r1249b1881],
19	the	DT	O	the	det	21	SENT_12	[p1l1265t1853r1315b1881],
20	lower	JJR	O	lower	amod	21	SENT_12	[p1l1331t1853r1417b1881],
21	dose	NN	O	dose	prep_with	15	SENT_12	[p1l1431t1853r1504b1881],
22	at	IN	O	at	_	0	SENT_12	[p1l1518t1857r1547b1881],
23	4	CD	NUMBER	4	num	24	SENT_12	[p1l1561t1855r1579b1880],
24	h	NN	O	h	prep_at	21	SENT_12	[p1l1594t1853r1610b1880],
25	(	CD	PERCENT	(	number	26	SENT_12	[p1l1628t1853r1711b1885],
26	37	CD	PERCENT	37	num	27	SENT_12	[p1l1628t1853r1711b1885],
27	%	NN	PERCENT	%	dep	24	SENT_12	[p1l1628t1853r1711b1885],
28	,	,	O	,	_	0	SENT_12	[p1l1628t1853r1711b1885],
29	8	CD	PERCENT	8	number	33	SENT_12	[p1l1726t1855r1772b1881],
30	%	NN	PERCENT	%	dep	33	SENT_12	[p1l1726t1855r1772b1881],
31	to	TO	O	to	dep	33	SENT_12	[p1l1786t1857r1818b1881],
32	87	CD	PERCENT	87	number	33	SENT_12	[p1l196t1904r261b1930],
33	%	NN	PERCENT	%	appos	24	SENT_12	[p1l196t1904r261b1930],
34	vs.	CC	O	vs.	prep	33	SENT_12	[p1l276t1910r314b1930],
35	14	CD	PERCENT	14	num	36	SENT_12	[p1l332t1904r403b1934],
36	%	NN	PERCENT	%	dep	34	SENT_12	[p1l332t1904r403b1934],
37	,	,	O	,	_	0	SENT_12	[p1l332t1904r403b1934],
38	o	NN	PERCENT	o	nn	39	SENT_12	[p1l418t1904r464b1930],
39	%	NN	PERCENT	%	appos	24	SENT_12	[p1l418t1904r464b1930],
40	to	TO	O	to	_	0	SENT_12	[p1l478t1906r510b1930],
41	22	CD	PERCENT	22	num	42	SENT_12	[p1l525t1904r598b1934],
42	%	NN	PERCENT	%	prep_to	39	SENT_12	[p1l525t1904r598b1934],
43	,	,	O	,	_	0	SENT_12	[p1l525t1904r598b1934],
44	p	NN	O	p	appos	24	SENT_12	[p1l614t1910r632b1937],
45	=	JJ	O	=	amod	47	SENT_12	[p1l650t1912r672b1921],
46	0.002	CD	NUMBER	0.002	num	47	SENT_12	[p1l690t1902r782b1934],
47	)	NN	O	)	dep	44	SENT_12	[p1l690t1902r782b1934],
48	and	CC	O	and	cc	47	SENT_12	[p1l798t1902r855b1930],
49	responded	VBD	O	respond	dep	15	SENT_12	[p1l872t1902r1037b1937],
50	better	JJR	O	better	dobj	49	SENT_12	[p1l1054t1902r1148b1930],
51	with	IN	O	with	_	0	SENT_12	[p1l1161t1902r1228b1930],
52	the	DT	O	the	det	56	SENT_12	[p1l1243t1902r1293b1930],
53	higher	JJR	O	higher	amod	56	SENT_12	[p1l1309t1902r1409b1937],
54	maintenance	NN	O	maintenance	nn	56	SENT_12	[p1l1424t1903r1626b1930],
55	dose	NN	O	dose	nn	56	SENT_12	[p1l1641t1902r1714b1930],
56	regimen	NN	O	regimen	prep_with	49	SENT_12	[p1l1730t1903r1799b1937, p1l197t1959r263b1979],
57	(	CD	PERCENT	(	num	59	SENT_12	[p1l280t1952r363b1983],
58	51	CD	PERCENT	51	num	59	SENT_12	[p1l280t1952r363b1983],
59	%	NN	PERCENT	%	nsubj	15	SENT_12	[p1l280t1952r363b1983],
60	,	,	O	,	_	0	SENT_12	[p1l280t1952r363b1983],
61	15	CD	PERCENT	15	number	65	SENT_12	[p1l381t1953r444b1979],
62	%	NN	PERCENT	%	dep	65	SENT_12	[p1l381t1953r444b1979],
63	to	TO	O	to	dep	65	SENT_12	[p1l458t1956r489b1979],
64	86	CD	PERCENT	86	number	65	SENT_12	[p1l504t1953r570b1979],
65	%	NN	PERCENT	%	appos	59	SENT_12	[p1l504t1953r570b1979],
66	vs.	CC	O	vs.	prep	65	SENT_12	[p1l584t1959r623b1979],
67	14	CD	PERCENT	14	num	68	SENT_12	[p1l641t1953r711b1983],
68	%	NN	PERCENT	%	dep	66	SENT_12	[p1l641t1953r711b1983],
69	,	,	O	,	_	0	SENT_12	[p1l641t1953r711b1983],
70	o	NN	PERCENT	o	nn	71	SENT_12	[p1l726t1953r773b1979],
71	%	NN	PERCENT	%	appos	68	SENT_12	[p1l726t1953r773b1979],
72	to	TO	O	to	_	0	SENT_12	[p1l787t1956r818b1979],
73	67	CD	PERCENT	67	num	74	SENT_12	[p1l833t1953r907b1983],
74	%	NN	PERCENT	%	prep_to	71	SENT_12	[p1l833t1953r907b1983],
75	,	,	O	,	_	0	SENT_12	[p1l833t1953r907b1983],
76	p	NN	O	p	dep	77	SENT_12	[p1l923t1959r940b1986],
77	=	JJ	O	=	dep	14	SENT_12	[p1l958t1962r981b1971],
78	0.042	CD	NUMBER	0.042	num	79	SENT_12	[p1l999t1952r1100b1983],
79	)	NN	O	)	prep_with	11	SENT_12	[p1l999t1952r1100b1983],
80	.	.	O	.	_	0	SENT_12	[p1l999t1952r1100b1983],

1	Conclusions	NNS	O	conclusion	nn	2	SENT_13	[p1l195t2040r396b2067],
2	Carriers	NNS	O	carrier	nsubj	12	SENT_13	[p1l417t2040r534b2067],
3	of	IN	O	of	_	0	SENT_13	[p1l549t2039r581b2067],
4	the	DT	O	the	det	6	SENT_13	[p1l592t2039r643b2067],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_13	[p1l658t2040r825b2067],
6	*	NN	O	*	prep_of	2	SENT_13	[p1l658t2040r825b2067],
7	2	CD	NUMBER	2	dep	6	SENT_13	[p1l658t2040r825b2067],
8	and	CC	O	and	_	0	SENT_13	[p1l839t2039r896b2067],
9	*	CD	NUMBER	*	number	10	SENT_13	[p1l913t2040r944b2067],
10	4	CD	NUMBER	4	num	11	SENT_13	[p1l913t2040r944b2067],
11	alleles	NNS	O	allele	prep_of	2	SENT_13	[p1l958t2039r1053b2067],
12	showed	VBD	O	show	_	0	SENT_13	[p1l1068t2039r1188b2067],
13	reduced	VBN	O	reduce	amod	15	SENT_13	[p1l1205t2039r1330b2067],
14	platelet	NN	O	platelet	nn	15	SENT_13	[p1l1347t2039r1464b2074],
15	inhibition	NN	O	inhibition	dobj	12	SENT_13	[p1l1479t2039r1626b2067],
16	after	IN	O	after	mark	25	SENT_13	[p1l1642t2039r1714b2067],
17	a	DT	O	a	det	23	SENT_13	[p1l1727t2047r1742b2067],
18	clopidogrel	NN	O	clopidogrel	nn	23	SENT_13	[p1l1758t2039r1814b2067, p1l197t2089r324b2124],
19	600	CD	NUMBER	600	num	23	SENT_13	[p1l341t2091r459b2124],
20	—	CD	NUMBER	—	num	23	SENT_13	[p1l341t2091r459b2124],
21	mg	NN	O	mg	nn	23	SENT_13	[p1l341t2091r459b2124],
22	loading	NN	O	loading	nn	23	SENT_13	[p1l476t2089r590b2124],
23	dose	NN	O	dose	nsubj	25	SENT_13	[p1l606t2089r679b2117],
24	but	CC	O	but	cc	25	SENT_13	[p1l695t2089r747b2117],
25	responded	VBD	O	respond	dep	15	SENT_13	[p1l762t2089r927b2124],
26	to	TO	O	to	_	0	SENT_13	[p1l943t2093r974b2117],
27	higher	JJR	O	higher	amod	28	SENT_13	[p1l990t2089r1090b2124],
28	loading	NN	O	loading	prep_to	25	SENT_13	[p1l1105t2089r1219b2124],
29	and	CC	O	and	_	0	SENT_13	[p1l1235t2089r1292b2117],
30	maintenance	NN	O	maintenance	nn	32	SENT_13	[p1l1309t2090r1511b2117],
31	dose	NN	O	dose	nn	32	SENT_13	[p1l1526t2089r1599b2117],
32	regimens	NNS	O	regimen	conj_and	28	SENT_13	[p1l1615t2090r1766b2124],
33	.	.	O	.	_	0	SENT_13	[p1l1615t2090r1766b2124],

1	Genotyping	VBG	O	genotype	csubj	8	SENT_14	[p1l195t2139r378b2174],
2	for	IN	O	for	_	0	SENT_14	[p1l394t2138r437b2166],
3	the	DT	O	the	det	6	SENT_14	[p1l450t2138r500b2166],
4	relevant	JJ	O	relevant	amod	6	SENT_14	[p1l516t2138r641b2166],
5	gene	NN	O	gene	nn	6	SENT_14	[p1l656t2146r733b2174],
6	polymorphisms	NNS	O	polymorphism	prep_for	1	SENT_14	[p1l749t2138r989b2174],
7	may	MD	O	may	aux	8	SENT_14	[p1l1006t2146r1070b2174],
8	help	VB	O	help	_	0	SENT_14	[p1l1085t2138r1151b2173],
9	to	TO	O	to	aux	10	SENT_14	[p1l1166t2143r1197b2166],
10	individualize	VB	O	individualize	xcomp	8	SENT_14	[p1l1213t2138r1408b2166],
11	and	CC	O	and	_	0	SENT_14	[p1l1423t2138r1479b2166],
12	optimize	VB	O	optimize	conj_and	10	SENT_14	[p1l1495t2140r1631b2173],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_14	[p1l1646t2138r1732b2173, p1l196t2188r294b2223],
14	treatment	NN	O	treatment	dobj	10	SENT_14	[p1l310t2192r473b2215],
15	.	.	O	.	_	0	SENT_14	[p1l310t2192r473b2215],

1	(	NNP	O	(	nn	7	SENT_15	[p1l489t2188r632b2219],
2	Australia	NNP	LOCATION	Australia	nn	7	SENT_15	[p1l489t2188r632b2219],
3	New	NNP	LOCATION	New	nn	7	SENT_15	[p1l650t2189r717b2215],
4	Zealand	NNP	LOCATION	Zealand	nn	7	SENT_15	[p1l731t2188r855b2215],
5	Clinical	JJ	O	clinical	amod	7	SENT_15	[p1l871t2188r980b2215],
6	Trials	NNS	O	trial	nn	7	SENT_15	[p1l994t2188r1075b2215],
7	Registry	NN	O	registry	_	0	SENT_15	[p1l1091t2189r1221b2223],
8	;	:	O	;	_	0	SENT_15	[p1l1091t2189r1221b2223],
9	ACTRN12606000129583	NN	O	actrn12606000129583	dep	7	SENT_15	[p1l1235t2188r1621b2219],
10	)	CD	NUMBER	)	number	11	SENT_15	[p1l1235t2188r1621b2219],
11	(	CD	NUMBER	(	dep	9	SENT_15	[p1l1665t2188r1685b2219],
12	J	NNP	O	J	nn	15	SENT_15	[p1l1665t2188r1685b2219],
13	Am	NNP	O	Am	nn	15	SENT_15	[p1l1700t2189r1751b2215],
14	Coll	NNP	PERSON	Coll	nn	15	SENT_15	[p1l195t2236r252b2264],
15	Cardiol	NNP	PERSON	Cardiol	dep	24	SENT_15	[p1l268t2236r376b2264],
16	lntv	NN	O	lntv	dep	15	SENT_15	[p1l393t2238r451b2264],
17	2008	CD	DATE	2008	num	16	SENT_15	[p1l465t2237r684b2268],
18	;	:	O	;	_	0	SENT_15	[p1l465t2237r684b2268],
19	1:620	CD	NUMBER	1:620	num	20	SENT_15	[p1l465t2237r684b2268],
20	—	NN	O	—	dep	16	SENT_15	[p1l465t2237r684b2268],
21	7	CD	NUMBER	7	num	22	SENT_15	[p1l465t2237r684b2268],
22	)	NN	O	)	dep	24	SENT_15	[p1l465t2237r684b2268],
23	©	CD	NUMBER	©	num	24	SENT_15	[p1l700t2239r723b2263],
24	2008	CD	DATE	2008	dep	7	SENT_15	[p1l738t2238r812b2264],
25	by	IN	O	by	_	0	SENT_15	[p1l828t2236r865b2272],
26	the	DT	O	the	det	28	SENT_15	[p1l878t2236r928b2264],
27	American	NNP	ORGANIZATION	American	nn	28	SENT_15	[p1l943t2238r1089b2264],
28	College	NNP	ORGANIZATION	College	prep_by	24	SENT_15	[p1l1105t2236r1222b2272],
29	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l1236t2236r1268b2264],
30	Cardiology	NNP	ORGANIZATION	Cardiology	nn	31	SENT_15	[p1l1280t2236r1450b2272],
31	Foundation	NNP	ORGANIZATION	Foundation	prep_of	28	SENT_15	[p1l1465t2236r1642b2264],

1	From	IN	O	from	dep	10	SENT_16	[p1l195t2391r259b2412],
2	*	NNP	O	*	nn	6	SENT_16	[p1l273t2391r356b2412],
3	Green	NNP	ORGANIZATION	Green	nn	6	SENT_16	[p1l273t2391r356b2412],
4	Lane	NNP	ORGANIZATION	Lane	nn	6	SENT_16	[p1l370t2391r428b2412],
5	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	6	SENT_16	[p1l442t2390r615b2412],
6	Service	NNP	ORGANIZATION	Service	pobj	1	SENT_16	[p1l629t2390r717b2417],
7	,	,	O	,	_	0	SENT_16	[p1l629t2390r717b2417],
8	Auckland	NNP	LOCATION	Auckland	nn	10	SENT_16	[p1l730t2390r844b2412],
9	City	NNP	LOCATION	City	nn	10	SENT_16	[p1l858t2391r909b2420],
10	Hospital	NNP	LOCATION	Hospital	_	0	SENT_16	[p1l922t2391r1029b2420],
11	,	,	O	,	_	0	SENT_16	[p1l922t2391r1029b2420],
12	Auckland	NNP	LOCATION	Auckland	conj_and	10	SENT_16	[p1l1043t2390r1163b2417],
13	,	,	O	,	_	0	SENT_16	[p1l1043t2390r1163b2417],
14	New	NNP	LOCATION	New	nn	15	SENT_16	[p1l1177t2391r1233b2412],
15	Zealand	NNP	LOCATION	Zealand	conj_and	10	SENT_16	[p1l1246t2391r1347b2417],
16	;	:	O	;	_	0	SENT_16	[p1l1246t2391r1347b2417],
17	and	CC	O	and	_	0	SENT_16	[p1l1362t2391r1404b2412],
18	‘	JJ	O	‘	amod	19	SENT_16	[p1l1417t2391r1575b2420],
19	l‘Depa	NN	O	l‘depa	conj_and	10	SENT_16	[p1l1417t2391r1575b2420],
20	.	.	O	.	_	0	SENT_16	[p1l1417t2391r1575b2420],

1	rtment	NN	O	rtment	_	0	SENT_17	[p1l1417t2391r1575b2420],
2	of	IN	O	of	_	0	SENT_17	[p1l1588t2391r1615b2412],
3	Medical	NNP	ORGANIZATION	Medical	nn	4	SENT_17	[p1l1624t2391r1720b2412],
4	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	1	SENT_17	[p1l196t2426r299b2453],
5	,	,	O	,	_	0	SENT_17	[p1l196t2426r299b2453],
6	Clinical	JJ	O	clinical	amod	7	SENT_17	[p1l316t2426r407b2448],
7	Pharmacology	NN	O	pharmacology	appos	1	SENT_17	[p1l423t2426r595b2456],
8	,	,	O	,	_	0	SENT_17	[p1l423t2426r595b2456],
9	Uppsala	NNP	ORGANIZATION	Uppsala	nn	10	SENT_17	[p1l611t2426r706b2456],
10	University	NNP	ORGANIZATION	University	appos	1	SENT_17	[p1l720t2426r847b2456],
11	,	,	O	,	_	0	SENT_17	[p1l720t2426r847b2456],
12	Uppsala	NNP	LOCATION	Uppsala	appos	1	SENT_17	[p1l863t2426r963b2456],
13	,	,	O	,	_	0	SENT_17	[p1l863t2426r963b2456],
14	Sweden	NNP	LOCATION	Sweden	appos	1	SENT_17	[p1l981t2426r1077b2448],
15	.	.	O	.	_	0	SENT_17	[p1l981t2426r1077b2448],

1	Funded	VBN	O	fund	_	0	SENT_18	[p1l1094t2426r1184b2448],
2	in	IN	O	in	_	0	SENT_18	[p1l1199t2427r1221b2448],
3	part	NN	O	part	prep_in	1	SENT_18	[p1l1237t2432r1283b2456],
4	by	IN	O	by	_	0	SENT_18	[p1l1298t2426r1326b2456],
5	the	DT	O	the	det	8	SENT_18	[p1l1341t2426r1377b2448],
6	Green	NNP	ORGANIZATION	Green	nn	8	SENT_18	[p1l1394t2426r1466b2448],
7	Lane	NNP	ORGANIZATION	Lane	nn	8	SENT_18	[p1l1482t2426r1540b2448],
8	Research	NNP	ORGANIZATION	Research	prep_by	3	SENT_18	[p1l1557t2426r1661b2448],
9	and	CC	ORGANIZATION	and	_	0	SENT_18	[p1l1677t2426r1719b2448],
10	Educational	NNP	ORGANIZATION	Educational	nn	11	SENT_18	[p1l195t2463r336b2484],
11	Fund	NNP	ORGANIZATION	Fund	conj_and	8	SENT_18	[p1l345t2463r408b2484],
12	and	CC	O	and	_	0	SENT_18	[p1l418t2463r460b2484],
13	National	NNP	ORGANIZATION	National	nn	15	SENT_18	[p1l469t2463r572b2484],
14	Heart	NNP	ORGANIZATION	Heart	nn	15	SENT_18	[p1l581t2463r650b2484],
15	Foundation	NNP	ORGANIZATION	Foundation	conj_and	3	SENT_18	[p1l659t2463r795b2484],
16	of	IN	O	of	_	0	SENT_18	[p1l805t2463r832b2484],
17	New	NNP	LOCATION	New	nn	18	SENT_18	[p1l838t2463r893b2484],
18	Zealand	NNP	LOCATION	Zealand	prep_of	15	SENT_18	[p1l903t2463r998b2484],
19	and	CC	O	and	_	0	SENT_18	[p1l1008t2463r1050b2484],
20	the	DT	O	the	det	23	SENT_18	[p1l1060t2463r1096b2484],
21	Swedish	NNP	ORGANIZATION	Swedish	nn	23	SENT_18	[p1l1107t2462r1203b2484],
22	Research	NNP	ORGANIZATION	Research	nn	23	SENT_18	[p1l1213t2463r1317b2484],
23	Council	NNP	ORGANIZATION	Council	conj_and	18	SENT_18	[p1l1328t2463r1426b2484],
24	.	.	O	.	_	0	SENT_18	[p1l1328t2463r1426b2484],

1	The	DT	O	the	det	5	SENT_19	[p1l1436t2462r1485b2484],
2	VerifyNow	NNP	O	VerifyNow	nn	5	SENT_19	[p1l1495t2463r1625b2492],
3	platelet	NN	O	platelet	nn	5	SENT_19	[p1l1634t2463r1720b2492],
4	function	NN	O	function	nn	5	SENT_19	[p1l195t2499r292b2520],
5	analyzer	NN	O	analyzer	nsubjpass	7	SENT_19	[p1l304t2499r398b2528],
6	was	VBD	O	be	auxpass	7	SENT_19	[p1l407t2507r450b2520],
7	provided	VBN	O	provide	_	0	SENT_19	[p1l461t2499r563b2528],
8	by	IN	O	by	_	0	SENT_19	[p1l573t2499r602b2528],
9	Sanoﬁ	NNP	PERSON	Sanoﬁ	nn	10	SENT_19	[p1l612t2499r685b2520],
10	Aventis	NNP	PERSON	Aventis	agent	7	SENT_19	[p1l695t2498r791b2525],
11	,	,	O	,	_	0	SENT_19	[p1l695t2498r791b2525],
12	New	NNP	LOCATION	New	nn	13	SENT_19	[p1l802t2499r858b2520],
13	Zealand	NNP	LOCATION	Zealand	appos	10	SENT_19	[p1l869t2499r969b2520],
14	.	.	O	.	_	0	SENT_19	[p1l869t2499r969b2520],

1	Medication	NN	MISC	medication	nn	2	SENT_20	[p1l981t2499r1116b2520],
2	packs	NNS	O	pack	nsubjpass	7	SENT_20	[p1l1126t2499r1190b2528],
3	and	CC	O	and	_	0	SENT_20	[p1l1202t2499r1243b2520],
4	placebo	NN	O	placebo	nn	5	SENT_20	[p1l1254t2499r1341b2528],
5	matching	NN	O	matching	conj_and	2	SENT_20	[p1l1353t2499r1463b2528],
6	were	VBD	O	be	auxpass	7	SENT_20	[p1l1472t2507r1526b2520],
7	supplied	VBN	O	supply	_	0	SENT_20	[p1l1538t2499r1635b2528],
8	by	IN	O	by	_	0	SENT_20	[p1l1645t2499r1673b2528],
9	the	DT	O	the	det	13	SENT_20	[p1l1683t2499r1719b2520],
10	Auckland	NNP	LOCATION	Auckland	nn	13	SENT_20	[p1l194t2534r308b2556],
11	City	NNP	LOCATION	City	nn	13	SENT_20	[p1l319t2535r370b2564],
12	Hospital	NNP	LOCATION	Hospital	nn	13	SENT_20	[p1l379t2535r481b2564],
13	Pharmacy	NNP	LOCATION	Pharmacy	agent	7	SENT_20	[p1l491t2535r613b2564],
14	,	,	O	,	_	0	SENT_20	[p1l491t2535r613b2564],
15	Clinical	JJ	O	clinical	amod	17	SENT_20	[p1l625t2534r716b2556],
16	Trials	NNS	O	trial	nn	17	SENT_20	[p1l725t2534r793b2556],
17	Unit	NN	O	unit	appos	13	SENT_20	[p1l804t2535r864b2556],
18	.	.	O	.	_	0	SENT_20	[p1l804t2535r864b2556],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_21	[p1l194t2570r330b2600],
2	received	VBD	O	receive	_	0	SENT_21	[p1l340t2570r434b2592],
3	May	NNP	DATE	May	tmod	2	SENT_21	[p1l444t2570r499b2600],
4	30	CD	DATE	30	num	3	SENT_21	[p1l509t2571r543b2597],
5	,	,	DATE	,	_	0	SENT_21	[p1l509t2571r543b2597],
6	2008	CD	DATE	2008	num	3	SENT_21	[p1l554t2571r618b2597],
7	;	:	O	;	_	0	SENT_21	[p1l554t2571r618b2597],
8	revised	VBN	O	revise	amod	9	SENT_21	[p1l630t2570r710b2592],
9	manuscript	NN	O	manuscript	nsubj	10	SENT_21	[p1l721t2571r851b2600],
10	received	VBD	O	receive	parataxis	2	SENT_21	[p1l861t2570r955b2592],
11	September	NNP	DATE	September	dobj	10	SENT_21	[p1l967t2570r1091b2600],
12	16	CD	DATE	16	num	11	SENT_21	[p1l1102t2571r1135b2597],
13	,	,	DATE	,	_	0	SENT_21	[p1l1102t2571r1135b2597],
14	2008	CD	DATE	2008	num	11	SENT_21	[p1l1147t2571r1211b2597],
15	,	,	O	,	_	0	SENT_21	[p1l1147t2571r1211b2597],
16	accepted	VBN	O	accept	partmod	11	SENT_21	[p1l1223t2570r1323b2600],
17	September	NNP	DATE	September	tmod	16	SENT_21	[p1l1334t2570r1458b2600],
18	29	CD	DATE	29	num	17	SENT_21	[p1l1468t2571r1503b2597],
19	,	,	DATE	,	_	0	SENT_21	[p1l1468t2571r1503b2597],
20	2008	CD	DATE	2008	num	17	SENT_21	[p1l1514t2571r1578b2593],
21	.	.	O	.	_	0	SENT_21	[p1l1514t2571r1578b2593],

1	JACC	NN	O	jacc	_	0	SENT_22	[p1l8t2760r158b2791],
2	:	:	O	:	_	0	SENT_22	[p1l8t2760r158b2791],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_22	[p1l195t2760r694b2791],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_22	[p1l731t2760r1190b2795],
5	,	,	O	,	_	0	SENT_22	[p1l731t2760r1190b2795],
6	VOL	NNP	O	VOL	appos	4	SENT_22	[p1l1226t2760r1348b2791],
7	.	.	O	.	_	0	SENT_22	[p1l1226t2760r1348b2791],

1	1	CD	NUMBER	1	_	0	SENT_23	[p1l1387t2761r1428b2796],
2	,	,	O	,	_	0	SENT_23	[p1l1387t2761r1428b2796],
3	NO.	NNP	O	NO.	appos	1	SENT_23	[p1l1467t2760r1557b2791],
4	6	CD	NUMBER	6	num	3	SENT_23	[p1l1593t2761r1637b2795],
5	,	,	O	,	_	0	SENT_23	[p1l1593t2761r1637b2795],
6	2008	CD	DATE	2008	num	3	SENT_23	[p1l1674t2761r1799b2791],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_23	[p1l11t2825r295b2856],
8	2008:620	CD	NUMBER	2008:620	num	7	SENT_23	[p1l332t2826r653b2856],
9	-7	CD	NUMBER	-7	dep	7	SENT_23	[p1l332t2826r653b2856],

1	Clopidogrel	NNP	O	Clopidogrel	nsubjpass	14	SENT_24	[p1l12t3018r454b3108],
2	,	,	O	,	_	0	SENT_24	[p1l12t3018r454b3108],
3	an	DT	O	a	det	8	SENT_24	[p1l504t3045r584b3084],
4	adenosine	NN	O	adenosine	nn	8	SENT_24	[p1l632t3018r980b3084],
5	diphosphate	NN	O	diphosphate	nn	8	SENT_24	[p1l1027t3018r1459b3108],
6	receptor	NN	O	receptor	nn	8	SENT_24	[p1l1505t3035r1795b3108],
7	(	NN	O	(	nn	8	SENT_24	[p1l1842t3016r2137b3099],
8	P2Y12	NN	O	p2y12	appos	1	SENT_24	[p1l1842t3016r2137b3099],
9	)	CD	NUMBER	)	num	10	SENT_24	[p1l1842t3016r2137b3099],
10	blocker	NN	O	blocker	dep	8	SENT_24	[p1l8t3126r287b3207],
11	,	,	O	,	_	0	SENT_24	[p1l8t3126r287b3207],
12	is	VBZ	O	be	auxpass	14	SENT_24	[p1l323t3129r373b3192],
13	clinically	RB	O	clinically	advmod	14	SENT_24	[p1l409t3126r721b3215],
14	used	VBN	O	use	_	0	SENT_24	[p1l749t3126r908b3192],
15	to	TO	O	to	aux	16	SENT_24	[p1l940t3143r1008b3192],
16	prevent	VB	O	prevent	xcomp	14	SENT_24	[p1l1041t3143r1306b3216],
17	thrombotic	JJ	O	thrombotic	amod	18	SENT_24	[p1l1338t3126r1735b3192],
18	events	NNS	O	event	nsubj	19	SENT_24	[p1l1768t3143r1984b3193],
19	*	VBP	O	*	ccomp	16	SENT_24	[p1l2021t3124r2136b3207],
20	OGj	NN	O	ogj	dobj	19	SENT_24	[p1l2021t3124r2136b3207],
21	+	CC	O	+	cc	23	SENT_24	[p1l2021t3124r2136b3207],
22	The	DT	O	the	det	23	SENT_24	[p1l8t3232r154b3300],
23	response	NN	O	response	nsubj	26	SENT_24	[p1l196t3260r499b3324],
24	to	TO	O	to	dep	23	SENT_24	[p1l540t3251r608b3300],
25	clopidogrel	NN	O	clopidogrel	dep	23	SENT_24	[p1l651t3234r1046b3324],
26	shows	VBZ	O	show	rcmod	20	SENT_24	[p1l1087t3234r1297b3301],
27	a	DT	O	a	det	33	SENT_24	[p1l1341t3260r1375b3300],
28	wide	JJ	O	wide	amod	33	SENT_24	[p1l1411t3234r1579b3301],
29	interindividual	JJ	O	interindividual	amod	33	SENT_24	[p1l1621t3234r2142b3300],
30	variation	NN	O	variation	nn	33	SENT_24	[p1l7t3345r319b3408],
31	(	NN	O	(	nn	33	SENT_24	[p1l351t3340r467b3423],
32	2	CD	NUMBER	2	num	33	SENT_24	[p1l351t3340r467b3423],
33	)	NN	O	)	dobj	26	SENT_24	[p1l351t3340r467b3423],
34	,	,	O	,	_	0	SENT_24	[p1l351t3340r467b3423],
35	with	IN	O	with	_	0	SENT_24	[p1l495t3342r657b3408],
36	5	CD	PERCENT	5	number	40	SENT_24	[p1l685t3342r792b3409],
37	%	NN	PERCENT	%	dep	40	SENT_24	[p1l685t3342r792b3409],
38	to	TO	O	to	dep	40	SENT_24	[p1l821t3359r889b3408],
39	30	CD	PERCENT	30	number	40	SENT_24	[p1l920t3345r1071b3409],
40	%	NN	PERCENT	%	nsubj	44	SENT_24	[p1l920t3345r1071b3409],
41	of	IN	O	of	_	0	SENT_24	[p1l1101t3342r1180b3408],
42	patients	NNS	O	patient	prep_of	40	SENT_24	[p1l1196t3345r1473b3431],
43	not	RB	O	not	neg	44	SENT_24	[p1l1504t3359r1621b3408],
44	responding	VBG	O	respond	prepc_with	19	SENT_24	[p1l1648t3342r2044b3432],
45	to	TO	O	to	_	0	SENT_24	[p1l2071t3359r2139b3408],
46	initial	JJ	O	initial	amod	48	SENT_24	[p1l10t3450r216b3516],
47	clopidogrel	NN	O	clopidogrel	nn	48	SENT_24	[p1l256t3450r651b3539],
48	therapy	NN	O	therapy	prep_to	44	SENT_24	[p1l691t3450r958b3539],
49	(	CD	NUMBER	(	num	51	SENT_24	[p1l998t3448r1180b3531],
50	3,4	CD	NUMBER	3,4	num	51	SENT_24	[p1l998t3448r1180b3531],
51	)	NN	O	)	dobj	44	SENT_24	[p1l998t3448r1180b3531],
52	.	.	O	.	_	0	SENT_24	[p1l998t3448r1180b3531],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	4	SENT_25	[p1l1227t3450r1651b3539],
2	is	VBZ	O	be	cop	4	SENT_25	[p1l1690t3453r1741b3516],
3	a	DT	O	a	det	4	SENT_25	[p1l1785t3476r1819b3516],
4	prodrug	NN	O	prodrug	_	0	SENT_25	[p1l1858t3450r2142b3539],
5	that	WDT	O	that	nsubj	6	SENT_25	[p1l10t3558r151b3624],
6	requires	VBZ	O	require	rcmod	4	SENT_25	[p1l188t3561r465b3647],
7	conversion	NN	O	conversion	dobj	6	SENT_25	[p1l506t3561r883b3624],
8	to	TO	O	to	_	0	SENT_25	[p1l922t3575r990b3624],
9	its	PRP$	O	its	poss	12	SENT_25	[p1l1030t3561r1108b3624],
10	active	JJ	O	active	amod	12	SENT_25	[p1l1150t3561r1347b3624],
11	thiol	NN	O	thiol	nn	12	SENT_25	[p1l1386t3558r1552b3624],
12	derivative	NN	O	derivative	prep_to	6	SENT_25	[p1l1590t3558r1928b3624],
13	catalyzed	VBN	O	catalyze	partmod	12	SENT_25	[p1l1968t3575r2137b3624, p1l9t3666r192b3755],
14	predominantly	RB	O	predominantly	amod	19	SENT_25	[p1l224t3666r748b3755],
15	by	IN	O	by	_	0	SENT_25	[p1l776t3666r863b3755],
16	cytochrome	NN	O	cytochrome	nn	17	SENT_25	[p1l894t3666r1305b3755],
17	P450	NN	O	p450	prep_by	14	SENT_25	[p1l1340t3666r1523b3732],
18	(	CD	NUMBER	(	num	17	SENT_25	[p1l1561t3664r1789b3746],
19	CYP	NN	O	cyp	dobj	13	SENT_25	[p1l1561t3664r1789b3746],
20	)	CD	NUMBER	)	num	21	SENT_25	[p1l1561t3664r1789b3746],
21	3A4	NN	O	3a4	tmod	13	SENT_25	[p1l1828t3664r1978b3732],
22	and	CC	O	and	advmod	21	SENT_25	[p1l2014t3666r2141b3732],

1	3A5	NN	O	3a5	nsubj	13	SENT_26	[p2l11t16r182b98],
2	,	,	O	,	_	0	SENT_26	[p2l11t16r182b98],
3	with	IN	O	with	_	0	SENT_26	[p2l227t18r388b83],
4	contributions	NNS	O	contribution	prep_with	13	SENT_26	[p2l435t18r904b83],
5	from	IN	O	from	_	0	SENT_26	[p2l951t18r1121b83],
6	ZC19	NN	O	zc19	prep_from	4	SENT_26	[p2l1165t18r1383b98],
7	,	,	O	,	_	0	SENT_26	[p2l1165t18r1383b98],
8	2C9	NN	O	2c9	nsubj	13	SENT_26	[p2l1430t18r1604b98],
9	,	,	O	,	_	0	SENT_26	[p2l1430t18r1604b98],
10	and	CC	O	and	_	0	SENT_26	[p2l1654t18r1781b83],
11	1A2	NN	O	1a2	nn	12	SENT_26	[p2l1830t16r1976b84],
12	enzymes	NNS	O	enzyme	conj_and	8	SENT_26	[p2l2024t44r2138b83, p2l9t152r224b215],
13	(	VBP	O	(	_	0	SENT_26	[p2l272t124r475b206],
14	5-7	CD	NUMBER	5-7	num	15	SENT_26	[p2l272t124r475b206],
15	)	CD	NUMBER	)	dobj	13	SENT_26	[p2l272t124r475b206],
16	.	.	O	.	_	0	SENT_26	[p2l272t124r475b206],

1	Several	JJ	O	several	amod	2	SENT_27	[p2l527t126r775b192],
2	studies	NNS	O	study	nsubj	3	SENT_27	[p2l819t126r1057b192],
3	(	VBP	O	(	dep	9	SENT_27	[p2l1105t124r1409b207],
4	6,8	CD	NUMBER	6,8	number	5	SENT_27	[p2l1105t124r1409b207],
5	—	CD	NUMBER	—	dobj	3	SENT_27	[p2l1105t124r1409b207],
6	10	CD	NUMBER	10	num	7	SENT_27	[p2l1105t124r1409b207],
7	)	NN	O	)	dep	5	SENT_27	[p2l1105t124r1409b207],
8	have	VBP	O	have	aux	9	SENT_27	[p2l1455t126r1614b192],
9	evaluated	VBN	O	evaluate	_	0	SENT_27	[p2l1659t126r1988b192],
10	the	DT	O	the	det	11	SENT_27	[p2l2030t126r2140b192],
11	impact	NN	O	impact	dobj	9	SENT_27	[p2l10t237r253b324],
12	of	IN	O	of	_	0	SENT_27	[p2l293t234r373b301],
13	polymorphisms	NNS	O	polymorphism	prep_of	11	SENT_27	[p2l400t234r946b324],
14	in	IN	O	in	_	0	SENT_27	[p2l988t237r1057b300],
15	genes	NNS	O	gene	nn	17	SENT_27	[p2l1096t261r1290b324],
16	encoding	VBG	O	encode	amod	17	SENT_27	[p2l1334t234r1657b324],
17	enzymes	NNS	O	enzyme	prep_in	13	SENT_27	[p2l1697t261r1995b324],
18	involved	VBN	O	involve	partmod	17	SENT_27	[p2l2038t237r2138b300, p2l7t342r236b409],
19	in	IN	O	in	_	0	SENT_27	[p2l296t345r364b408],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_27	[p2l426t342r820b432],
21	metabolism	NN	O	metabolism	prep_in	18	SENT_27	[p2l881t342r1290b409],
22	(	CD	NUMBER	(	num	23	SENT_27	[p2l1355t340r1683b423],
23	CYPZCJ	NNP	O	CYPZCJ	dobj	18	SENT_27	[p2l1355t340r1683b423],
24	9	CD	NUMBER	9	num	23	SENT_27	[p2l1694t349r1750b423],
25	,	,	O	,	_	0	SENT_27	[p2l1694t349r1750b423],
26	CYP2C9	NN	O	cyp2c9	conj_and	23	SENT_27	[p2l1821t346r2138b423],
27	,	,	O	,	_	0	SENT_27	[p2l1821t346r2138b423],
28	CYP3ﬂ4	NN	O	cyp3ﬂ4	conj_and	23	SENT_27	[p2l17t453r326b526],
29	,	,	O	,	_	0	SENT_27	[p2l17t453r326b526],
30	and	CC	O	and	_	0	SENT_27	[p2l397t450r525b516],
31	CYPJAIZ	NNP	O	CYPJAIZ	conj_and	23	SENT_27	[p2l592t451r933b534],
32	)	CD	NUMBER	)	num	31	SENT_27	[p2l592t451r933b534],
33	,	,	O	,	_	0	SENT_27	[p2l592t451r933b534],
34	as	RB	O	as	_	0	SENT_27	[p2l1003t476r1066b516],
35	well	RB	O	well	_	0	SENT_27	[p2l1127t450r1272b517],
36	as	IN	O	as	_	0	SENT_27	[p2l1335t476r1398b516],
37	polymorphisms	NNS	O	polymorphism	dobj	18	SENT_27	[p2l1461t450r2007b540],
38	of	IN	O	of	_	0	SENT_27	[p2l2072t450r2152b516],
39	P-glycoprotein	NN	O	p-glycoprotein	nn	41	SENT_27	[p2l11t558r540b648],
40	transporter	NN	O	transporter	nn	41	SENT_27	[p2l582t575r972b648],
41	protein	NN	O	protein	prep_of	37	SENT_27	[p2l1012t561r1267b648],
42	coding	VBG	O	code	partmod	41	SENT_27	[p2l1310t558r1549b647],
43	gene	NN	O	gene	nn	44	SENT_27	[p2l1588t585r1751b647],
44	(	NN	O	(	dobj	42	SENT_27	[p2l1797t556r2138b639],
45	143031	CD	NUMBER	143031	num	46	SENT_27	[p2l1797t556r2138b639],
46	)	NN	O	)	nsubj	9	SENT_27	[p2l1797t556r2138b639],
47	,	,	O	,	_	0	SENT_27	[p2l1797t556r2138b639],
48	on	IN	O	on	_	0	SENT_27	[p2l11t693r99b733],
49	clopidogrel	NN	O	clopidogrel	nn	50	SENT_27	[p2l133t667r527b757],
50	response	NN	O	response	prep_on	9	SENT_27	[p2l558t693r880b757],
51	.	.	O	.	_	0	SENT_27	[p2l558t693r880b757],

1	See	VB	O	see	_	0	SENT_28	[p2l837t886r961b939],
2	page	NN	O	page	dobj	1	SENT_28	[p2l992t893r1151b952],
3	628	CD	NUMBER	628	num	2	SENT_28	[p2l1180t886r1312b939],

1	The	DT	O	the	det	2	SENT_29	[p2l96t1101r243b1168],
2	activity	NN	O	activity	nsubj	13	SENT_29	[p2l269t1105r524b1191],
3	of	IN	O	of	_	0	SENT_29	[p2l544t1102r624b1168],
4	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_29	[p2l636t1101r985b1183],
5	,	,	O	,	_	0	SENT_29	[p2l636t1101r985b1183],
6	measured	VBN	O	measure	partmod	2	SENT_29	[p2l1012t1102r1347b1168],
7	by	IN	O	by	_	0	SENT_29	[p2l1367t1102r1453b1191],
8	radiolabeled	VBN	O	radiolabele	agent	6	SENT_29	[p2l1472t1102r1903b1168],
9	erythromycin	NN	O	erythromycin	nn	11	SENT_29	[p2l1926t1102r2138b1191, p2l10t1214r299b1300],
10	breath	NN	O	breath	nn	11	SENT_29	[p2l352t1211r578b1277],
11	testing	NN	O	testing	dobj	8	SENT_29	[p2l633t1214r889b1300],
12	,	,	O	,	_	0	SENT_29	[p2l633t1214r889b1300],
13	correlates	VBZ	O	correlate	_	0	SENT_29	[p2l948t1211r1280b1277],
14	with	IN	O	with	_	0	SENT_29	[p2l1333t1211r1494b1277],
15	the	DT	O	the	det	16	SENT_29	[p2l1548t1211r1658b1277],
16	response	NN	O	response	prep_with	13	SENT_29	[p2l1713t1237r2016b1300],
17	to	TO	O	to	_	0	SENT_29	[p2l2072t1228r2139b1277],
18	clopidogrel	NN	O	clopidogrel	prep_to	13	SENT_29	[p2l11t1319r406b1408],
19	(	CD	NUMBER	(	num	18	SENT_29	[p2l431t1317r590b1399],
20	11	CD	NUMBER	11	num	21	SENT_29	[p2l431t1317r590b1399],
21	)	NN	O	)	dep	18	SENT_29	[p2l431t1317r590b1399],
22	.	.	O	.	_	0	SENT_29	[p2l431t1317r590b1399],

1	CYP3A4	NN	O	cyp3a4	nn	2	SENT_30	[p2l619t1317r949b1385],
2	expression	NN	O	expression	nsubj	6	SENT_30	[p2l972t1322r1337b1408],
3	may	MD	O	may	aux	6	SENT_30	[p2l1361t1345r1509b1408],
4	be	VB	O	be	cop	6	SENT_30	[p2l1526t1319r1607b1385],
5	variable	JJ	O	variable	amod	6	SENT_30	[p2l1627t1319r1900b1385],
6	due	JJ	O	due	_	0	SENT_30	[p2l1925t1319r2049b1385],
7	in	IN	O	in	_	0	SENT_30	[p2l2073t1322r2140b1384],
8	part	NN	O	part	prep_in	6	SENT_30	[p2l9t1445r151b1517],
9	to	TO	O	to	_	0	SENT_30	[p2l197t1445r264b1494],
10	polymorphisms	NNS	O	polymorphism	prep_to	6	SENT_30	[p2l312t1428r858b1517],
11	in	IN	O	in	_	0	SENT_30	[p2l906t1431r974b1493],
12	the	DT	O	the	det	13	SENT_30	[p2l1021t1428r1131b1494],
13	gene	NN	O	gene	prep_in	10	SENT_30	[p2l1178t1454r1341b1517],
14	coding	VBG	O	code	partmod	13	SENT_30	[p2l1390t1428r1629b1517],
15	this	DT	O	this	det	16	SENT_30	[p2l1674t1428r1800b1494],
16	enzyme	NN	O	enzyme	dobj	14	SENT_30	[p2l1850t1454r2137b1517],
17	,	,	O	,	_	0	SENT_30	[p2l1850t1454r2137b1517],
18	including	VBG	O	include	_	0	SENT_30	[p2l10t1537r345b1626],
19	CYP3ﬂ4	NN	O	cyp3ﬂ4	nn	21	SENT_30	[p2l381t1540r816b1613],
20	*	CD	NUMBER	*	num	21	SENT_30	[p2l381t1540r816b1613],
21	ZB	NN	O	zb	prep_including	16	SENT_30	[p2l381t1540r816b1613],
22	,	,	O	,	_	0	SENT_30	[p2l381t1540r816b1613],
23	CYP3A4	NN	O	cyp3a4	appos	21	SENT_30	[p2l861t1540r1240b1613],
24	*	CD	NUMBER	*	number	25	SENT_30	[p2l861t1540r1240b1613],
25	3	CD	NUMBER	3	dep	23	SENT_30	[p2l861t1540r1240b1613],
26	,	,	O	,	_	0	SENT_30	[p2l861t1540r1240b1613],
27	and	CC	O	and	_	0	SENT_30	[p2l1280t1537r1408b1603],
28	CYP3ﬂ4	NN	O	cyp3ﬂ4	conj_and	25	SENT_30	[p2l1445t1540r1814b1604],
29	*	CD	NUMBER	*	number	30	SENT_30	[p2l1445t1540r1814b1604],
30	4	CD	NUMBER	4	num	31	SENT_30	[p2l1445t1540r1814b1604],
31	(	NN	O	(	dep	28	SENT_30	[p2l1844t1535r2136b1617],
32	12-14	CD	NUMBER	12-14	num	33	SENT_30	[p2l1844t1535r2136b1617],
33	)	NN	O	)	dep	28	SENT_30	[p2l1844t1535r2136b1617],
34	.	.	O	.	_	0	SENT_30	[p2l1844t1535r2136b1617],

1	These	DT	O	these	det	2	SENT_31	[p2l8t1643r224b1710],
2	variants	NNS	O	variant	nsubj	4	SENT_31	[p2l256t1647r530b1710],
3	are	VBP	O	be	cop	4	SENT_31	[p2l567t1670r668b1710],
4	uncommon	JJ	O	uncommon	dep	7	SENT_31	[p2l702t1671r1107b1710],
5	in	IN	O	in	_	0	SENT_31	[p2l1142t1647r1209b1709],
6	Caucasians	NNPS	MISC	Caucasians	prep_in	4	SENT_31	[p2l1246t1644r1635b1710],
7	(	VBP	O	(	_	0	SENT_31	[p2l1674t1642r1946b1725],
8	15,16	CD	NUMBER	15,16	number	9	SENT_31	[p2l1674t1642r1946b1725],
9	)	CD	NUMBER	)	dobj	7	SENT_31	[p2l1674t1642r1946b1725],
10	,	,	O	,	_	0	SENT_31	[p2l1674t1642r1946b1725],
11	with	IN	O	with	_	0	SENT_31	[p2l1979t1644r2141b1710],
12	only	RB	O	only	quantmod	13	SENT_31	[p2l11t1752r164b1841],
13	1	CD	NUMBER	1	num	17	SENT_31	[p2l197t1756r229b1818],
14	Cl/P3144	NN	O	cl/p3144	nn	17	SENT_31	[p2l273t1755r571b1819],
15	polymorphism	NN	O	polymorphism	nn	17	SENT_31	[p2l598t1752r1113b1842],
16	(	NN	O	(	nn	17	SENT_31	[p2l1149t1750r1807b1833],
17	IVS10	NN	O	ivs10	prep_with	9	SENT_31	[p2l1149t1750r1807b1833],
18	+12	CD	NUMBER	+12	num	19	SENT_31	[p2l1149t1750r1807b1833],
19	G	NN	O	g	npadvmod	20	SENT_31	[p2l1149t1750r1807b1833],
20	>	JJR	O	>	amod	17	SENT_31	[p2l1149t1750r1807b1833],
21	A	DT	O	a	det	22	SENT_31	[p2l1149t1750r1807b1833],
22	)	NN	O	)	nsubj	23	SENT_31	[p2l1149t1750r1807b1833],
23	reported	VBD	O	report	rcmod	17	SENT_31	[p2l1843t1752r2141b1842],
24	to	TO	O	to	_	0	SENT_31	[p2l10t1877r78b1926],
25	date	NN	O	date	prep_to	23	SENT_31	[p2l117t1860r263b1926],
26	to	TO	O	to	aux	28	SENT_31	[p2l300t1877r368b1926],
27	be	VB	O	be	auxpass	28	SENT_31	[p2l404t1860r484b1926],
28	associated	VBN	O	associate	xcomp	23	SENT_31	[p2l523t1860r875b1926],
29	with	IN	O	with	_	0	SENT_31	[p2l907t1860r1068b1926],
30	a	DT	O	a	det	32	SENT_31	[p2l1107t1886r1141b1926],
31	reduced	VBN	O	reduce	amod	32	SENT_31	[p2l1176t1860r1454b1926],
32	response	NN	O	response	prep_with	28	SENT_31	[p2l1489t1886r1792b1950],
33	to	TO	O	to	_	0	SENT_31	[p2l1829t1877r1897b1926],
34	clopidogrel	NN	O	clopidogrel	prep_to	32	SENT_31	[p2l1936t1860r2137b1950, p2l11t1968r233b2057],
35	(	CD	NUMBER	(	num	34	SENT_31	[p2l269t1966r540b2049],
36	10,17	CD	NUMBER	10,17	num	37	SENT_31	[p2l269t1966r540b2049],
37	)	NN	O	)	nsubj	7	SENT_31	[p2l269t1966r540b2049],
38	.	.	O	.	_	0	SENT_31	[p2l269t1966r540b2049],

1	Expression	NN	O	expression	nsubj	6	SENT_32	[p2l581t1969r968b2057],
2	of	IN	O	of	_	0	SENT_32	[p2l1004t1968r1083b2034],
3	the	DT	O	the	det	5	SENT_32	[p2l1106t1968r1216b2034],
4	CYP3A5	NN	O	cyp3a5	nn	5	SENT_32	[p2l1253t1966r1579b2034],
5	enzyme	NN	O	enzyme	prep_of	1	SENT_32	[p2l1618t1994r1885b2057],
6	occurs	VBZ	O	occur	_	0	SENT_32	[p2l1921t1994r2139b2034],
7	only	RB	O	only	advmod	6	SENT_32	[p2l11t2076r164b2165],
8	in	IN	O	in	_	0	SENT_32	[p2l186t2079r254b2141],
9	subjects	NNS	O	subject	prep_in	6	SENT_32	[p2l281t2076r552b2165],
10	carrying	VBG	O	carry	partmod	9	SENT_32	[p2l580t2079r866b2165],
11	at	IN	O	at	quantmod	13	SENT_32	[p2l891t2093r954b2142],
12	least	JJS	O	least	mwe	11	SENT_32	[p2l977t2076r1135b2142],
13	1	CD	NUMBER	1	num	17	SENT_32	[p2l1163t2079r1195b2141],
14	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	17	SENT_32	[p2l1232t2079r1530b2143],
15	*	NN	O	*	nn	17	SENT_32	[p2l1534t2079r1593b2141],
16	1	CD	NUMBER	1	num	17	SENT_32	[p2l1534t2079r1593b2141],
17	allele	NN	O	allele	dobj	10	SENT_32	[p2l1624t2076r1821b2157],
18	,	,	O	,	_	0	SENT_32	[p2l1624t2076r1821b2157],
19	which	WDT	O	which	nsubj	21	SENT_32	[p2l1846t2076r2063b2142],
20	is	VBZ	O	be	cop	21	SENT_32	[p2l2089t2079r2139b2142],
21	present	JJ	DATE	present	rcmod	17	SENT_32	[p2l9t2202r268b2274],
22	in	IN	O	in	prep	21	SENT_32	[p2l299t2188r367b2250],
23	up	RB	O	up	advmod	29	SENT_32	[p2l398t2211r485b2274],
24	to	TO	O	to	_	0	SENT_32	[p2l519t2202r587b2251],
25	15	CD	PERCENT	15	num	26	SENT_32	[p2l625t2185r773b2251],
26	%	NN	PERCENT	%	prep_to	23	SENT_32	[p2l625t2185r773b2251],
27	of	IN	O	of	_	0	SENT_32	[p2l807t2185r887b2251],
28	Caucasians	NNPS	MISC	Caucasians	prep_of	26	SENT_32	[p2l909t2185r1298b2251],
29	(	VBP	O	(	dep	22	SENT_32	[p2l1336t2183r1495b2265],
30	18	CD	NUMBER	18	number	31	SENT_32	[p2l1336t2183r1495b2265],
31	)	CD	NUMBER	)	dobj	29	SENT_32	[p2l1336t2183r1495b2265],
32	.	.	O	.	_	0	SENT_32	[p2l1336t2183r1495b2265],

1	Subjects	NNS	O	subject	nsubj	8	SENT_33	[p2l1535t2185r1822b2274],
2	carrying	VBG	O	carry	partmod	1	SENT_33	[p2l1857t2188r2142b2274],
3	the	DT	O	the	det	7	SENT_33	[p2l10t2292r120b2359],
4	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	7	SENT_33	[p2l161t2296r458b2359],
5	*	NN	O	*	nn	7	SENT_33	[p2l463t2296r522b2358],
6	1	CD	NUMBER	1	num	7	SENT_33	[p2l463t2296r522b2358],
7	allele	NN	O	allele	dobj	2	SENT_33	[p2l560t2292r737b2359],
8	appear	VBP	O	appear	_	0	SENT_33	[p2l772t2318r1004b2382],
9	to	TO	O	to	aux	10	SENT_33	[p2l1036t2309r1104b2359],
10	have	VB	O	have	xcomp	8	SENT_33	[p2l1138t2292r1296b2359],
11	greater	JJR	O	greater	amod	13	SENT_33	[p2l1329t2309r1574b2382],
12	platelet	NN	O	platelet	nn	13	SENT_33	[p2l1605t2292r1866b2382],
13	inhibition	NN	O	inhibition	dobj	10	SENT_33	[p2l1897t2292r2138b2359, p2l10t2403r151b2466],
14	and	CC	O	and	_	0	SENT_33	[p2l187t2400r314b2466],
15	fewer	JJR	O	fewer	amod	17	SENT_33	[p2l348t2400r541b2467],
16	atherothrombotic	JJ	O	atherothrombotic	amod	17	SENT_33	[p2l575t2400r1197b2466],
17	events	NNS	O	event	dobj	10	SENT_33	[p2l1232t2417r1447b2467],
18	after	IN	O	after	_	0	SENT_33	[p2l1485t2400r1644b2466],
19	percutaneous	JJ	O	percutaneous	amod	21	SENT_33	[p2l1675t2417r2139b2490],
20	coronary	JJ	O	coronary	amod	21	SENT_33	[p2l12t2534r321b2597],
21	intervention	NN	O	intervention	prep_after	10	SENT_33	[p2l358t2511r789b2575],
22	(	CD	NUMBER	(	num	24	SENT_33	[p2l833t2506r1035b2589],
23	PCI	NN	O	pcus	nn	24	SENT_33	[p2l833t2506r1035b2589],
24	)	NN	O	)	tmod	8	SENT_33	[p2l833t2506r1035b2589],
25	than	IN	O	than	_	0	SENT_33	[p2l1080t2508r1238b2574],
26	those	DT	O	those	prep_than	24	SENT_33	[p2l1278t2508r1464b2574],
27	who	WP	O	who	dobj	30	SENT_33	[p2l1502t2508r1654b2575],
28	do	VBP	O	do	aux	30	SENT_33	[p2l1698t2508r1782b2574],
29	not	RB	O	not	neg	30	SENT_33	[p2l1826t2525r1943b2574],
30	have	VB	O	have	rcmod	26	SENT_33	[p2l1982t2508r2140b2575],
31	this	DT	O	this	det	32	SENT_33	[p2l10t2616r137b2681],
32	allele	NN	O	allele	nsubj	33	SENT_33	[p2l173t2616r350b2681],
33	&	CC	O	&	xcomp	30	SENT_33	[p2l387t2614r501b2696],
34	+	CC	O	+	dep	30	SENT_33	[p2l387t2614r501b2696],

1	A	DT	O	a	det	2	SENT_34	[p2l97t2722r164b2789],
2	number	NN	O	number	nsubj	8	SENT_34	[p2l196t2724r469b2790],
3	of	IN	O	of	_	0	SENT_34	[p2l501t2724r581b2790],
4	well	RB	O	well	advmod	5	SENT_34	[p2l597t2724r1113b2790],
5	—	JJ	O	—	prep_of	2	SENT_34	[p2l597t2724r1113b2790],
6	described	VBN	O	describe	partmod	5	SENT_34	[p2l597t2724r1113b2790],
7	polymorphisms	NNS	O	polymorphism	dobj	6	SENT_34	[p2l1144t2724r1689b2813],
8	exist	VBP	O	exist	_	0	SENT_34	[p2l1724t2727r1882b2790],
9	within	IN	O	within	_	0	SENT_34	[p2l1909t2724r2141b2790],
10	the	DT	O	the	det	11	SENT_34	[p2l10t2833r120b2899],
11	CYP2C1	NN	O	cyp2c1	prep_within	8	SENT_34	[p2l155t2836r450b2900],
12	9	CD	NUMBER	9	num	11	SENT_34	[p2l460t2839r499b2899],
13	and	CC	O	and	_	0	SENT_34	[p2l526t2833r653b2899],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_34	[p2l686t2836r985b2900],
15	genes	NNS	O	gene	conj_and	11	SENT_34	[p2l1010t2859r1223b2922],
16	.	.	O	.	_	0	SENT_34	[p2l1010t2859r1223b2922],

1	The	DT	O	the	det	2	SENT_35	[p2l1252t2831r1399b2899],
2	CYP2C	NN	O	cyp2c	nsubj	15	SENT_35	[p2l1433t2836r1862b2909],
3	]	CD	NUMBER	]	number	4	SENT_35	[p2l1433t2836r1862b2909],
4	9	CD	NUMBER	9	num	2	SENT_35	[p2l1433t2836r1862b2909],
5	*	NN	O	*	dep	2	SENT_35	[p2l1433t2836r1862b2909],
6	2	CD	NUMBER	2	num	5	SENT_35	[p2l1433t2836r1862b2909],
7	,	,	O	,	_	0	SENT_35	[p2l1433t2836r1862b2909],
8	*	CD	NUMBER	*	number	9	SENT_35	[p2l1901t2836r1979b2909],
9	3	CD	NUMBER	3	appos	2	SENT_35	[p2l1901t2836r1979b2909],
10	,	,	O	,	_	0	SENT_35	[p2l1901t2836r1979b2909],
11	and	CC	O	and	_	0	SENT_35	[p2l2014t2833r2141b2899],
12	*	NN	O	*	appos	2	SENT_35	[p2l16t2944r83b3006],
13	4	CD	NUMBER	4	num	14	SENT_35	[p2l16t2944r83b3006],
14	alleles	NNS	O	allele	dep	12	SENT_35	[p2l126t2940r334b3007],
15	display	VBP	O	display	_	0	SENT_35	[p2l383t2940r629b3030],
16	a	DT	O	a	det	17	SENT_35	[p2l673t2967r708b3007],
17	loss	NN	O	loss	dobj	15	SENT_35	[p2l752t2940r878b3007],
18	of	IN	O	of	_	0	SENT_35	[p2l928t2940r1008b3007],
19	function	NN	O	function	prep_of	17	SENT_35	[p2l1042t2940r1338b3007],
20	of	IN	O	of	_	0	SENT_35	[p2l1386t2940r1466b3007],
21	this	DT	O	this	det	22	SENT_35	[p2l1500t2940r1627b3007],
22	enzyme	NN	O	enzyme	prep_of	19	SENT_35	[p2l1676t2967r1963b3030],
23	,	,	O	,	_	0	SENT_35	[p2l1676t2967r1963b3030],
24	and	CC	O	and	_	0	SENT_35	[p2l2015t2940r2142b3007],
25	CYP2C19	NN	O	cyp2c19	nsubjpass	29	SENT_35	[p2l17t3051r480b3115],
26	*	CD	NUMBER	*	num	27	SENT_35	[p2l17t3051r480b3115],
27	J7	NN	O	j7	dep	25	SENT_35	[p2l17t3051r480b3115],
28	is	VBZ	O	be	auxpass	29	SENT_35	[p2l515t3051r565b3114],
29	associated	VBN	O	associate	conj_and	15	SENT_35	[p2l607t3048r960b3114],
30	with	IN	O	with	_	0	SENT_35	[p2l995t3048r1156b3115],
31	ultrarapid	JJ	O	ultrarapid	amod	33	SENT_35	[p2l1195t3048r1542b3138],
32	enzyme	NN	O	enzyme	nn	33	SENT_35	[p2l1581t3074r1848b3137],
33	activity	NN	O	activity	prep_with	29	SENT_35	[p2l1890t3051r2145b3137],
34	(	CD	NUMBER	(	number	35	SENT_35	[p2l14t3154r173b3237],
35	19	CD	NUMBER	19	num	36	SENT_35	[p2l14t3154r173b3237],
36	)	NN	O	)	dep	29	SENT_35	[p2l14t3154r173b3237],
37	.	.	O	.	_	0	SENT_35	[p2l14t3154r173b3237],

1	CYP2C	NN	O	cyp2c	nsubj	7	SENT_36	[p2l230t3159r644b3223],
2	]	CD	NUMBER	]	num	6	SENT_36	[p2l230t3159r644b3223],
3	9	CD	NUMBER	9	num	6	SENT_36	[p2l230t3159r644b3223],
4	*	NN	O	*	nn	6	SENT_36	[p2l230t3159r644b3223],
5	2	CD	NUMBER	2	num	6	SENT_36	[p2l230t3159r644b3223],
6	carriers	NNS	O	carrier	dep	1	SENT_36	[p2l690t3159r943b3222],
7	have	VBP	O	have	_	0	SENT_36	[p2l990t3156r1149b3222],
8	a	DT	O	a	det	11	SENT_36	[p2l1197t3182r1231b3222],
9	reduced	VBN	O	reduce	amod	11	SENT_36	[p2l1275t3156r1553b3222],
10	antiplatelet	JJ	O	antiplatelet	amod	11	SENT_36	[p2l1600t3156r1996b3246],
11	response	NN	O	response	dobj	7	SENT_36	[p2l2040t3182r2138b3222, p2l12t3290r245b3353],
12	to	TO	O	to	_	0	SENT_36	[p2l278t3281r346b3330],
13	a	DT	O	a	det	16	SENT_36	[p2l381t3290r416b3330],
14	300	CD	NUMBER	300	num	16	SENT_36	[p2l448t3267r729b3353],
15	—	NN	O	—	nn	16	SENT_36	[p2l448t3267r729b3353],
16	mg	NN	O	mg	prep_to	11	SENT_36	[p2l448t3267r729b3353],
17	loading	VBG	O	load	partmod	16	SENT_36	[p2l759t3264r1024b3353],
18	dose	NN	O	dose	nn	19	SENT_36	[p2l1056t3264r1211b3330],
19	(	NN	O	(	dobj	17	SENT_36	[p2l1247t3262r1340b3344],
20	6	CD	NUMBER	6	num	21	SENT_36	[p2l1247t3262r1340b3344],
21	)	NN	O	)	dep	19	SENT_36	[p2l1247t3262r1340b3344],
22	and	CC	O	and	_	0	SENT_36	[p2l1378t3264r1505b3330],
23	to	TO	O	to	_	0	SENT_36	[p2l1537t3281r1605b3330],
24	a	DT	O	a	det	27	SENT_36	[p2l1640t3290r1674b3330],
25	75	CD	NUMBER	75	number	26	SENT_36	[p2l1708t3264r1944b3353],
26	—	CD	NUMBER	—	num	27	SENT_36	[p2l1708t3264r1944b3353],
27	mg	NN	O	mg	conj_and	16	SENT_36	[p2l1708t3264r1944b3353],
28	daily	JJ	SET	daily	amod	30	SENT_36	[p2l1976t3264r2144b3353],
29	maintenance	NN	O	maintenance	nn	30	SENT_36	[p2l11t3375r479b3438],
30	dosage	NN	O	dosage	dep	27	SENT_36	[p2l546t3372r792b3461],
31	of	IN	O	of	_	0	SENT_36	[p2l859t3372r940b3438],
32	clopidogrel	NN	O	clopidogrel	prep_of	30	SENT_36	[p2l995t3372r1408b3461],
33	(	CD	NUMBER	(	number	34	SENT_36	[p2l1476t3370r1713b3453],
34	9,10	CD	NUMBER	9,10	num	35	SENT_36	[p2l1476t3370r1713b3453],
35	)	NN	O	)	dep	30	SENT_36	[p2l1476t3370r1713b3453],
36	.	.	O	.	_	0	SENT_36	[p2l1476t3370r1713b3453],

1	Similarly	RB	O	similarly	advmod	31	SENT_37	[p2l1787t3372r2137b3461],
2	,	,	O	,	_	0	SENT_37	[p2l1787t3372r2137b3461],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_37	[p2l17t3484r387b3548],
4	*	NN	O	*	nsubjpass	31	SENT_37	[p2l17t3484r387b3548],
5	2	CD	NUMBER	2	number	9	SENT_37	[p2l17t3484r387b3548],
6	and	CC	O	and	_	0	SENT_37	[p2l415t3481r543b3547],
7	CYP2C9	CD	NUMBER	cyp2c9	conj_and	9	SENT_37	[p2l576t3484r946b3548],
8	*	CD	NUMBER	*	number	9	SENT_37	[p2l576t3484r946b3548],
9	3	CD	NUMBER	3	num	10	SENT_37	[p2l576t3484r946b3548],
10	code	NN	O	code	dep	4	SENT_37	[p2l973t3481r1133b3547],
11	for	IN	O	for	_	0	SENT_37	[p2l1162t3481r1262b3547],
12	enzymes	NNS	O	enzyme	prep_for	4	SENT_37	[p2l1289t3507r1587b3570],
13	with	IN	O	with	_	0	SENT_37	[p2l1612t3481r1774b3547],
14	decreased	VBN	O	decrease	amod	15	SENT_37	[p2l1802t3481r2141b3547],
15	activity	NN	O	activity	prep_with	12	SENT_37	[p2l12t3591r267b3678],
16	compared	VBN	O	compare	_	0	SENT_37	[p2l290t3588r637b3678],
17	with	IN	O	with	prepc_compared_with	15	SENT_37	[p2l658t3588r820b3655],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_37	[p2l853t3592r1218b3656],
19	*	NN	O	*	pobj	15	SENT_37	[p2l853t3592r1218b3656],
20	1	CD	NUMBER	1	num	21	SENT_37	[p2l853t3592r1218b3656],
21	allele	NN	O	allele	dep	19	SENT_37	[p2l1249t3588r1445b3670],
22	,	,	O	,	_	0	SENT_37	[p2l1249t3588r1445b3670],
23	and	CC	O	and	_	0	SENT_37	[p2l1476t3588r1603b3655],
24	the	DT	O	the	det	28	SENT_37	[p2l1628t3588r1738b3655],
25	CYP2C9	NN	O	cyp2c9	nn	28	SENT_37	[p2l1772t3592r2141b3655],
26	*	NN	O	*	nn	28	SENT_37	[p2l1772t3592r2141b3655],
27	2	CD	NUMBER	2	num	28	SENT_37	[p2l1772t3592r2141b3655],
28	allele	NN	O	allele	pobj	15	SENT_37	[p2l12t3696r188b3762],
29	has	VBZ	O	have	aux	31	SENT_37	[p2l238t3696r351b3762],
30	been	VBN	O	be	auxpass	31	SENT_37	[p2l400t3696r566b3762],
31	associated	VBN	O	associate	_	0	SENT_37	[p2l617t3696r969b3762],
32	with	IN	O	with	_	0	SENT_37	[p2l1014t3696r1175b3763],
33	a	DT	O	a	det	35	SENT_37	[p2l1226t3722r1261b3762],
34	reduced	VBN	O	reduce	amod	35	SENT_37	[p2l1308t3696r1586b3762],
35	response	NN	O	response	prep_with	31	SENT_37	[p2l1634t3722r1937b3786],
36	to	TO	O	to	_	0	SENT_37	[p2l1987t3713r2055b3762],
37	a	DT	O	a	det	38	SENT_37	[p2l2107t3722r2142b3762],
38	clopidogrel	NN	O	clopidogrel	prep_to	35	SENT_37	[p3l11t17r406b106],
39	300	CD	NUMBER	300	number	40	SENT_37	[p3l439t20r720b106],
40	—	CD	NUMBER	—	num	44	SENT_37	[p3l439t20r720b106],
41	mg	NN	O	mg	nn	44	SENT_37	[p3l439t20r720b106],
42	loading	NN	O	loading	nn	44	SENT_37	[p3l750t17r1015b106],
43	dose	NN	O	dose	nn	44	SENT_37	[p3l1047t17r1202b83],
44	(	NN	O	(	dep	38	SENT_37	[p3l1239t15r1398b98],
45	20	CD	NUMBER	20	num	46	SENT_37	[p3l1239t15r1398b98],
46	)	NN	O	)	dep	44	SENT_37	[p3l1239t15r1398b98],
47	.	.	O	.	_	0	SENT_37	[p3l1239t15r1398b98],

1	The	DT	O	the	det	2	SENT_38	[p3l96t123r244b191],
2	ISAR	NN	O	isar	_	0	SENT_38	[p3l282t123r899b191],
3	.	.	O	.	_	0	SENT_38	[p3l282t123r899b191],

1	—	NN	O	—	_	0	SENT_39	[p3l282t123r899b191],
2	.	.	O	.	_	0	SENT_39	[p3l282t123r899b191],

1	CHOICE	NN	O	choice	npadvmod	3	SENT_40	[p3l282t123r899b191],
2	(	CD	NUMBER	(	num	1	SENT_40	[p3l941t123r1455b214],
3	Intracoronary	JJ	O	intracoronary	amod	4	SENT_40	[p3l941t123r1455b214],
4	Stenting	NN	O	stenting	nsubj	9	SENT_40	[p3l1493t125r1792b214],
5	and	CC	O	and	_	0	SENT_40	[p3l1830t125r1957b191],
6	Antithrombotic	JJ	O	antithrombotic	amod	7	SENT_40	[p3l1993t123r2138b190, p3l10t233r460b299],
7	Regimen	NN	O	regimen	conj_and	4	SENT_40	[p3l485t234r821b322],
8	:	:	O	:	_	0	SENT_40	[p3l485t234r821b322],
9	Choose	VB	O	choose	_	0	SENT_40	[p3l850t233r1116b299],
10	Between	IN	O	between	_	0	SENT_40	[p3l1140t234r1446b299],
11	3	CD	NUMBER	3	num	14	SENT_40	[p3l1469t236r1505b299],
12	High	JJ	O	high	amod	14	SENT_40	[p3l1533t233r1720b322],
13	Oral	JJ	O	oral	amod	14	SENT_40	[p3l1744t233r1905b299],
14	Doses	NNS	O	dose	prep_between	24	SENT_40	[p3l1927t234r2139b299],
15	for	IN	O	for	_	0	SENT_40	[p3l10t342r111b408],
16	Immediate	NNP	O	Immediate	nn	20	SENT_40	[p3l144t342r528b408],
17	Clopidogrel	NNP	O	Clopidogrel	nn	20	SENT_40	[p3l566t342r989b431],
18	Effect	NN	O	effect	nn	20	SENT_40	[p3l1024t340r1256b422],
19	)	NN	O	)	nn	20	SENT_40	[p3l1024t340r1256b422],
20	study	NN	O	study	prep_for	14	SENT_40	[p3l1296t342r1486b431],
21	(	CD	NUMBER	(	number	22	SENT_40	[p3l1519t340r1657b422],
22	21	CD	NUMBER	21	num	23	SENT_40	[p3l1519t340r1657b422],
23	)	NN	O	)	nsubj	24	SENT_40	[p3l1519t340r1657b422],
24	supports	VBZ	O	support	ccomp	9	SENT_40	[p3l1697t359r1993b431],
25	the	DT	O	the	det	26	SENT_40	[p3l2030t342r2140b408],
26	idea	NN	O	idea	dobj	24	SENT_40	[p3l10t450r154b517],
27	that	IN	O	that	complm	38	SENT_40	[p3l185t450r326b517],
28	the	DT	O	the	det	32	SENT_40	[p3l356t450r466b517],
29	apparent	JJ	O	apparent	amod	32	SENT_40	[p3l500t467r808b540],
30	ceiling	NN	O	ceiling	nn	32	SENT_40	[p3l839t450r1072b540],
31	antiplatelet	JJ	O	antiplatelet	amod	32	SENT_40	[p3l1103t450r1499b540],
32	effect	NN	O	effect	nsubj	38	SENT_40	[p3l1530t450r1716b517],
33	with	IN	O	with	_	0	SENT_40	[p3l1742t450r1903b517],
34	clopidogrel	NN	O	clopidogrel	nn	36	SENT_40	[p3l1936t450r2137b540, p3l11t558r233b647],
35	600	CD	NUMBER	600	num	36	SENT_40	[p3l271t562r398b625],
36	mg	NN	O	mg	prep_with	32	SENT_40	[p3l438t584r550b647],
37	is	VBZ	O	be	cop	38	SENT_40	[p3l586t561r636b624],
38	due	JJ	O	due	ccomp	24	SENT_40	[p3l677t558r801b624],
39	to	TO	O	to	_	0	SENT_40	[p3l839t575r906b624],
40	saturable	JJ	O	saturable	amod	42	SENT_40	[p3l947t558r1258b624],
41	intestinal	JJ	O	intestinal	amod	42	SENT_40	[p3l1296t558r1623b624],
42	absorption	NN	O	absorption	prep_to	38	SENT_40	[p3l1661t558r2035b648],
43	of	IN	O	of	_	0	SENT_40	[p3l2073t558r2153b624],
44	the	DT	O	the	det	45	SENT_40	[p3l10t667r120b733],
45	drug	NN	O	drug	prep_of	42	SENT_40	[p3l161t667r341b756],
46	,	,	O	,	_	0	SENT_40	[p3l161t667r341b756],
47	mediated	VBN	O	mediate	partmod	45	SENT_40	[p3l384t667r710b733],
48	by	IN	O	by	_	0	SENT_40	[p3l747t667r833b756],
49	the	DT	O	the	det	52	SENT_40	[p3l868t667r978b733],
50	P-glycoprotein	NN	MISC	p-glycoprotein	nn	52	SENT_40	[p3l1018t667r1547b756],
51	efﬂux	NN	O	efﬂux	nn	52	SENT_40	[p3l1587t667r1774b733],
52	pump	NN	O	pump	agent	47	SENT_40	[p3l1810t693r2034b757],
53	.	.	O	.	_	0	SENT_40	[p3l1810t693r2034b757],

1	A	DT	O	a	det	2	SENT_41	[p3l2075t666r2142b732],
2	polymorphism	NN	O	polymorphism	tmod	10	SENT_41	[p3l9t775r525b864],
3	of	IN	O	of	_	0	SENT_41	[p3l575t775r655b841],
4	the	DT	O	the	det	6	SENT_41	[p3l692t775r802b841],
5	A/BCBZ	NN	O	a/bcbz	nn	6	SENT_41	[p3l843t778r1114b842],
6	gene	NN	O	gene	prep_of	2	SENT_41	[p3l1165t801r1328b864],
7	(	CD	NUMBER	(	num	9	SENT_41	[p3l1381t773r1736b855],
8	C3435T	NN	O	c3435t	nn	9	SENT_41	[p3l1381t773r1736b855],
9	)	NN	O	)	nsubj	10	SENT_41	[p3l1381t773r1736b855],
10	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_41	[p3l1788t775r2139b841],
11	plasma	NN	O	plasma	nn	12	SENT_41	[p3l9t883r256b972],
12	levels	NNS	O	level	dobj	10	SENT_41	[p3l315t883r502b949],
13	of	IN	O	of	_	0	SENT_41	[p3l567t883r646b949],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_41	[p3l697t883r1091b972],
15	and	CC	O	and	_	0	SENT_41	[p3l1153t883r1280b949],
16	its	PRP$	O	its	poss	18	SENT_41	[p3l1341t886r1419b949],
17	active	JJ	O	active	amod	18	SENT_41	[p3l1484t886r1682b949],
18	metabolite	NN	O	metabolite	conj_and	14	SENT_41	[p3l1745t883r2138b964],
19	;	:	O	;	_	0	SENT_41	[p3l1745t883r2138b964],
20	patients	NNS	O	patient	nsubj	25	SENT_41	[p3l9t995r286b1081],
21	with	IN	O	with	_	0	SENT_41	[p3l316t992r478b1058],
22	the	DT	O	the	det	24	SENT_41	[p3l510t992r620b1058],
23	3435T/T	NNP	O	3435T/T	nn	24	SENT_41	[p3l653t990r984b1058],
24	genotype	NN	O	genotype	prep_with	20	SENT_41	[p3l1014t1009r1334b1081],
25	have	VBP	O	have	parataxis	10	SENT_41	[p3l1367t992r1525b1058],
26	lower	JJR	O	lower	amod	28	SENT_41	[p3l1557t992r1753b1058],
27	maximum	NN	O	maximum	nn	28	SENT_41	[p3l1784t995r2139b1058],
28	concentration	NN	O	concentration	dobj	25	SENT_41	[p3l11t1102r497b1165],
29	and	CC	O	and	_	0	SENT_41	[p3l556t1099r683b1165],
30	area-under	JJ	O	area-under	amod	31	SENT_41	[p3l742t1099r1497b1165],
31	—	NN	O	—	dobj	25	SENT_41	[p3l742t1099r1497b1165],
32	the	DT	O	the	det	35	SENT_41	[p3l742t1099r1497b1165],
33	—	NN	O	—	nn	35	SENT_41	[p3l742t1099r1497b1165],
34	curve	NN	O	curve	nn	35	SENT_41	[p3l742t1099r1497b1165],
35	values	NNS	O	value	dep	31	SENT_41	[p3l1551t1099r1764b1165],
36	for	IN	O	for	_	0	SENT_41	[p3l1822t1099r1923b1165],
37	both	DT	O	both	prep_for	25	SENT_41	[p3l1977t1099r2141b1165],

1	Gladding	NNP	PERSON	Gladding	_	0	SENT_42	[p3l1435t1204r1670b1257],
2	et	FW	O	et	nn	3	SENT_42	[p3l1689t1206r1741b1247],
3	al.	FW	O	al.	dep	1	SENT_42	[p3l1759t1204r1817b1247],
4	621	CD	NUMBER	621	dep	1	SENT_42	[p3l2034t1204r2141b1247],

1	The	DT	O	the	det	5	SENT_43	[p3l888t1287r983b1329],
2	PRINC	NNP	O	PRINC	nn	5	SENT_43	[p3l1007t1286r1172b1329],
3	Trial	NNP	O	Trial	nn	5	SENT_43	[p3l1191t1287r1302b1329],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	nn	5	SENT_43	[p3l1328t1287r1821b1339],
5	clopidogrel	NN	O	clopidogrel	nsubj	30	SENT_43	[p3l11t1499r406b1589],
6	and	CC	O	and	_	0	SENT_43	[p3l444t1499r572b1566],
7	its	PRP$	O	its	poss	9	SENT_43	[p3l609t1502r688b1566],
8	active	JJ	O	active	amod	9	SENT_43	[p3l730t1502r927b1566],
9	metabolite	NN	O	metabolite	conj_and	5	SENT_43	[p3l967t1499r1340b1566],
10	compared	VBN	O	compare	partmod	9	SENT_43	[p3l1380t1499r1727b1589],
11	with	IN	O	with	_	0	SENT_43	[p3l1761t1500r1922b1566],
12	these	DT	O	these	det	13	SENT_43	[p3l1960t1500r2140b1566],
13	values	NNS	O	value	prep_with	10	SENT_43	[p3l7t1604r219b1670],
14	in	IN	O	in	_	0	SENT_43	[p3l268t1607r336b1669],
15	3435C/T	NN	O	3435c/t	nn	18	SENT_43	[p3l384t1603r718b1670],
16	and	CC	O	and	_	0	SENT_43	[p3l766t1604r893b1670],
17	3435C/C	NN	O	3435c/c	nn	18	SENT_43	[p3l941t1604r1276b1670],
18	carriers	NNS	O	carrier	prep_in	13	SENT_43	[p3l1326t1607r1600b1685],
19	,	,	O	,	_	0	SENT_43	[p3l1326t1607r1600b1685],
20	after	IN	O	after	_	0	SENT_43	[p3l1652t1604r1811b1670],
21	300	CD	NUMBER	300	prep_after	10	SENT_43	[p3l1857t1608r2019b1670],
22	-	:	O	-	_	0	SENT_43	[p3l1857t1608r2019b1670],
23	or	CC	O	or	_	0	SENT_43	[p3l2070t1630r2142b1670],
24	600	CD	NUMBER	600	number	25	SENT_43	[p3l12t1714r293b1800],
25	—	CD	NUMBER	—	num	29	SENT_43	[p3l12t1714r293b1800],
26	mg	NN	O	mg	nn	29	SENT_43	[p3l12t1714r293b1800],
27	single	JJ	O	single	amod	29	SENT_43	[p3l327t1711r528b1800],
28	loading	NN	O	loading	nn	29	SENT_43	[p3l562t1711r827b1800],
29	doses	NNS	O	dose	conj_or	9	SENT_43	[p3l861t1711r1047b1777],
30	(	VBP	O	(	_	0	SENT_43	[p3l1087t1709r1246b1791],
31	22	CD	NUMBER	22	num	32	SENT_43	[p3l1087t1709r1246b1791],
32	)	CD	NUMBER	)	dobj	30	SENT_43	[p3l1087t1709r1246b1791],
33	.	.	O	.	_	0	SENT_43	[p3l1087t1709r1246b1791],

1	However	RB	O	however	advmod	8	SENT_44	[p3l1286t1712r1627b1792],
2	,	,	O	,	_	0	SENT_44	[p3l1286t1712r1627b1792],
3	the	DT	O	the	det	4	SENT_44	[p3l1665t1711r1775b1777],
4	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_44	[p3l1809t1711r2138b1800, p3l9t1817r227b1906],
5	has	VBZ	O	have	aux	8	SENT_44	[p3l270t1817r383b1883],
6	not	RB	O	not	neg	8	SENT_44	[p3l428t1834r545b1883],
7	been	VBN	O	be	auxpass	8	SENT_44	[p3l584t1817r751b1883],
8	related	VBN	O	relate	_	0	SENT_44	[p3l793t1817r1032b1883],
9	to	TO	O	to	_	0	SENT_44	[p3l1073t1834r1142b1883],
10	the	DT	O	the	det	12	SENT_44	[p3l1185t1817r1295b1883],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_44	[p3l1340t1817r1736b1906],
12	activity	NN	O	activity	prep_to	8	SENT_44	[p3l1778t1820r2033b1906],
13	of	IN	O	of	_	0	SENT_44	[p3l2073t1817r2152b1883],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_44	[p3l11t1924r423b2013],
15	.	.	O	.	_	0	SENT_44	[p3l11t1924r423b2013],

1	A	DT	O	a	det	2	SENT_45	[p3l97t2028r164b2095],
2	haplotype	NN	O	haplotype	nsubj	13	SENT_45	[p3l192t2030r537b2119],
3	of	IN	O	of	_	0	SENT_45	[p3l569t2030r649b2096],
4	the	DT	O	the	det	8	SENT_45	[p3l667t2030r777b2096],
5	P2Y	NN	O	p2y	nn	8	SENT_45	[p3l808t2034r1040b2097],
6	]	NN	O	]	nn	8	SENT_45	[p3l808t2034r1040b2097],
7	2	CD	NUMBER	2	num	8	SENT_45	[p3l808t2034r1040b2097],
8	gene	NN	O	gene	prep_of	2	SENT_45	[p3l1068t2056r1252b2119],
9	,	,	O	,	_	0	SENT_45	[p3l1068t2056r1252b2119],
10	denoted	VBN	O	denote	partmod	2	SENT_45	[p3l1286t2030r1571b2096],
11	H2	NN	O	h2	dobj	10	SENT_45	[p3l1601t2031r1737b2111],
12	,	,	O	,	_	0	SENT_45	[p3l1601t2031r1737b2111],
13	consists	VBZ	O	consist	dep	19	SENT_45	[p3l1771t2033r2040b2096],
14	of	IN	O	of	_	0	SENT_45	[p3l2073t2030r2153b2096],
15	5	CD	NUMBER	5	num	18	SENT_45	[p3l10t2136r48b2202],
16	single	JJ	O	single	amod	18	SENT_45	[p3l119t2136r329b2225],
17	nucleotide	NN	O	nucleotide	nn	18	SENT_45	[p3l397t2136r779b2202],
18	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_45	[p3l845t2136r1414b2225],
19	(	VBP	O	(	_	0	SENT_45	[p3l1484t2134r1748b2216],
20	SNPS	NN	O	snp	nn	22	SENT_45	[p3l1484t2134r1748b2216],
21	)	CD	NUMBER	)	num	22	SENT_45	[p3l1484t2134r1748b2216],
22	(	NN	O	(	dobj	19	SENT_45	[p3l1820t2134r2141b2216],
23	intronic	JJ	O	intronic	amod	24	SENT_45	[p3l1820t2134r2141b2216],
24	[	NN	O	[	nsubj	19	SENT_45	[p3l16t2241r411b2323],
25	i	FW	O	i	nn	26	SENT_45	[p3l16t2241r411b2323],
26	]	FW	O	]	dep	24	SENT_45	[p3l16t2241r411b2323],
27	.	.	O	.	_	0	SENT_45	[p3l16t2241r411b2323],

1	—	NN	O	—	_	0	SENT_46	[p3l16t2241r411b2323],
2	.	.	O	.	_	0	SENT_46	[p3l16t2241r411b2323],

1	C139T	NN	O	c139t	_	0	SENT_47	[p3l16t2241r411b2323],
2	,	,	O	,	_	0	SENT_47	[p3l16t2241r411b2323],
3	i	FW	O	i	appos	1	SENT_47	[p3l452t2241r789b2323],
4	.	.	O	.	_	0	SENT_47	[p3l452t2241r789b2323],

1	—	NN	O	—	_	0	SENT_48	[p3l452t2241r789b2323],
2	.	.	O	.	_	0	SENT_48	[p3l452t2241r789b2323],

1	T744C	NN	O	t744c	_	0	SENT_49	[p3l452t2241r789b2323],
2	,	,	O	,	_	0	SENT_49	[p3l452t2241r789b2323],
3	i-ins801A	NN	O	i-ins801a	conj_and	1	SENT_49	[p3l829t2242r1207b2323],
4	,	,	O	,	_	0	SENT_49	[p3l829t2242r1207b2323],
5	C34T	NN	O	c34t	conj_and	1	SENT_49	[p3l1249t2241r1481b2323],
6	,	,	O	,	_	0	SENT_49	[p3l1249t2241r1481b2323],
7	and	CC	O	and	_	0	SENT_49	[p3l1523t2243r1650b2309],
8	G52T	NN	O	g52t	conj_and	1	SENT_49	[p3l1689t2241r1933b2323],
9	)	CD	NUMBER	)	number	10	SENT_49	[p3l1689t2241r1933b2323],
10	(	CD	NUMBER	(	dep	1	SENT_49	[p3l1977t2241r2136b2323],
11	23	CD	NUMBER	23	num	12	SENT_49	[p3l1977t2241r2136b2323],
12	)	NN	O	)	dep	10	SENT_49	[p3l1977t2241r2136b2323],
13	.	.	O	.	_	0	SENT_49	[p3l1977t2241r2136b2323],

1	As	IN	O	as	mark	4	SENT_50	[p3l8t2348r103b2415],
2	the	DT	O	the	det	3	SENT_50	[p3l131t2349r241b2415],
3	SNPS	NNS	O	snp	nsubj	4	SENT_50	[p3l271t2349r467b2415],
4	occur	VBP	O	occur	advcl	13	SENT_50	[p3l496t2375r686b2415],
5	in	IN	O	in	_	0	SENT_50	[p3l710t2352r778b2414],
6	complete	JJ	O	complete	amod	8	SENT_50	[p3l805t2349r1125b2439],
7	linkage	NN	O	linkage	nn	8	SENT_50	[p3l1150t2349r1404b2438],
8	disequilibrium	NN	O	disequilibrium	prep_in	4	SENT_50	[p3l1432t2349r1962b2439],
9	,	,	O	,	_	0	SENT_50	[p3l1432t2349r1962b2439],
10	they	PRP	O	they	nsubjpass	13	SENT_50	[p3l1991t2349r2144b2438],
11	can	MD	O	can	aux	13	SENT_50	[p3l11t2482r129b2521],
12	be	VB	O	be	auxpass	13	SENT_50	[p3l163t2455r244b2521],
13	tagged	VBN	O	tag	_	0	SENT_50	[p3l280t2455r514b2544],
14	by	IN	O	by	_	0	SENT_50	[p3l548t2455r633b2544],
15	the	DT	O	the	det	17	SENT_50	[p3l666t2455r776b2521],
16	intronic	JJ	O	intronic	amod	17	SENT_50	[p3l813t2458r1092b2521],
17	SNP	NN	O	snp	agent	13	SENT_50	[p3l1131t2455r1297b2522],
18	(	CD	NUMBER	(	num	19	SENT_50	[p3l1336t2453r1706b2536],
19	i-T744C	NN	O	i-t744c	dep	17	SENT_50	[p3l1336t2453r1706b2536],
20	)	CD	NUMBER	)	number	21	SENT_50	[p3l1336t2453r1706b2536],
21	(	CD	NUMBER	(	dep	19	SENT_50	[p3l1749t2453r1908b2536],
22	24	CD	NUMBER	24	num	23	SENT_50	[p3l1749t2453r1908b2536],
23	)	NN	O	)	dep	21	SENT_50	[p3l1749t2453r1908b2536],
24	.	.	O	.	_	0	SENT_50	[p3l1749t2453r1908b2536],

1	Haplotype	NN	O	haplotype	nn	2	SENT_51	[p3l1949t2456r2138b2545, p3l9t2561r224b2651],
2	H2	NN	O	h2	nsubj	15	SENT_51	[p3l261t2562r375b2628],
3	is	VBZ	O	be	auxpass	4	SENT_51	[p3l413t2564r464b2627],
4	associated	VBN	O	associate	_	0	SENT_51	[p3l503t2561r855b2627],
5	with	IN	O	with	_	0	SENT_51	[p3l886t2561r1047b2628],
6	increased	VBN	O	increase	amod	8	SENT_51	[p3l1083t2561r1410b2627],
7	platelet	NN	O	platelet	nn	8	SENT_51	[p3l1444t2561r1705b2651],
8	responsiveness	NN	O	responsiveness	prep_with	4	SENT_51	[p3l1739t2564r2137b2651, p3l11t2695r154b2735],
9	to	TO	O	to	_	0	SENT_51	[p3l210t2686r278b2735],
10	adenosine	NN	O	adenosine	nn	11	SENT_51	[p3l336t2668r685b2735],
11	diphosphate	NN	O	diphosphate	prep_to	8	SENT_51	[p3l742t2668r1174b2758],
12	but	CC	O	but	_	0	SENT_51	[p3l1228t2668r1347b2735],
13	does	VBZ	O	do	aux	15	SENT_51	[p3l1401t2668r1555b2735],
14	not	RB	O	not	neg	15	SENT_51	[p3l1613t2685r1730b2735],
15	appear	VB	O	appear	conj_but	4	SENT_51	[p3l1785t2694r2018b2758],
16	to	TO	O	to	aux	17	SENT_51	[p3l2071t2686r2139b2735],
17	inﬂuence	VB	O	inﬂuence	xcomp	15	SENT_51	[p3l10t2774r330b2841],
18	the	DT	O	the	det	19	SENT_51	[p3l368t2774r479b2841],
19	response	NN	O	response	dobj	17	SENT_51	[p3l517t2800r820b2864],
20	to	TO	O	to	_	0	SENT_51	[p3l858t2791r926b2841],
21	clopidogrel	NN	O	clopidogrel	prep_to	17	SENT_51	[p3l966t2774r1361b2864],
22	(	CD	NUMBER	(	num	21	SENT_51	[p3l1400t2772r1671b2855],
23	23,25	CD	NUMBER	23,25	num	24	SENT_51	[p3l1400t2772r1671b2855],
24	)	NN	O	)	dep	21	SENT_51	[p3l1400t2772r1671b2855],
25	.	.	O	.	_	0	SENT_51	[p3l1400t2772r1671b2855],

1	Plasma	NN	O	plasma	nn	2	SENT_52	[p3l1714t2774r1967b2841],
2	carboxylesterases	NNS	O	carboxylesterase	nsubj	3	SENT_52	[p3l2004t2800r2138b2841, p3l8t2880r500b2970],
3	break	VBP	O	break	_	0	SENT_52	[p3l541t2880r739b2947],
4	down	RP	O	down	prt	3	SENT_52	[p3l778t2880r972b2947],
5	the	DT	O	the	det	7	SENT_52	[p3l1014t2880r1124b2947],
6	active	JJ	O	active	amod	7	SENT_52	[p3l1168t2883r1365b2947],
7	metabolite	NN	O	metabolite	dobj	3	SENT_52	[p3l1409t2880r1782b2947],
8	of	IN	O	of	_	0	SENT_52	[p3l1825t2880r1905b2947],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_52	[p3l1935t2880r2137b2970, p3l11t2987r233b3076],
10	(	CD	NUMBER	(	num	9	SENT_52	[p3l277t2985r436b3067],
11	26	CD	NUMBER	26	num	12	SENT_52	[p3l277t2985r436b3067],
12	)	NN	O	)	dep	9	SENT_52	[p3l277t2985r436b3067],
13	.	.	O	.	_	0	SENT_52	[p3l277t2985r436b3067],

1	Although	IN	O	although	mark	10	SENT_53	[p3l479t2985r824b3076],
2	the	DT	O	the	det	7	SENT_53	[p3l865t2987r975b3053],
3	carboxylesterase	NN	O	carboxylesterase	nn	7	SENT_53	[p3l1019t2987r1581b3076],
4	gene	NN	O	gene	nn	7	SENT_53	[p3l1623t3013r1786b3076],
5	(	CD	NUMBER	(	num	7	SENT_53	[p3l1831t2985r2043b3067],
6	CES	NN	O	ce	nn	7	SENT_53	[p3l1831t2985r2043b3067],
7	)	NN	O	)	nsubjpass	10	SENT_53	[p3l1831t2985r2043b3067],
8	is	VBZ	O	be	auxpass	10	SENT_53	[p3l2089t2990r2139b3053],
9	well	RB	O	well	advmod	10	SENT_53	[p3l7t3093r152b3159],
10	conserved	VBN	O	conserve	advcl	16	SENT_53	[p3l198t3093r564b3174],
11	,	,	O	,	_	0	SENT_53	[p3l198t3093r564b3174],
12	a	DT	O	a	det	13	SENT_53	[p3l614t3119r648b3159],
13	polymorphism	NN	O	polymorphism	nsubjpass	16	SENT_53	[p3l692t3093r1207b3182],
14	has	VBZ	O	have	aux	16	SENT_53	[p3l1254t3093r1366b3159],
15	been	VBN	O	be	auxpass	16	SENT_53	[p3l1412t3093r1578b3159],
16	described	VBN	O	describe	_	0	SENT_53	[p3l1625t3093r1956b3159],
17	that	IN	O	that	complm	18	SENT_53	[p3l2001t3093r2142b3159],
18	decreases	VBZ	O	decrease	ccomp	16	SENT_53	[p3l11t3199r333b3265],
19	messenger	NN	O	messenger	dobj	18	SENT_53	[p3l369t3225r736b3288],
20	ribonucleic	JJ	O	ribonucleic	amod	23	SENT_53	[p3l766t3199r1157b3265],
21	acid	NN	O	acid	nn	23	SENT_53	[p3l1191t3199r1331b3265],
22	transcription	NN	O	transcription	nn	23	SENT_53	[p3l1363t3202r1815b3288],
23	(	NN	O	(	tmod	18	SENT_53	[p3l1851t3197r2011b3279],
24	27	CD	NUMBER	27	num	25	SENT_53	[p3l1851t3197r2011b3279],
25	)	NN	O	)	dep	23	SENT_53	[p3l1851t3197r2011b3279],
26	.	.	O	.	_	0	SENT_53	[p3l1851t3197r2011b3279],

1	We	PRP	O	we	nsubj	2	SENT_54	[p3l95t3306r226b3372],
2	evaluated	VBD	O	evaluate	_	0	SENT_54	[p3l258t3305r587b3371],
3	the	DT	O	the	det	4	SENT_54	[p3l616t3305r726b3371],
4	impact	NN	O	impact	dobj	2	SENT_54	[p3l758t3308r1000b3394],
5	of	IN	O	of	_	0	SENT_54	[p3l1029t3305r1109b3371],
6	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_54	[p3l1127t3305r1672b3394],
7	in	IN	O	in	_	0	SENT_54	[p3l1704t3308r1772b3370],
8	a	DT	O	a	det	9	SENT_54	[p3l1804t3331r1838b3371],
9	number	NN	O	number	prep_in	2	SENT_54	[p3l1868t3305r2142b3371],
10	of	IN	O	of	_	0	SENT_54	[p3l11t3411r91b3477],
11	genes	NNS	O	gene	prep_of	9	SENT_54	[p3l117t3437r310b3500],
12	to	TO	O	to	aux	13	SENT_54	[p3l350t3428r418b3477],
13	determine	VB	O	determine	xcomp	2	SENT_54	[p3l460t3411r816b3477],
14	whether	IN	O	whether	complm	16	SENT_54	[p3l852t3411r1145b3477],
15	they	PRP	O	they	nsubj	16	SENT_54	[p3l1182t3411r1335b3500],
16	inﬂuence	VBP	O	inﬂuence	ccomp	13	SENT_54	[p3l1370t3411r1690b3477],
17	response	NN	O	response	dobj	16	SENT_54	[p3l1729t3436r2032b3500],
18	to	TO	O	to	_	0	SENT_54	[p3l2071t3428r2139b3477],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_54	[p3l11t3518r406b3608],
20	therapy	NN	O	therapy	prep_to	17	SENT_54	[p3l464t3518r732b3608],
21	as	IN	O	as	_	0	SENT_54	[p3l789t3544r852b3584],
22	part	NN	O	part	prep_as	16	SENT_54	[p3l912t3535r1054b3608],
23	of	IN	O	of	_	0	SENT_54	[p3l1113t3518r1193b3584],
24	a	DT	O	a	prep_of	22	SENT_54	[p3l1242t3544r1277b3584],
25	randomized	VBN	O	randomize	partmod	24	SENT_54	[p3l1335t3518r1776b3599],
26	,	,	O	,	_	0	SENT_54	[p3l1335t3518r1776b3599],
27	placebocontrolled	JJ	O	placebocontrolled	amod	28	SENT_54	[p3l1837t3518r2138b3607, p3l11t3624r369b3690],
28	trial	NN	O	trial	dobj	25	SENT_54	[p3l407t3624r548b3690],
29	comparing	VBG	O	compare	partmod	28	SENT_54	[p3l587t3627r965b3714],
30	the	DT	O	the	det	32	SENT_54	[p3l1002t3624r1112b3690],
31	antiplatelet	JJ	O	antiplatelet	amod	32	SENT_54	[p3l1153t3624r1549b3714],
32	effect	NN	O	effect	dobj	29	SENT_54	[p3l1588t3624r1773b3690],
33	of	IN	O	of	_	0	SENT_54	[p3l1811t3624r1891b3690],
34	a	DT	O	a	det	38	SENT_54	[p3l1919t3650r1954b3690],
35	split	NN	O	split	nn	38	SENT_54	[p3l1993t3624r2142b3714],
36	dose	NN	O	dose	nn	38	SENT_54	[p3l11t3730r166b3796],
37	1,200-mg	JJ	O	1,200-mg	amod	38	SENT_54	[p3l217t3734r562b3819],
38	clopidogrel	NN	O	clopidogrel	prep_of	32	SENT_54	[p3l606t3730r1001b3820],
39	loading	VBG	O	load	partmod	38	SENT_54	[p3l1044t3730r1309b3819],
40	dose	NN	O	dose	dobj	39	SENT_54	[p3l1354t3730r1508b3796],
41	with	IN	O	with	_	0	SENT_54	[p3l1551t3730r1713b3797],
42	a	DT	O	a	det	43	SENT_54	[p3l1759t3756r1794b3796],
43	standard	NN	O	standard	prep_with	39	SENT_54	[p3l1839t3730r2141b3796],

1	600-mg	JJ	O	600-mg	_	0	SENT_55	[p4l12t20r293b105],
2	loading	VBG	O	load	dep	1	SENT_55	[p4l327t16r592b105],
3	dose	NN	O	dose	dobj	2	SENT_55	[p4l628t16r783b82],
4	and	CC	O	and	_	0	SENT_55	[p4l823t16r950b82],
5	comparing	VBG	O	compare	conj_and	2	SENT_55	[p4l987t42r1168b82, p4l9t127r237b213],
6	a	DT	O	a	det	11	SENT_55	[p4l265t150r299b189],
7	150	CD	NUMBER	150	number	8	SENT_55	[p4l330t123r609b212],
8	—	CD	NUMBER	—	num	9	SENT_55	[p4l330t123r609b212],
9	mg	NN	O	mg	nn	11	SENT_55	[p4l330t123r609b212],
10	daily	JJ	SET	daily	amod	11	SENT_55	[p4l636t123r805b212],
11	dose	NN	O	dose	dobj	5	SENT_55	[p4l830t123r985b189],
12	with	IN	O	with	_	0	SENT_55	[p4l1010t123r1172b190],
13	Abb	NN	ORGANIZATION	abb	prep_with	11	SENT_55	[p4l1378t117r1836b170],
14	'	''	O	'	_	0	SENT_55	[p4l1378t117r1836b170],
15	eViati	FW	O	eviati	nn	16	SENT_55	[p4l1378t117r1836b170],
16	°	FW	O	°	amod	11	SENT_55	[p4l1378t117r1836b170],
17	"	``	O	"	punct	11	SENT_55	[p4l1378t117r1836b170],
18	5	CD	NUMBER	5	nsubj	28	SENT_55	[p4l1378t117r1836b170],
19	a	DT	O	a	det	22	SENT_55	[p4l12t283r46b323],
20	75	CD	NUMBER	75	number	21	SENT_55	[p4l76t257r157b324],
21	—	CD	NUMBER	—	num	22	SENT_55	[p4l166t283r313b346],
22	mg	NN	O	mg	dep	18	SENT_55	[p4l166t283r313b346],
23	daily	JJ	SET	daily	amod	25	SENT_55	[p4l342t257r511b346],
24	maintenance	NN	O	maintenance	nn	25	SENT_55	[p4l537t260r986b323],
25	dos	NN	O	do	dep	18	SENT_55	[p4l1018t257r1168b323],
26	—	CD	NUMBER	—	dep	18	SENT_55	[p4l1018t257r1168b323],
27	am	VBP	O	be	cop	28	SENT_55	[p4l1380t242r1496b295],
28	‘	CD	NUMBER	‘	dep	11	SENT_55	[p4l1380t242r1496b295],
29	A	DT	O	a	det	30	SENT_55	[p4l1526t242r1855b307],
30	°	NN	O	°	dep	28	SENT_55	[p4l1526t242r1855b307],
31	"	''	O	"	punct	11	SENT_55	[p4l1526t242r1855b307],
32	°	CD	NUMBER	°	dobj	2	SENT_55	[p4l1526t242r1855b307],
33	"	``	O	"	punct	32	SENT_55	[p4l1526t242r1855b307],
34	ym5	NN	O	ym5	dep	32	SENT_55	[p4l1526t242r1855b307],

1	age	NN	O	age	_	0	SENT_56	[p4l12t426r125b489],
2	in	IN	O	in	_	0	SENT_56	[p4l156t403r224b465],
3	patients	NNS	O	patient	prep_in	1	SENT_56	[p4l254t403r531b490],
4	undergoing	VBG	O	undergo	partmod	1	SENT_56	[p4l562t400r970b489],
5	PCI	NN	O	pcus	dobj	4	SENT_56	[p4l999t400r1167b466],
6	.	.	O	.	_	0	SENT_56	[p4l999t400r1167b466],

1	cyp	NN	O	cyp	_	0	SENT_57	[p4l1379t437r1484b478],
2	=	JJ	O	=	amod	4	SENT_57	[p4l1511t450r1547b469],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_57	[p4l1574t437r1875b488],
4	P450	NN	O	p450	dep	1	SENT_57	[p4l1899t437r2034b478],

1	i	FW	O	i	_	0	SENT_58	[p4l1381t557r1389b598],
2	=	JJ	O	=	amod	3	SENT_58	[p4l1418t571r1453b589],
3	intronic	JJ	O	intronic	amod	1	SENT_58	[p4l1482t557r1673b598],

1	Methods	NNS	O	method	_	0	SENT_59	[p4l13t697r378b760],

1	PCI	NN	O	pcus	_	0	SENT_60	[p4l1381t748r1464b789],
2	=	JJ	O	=	amod	5	SENT_60	[p4l1494t762r1530b780],
3	percutaneous	JJ	O	percutaneous	amod	5	SENT_60	[p4l1558t750r1905b799],
4	coronary	JJ	O	coronary	amod	5	SENT_60	[p4l1379t842r1600b883],
5	intervention	NN	O	intervention	dep	1	SENT_60	[p4l1623t832r1926b874],

1	The	DT	O	the	det	3	SENT_61	[p4l8t891r156b959],
2	Study	NNP	O	Study	nn	3	SENT_61	[p4l223t893r416b982],
3	protocol	NN	O	protocol	nsubjpass	23	SENT_61	[p4l475t893r777b982],
4	*	CD	NUMBER	*	num	6	SENT_61	[p4l843t891r1008b982],
5	1	CD	NUMBER	1	num	6	SENT_61	[p4l1081t890r1169b973],
6	)	NN	O	)	dep	3	SENT_61	[p4l1081t890r1169b973],
7	’	CD	NUMBER	’	num	14	SENT_61	[p4l1081t890r1169b973],
8	SNP	NN	O	snp	nn	14	SENT_61	[p4l1378t952r1485b993],
9	=	JJ	O	=	amod	14	SENT_61	[p4l1512t966r1547b984],
10	single	JJ	O	single	amod	14	SENT_61	[p4l1573t952r1725b1003],
11	nucleotide	NN	O	nucleotide	nn	14	SENT_61	[p4l1748t952r2014b993],
12	baseline	NN	O	baseline	nn	14	SENT_61	[p4l8t999r290b1066],
13	patient	NN	O	patient	nn	14	SENT_61	[p4l348t1002r597b1089],
14	characteristics	NNS	O	characteristic	dep	3	SENT_61	[p4l654t999r1169b1080],
15	,	,	O	,	_	0	SENT_61	[p4l654t999r1169b1080],
16	po	NN	O	po	nn	18	SENT_61	[p4l1381t1037r1732b1088],
17	|	NN	O	|	nn	18	SENT_61	[p4l1381t1037r1732b1088],
18	ymofphism	NN	O	ymofphism	conj_and	14	SENT_61	[p4l1381t1037r1732b1088],
19	and	CC	O	and	_	0	SENT_61	[p4l12t1106r139b1172],
20	additional	JJ	O	additional	amod	21	SENT_61	[p4l196t1106r550b1172],
21	pharmacotherapies	NNS	O	pharmacotherapy	conj_and	14	SENT_61	[p4l603t1106r1169b1196, p4l9t1216r144b1303],
22	are	VBP	O	be	auxpass	23	SENT_61	[p4l183t1239r283b1279],
23	described	VBN	O	describe	_	0	SENT_61	[p4l321t1213r653b1279],
24	in	IN	O	in	_	0	SENT_61	[p4l687t1216r755b1279],
25	the	DT	O	the	det	27	SENT_61	[p4l791t1213r901b1279],
26	accompanying	VBG	O	accompany	amod	27	SENT_61	[p4l939t1216r1446b1303],
27	report	NN	O	report	prep_in	23	SENT_61	[p4l1480t1230r1696b1303],
28	(	CD	NUMBER	(	number	29	SENT_61	[p4l1733t1211r1870b1294],
29	28	CD	NUMBER	28	num	30	SENT_61	[p4l1733t1211r1870b1294],
30	)	NN	O	)	npadvmod	27	SENT_61	[p4l1733t1211r1870b1294],
31	in	IN	O	in	_	0	SENT_61	[p4l1909t1216r1977b1279],
32	this	DT	O	this	det	33	SENT_61	[p4l2012t1213r2139b1279],
33	issue	NN	O	issue	prep_in	27	SENT_61	[p4l10t1321r176b1384],
34	of	IN	O	of	_	0	SENT_61	[p4l211t1318r291b1384],
35	]	CD	NUMBER	]	num	36	SENT_61	[p4l297t1321r536b1400],
36	ﬂCC	NN	O	ﬂcc	prep_of	33	SENT_61	[p4l297t1321r536b1400],
37	.	.	O	.	_	0	SENT_61	[p4l297t1321r536b1400],
38	'	''	O	'	_	0	SENT_61	[p4l297t1321r536b1400],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_62	[p4l574t1321r1081b1385],
2	Interventions	NNPS	O	Interventions	_	0	SENT_62	[p4l1105t1321r1576b1384],
3	.	.	O	.	_	0	SENT_62	[p4l1105t1321r1576b1384],

1	Genotyping	NN	O	genotyping	_	0	SENT_63	[p4l11t1433r443b1507],
2	.	.	O	.	_	0	SENT_63	[p4l11t1433r443b1507],

1	Deoxyribonucleic	JJ	MISC	deoxyribonucleic	amod	2	SENT_64	[p4l492t1424r1122b1514],
2	acid	NN	O	acid	nsubjpass	4	SENT_64	[p4l1186t1424r1328b1491],
3	was	VBD	O	be	auxpass	4	SENT_64	[p4l1387t1451r1517b1491],
4	extracted	VBN	O	extract	_	0	SENT_64	[p4l1582t1424r1906b1491],
5	from	IN	O	from	_	0	SENT_64	[p4l1968t1424r2139b1491],
6	whole	JJ	O	whole	amod	7	SENT_64	[p4l7t1530r220b1597],
7	blood	NN	O	blood	prep_from	4	SENT_64	[p4l268t1530r470b1597],
8	using	VBG	O	use	xcomp	4	SENT_64	[p4l517t1533r707b1620],
9	the	DT	O	the	det	11	SENT_64	[p4l753t1530r864b1597],
10	(	NN	O	(	nn	11	SENT_64	[p4l915t1529r1235b1620],
11	lIAamp	NN	O	liaamp	dobj	8	SENT_64	[p4l915t1529r1235b1620],
12	DNA	NN	O	dna	nn	13	SENT_64	[p4l1286t1529r1493b1597],
13	Blood	NN	O	blood	dep	18	SENT_64	[p4l1540t1530r1753b1597],
14	Mini	NNP	O	Mini	dep	13	SENT_64	[p4l1800t1531r1980b1596],
15	Kit	NN	O	kit	dep	18	SENT_64	[p4l2031t1531r2142b1597],
16	(	CD	NUMBER	(	num	15	SENT_64	[p4l13t1634r411b1719],
17	CLIAGEN	NNP	ORGANIZATION	CLIAGEN	nn	18	SENT_64	[p4l13t1634r411b1719],
18	N.V.	NNP	ORGANIZATION	N.V.	dep	8	SENT_64	[p4l457t1637r652b1716],
19	,	,	O	,	_	0	SENT_64	[p4l457t1637r652b1716],
20	Venlo	NNP	LOCATION	Venlo	appos	18	SENT_64	[p4l700t1636r931b1716],
21	,	,	O	,	_	0	SENT_64	[p4l700t1636r931b1716],
22	the	DT	O	the	det	24	SENT_64	[p4l979t1636r1089b1701],
23	Netherlands	NNP	LOCATION	Netherlands	nn	24	SENT_64	[p4l1134t1634r1596b1716],
24	)	NN	O	)	appos	18	SENT_64	[p4l1134t1634r1596b1716],
25	and	CC	O	and	_	0	SENT_64	[p4l1646t1636r1773b1701],
26	stored	VBD	O	store	conj_and	4	SENT_64	[p4l1819t1636r2034b1701],
27	at	IN	O	at	_	0	SENT_64	[p4l2079t1653r2142b1701],
28	—	CD	NUMBER	—	prep_at	36	SENT_64	[p4l19t1742r281b1809],
29	20	CD	NUMBER	20	number	30	SENT_64	[p4l19t1742r281b1809],
30	°	CD	NUMBER	°	num	32	SENT_64	[p4l19t1742r281b1809],
31	C.	NNP	O	C.	nn	32	SENT_64	[p4l19t1742r281b1809],
32	Genes	NNS	O	gene	nsubjpass	36	SENT_64	[p4l317t1742r538b1808],
33	of	IN	O	of	_	0	SENT_64	[p4l570t1742r650b1808],
34	interest	NN	O	interest	prep_of	32	SENT_64	[p4l668t1745r932b1808],
35	were	VBD	O	be	auxpass	36	SENT_64	[p4l956t1767r1123b1808],
36	identified	VBN	O	identify	ccomp	26	SENT_64	[p4l1153t1742r1491b1808],
37	using	VBG	O	use	xcomp	36	SENT_64	[p4l1519t1745r1709b1831],
38	a	DT	O	a	det	40	SENT_64	[p4l1739t1768r1773b1808],
39	candidate	NN	O	candidate	nn	40	SENT_64	[p4l1803t1742r2140b1808],
40	gene	NN	O	gene	dobj	37	SENT_64	[p4l9t1874r172b1937],
41	approach	NN	O	approach	nn	43	SENT_64	[p4l205t1848r526b1937],
42	(	CD	NUMBER	(	num	43	SENT_64	[p4l559t1846r788b1928],
43	Table	NNP	O	Table	dep	40	SENT_64	[p4l559t1846r788b1928],
44	1	CD	NUMBER	1	number	45	SENT_64	[p4l823t1846r907b1928],
45	)	CD	NUMBER	)	dep	43	SENT_64	[p4l823t1846r907b1928],
46	.	.	O	.	_	0	SENT_64	[p4l823t1846r907b1928],

1	The	DT	O	the	det	14	SENT_65	[p4l938t1846r1085b1914],
2	CYP3ﬂ4	NN	O	cyp3ﬂ4	nn	14	SENT_65	[p4l1123t1851r1545b1915],
3	*	CD	NUMBER	*	num	14	SENT_65	[p4l1123t1851r1545b1915],
4	1B	NN	O	1b	nn	14	SENT_65	[p4l1123t1851r1545b1915],
5	(	CD	NUMBER	(	num	14	SENT_65	[p4l1576t1846r1736b1929],
6	16	CD	NUMBER	16	num	14	SENT_65	[p4l1576t1846r1736b1929],
7	)	NN	O	)	nn	14	SENT_65	[p4l1576t1846r1736b1929],
8	,	,	O	,	_	0	SENT_65	[p4l1576t1846r1736b1929],
9	CYP3Al4	NN	O	cyp3al4	dep	14	SENT_65	[p4l1776t1851r2141b1915],
10	*	CD	NUMBER	*	num	14	SENT_65	[p4l1776t1851r2141b1915],
11	3	CD	NUMBER	3	num	14	SENT_65	[p4l1776t1851r2141b1915],
12	(	NN	O	(	nn	14	SENT_65	[p4l13t1952r174b2035],
13	15	CD	NUMBER	15	num	14	SENT_65	[p4l13t1952r174b2035],
14	)	NN	O	)	nsubjpass	33	SENT_65	[p4l13t1952r174b2035],
15	,	,	O	,	_	0	SENT_65	[p4l13t1952r174b2035],
16	CYP3ﬂ4	NN	O	cyp3ﬂ4	nn	17	SENT_65	[p4l208t1957r577b2021],
17	*	NN	O	*	dep	28	SENT_65	[p4l208t1957r577b2021],
18	4	CD	NUMBER	4	number	19	SENT_65	[p4l208t1957r577b2021],
19	(	CD	NUMBER	(	dep	17	SENT_65	[p4l599t1952r760b2035],
20	12	CD	NUMBER	12	num	21	SENT_65	[p4l599t1952r760b2035],
21	)	NN	O	)	dep	19	SENT_65	[p4l599t1952r760b2035],
22	,	,	O	,	_	0	SENT_65	[p4l599t1952r760b2035],
23	and	CC	O	and	_	0	SENT_65	[p4l788t1954r915b2020],
24	CYP2CJ9	NN	O	cyp2cj9	conj_and	19	SENT_65	[p4l945t1957r1355b2021],
25	*	CD	NUMBER	*	num	26	SENT_65	[p4l945t1957r1355b2021],
26	Z	NN	O	z	dep	28	SENT_65	[p4l945t1957r1355b2021],
27	7	CD	NUMBER	7	num	28	SENT_65	[p4l1370t1959r1408b2020],
28	(	CD	NUMBER	(	dep	33	SENT_65	[p4l1429t1952r1567b2034],
29	19	CD	NUMBER	19	num	30	SENT_65	[p4l1429t1952r1567b2034],
30	)	NN	O	)	dep	28	SENT_65	[p4l1429t1952r1567b2034],
31	polymorphisms	NNS	O	polymorphism	nsubjpass	33	SENT_65	[p4l1593t1954r2139b2043],
32	were	VBD	O	be	auxpass	33	SENT_65	[p4l7t2086r173b2126],
33	identiﬁed	VBN	O	identiﬁed	_	0	SENT_65	[p4l229t2060r567b2126],
34	by	IN	O	by	_	0	SENT_65	[p4l619t2060r705b2149],
35	polymerase	NN	O	polymerase	nn	43	SENT_65	[p4l755t2060r1150b2150],
36	chain	NN	O	chain	nn	43	SENT_65	[p4l1207t2060r1396b2126],
37	reaction	NN	O	reaction	nn	43	SENT_65	[p4l1451t2063r2141b2126],
38	—	NN	O	—	nn	43	SENT_65	[p4l1451t2063r2141b2126],
39	restriction	NN	O	restriction	nn	43	SENT_65	[p4l1451t2063r2141b2126],
40	fragment	NN	O	fragment	nn	43	SENT_65	[p4l10t2167r333b2256],
41	length	NN	O	length	nn	43	SENT_65	[p4l389t2167r614b2256],
42	polymorphism	NN	O	polymorphism	nn	43	SENT_65	[p4l672t2167r1187b2257],
43	methods	NNS	O	method	nsubj	45	SENT_65	[p4l1247t2167r1549b2233],
44	previously	RB	DATE	previously	advmod	45	SENT_65	[p4l1609t2167r1969b2257],
45	described	VBN	O	describe	agent	33	SENT_65	[p4l2025t2167r2138b2233, p4l12t2273r280b2339],
46	and	CC	O	and	_	0	SENT_65	[p4l349t2273r484b2339],
47	the	DT	O	the	det	49	SENT_65	[p4l552t2273r669b2339],
48	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	49	SENT_65	[p4l745t2276r1157b2353],
49	*	NN	O	*	dep	56	SENT_65	[p4l745t2276r1157b2353],
50	3	CD	NUMBER	3	dep	49	SENT_65	[p4l745t2276r1157b2353],
51	,	,	O	,	_	0	SENT_65	[p4l745t2276r1157b2353],
52	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	53	SENT_65	[p4l1236t2276r1647b2353],
53	”‘	NN	O	”‘	appos	49	SENT_65	[p4l1236t2276r1647b2353],
54	2	CD	NUMBER	2	dep	53	SENT_65	[p4l1236t2276r1647b2353],
55	,	,	O	,	_	0	SENT_65	[p4l1236t2276r1647b2353],
56	CYP3	NN	O	cyp3	agent	33	SENT_65	[p4l1726t2276r2134b2349],
57	.	.	O	.	_	0	SENT_65	[p4l1726t2276r2134b2349],

1	/	:	O	/	punct	39	SENT_66	[p4l1726t2276r2134b2349],
2	45	CD	NUMBER	45	number	3	SENT_66	[p4l1726t2276r2134b2349],
3	*	CD	NUMBER	*	dep	39	SENT_66	[p4l1726t2276r2134b2349],
4	6	CD	NUMBER	6	dep	3	SENT_66	[p4l1726t2276r2134b2349],
5	,	,	O	,	_	0	SENT_66	[p4l1726t2276r2134b2349],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_66	[p4l17t2382r494b2455],
7	*	NN	O	*	dep	39	SENT_66	[p4l17t2382r494b2455],
8	2	CD	NUMBER	2	dep	7	SENT_66	[p4l17t2382r494b2455],
9	,	,	O	,	_	0	SENT_66	[p4l17t2382r494b2455],
10	CYP2C19	NN	O	cyp2c19	dep	39	SENT_66	[p4l580t2382r1057b2455],
11	*	CD	NUMBER	*	number	12	SENT_66	[p4l580t2382r1057b2455],
12	3	CD	NUMBER	3	dep	10	SENT_66	[p4l580t2382r1057b2455],
13	,	,	O	,	_	0	SENT_66	[p4l580t2382r1057b2455],
14	CYP2C19	NN	O	cyp2c19	nn	15	SENT_66	[p4l1143t2382r1620b2455],
15	*	NN	O	*	dep	39	SENT_66	[p4l1143t2382r1620b2455],
16	4	CD	NUMBER	4	dep	15	SENT_66	[p4l1143t2382r1620b2455],
17	,	,	O	,	_	0	SENT_66	[p4l1143t2382r1620b2455],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_66	[p4l1706t2382r2133b2455],
19	*	NN	O	*	dep	39	SENT_66	[p4l1706t2382r2133b2455],
20	2	CD	NUMBER	2	dep	19	SENT_66	[p4l1706t2382r2133b2455],
21	,	,	O	,	_	0	SENT_66	[p4l1706t2382r2133b2455],
22	CYP2C9	NN	O	cyp2c9	dep	39	SENT_66	[p4l17t2489r466b2562],
23	*	CD	NUMBER	*	number	24	SENT_66	[p4l17t2489r466b2562],
24	3	CD	NUMBER	3	dep	22	SENT_66	[p4l17t2489r466b2562],
25	,	,	O	,	_	0	SENT_66	[p4l17t2489r466b2562],
26	and	CC	NUMBER	and	_	0	SENT_66	[p4l552t2486r696b2552],
27	11190131	CD	NUMBER	11190131	num	28	SENT_66	[p4l764t2489r1068b2553],
28	1236C	NN	O	1236c	dep	39	SENT_66	[p4l1153t2485r1603b2567],
29	>	JJR	O	>	amod	30	SENT_66	[p4l1153t2485r1603b2567],
30	T	NN	O	t	nn	36	SENT_66	[p4l1153t2485r1603b2567],
31	,	,	O	,	_	0	SENT_66	[p4l1153t2485r1603b2567],
32	3435C	NN	O	3435c	appos	30	SENT_66	[p4l1685t2485r2137b2567],
33	>	JJR	O	>	amod	34	SENT_66	[p4l1685t2485r2137b2567],
34	T	NN	O	t	dep	32	SENT_66	[p4l1685t2485r2137b2567],
35	,	,	O	,	_	0	SENT_66	[p4l1685t2485r2137b2567],
36	2677G	NN	O	2677g	dep	28	SENT_66	[p4l9t2591r492b2660],
37	>	JJR	O	>	amod	39	SENT_66	[p4l9t2591r492b2660],
38	A/T	NN	O	a/t	nn	39	SENT_66	[p4l9t2591r492b2660],
39	polymorphisms	NNS	O	polymorphism	nsubjpass	41	SENT_66	[p4l513t2592r1059b2682],
40	were	VBD	O	be	auxpass	41	SENT_66	[p4l1080t2618r1246b2659],
41	investigated	VBN	O	investigate	_	0	SENT_66	[p4l1271t2592r1692b2682],
42	by	IN	O	by	_	0	SENT_66	[p4l1713t2592r1799b2682],
43	real	JJ	O	real	amod	48	SENT_66	[p4l1818t2593r2140b2659],
44	—	JJ	O	—	amod	48	SENT_66	[p4l1818t2593r2140b2659],
45	time	NN	O	time	nn	48	SENT_66	[p4l1818t2593r2140b2659],
46	polymerase	NN	O	polymerase	nn	48	SENT_66	[p4l9t2700r405b2789],
47	chain	NN	O	chain	nn	48	SENT_66	[p4l460t2700r649b2766],
48	reaction	NN	O	reaction	agent	41	SENT_66	[p4l703t2702r986b2766],
49	using	VBG	O	use	xcomp	41	SENT_66	[p4l1038t2702r1229b2789],
50	TaqMan	NNP	O	TaqMan	nn	51	SENT_66	[p4l1277t2698r1595b2789],
51	kits	NNS	O	kit	dobj	49	SENT_66	[p4l1649t2700r1771b2766],
52	(	CD	NUMBER	(	num	54	SENT_66	[p4l1830t2697r2141b2789],
53	Applied	NNP	O	Applied	nn	54	SENT_66	[p4l1830t2697r2141b2789],
54	Biosystems	NNP	O	Biosystems	dep	66	SENT_66	[p4l11t2806r425b2895],
55	,	,	O	,	_	0	SENT_66	[p4l11t2806r425b2895],
56	Foster	NNP	LOCATION	Foster	nn	57	SENT_66	[p4l455t2806r678b2872],
57	City	NNP	LOCATION	City	dep	66	SENT_66	[p4l706t2805r877b2895],
58	,	,	O	,	_	0	SENT_66	[p4l706t2805r877b2895],
59	California	NNP	LOCATION	California	nn	60	SENT_66	[p4l909t2803r1291b2886],
60	)	NN	O	)	dep	66	SENT_66	[p4l909t2803r1291b2886],
61	and	CC	O	and	_	0	SENT_66	[p4l1323t2805r1450b2872],
62	ABI	NN	O	abus	conj_and	54	SENT_66	[p4l1474t2804r1629b2871],
63	PRISM	NN	O	prism	dep	66	SENT_66	[p4l1658t2805r1938b2872],
64	7000	CD	NUMBER	7000	num	63	SENT_66	[p4l1968t2807r2139b2872],
65	Sequence	NN	O	sequence	nn	66	SENT_66	[p4l14t2912r342b3001],
66	Detection	NN	O	detection	dep	49	SENT_66	[p4l390t2913r743b2978],
67	System	NNP	O	System	nn	71	SENT_66	[p4l793t2912r1042b3001],
68	(	NNP	O	(	nn	71	SENT_66	[p4l1093t2910r1404b3001],
69	Applied	NNP	O	Applied	nn	71	SENT_66	[p4l1093t2910r1404b3001],
70	Biosystems	NNP	O	Biosystems	nn	71	SENT_66	[p4l1450t2910r1871b3001],
71	)	NN	O	)	dep	66	SENT_66	[p4l1450t2910r1871b3001],
72	at	IN	O	at	_	0	SENT_66	[p4l1922t2929r1985b2978],
73	the	DT	O	the	det	74	SENT_66	[p4l2030t2912r2140b2978],
74	Department	NNP	ORGANIZATION	Department	prep_at	49	SENT_66	[p4l11t3019r446b3107],
75	of	IN	ORGANIZATION	of	_	0	SENT_66	[p4l494t3018r574b3084],
76	Medical	NNP	ORGANIZATION	Medical	nn	77	SENT_66	[p4l609t3018r901b3084],
77	Science	NNP	ORGANIZATION	Science	prep_of	74	SENT_66	[p4l952t3018r1234b3099],
78	,	,	O	,	_	0	SENT_66	[p4l952t3018r1234b3099],
79	Clinical	JJ	O	clinical	amod	80	SENT_66	[p4l1287t3018r1564b3084],
80	Pharmacology	NN	O	pharmacology	appos	77	SENT_66	[p4l1612t3018r2137b3107],
81	,	,	O	,	_	0	SENT_66	[p4l1612t3018r2137b3107],
82	Uppsala	NNP	ORGANIZATION	Uppsala	nn	83	SENT_66	[p4l9t3125r296b3214],
83	University	NNP	ORGANIZATION	University	appos	77	SENT_66	[p4l330t3126r714b3214],
84	,	,	O	,	_	0	SENT_66	[p4l330t3126r714b3214],
85	Uppsala	NNP	LOCATION	Uppsala	appos	77	SENT_66	[p4l752t3125r1058b3214],
86	,	,	O	,	_	0	SENT_66	[p4l752t3125r1058b3214],
87	Sweden	NNP	LOCATION	Sweden	appos	77	SENT_66	[p4l1101t3125r1392b3191],
88	.	.	O	.	_	0	SENT_66	[p4l1101t3125r1392b3191],

1	Genotyping	VBG	O	genotype	_	0	SENT_67	[p4l1434t3125r1860b3214],
2	for	IN	O	for	_	0	SENT_67	[p4l1895t3125r1995b3191],
3	the	DT	O	the	det	8	SENT_67	[p4l2030t3125r2140b3191],
4	P2Y	NN	O	p2y	nn	8	SENT_67	[p4l10t3235r242b3298],
5	]	NN	O	]	nn	8	SENT_67	[p4l10t3235r242b3298],
6	2	CD	NUMBER	2	num	8	SENT_67	[p4l10t3235r242b3298],
7	H2	NN	O	h2	nn	8	SENT_67	[p4l291t3232r405b3298],
8	haplotype	NN	O	haplotype	prep_for	1	SENT_67	[p4l457t3231r802b3320],
9	and	CC	O	and	_	0	SENT_67	[p4l854t3231r981b3297],
10	carboxylesterase	NN	O	carboxylesterase	nn	12	SENT_67	[p4l1030t3231r1593b3320],
11	intronic	JJ	O	intronic	amod	12	SENT_67	[p4l1643t3234r1922b3297],
12	SNP	NN	O	snp	prep_for	1	SENT_67	[p4l1974t3231r2141b3297],
13	(	CD	NUMBER	(	num	14	SENT_67	[p4l13t3335r424b3417],
14	IVS10	NN	O	ivs10	dep	12	SENT_67	[p4l13t3335r424b3417],
15	—	CD	NUMBER	—	number	16	SENT_67	[p4l13t3335r424b3417],
16	88	CD	NUMBER	88	num	17	SENT_67	[p4l13t3335r424b3417],
17	)	NN	O	)	dep	14	SENT_67	[p4l13t3335r424b3417],
18	was	VBD	O	be	auxpass	19	SENT_67	[p4l487t3363r617b3403],
19	performed	VBN	O	perform	aux	1	SENT_67	[p4l680t3337r1054b3427],
20	using	VBG	O	use	xcomp	19	SENT_67	[p4l1115t3340r1307b3426],
21	iPlex	NN	O	iplex	nn	22	SENT_67	[p4l1368t3337r1545b3403],
22	assays	NNS	O	assay	dobj	20	SENT_67	[p4l1608t3363r1813b3426],
23	on	IN	O	on	_	0	SENT_67	[p4l1878t3363r1966b3403],
24	the	DT	O	the	det	26	SENT_67	[p4l2029t3337r2140b3403],
25	Autoﬂex	NNP	MISC	Autoﬂex	nn	26	SENT_67	[p4l8t3442r317b3509],
26	mass	NN	O	mass	prep_on	20	SENT_67	[p4l353t3469r520b3509],
27	spectrometer	NN	O	spectrometer	nn	29	SENT_67	[p4l559t3460r1017b3532],
28	(	CD	NUMBER	(	num	29	SENT_67	[p4l1054t3441r1475b3533],
29	Sequenom	NNP	ORGANIZATION	Sequenom	nsubj	1	SENT_67	[p4l1054t3441r1475b3533],
30	,	,	O	,	_	0	SENT_67	[p4l1054t3441r1475b3533],
31	San	NNP	LOCATION	San	nn	32	SENT_67	[p4l1517t3443r1645b3510],
32	Diego	NNP	LOCATION	Diego	appos	29	SENT_67	[p4l1681t3444r1918b3532],
33	,	,	O	,	_	0	SENT_67	[p4l1681t3444r1918b3532],
34	Cali622	NN	O	cali622	appos	32	SENT_67	[p4l1960t3443r2138b3510, p4l44t3608r93b3628],

1	Gladdingetal	JJ	O	gladdingetal	_	0	SENT_68	[p4l194t3608r373b3633],
2	.	.	O	.	_	0	SENT_68	[p4l194t3608r373b3633],

1	JACC	NN	O	jacc	_	0	SENT_69	[p4l1278t3613r1348b3628],
2	:	:	O	:	_	0	SENT_69	[p4l1278t3613r1348b3628],
3	AAAAAAAAAAAAAAAAAAAAAAAAAAAAA	NNP	O	AAAAAAAAAAAAAAAAAAAAAAAAAAAAA	nn	4	SENT_69	[p4l1365t3613r1862b3630],
4	oL	NN	O	ol	dep	1	SENT_69	[p4l1867t3613r1906b3628],
5	.	.	O	.	_	0	SENT_69	[p4l1867t3613r1906b3628],

1	1	CD	NUMBER	1	dep	24	SENT_70	[p4l1924t3614r1944b3630],
2	,	,	O	,	_	0	SENT_70	[p4l1924t3614r1944b3630],
3	No.	NN	O	no.	nn	4	SENT_70	[p4l1961t3613r2004b3628],
4	s	NNS	O	s	appos	1	SENT_70	[p4l2021t3614r2031b3628],
5	,	,	O	,	_	0	SENT_70	[p4l2036t3624r2041b3630],
6	2	CD	NUMBER	2	num	7	SENT_70	[p4l2059t3614r2069b3628],
7	o	NN	O	o	appos	1	SENT_70	[p4l2075t3614r2085b3628],
8	as	IN	O	as	_	0	SENT_70	[p4l2091t3614r2117b3628],
9	The	DT	O	the	det	14	SENT_70	[p4l192t3646r237b3666],
10	PRINC	NNP	O	PRINC	nn	14	SENT_70	[p4l248t3646r326b3666],
11	Trial	NNP	O	Trial	nn	14	SENT_70	[p4l334t3646r387b3666],
12	Ph	NN	O	ph	nn	14	SENT_70	[p4l399t3646r428b3666],
13	aaaa	NN	O	aaaa	nn	14	SENT_70	[p4l431t3651r495b3666],
14	cogeneti	NN	O	cogenetus	prep_as	1	SENT_70	[p4l498t3646r602b3671],
15	c	NN	O	c	nn	16	SENT_70	[p4l605t3651r617b3666],
16	s	NNS	O	s	dep	24	SENT_70	[p4l618t3651r630b3666],
17	D	NN	O	d	nn	24	SENT_70	[p4l1816t3652r1829b3666],
18	E	NN	O	e	nn	24	SENT_70	[p4l1835t3652r1844b3666],
19	c	NN	O	c	nn	24	SENT_70	[p4l1850t3651r1861b3666],
20	E	NN	O	e	nn	24	SENT_70	[p4l1868t3652r1877b3666],
21	M	NN	O	m	nn	24	SENT_70	[p4l1883t3652r1899b3666],
22	3	CD	NUMBER	3	num	24	SENT_70	[p4l1906t3652r1916b3666],
23	E	NN	O	e	nn	24	SENT_70	[p4l1923t3652r1932b3666],
24	n	NN	O	n	dep	28	SENT_70	[p4l1938t3652r1949b3666],
25	2	CD	NUMBER	2	num	26	SENT_70	[p4l1966t3652r1977b3666],
26	o	NN	O	o	dep	24	SENT_70	[p4l1982t3652r1993b3666],
27	081620	CD	NUMBER	081620	num	28	SENT_70	[p4l1998t3652r2084b3666],
28	-7	CD	NUMBER	-7	_	0	SENT_70	[p4l2092t3652r2117b3666],

1	Percutaneous	JJ	O	percutaneous	amod	4	SENT_71	[p5l524t100r744b126],
2	coronary	JJ	O	coronary	amod	4	SENT_71	[p5l753t106r897b133],
3	D,-schame	NN	O	d,-schame	nn	4	SENT_71	[p5l1316t110r1477b142],
4	intervention	NN	O	intervention	_	0	SENT_71	[p5l621t143r810b169],
5	1	CD	NUMBER	1	dep	4	SENT_71	[p5l1403t161r1417b218],

1	n	NN	O	n	_	0	SENT_72	[p5l1481t196r1534b214],
2	=	JJ	O	=	amod	8	SENT_72	[p5l1481t196r1534b214],
3	22	CD	NUMBER	22	number	4	SENT_72	[p5l1481t196r1534b214],
4	75	CD	NUMBER	75	amod	8	SENT_72	[p5l1453t223r1479b241],
5	mglday	NN	O	mglday	nn	8	SENT_72	[p5l1487t223r1564b246],
6	n	NN	O	n	nn	8	SENT_72	[p5l469t196r522b214],
7	=	JJ	O	=	amod	8	SENT_72	[p5l469t196r522b214],
8	2Q	NN	O	2q	dep	1	SENT_72	[p5l469t196r522b214],
9	1	CD	NUMBER	1	number	10	SENT_72	[p5l676t184r690b241],
10	intraanerial	JJ	O	intraanerial	amod	8	SENT_72	[p5l430t223r549b243],
11	"	``	O	"	punct	8	SENT_72	[p5l932t218r984b237],
12	=	JJ	O	=	dep	8	SENT_72	[p5l932t218r984b237],
13	37	CD	NUMBER	37	dep	12	SENT_72	[p5l932t218r984b237],

1	Placebo	NN	O	placebo	_	0	SENT_73	[p5l454t254r539b272],
2	609	CD	NUMBER	609	dep	1	SENT_73	[p5l917t247r956b278],
3	"	``	O	"	punct	2	SENT_73	[p5l964t251r996b271],
4	19	CD	NUMBER	19	num	6	SENT_73	[p5l964t251r996b271],
5	Clopidogrel	NN	O	clopidogrel	nn	6	SENT_73	[p5l1447t253r1567b275],
6	j	NN	O	j	dep	2	SENT_73	[p5l1640t260r1720b263],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_74	[p5l900t275r1020b298],
2	n	NN	O	n	_	0	SENT_74	[p5l666t329r719b347],
3	=	JJ	O	=	rcmod	2	SENT_74	[p5l666t329r719b347],
4	60	CD	NUMBER	60	iobj	3	SENT_74	[p5l666t329r719b347],
5	I	PRP	O	I	dobj	3	SENT_74	[p5l1475t350r1480b355],
6	'	''	O	'	_	0	SENT_74	[p5l1517t350r1522b355],
7	500	CD	NUMBER	500	dep	2	SENT_74	[p5l654t357r693b375],
8	"	``	O	"	punct	9	SENT_74	[p5l700t360r732b380],
9	'19	CD	NUMBER	'19	dep	7	SENT_74	[p5l700t360r732b380],
10	Randomization	NN	O	randomization	prep	9	SENT_74	[p5l820t360r999b380],
11	Ha	FW	O	ha	dep	10	SENT_74	[p5l1372t351r1551b370],
12	"	``	O	"	punct	11	SENT_74	[p5l1372t351r1551b370],
13	d	NN	O	d	prep	11	SENT_74	[p5l1372t351r1551b370],
14	°	CD	NUMBER	°	num	15	SENT_74	[p5l1372t351r1551b370],
15	’	CD	NUMBER	’	dep	13	SENT_74	[p5l1372t351r1551b370],
16	"	``	O	"	punct	11	SENT_74	[p5l1372t351r1551b370],
17	'	''	O	'	_	0	SENT_74	[p5l1372t351r1551b370],
18	za	FW	O	za	dep	7	SENT_74	[p5l1372t351r1551b370],
19	"	``	O	"	punct	20	SENT_74	[p5l1372t351r1551b370],
20	°	CD	NUMBER	°	dep	18	SENT_74	[p5l1372t351r1551b370],
21	"	``	O	"	punct	20	SENT_74	[p5l1372t351r1551b370],
22	Clopidogrel	NN	O	clopidogrel	dep	20	SENT_74	[p5l633t384r753b408],
23	intraarterial	JJ	O	intraarterial	amod	22	SENT_74	[p5l445t465r564b485],
24	-	:	O	-	_	0	SENT_74	[p5l883t446r1057b515],
25	159	CD	NUMBER	159	num	29	SENT_74	[p5l1456t473r1495b491],
26	mg/day	JJ	O	mg/day	amod	29	SENT_74	[p5l1502t471r1581b496],
27	5mg	JJ	O	5mg	amod	29	SENT_74	[p5l426t497r471b519],
28	Verapamil	NN	MISC	verapamil	nn	29	SENT_74	[p5l480t495r585b518],
29	P	NN	O	p	dep	20	SENT_74	[p5l927t485r1011b503],
30	'	''	O	'	_	0	SENT_74	[p5l927t485r1011b503],
31	a	DT	O	a	det	32	SENT_74	[p5l927t485r1011b503],
32	°	NN	O	°	dep	29	SENT_74	[p5l927t485r1011b503],
33	eb	NN	O	eb	nn	35	SENT_74	[p5l927t485r1011b503],
34	°	CD	NUMBER	°	num	35	SENT_74	[p5l927t485r1011b503],
35	Clopidogrel	NNP	O	Clopidogrel	dep	29	SENT_74	[p5l1456t501r1576b524],

1	Sampling	VBG	O	sample	_	0	SENT_75	[p5l631t536r744b563],
2	Sampling	VBG	O	sample	xcomp	1	SENT_75	[p5l829t536r942b563],
3	Sampling	VBG	O	sample	xcomp	2	SENT_75	[p5l1051t536r1164b563],
4	Sampling	VBG	O	sample	xcomp	3	SENT_75	[p5l1249t536r1362b563],
5	Sampling	VBG	O	sample	xcomp	4	SENT_75	[p5l1626t536r1738b563],
6	-10	CD	DURATION	-10	num	7	SENT_75	[p5l451t595r489b616],
7	minutes	NNS	NUMBER	minute	nn	8	SENT_75	[p5l499t595r600b616],
8	Baseline	NN	O	baseline	dobj	5	SENT_75	[p5l626t594r735b615],
9	2	CD	DURATION	2	num	10	SENT_75	[p5l835t595r849b615],
10	hours	NNS	NUMBER	hour	amod	8	SENT_75	[p5l858t594r932b615],
11	4	CD	DURATION	4	num	12	SENT_75	[p5l1061t595r1076b615],
12	hours	NNS	NUMBER	hour	dep	10	SENT_75	[p5l1084t595r1158b615],
13	7	CD	DURATION	7	num	14	SENT_75	[p5l1270t594r1285b615],
14	hours	NNS	NUMBER	hour	tmod	8	SENT_75	[p5l1294t594r1368b615],
15	7	CD	DURATION	7	num	16	SENT_75	[p5l1642t594r1657b615],
16	days	NNS	NUMBER	day	tmod	5	SENT_75	[p5l1665t594r1726b620],

1	Time	NNP	O	Time	_	0	SENT_76	[p5l985t697r1072b726],
2	table	NN	O	table	dep	1	SENT_76	[p5l1083t697r1170b726],

1	Figure	NNP	O	Figure	_	0	SENT_77	[p5l69t792r148b818],
2	1	CD	NUMBER	1	dep	1	SENT_77	[p5l159t792r183b812],
3	.	.	O	.	_	0	SENT_77	[p5l159t792r183b812],

1	Timetable	NN	O	timetable	_	0	SENT_78	[p5l195t792r323b813],
2	of	IN	O	of	_	0	SENT_78	[p5l334t792r358b813],
3	the	DT	O	the	det	8	SENT_78	[p5l367t792r409b813],
4	Study	NNP	O	Study	nn	8	SENT_78	[p5l420t792r493b818],
5	Protocol	NNP	O	Protocol	nn	8	SENT_78	[p5l505t792r612b813],
6	A	NNP	O	A	nn	8	SENT_78	[p5l68t855r85b875],
7	double	JJ	O	double	amod	8	SENT_78	[p5l96t854r259b878],
8	—	NN	O	—	prep_of	1	SENT_78	[p5l96t854r259b878],
9	blind	JJ	O	blind	amod	1	SENT_78	[p5l96t854r259b878],
10	,	,	O	,	_	0	SENT_78	[p5l96t854r259b878],
11	randomized	VBN	O	randomize	partmod	1	SENT_78	[p5l271t854r422b879],
12	,	,	O	,	_	0	SENT_78	[p5l271t854r422b879],
13	placebo	NN	O	placebo	nn	14	SENT_78	[p5l434t854r662b881],
14	—	NN	O	—	nsubjpass	24	SENT_78	[p5l434t854r662b881],
15	controlled	VBN	O	control	partmod	14	SENT_78	[p5l434t854r662b881],
16	trial	NN	O	trial	dobj	15	SENT_78	[p5l674t854r719b875],
17	with	IN	O	with	_	0	SENT_78	[p5l731t854r783b875],
18	2	CD	NUMBER	2	number	19	SENT_78	[p5l796t855r808b875],
19	X	NN	O	x	amod	22	SENT_78	[p5l823t857r840b874],
20	2	CD	NUMBER	2	number	21	SENT_78	[p5l854t855r867b875],
21	factorial	JJ	O	factorial	amod	22	SENT_78	[p5l878t854r975b875],
22	design	NN	O	design	prep_with	15	SENT_78	[p5l987t854r1066b881],
23	was	VBD	O	be	auxpass	24	SENT_78	[p5l1078t860r1124b875],
24	undertaken	VBN	O	undertake	dep	1	SENT_78	[p5l1136t854r1274b875],
25	in	IN	O	in	_	0	SENT_78	[p5l1287t855r1307b875],
26	60	CD	NUMBER	60	num	27	SENT_78	[p5l1319t855r1347b875],
27	patients	NNS	O	patient	prep_in	24	SENT_78	[p5l1360t855r1456b881],
28	undergoing	VBG	O	undergo	partmod	27	SENT_78	[p5l1468t854r1609b881],
29	elective	JJ	O	elective	amod	32	SENT_78	[p5l1622t854r1714b875],
30	percutaneous	JJ	O	percutaneous	amod	32	SENT_78	[p5l1727t857r1892b881],
31	coronary	JJ	O	coronary	amod	32	SENT_78	[p5l1903t860r2010b881],
32	intervention	NN	O	intervention	dobj	28	SENT_78	[p5l69t894r223b915],
33	.	.	O	.	_	0	SENT_78	[p5l69t894r223b915],

1	fornia	NN	O	fornium	_	0	SENT_79	[p5l44t1004r163b1043],
2	)	NN	O	)	dep	1	SENT_79	[p5l44t1004r163b1043],
3	.	.	O	.	_	0	SENT_79	[p5l44t1004r163b1043],

1	Genotyping	VBG	O	genotype	csubjpass	17	SENT_80	[p5l178t1005r377b1047],
2	using	VBG	O	use	xcomp	1	SENT_80	[p5l387t1006r476b1047],
3	the	DT	O	the	det	7	SENT_80	[p5l487t1005r538b1036],
4	Sequenom	NNP	O	Sequenom	nn	7	SENT_80	[p5l552t1005r725b1047],
5	mass	NN	O	mass	nn	7	SENT_80	[p5l737t1017r816b1036],
6	spectrometer	NN	O	spectrometer	nn	7	SENT_80	[p5l829t1013r1043b1047],
7	regimens	NNS	O	regimen	dobj	2	SENT_80	[p5l1119t1006r1268b1047],
8	evaluated	VBN	O	evaluate	partmod	7	SENT_80	[p5l1294t1005r1448b1036],
9	in	IN	O	in	_	0	SENT_80	[p5l1473t1006r1505b1036],
10	the	DT	O	the	det	14	SENT_80	[p5l1530t1005r1582b1036],
11	PRINC	NNP	O	PRINC	nn	14	SENT_80	[p5l1607t1005r1739b1036],
12	(	CD	NUMBER	(	num	14	SENT_80	[p5l1766t1004r1879b1043],
13	Plavix	NNP	O	Plavix	nn	14	SENT_80	[p5l1766t1004r1879b1043],
14	Response	NN	O	response	prep_in	8	SENT_80	[p5l1904t1005r2060b1047],
15	in	IN	O	in	prep	8	SENT_80	[p5l2085t1006r2117b1036],
16	was	VBD	O	be	auxpass	17	SENT_80	[p5l42t1067r102b1086],
17	performed	VBN	O	perform	_	0	SENT_80	[p5l116t1055r290b1097],
18	at	IN	O	at	_	0	SENT_80	[p5l304t1063r334b1086],
19	the	DT	O	the	det	27	SENT_80	[p5l346t1055r398b1086],
20	Australian	JJ	ORGANIZATION	australian	amod	27	SENT_80	[p5l411t1054r585b1086],
21	Genome	NNP	ORGANIZATION	Genome	nn	27	SENT_80	[p5l599t1055r742b1086],
22	Research	NNP	ORGANIZATION	Research	nn	27	SENT_80	[p5l757t1055r906b1086],
23	Facility	NNP	ORGANIZATION	Facility	nn	27	SENT_80	[p5l920t1055r1044b1097],
24	Coronary	NNP	ORGANIZATION	Coronary	nn	27	SENT_80	[p5l1120t1055r1278b1097],
25	Intervention	NN	ORGANIZATION	intervention	nn	27	SENT_80	[p5l1291t1054r1510b1093],
26	)	NN	O	)	nn	27	SENT_80	[p5l1291t1054r1510b1093],
27	study	NN	O	study	prep_at	17	SENT_80	[p5l1528t1055r1623b1097],
28	.	.	O	.	_	0	SENT_80	[p5l1528t1055r1623b1097],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_81	[p5l1641t1055r1841b1097],
2	was	VBD	O	be	auxpass	3	SENT_81	[p5l1853t1067r1914b1086],
3	undertaken	VBN	O	undertake	_	0	SENT_81	[p5l1930t1055r2117b1086],
4	(	NNP	O	(	nn	5	SENT_81	[p5l45t1104r229b1147],
5	University	NNP	ORGANIZATION	University	dobj	3	SENT_81	[p5l45t1104r229b1147],
6	of	IN	ORGANIZATION	of	_	0	SENT_81	[p5l243t1105r281b1136],
7	Qieensland	NNP	ORGANIZATION	Qieensland	prep_of	5	SENT_81	[p5l291t1105r498b1144],
8	,	,	O	,	_	0	SENT_81	[p5l291t1105r498b1144],
9	St.	NNP	LOCATION	St.	nn	10	SENT_81	[p5l517t1105r558b1136],
10	Lucia	NNP	LOCATION	Lucia	appos	7	SENT_81	[p5l576t1105r678b1143],
11	,	,	O	,	_	0	SENT_81	[p5l576t1105r678b1143],
12	Australia	NNP	LOCATION	Australia	appos	10	SENT_81	[p5l693t1104r867b1143],
13	)	CD	NUMBER	)	num	12	SENT_81	[p5l693t1104r867b1143],
14	.	.	O	.	_	0	SENT_81	[p5l693t1104r867b1143],

1	as	IN	O	as	_	0	SENT_82	[p5l1119t1117r1149b1136],
2	a	DT	O	a	det	4	SENT_82	[p5l1165t1117r1181b1136],
3	secondary	JJ	O	secondary	amod	4	SENT_82	[p5l1196t1105r1360b1147],
4	analysis	NN	O	analysis	pobj	1	SENT_82	[p5l1373t1105r1507b1147],
5	.	.	O	.	_	0	SENT_82	[p5l1373t1105r1507b1147],

1	Results	NNS	O	result	nsubjpass	3	SENT_83	[p5l1524t1105r1642b1136],
2	are	VBP	O	be	auxpass	3	SENT_83	[p5l1658t1117r1705b1136],
3	reported	VBN	O	report	_	0	SENT_83	[p5l1720t1105r1860b1147],
4	as	IN	O	as	_	0	SENT_83	[p5l1875t1117r1905b1136],
5	median	NN	O	median	prep_as	3	SENT_83	[p5l1921t1105r2043b1136],
6	and	CC	O	and	_	0	SENT_83	[p5l2058t1105r2118b1136],
7	Statistical	JJ	O	statistical	amod	8	SENT_83	[p5l44t1158r199b1186],
8	analysis	NN	O	analysis	conj_and	5	SENT_83	[p5l215t1158r351b1194],
9	.	.	O	.	_	0	SENT_83	[p5l215t1158r351b1194],

1	The	DT	O	the	det	3	SENT_84	[p5l372t1154r441b1186],
2	sample	NN	O	sample	nn	3	SENT_84	[p5l457t1155r570b1197],
3	size	NN	O	size	nsubjpass	5	SENT_84	[p5l586t1156r645b1186],
4	was	VBD	O	be	auxpass	5	SENT_84	[p5l658t1167r719b1186],
5	determined	VBN	O	determine	_	0	SENT_84	[p5l734t1155r924b1186],
6	by	IN	O	by	_	0	SENT_84	[p5l937t1155r977b1197],
7	the	DT	O	the	det	8	SENT_84	[p5l990t1155r1042b1186],
8	range	NN	O	range	agent	5	SENT_84	[p5l1119t1167r1218b1197],
9	,	,	O	,	_	0	SENT_84	[p5l1119t1167r1218b1197],
10	unless	IN	O	unless	mark	12	SENT_84	[p5l1234t1155r1334b1186],
11	otherwise	RB	O	otherwise	advmod	12	SENT_84	[p5l1349t1155r1508b1186],
12	speciﬁed	VBN	O	speciﬁed	dep	8	SENT_84	[p5l1524t1155r1675b1197],
13	.	.	O	.	_	0	SENT_84	[p5l1524t1155r1675b1197],

1	A	DT	O	a	det	4	SENT_85	[p5l1690t1154r1722b1186],
2	receiver	NN	O	receiver	nn	4	SENT_85	[p5l1736t1156r1863b1186],
3	operator	NN	O	operator	nn	4	SENT_85	[p5l1877t1163r2016b1197],
4	charnumber	NN	O	charnumber	nsubjpass	14	SENT_85	[p5l2031t1155r2116b1186, p5l44t1204r173b1235],
5	needed	VBN	O	need	partmod	4	SENT_85	[p5l186t1204r303b1235],
6	to	TO	O	to	aux	7	SENT_85	[p5l316t1212r348b1235],
7	detect	VB	O	detect	xcomp	5	SENT_85	[p5l363t1204r463b1235],
8	differences	NNS	O	difference	dobj	7	SENT_85	[p5l476t1204r650b1235],
9	between	IN	O	between	_	0	SENT_85	[p5l664t1204r801b1235],
10	the	DT	O	the	det	12	SENT_85	[p5l815t1204r866b1235],
11	treatment	NN	O	treatment	nn	12	SENT_85	[p5l881t1212r1043b1235],
12	acteristic	NN	O	acteristic	prep_between	8	SENT_85	[p5l1119t1205r1265b1235],
13	was	VBD	O	be	auxpass	14	SENT_85	[p5l1277t1216r1337b1235],
14	used	VBN	O	use	_	0	SENT_85	[p5l1352t1204r1426b1235],
15	to	TO	O	to	aux	16	SENT_85	[p5l1440t1212r1472b1235],
16	assess	VB	O	assess	xcomp	14	SENT_85	[p5l1487t1216r1579b1235],
17	the	DT	O	the	det	19	SENT_85	[p5l1593t1204r1645b1235],
18	predictive	JJ	O	predictive	amod	19	SENT_85	[p5l1658t1204r1821b1246],
19	value	NN	O	value	dobj	16	SENT_85	[p5l1833t1204r1918b1235],
20	of	IN	O	of	_	0	SENT_85	[p5l1933t1204r1970b1235],
21	percentTable	JJ	O	percenttable	prep_of	19	SENT_85	[p5l1978t1212r2116b1246, p5l68t1319r138b1340],

1	1	LS	NUMBER	1	_	0	SENT_86	[p5l149t1319r172b1339],
2	.	.	O	.	_	0	SENT_86	[p5l149t1319r172b1339],

1	candidate	NN	O	candidate	nn	2	SENT_87	[p5l185t1319r316b1340],
2	SNPs	NNS	O	snp	nsubj	3	SENT_87	[p5l326t1319r395b1340],
3	Associated	VBN	O	associate	_	0	SENT_87	[p5l405t1319r549b1340],
4	With	IN	O	with	_	0	SENT_87	[p5l560t1319r620b1340],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_87	[p5l631t1319r776b1345],
6	Response	NN	O	response	prep_with	3	SENT_87	[p5l789t1319r914b1344],
7	in	IN	O	in	_	0	SENT_87	[p5l925t1319r946b1339],
8	the	DT	O	the	det	12	SENT_87	[p5l957t1319r999b1340],
9	Literature	NNP	O	Literature	nn	12	SENT_87	[p5l1011t1319r1136b1340],
10	dbSNP	NNP	O	dbSNP	nn	12	SENT_87	[p5l711t1387r790b1406],
11	Reference	NNP	O	Reference	nn	12	SENT_87	[p5l801t1387r922b1406],
12	Effect	NN	O	effect	prep_in	3	SENT_87	[p5l1550t1387r1619b1406],
13	on	IN	O	on	prep	3	SENT_87	[p5l1629t1392r1657b1406],

1	Allele	NN	O	allele	nn	4	SENT_88	[p5l152t1420r219b1440],
2	SNP	NN	O	snp	nn	4	SENT_88	[p5l481t1420r531b1440],
3	Sequence	NN	O	sequence	nn	4	SENT_88	[p5l732t1420r850b1444],
4	No.	NN	O	no.	_	0	SENT_88	[p5l861t1420r899b1440],
5	.	.	O	.	_	0	SENT_88	[p5l861t1420r899b1440],

1	Functional	JJ	O	functional	amod	4	SENT_89	[p5l1095t1420r1219b1440],
2	Effect	NN	O	effect	nn	4	SENT_89	[p5l1231t1420r1300b1440],
3	clopidogrel	NN	O	clopidogrel	nn	4	SENT_89	[p5l1472t1420r1607b1444],
4	Response	NN	O	response	_	0	SENT_89	[p5l1619t1420r1735b1444],
5	Reference	NNP	O	Reference	dep	4	SENT_89	[p5l1876t1420r1997b1440],
6	#	#	O	#	dep	4	SENT_89	[p5l2007t1420r2022b1439],

1	ABCBl	NN	O	abcbl	dep	6	SENT_90	[p5l67t1491r164b1511],
2	*	NN	O	*	dep	1	SENT_90	[p5l67t1491r164b1511],
3	2	CD	NUMBER	2	num	4	SENT_90	[p5l67t1491r164b1511],
4	1236C	NN	O	1236c	dep	6	SENT_90	[p5l374t1491r479b1511],
5	>	JJR	O	>	amod	6	SENT_90	[p5l374t1491r479b1511],
6	T	NN	O	t	dep	10	SENT_90	[p5l374t1491r479b1511],
7	rs1128503	NN	O	rs1128503	dep	6	SENT_90	[p5l753t1492r866b1511],
8	Increased	VBN	O	increase	amod	10	SENT_90	[p5l993t1491r1099b1511],
9	intestinal	JJ	O	intestinal	amod	10	SENT_90	[p5l1111t1491r1212b1511],
10	efﬂux	NN	O	efﬂux	_	0	SENT_90	[p5l1224t1490r1285b1511],
11	of	IN	O	of	_	0	SENT_90	[p5l1296t1490r1319b1511],
12	drugs	NNS	O	drug	prep_of	10	SENT_90	[p5l1328t1491r1391b1516],
13	—	CD	NUMBER	—	num	15	SENT_90	[p5l1590t1502r1616b1504],
14	—	CD	NUMBER	—	num	15	SENT_90	[p5l1935t1502r1961b1504],
15	3435C	NN	O	3435c	dep	21	SENT_90	[p5l373t1539r479b1559],
16	>	JJR	O	>	amod	18	SENT_90	[p5l373t1539r479b1559],
17	T	NN	O	t	nn	18	SENT_90	[p5l373t1539r479b1559],
18	rs1045642	NN	O	rs1045642	dep	15	SENT_90	[p5l753t1540r867b1559],
19	Negative	JJ	O	negative	amod	20	SENT_90	[p5l1554t1540r1653b1564],
20	Taubert	NNP	PERSON	Taubert	dep	21	SENT_90	[p5l1804t1539r1892b1559],
21	et	FW	O	et	dep	31	SENT_90	[p5l1902t1542r1924b1559],
22	al.	FW	O	al.	nn	23	SENT_90	[p5l1934t1539r1957b1559],
23	(	FW	O	(	dep	21	SENT_90	[p5l1969t1539r2009b1562],
24	22	CD	NUMBER	22	number	25	SENT_90	[p5l1969t1539r2009b1562],
25	)	CD	NUMBER	)	num	26	SENT_90	[p5l1969t1539r2009b1562],
26	2677G	NN	O	2677g	npadvmod	27	SENT_90	[p5l373t1587r506b1607],
27	>	JJR	O	>	amod	29	SENT_90	[p5l373t1587r506b1607],
28	T/A	NN	O	t/a	nn	29	SENT_90	[p5l373t1587r506b1607],
29	rs2032582	NN	O	rs2032582	dep	23	SENT_90	[p5l753t1588r867b1607],
30	—	CD	NUMBER	—	num	31	SENT_90	[p5l1590t1598r1616b1600],
31	—	NN	O	—	dep	10	SENT_90	[p5l1935t1598r1961b1600],

1	CYP3A4	NN	O	cyp3a4	nsubj	9	SENT_91	[p5l69t1635r191b1654],
2	*	CD	NUMBER	*	num	3	SENT_91	[p5l69t1635r191b1654],
3	1B	NN	O	1b	dep	1	SENT_91	[p5l69t1635r191b1654],
4	—	CD	NUMBER	—	num	5	SENT_91	[p5l375t1635r491b1654],
5	392A	NN	O	392a	dep	1	SENT_91	[p5l375t1635r491b1654],
6	>	JJR	O	>	amod	8	SENT_91	[p5l375t1635r491b1654],
7	G	NN	O	g	nn	8	SENT_91	[p5l375t1635r491b1654],
8	rs2740574	NN	O	rs2740574	dep	5	SENT_91	[p5l753t1636r868b1654],
9	Reduced	VBN	O	reduce	_	0	SENT_91	[p5l993t1634r1089b1654],
10	enzyme	NN	O	enzyme	nn	13	SENT_91	[p5l1101t1640r1188b1660],
11	function	NN	O	function	nn	13	SENT_91	[p5l1198t1634r1292b1654],
12	None	NN	O	none	nn	13	SENT_91	[p5l1554t1635r1613b1654],
13	Angiolillo	NNP	O	Angiolillo	nsubj	16	SENT_91	[p5l1805t1634r1912b1660],
14	et	FW	O	et	nn	16	SENT_91	[p5l1922t1637r1944b1654],
15	a	FW	O	a	nn	16	SENT_91	[p5l1954t1634r2020b1657],
16	|	NN	O	|	xcomp	9	SENT_91	[p5l1954t1634r2020b1657],
17	.	.	O	.	_	0	SENT_91	[p5l1954t1634r2020b1657],

1	(	NN	O	(	dep	248	SENT_92	[p5l1954t1634r2020b1657],
2	17	CD	NUMBER	17	dep	248	SENT_92	[p5l1954t1634r2020b1657],
3	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1954t1634r2020b1657],
4	CYP3A4	NN	O	cyp3a4	dep	248	SENT_92	[p5l69t1683r176b1702],
5	*	CD	NUMBER	*	dep	248	SENT_92	[p5l69t1683r176b1702],
6	3	CD	NUMBER	3	dep	248	SENT_92	[p5l69t1683r176b1702],
7	23171T	NN	O	23171t	dep	248	SENT_92	[p5l373t1683r492b1702],
8	>	JJR	O	>	dep	248	SENT_92	[p5l373t1683r492b1702],
9	C	NN	O	c	dep	248	SENT_92	[p5l373t1683r492b1702],
10	rs49869l0	NN	O	rs49869l0	dep	248	SENT_92	[p5l753t1684r867b1702],
11	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l993t1682r1089b1702],
12	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1101t1688r1188b1708],
13	function	NN	O	function	dep	248	SENT_92	[p5l1198t1682r1292b1702],
14	None	NN	O	none	dep	248	SENT_92	[p5l1554t1683r1613b1702],
15	Angiolillo	NNP	O	Angiolillo	dep	248	SENT_92	[p5l1805t1682r1912b1708],
16	et	FW	O	et	dep	248	SENT_92	[p5l1922t1685r1944b1702],
17	al.	FW	O	al.	dep	248	SENT_92	[p5l1954t1682r1977b1702],
18	(	FW	O	(	dep	248	SENT_92	[p5l1989t1683r2029b1705],
19	17	CD	NUMBER	17	dep	248	SENT_92	[p5l1989t1683r2029b1705],
20	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1989t1683r2029b1705],
21	CYP3A4	NN	O	cyp3a4	dep	248	SENT_92	[p5l69t1731r177b1750],
22	*	CD	NUMBER	*	dep	248	SENT_92	[p5l69t1731r177b1750],
23	4	CD	NUMBER	4	dep	248	SENT_92	[p5l69t1731r177b1750],
24	13871A	NN	O	13871a	dep	248	SENT_92	[p5l374t1731r496b1750],
25	>	JJR	O	>	dep	248	SENT_92	[p5l374t1731r496b1750],
26	G	NN	O	g	dep	248	SENT_92	[p5l374t1731r496b1750],
27	—	CD	NUMBER	—	dep	248	SENT_92	[p5l803t1742r829b1744],
28	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l994t1730r1089b1750],
29	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1101t1736r1188b1756],
30	function	NN	O	function	dep	248	SENT_92	[p5l1198t1730r1292b1750],
31	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1590t1742r1616b1744],
32	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1935t1742r1961b1744],
33	CYP3A5	NN	O	cyp3a5	dep	248	SENT_92	[p5l69t1779r174b1798],
34	*	NN	O	*	dep	248	SENT_92	[p5l69t1779r174b1798],
35	1	CD	NUMBER	1	dep	248	SENT_92	[p5l69t1779r174b1798],
36	6986G	NN	O	6986g	dep	248	SENT_92	[p5l372t1779r483b1798],
37	>	JJR	O	>	dep	248	SENT_92	[p5l372t1779r483b1798],
38	A	DT	O	a	dep	248	SENT_92	[p5l372t1779r483b1798],
39	31611T	NN	O	31611t	dep	248	SENT_92	[p5l494t1779r613b1798],
40	>	JJR	O	>	dep	248	SENT_92	[p5l494t1779r613b1798],
41	C	NN	O	c	dep	248	SENT_92	[p5l494t1779r613b1798],
42	rs776746	NN	O	rs776746	dep	248	SENT_92	[p5l753t1780r853b1798],
43	Normal	JJ	O	normal	dep	248	SENT_92	[p5l993t1778r1074b1798],
44	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1085t1784r1173b1804],
45	function	NN	O	function	dep	248	SENT_92	[p5l1183t1778r1276b1798],
46	Positive	JJ	O	positive	dep	248	SENT_92	[p5l1554t1779r1640b1798],
47	Suh	NNP	O	Suh	dep	248	SENT_92	[p5l1805t1778r1846b1798],
48	et	FW	O	et	dep	248	SENT_92	[p5l1857t1781r1879b1798],
49	al.	FW	O	al.	dep	248	SENT_92	[p5l1889t1778r1912b1798],
50	(	FW	O	(	dep	248	SENT_92	[p5l1924t1779r1950b1801],
51	7	CD	NUMBER	7	dep	248	SENT_92	[p5l1924t1779r1950b1801],
52	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1924t1779r1950b1801],
53	CYP3A5	NN	O	cyp3a5	dep	248	SENT_92	[p5l69t1827r176b1846],
54	*	CD	NUMBER	*	dep	248	SENT_92	[p5l69t1827r176b1846],
55	3	CD	NUMBER	3	dep	248	SENT_92	[p5l69t1827r176b1846],
56	6986A	NN	O	6986a	dep	248	SENT_92	[p5l372t1827r483b1846],
57	>	JJR	O	>	dep	248	SENT_92	[p5l372t1827r483b1846],
58	G	NN	O	g	dep	248	SENT_92	[p5l372t1827r483b1846],
59	Nonfunctional	JJ	O	nonfunctional	dep	248	SENT_92	[p5l994t1826r1152b1846],
60	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1164t1832r1251b1852],
61	Negative	JJ	O	negative	dep	248	SENT_92	[p5l1554t1827r1653b1852],
62	Suh	NNP	O	Suh	dep	248	SENT_92	[p5l1805t1826r1846b1846],
63	et	FW	O	et	dep	248	SENT_92	[p5l1857t1829r1879b1846],
64	al.	FW	O	al.	dep	248	SENT_92	[p5l1889t1826r1912b1846],
65	(	FW	O	(	dep	248	SENT_92	[p5l1924t1827r1950b1849],
66	7	CD	NUMBER	7	dep	248	SENT_92	[p5l1924t1827r1950b1849],
67	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1924t1827r1950b1849],
68	CYP2C19	NN	O	cyp2c19	dep	248	SENT_92	[p5l69t1875r187b1894],
69	*	NN	O	*	dep	248	SENT_92	[p5l69t1875r187b1894],
70	1	CD	NUMBER	1	dep	248	SENT_92	[p5l69t1875r187b1894],
71	—	CD	NUMBER	—	dep	248	SENT_92	[p5l493t1886r519b1888],
72	—	CD	NUMBER	—	dep	248	SENT_92	[p5l803t1886r829b1888],
73	Normal	JJ	O	normal	dep	248	SENT_92	[p5l993t1874r1073b1894],
74	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1085t1880r1173b1900],
75	function	NN	O	function	dep	248	SENT_92	[p5l1183t1874r1276b1894],
76	Normal	JJ	O	normal	dep	248	SENT_92	[p5l1554t1874r1634b1894],
77	Romkes	NNS	O	romke	dep	248	SENT_92	[p5l1806t1874r1892b1894],
78	et	FW	O	et	dep	248	SENT_92	[p5l1903t1877r1924b1894],
79	al.	FW	O	al.	dep	248	SENT_92	[p5l1935t1874r1958b1894],
80	(	FW	O	(	dep	248	SENT_92	[p5l1969t1875r2010b1897],
81	36	CD	NUMBER	36	dep	248	SENT_92	[p5l1969t1875r2010b1897],
82	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1969t1875r2010b1897],
83	Fontana	NNP	ORGANIZATION	Fontana	dep	248	SENT_92	[p5l1806t1923r1896b1942],
84	et	FW	O	et	dep	248	SENT_92	[p5l1907t1925r1929b1942],
85	al.	FW	O	al.	dep	248	SENT_92	[p5l1939t1922r1962b1942],
86	(	FW	O	(	dep	248	SENT_92	[p5l1974t1922r2014b1945],
87	10	CD	NUMBER	10	dep	248	SENT_92	[p5l1974t1922r2014b1945],
88	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1974t1922r2014b1945],
89	Hulot	NNP	PERSON	Hulot	dep	248	SENT_92	[p5l1806t1970r1867b1990],
90	et	FW	O	et	dep	248	SENT_92	[p5l1877t1973r1898b1990],
91	al.	FW	O	al.	dep	248	SENT_92	[p5l1908t1970r1932b1990],
92	(	FW	O	(	dep	248	SENT_92	[p5l1943t1970r1969b1993],
93	9	CD	NUMBER	9	dep	248	SENT_92	[p5l1943t1970r1969b1993],
94	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1943t1970r1969b1993],
95	Brandt	NNP	PERSON	Brandt	dep	248	SENT_92	[p5l1806t2018r1880b2038],
96	et	FW	O	et	dep	248	SENT_92	[p5l1890t2021r1911b2038],
97	al.	FW	O	al.	dep	248	SENT_92	[p5l1921t2018r1945b2038],
98	(	FW	O	(	dep	248	SENT_92	[p5l1956t2018r1982b2041],
99	6	CD	NUMBER	6	dep	248	SENT_92	[p5l1956t2018r1982b2041],
100	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1956t2018r1982b2041],
101	CYP2C19	NN	O	cyp2c19	dep	248	SENT_92	[p5l69t2067r190b2086],
102	*	NN	O	*	dep	248	SENT_92	[p5l69t2067r190b2086],
103	2	CD	NUMBER	2	dep	248	SENT_92	[p5l69t2067r190b2086],
104	19154G	NN	O	19154g	dep	248	SENT_92	[p5l374t2067r497b2086],
105	>	JJR	O	>	dep	248	SENT_92	[p5l374t2067r497b2086],
106	A	DT	O	a	dep	248	SENT_92	[p5l374t2067r497b2086],
107	rs4244285	NN	O	rs4244285	dep	248	SENT_92	[p5l753t2067r866b2086],
108	Lack	NN	O	lack	dep	248	SENT_92	[p5l993t2066r1042b2086],
109	of	IN	O	of	dep	248	SENT_92	[p5l1052t2066r1075b2086],
110	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1084t2072r1172b2091],
111	activity	NN	O	activity	dep	248	SENT_92	[p5l1182t2067r1263b2091],
112	Negative	JJ	O	negative	dep	248	SENT_92	[p5l1554t2067r1653b2091],
113	Fontana	NNP	O	Fontana	dep	248	SENT_92	[p5l1806t2067r1896b2086],
114	et	FW	O	et	dep	248	SENT_92	[p5l1907t2069r1928b2086],
115	al.	FW	O	al.	dep	248	SENT_92	[p5l1939t2066r1962b2086],
116	(	FW	O	(	dep	248	SENT_92	[p5l1974t2066r2014b2089],
117	10	CD	NUMBER	10	dep	248	SENT_92	[p5l1974t2066r2014b2089],
118	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1974t2066r2014b2089],
119	Hulot	NNP	PERSON	Hulot	dep	248	SENT_92	[p5l1806t2114r1867b2134],
120	et	FW	O	et	dep	248	SENT_92	[p5l1877t2117r1898b2134],
121	al.	FW	O	al.	dep	248	SENT_92	[p5l1908t2114r1932b2134],
122	(	FW	O	(	dep	248	SENT_92	[p5l1943t2114r1969b2137],
123	9	CD	NUMBER	9	dep	248	SENT_92	[p5l1943t2114r1969b2137],
124	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1943t2114r1969b2137],
125	Brandt	NNP	PERSON	Brandt	dep	248	SENT_92	[p5l1806t2162r1880b2182],
126	et	FW	O	et	dep	248	SENT_92	[p5l1890t2165r1911b2182],
127	al.	FW	O	al.	dep	248	SENT_92	[p5l1921t2162r1945b2182],
128	(	FW	O	(	dep	248	SENT_92	[p5l1956t2162r1982b2185],
129	6	CD	NUMBER	6	dep	248	SENT_92	[p5l1956t2162r1982b2185],
130	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1956t2162r1982b2185],
131	CYP2C19	NN	O	cyp2c19	dep	248	SENT_92	[p5l69t2210r190b2230],
132	*	CD	NUMBER	*	dep	248	SENT_92	[p5l69t2210r190b2230],
133	4	CD	NUMBER	4	dep	248	SENT_92	[p5l69t2210r190b2230],
134	1A	NN	O	1a	dep	248	SENT_92	[p5l374t2210r441b2229],
135	>	JJR	O	>	dep	248	SENT_92	[p5l374t2210r441b2229],
136	G	NN	O	g	dep	248	SENT_92	[p5l374t2210r441b2229],
137	rs28399504	NN	O	rs28399504	dep	248	SENT_92	[p5l753t2211r882b2230],
138	Lack	NN	O	lack	dep	248	SENT_92	[p5l993t2210r1042b2230],
139	of	IN	O	of	dep	248	SENT_92	[p5l1052t2209r1075b2230],
140	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1084t2215r1172b2235],
141	activity	NN	O	activity	dep	248	SENT_92	[p5l1182t2211r1263b2235],
142	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1590t2221r1616b2223],
143	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1935t2221r1961b2223],
144	CYP2C19	NN	O	cyp2c19	dep	248	SENT_92	[p5l69t2258r204b2278],
145	*	NN	O	*	dep	248	SENT_92	[p5l69t2258r204b2278],
146	17	CD	NUMBER	17	dep	248	SENT_92	[p5l69t2258r204b2278],
147	—	CD	NUMBER	—	dep	248	SENT_92	[p5l375t2258r488b2278],
148	806C	NN	O	806c	dep	248	SENT_92	[p5l375t2258r488b2278],
149	>	JJR	O	>	dep	248	SENT_92	[p5l375t2258r488b2278],
150	T	NN	O	t	dep	248	SENT_92	[p5l375t2258r488b2278],
151	rs12248560	NN	O	rs12248560	dep	248	SENT_92	[p5l753t2259r881b2278],
152	Increased	VBN	O	increase	dep	248	SENT_92	[p5l993t2258r1099b2278],
153	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1110t2263r1198b2283],
154	function	NN	O	function	dep	248	SENT_92	[p5l1208t2257r1301b2278],
155	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1590t2269r1616b2271],
156	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1935t2269r1961b2271],
157	CYP2C9	NN	O	cyp2c9	dep	248	SENT_92	[p5l69t2306r174b2325],
158	*	NN	O	*	dep	248	SENT_92	[p5l69t2306r174b2325],
159	1	CD	NUMBER	1	dep	248	SENT_92	[p5l69t2306r174b2325],
160	—	CD	NUMBER	—	dep	248	SENT_92	[p5l493t2317r519b2319],
161	—	CD	NUMBER	—	dep	248	SENT_92	[p5l803t2317r829b2319],
162	Normal	JJ	O	normal	dep	248	SENT_92	[p5l993t2305r1073b2326],
163	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1085t2311r1173b2331],
164	function	NN	O	function	dep	248	SENT_92	[p5l1182t2305r1276b2326],
165	Normal	JJ	O	normal	dep	248	SENT_92	[p5l1554t2305r1634b2326],
166	Brandt	NNP	PERSON	Brandt	dep	248	SENT_92	[p5l1806t2305r1880b2326],
167	et	FW	O	et	dep	248	SENT_92	[p5l1890t2309r1911b2325],
168	al.	FW	O	al.	dep	248	SENT_92	[p5l1921t2305r1945b2325],
169	(	FW	O	(	dep	248	SENT_92	[p5l1956t2306r1982b2329],
170	6	CD	NUMBER	6	dep	248	SENT_92	[p5l1956t2306r1982b2329],
171	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1956t2306r1982b2329],
172	CYP2C9	NN	O	cyp2c9	dep	248	SENT_92	[p5l69t2354r176b2373],
173	*	NN	O	*	dep	248	SENT_92	[p5l69t2354r176b2373],
174	2	CD	NUMBER	2	dep	248	SENT_92	[p5l69t2354r176b2373],
175	3608C	NN	O	3608c	dep	248	SENT_92	[p5l373t2354r479b2373],
176	>	JJR	O	>	dep	248	SENT_92	[p5l373t2354r479b2373],
177	T	NN	O	t	dep	248	SENT_92	[p5l373t2354r479b2373],
178	rs1799853	NN	O	rs1799853	dep	248	SENT_92	[p5l753t2355r866b2373],
179	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l993t2353r1089b2373],
180	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1101t2359r1188b2379],
181	function	NN	O	function	dep	248	SENT_92	[p5l1198t2353r1292b2373],
182	Negative	JJ	O	negative	dep	248	SENT_92	[p5l1554t2354r1653b2379],
183	Brandt	NNP	PERSON	Brandt	dep	248	SENT_92	[p5l1806t2353r1880b2373],
184	et	FW	O	et	dep	248	SENT_92	[p5l1890t2357r1911b2373],
185	al.	FW	O	al.	dep	248	SENT_92	[p5l1921t2353r1945b2373],
186	(	FW	O	(	dep	248	SENT_92	[p5l1956t2354r1982b2376],
187	6	CD	NUMBER	6	dep	248	SENT_92	[p5l1956t2354r1982b2376],
188	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1956t2354r1982b2376],
189	CYP2C9	NN	O	cyp2c9	dep	248	SENT_92	[p5l69t2402r176b2421],
190	*	CD	NUMBER	*	dep	248	SENT_92	[p5l69t2402r176b2421],
191	3	CD	NUMBER	3	dep	248	SENT_92	[p5l69t2402r176b2421],
192	42614A	NN	O	42614a	dep	248	SENT_92	[p5l372t2402r495b2421],
193	>	JJR	O	>	dep	248	SENT_92	[p5l372t2402r495b2421],
194	C	NN	O	c	dep	248	SENT_92	[p5l372t2402r495b2421],
195	rs1057910	NN	O	rs1057910	dep	248	SENT_92	[p5l753t2403r867b2421],
196	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l993t2401r1089b2421],
197	enzyme	NN	O	enzyme	dep	248	SENT_92	[p5l1101t2407r1188b2427],
198	function	NN	O	function	dep	248	SENT_92	[p5l1198t2401r1292b2421],
199	Negative	JJ	O	negative	dep	248	SENT_92	[p5l1554t2402r1653b2427],
200	Brandt	NNP	PERSON	Brandt	dep	248	SENT_92	[p5l1806t2401r1880b2421],
201	et	FW	O	et	dep	248	SENT_92	[p5l1890t2404r1911b2421],
202	al.	FW	O	al.	dep	248	SENT_92	[p5l1921t2401r1945b2421],
203	(	FW	O	(	dep	248	SENT_92	[p5l1956t2402r1982b2424],
204	6	CD	NUMBER	6	dep	248	SENT_92	[p5l1956t2402r1982b2424],
205	)	CD	NUMBER	)	dep	248	SENT_92	[p5l1956t2402r1982b2424],
206	P2Y12	NN	O	p2y12	dep	248	SENT_92	[p5l68t2450r135b2469],
207	H2	NN	O	h2	dep	248	SENT_92	[p5l146t2450r175b2469],
208	haplotype	NN	O	haplotype	dep	248	SENT_92	[p5l187t2449r300b2475],
209	i-T744C	NN	O	i-t744c	dep	248	SENT_92	[p5l373t2450r456b2469],
210	rs2046934	NN	O	rs2046934	dep	248	SENT_92	[p5l753t2451r868b2469],
211	Increased	VBN	O	increase	dep	248	SENT_92	[p5l993t2449r1099b2469],
212	platelet	NN	O	platelet	dep	248	SENT_92	[p5l1111t2449r1195b2474],
213	response	NN	O	response	dep	248	SENT_92	[p5l1206t2455r1307b2474],
214	to	TO	O	to	dep	248	SENT_92	[p5l1317t2452r1339b2469],
215	ADP	NN	O	adp	dep	248	SENT_92	[p5l1350t2450r1397b2469],
216	None	NN	O	none	dep	248	SENT_92	[p5l1554t2450r1613b2469],
217	Von	NNP	O	Von	dep	248	SENT_92	[p5l1804t2450r1848b2469],
218	Beckerath	NNP	O	Beckerath	dep	248	SENT_92	[p5l1860t2449r1969b2469],
219	et	FW	O	et	dep	248	SENT_92	[p5l1981t2452r2002b2469],
220	al.	FW	O	al.	dep	248	SENT_92	[p5l2012t2449r2036b2469],
221	(	FW	O	(	dep	248	SENT_92	[p5l2047t2450r2087b2472],
222	21	CD	NUMBER	21	dep	248	SENT_92	[p5l2047t2450r2087b2472],
223	)	CD	NUMBER	)	dep	248	SENT_92	[p5l2047t2450r2087b2472],
224	CESZ	NN	O	cesz	dep	248	SENT_92	[p5l69t2498r121b2517],
225	g.	NN	O	g.	dep	248	SENT_92	[p5l373t2498r489b2523],
226	275A	NN	O	275a	dep	248	SENT_92	[p5l373t2498r489b2523],
227	>	JJR	O	>	dep	248	SENT_92	[p5l373t2498r489b2523],
228	G	NN	O	g	dep	248	SENT_92	[p5l373t2498r489b2523],
229	rs1464602	NN	O	rs1464602	dep	248	SENT_92	[p5l753t2499r867b2517],
230	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l993t2497r1089b2517],
231	midazolam	NN	O	midazolam	dep	248	SENT_92	[p5l1102t2497r1224b2517],
232	clearance	NN	O	clearance	dep	248	SENT_92	[p5l1236t2497r1342b2517],
233	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1590t2509r1616b2511],
234	—	NN	O	—	dep	248	SENT_92	[p5l1935t2509r1961b2511],
235	lntronic	JJ	O	lntronic	dep	248	SENT_92	[p5l373t2546r459b2565],
236	SNP	NN	O	snp	dep	248	SENT_92	[p5l469t2546r513b2565],
237	(	CD	NUMBER	(	dep	248	SENT_92	[p5l525t2545r636b2568],
238	lVS10	NN	O	lvs10	dep	248	SENT_92	[p5l525t2545r636b2568],
239	—	CD	NUMBER	—	dep	248	SENT_92	[p5l525t2545r636b2568],
240	88	CD	NUMBER	88	dep	248	SENT_92	[p5l525t2545r636b2568],
241	)	CD	NUMBER	)	dep	248	SENT_92	[p5l525t2545r636b2568],
242	rs3893757	NN	O	rs3893757	dep	248	SENT_92	[p5l753t2546r867b2565],
243	Reduced	VBN	O	reduce	dep	248	SENT_92	[p5l994t2545r1089b2565],
244	mRNA	NN	O	mrna	dep	248	SENT_92	[p5l1102t2546r1171b2565],
245	gene	NN	O	gene	dep	248	SENT_92	[p5l1181t2551r1237b2570],
246	expression	NN	O	expression	dep	248	SENT_92	[p5l1248t2546r1367b2570],
247	—	CD	NUMBER	—	dep	248	SENT_92	[p5l1590t2557r1616b2559],
248	—	NN	O	—	_	0	SENT_92	[p5l1935t2557r1961b2559],

1	—	NN	O	—	_	0	SENT_93	[p5l68t2617r91b2619],
2	=	JJ	O	=	amod	3	SENT_93	[p5l99t2613r114b2619],
3	information	NN	O	information	dep	1	SENT_93	[p5l123t2607r239b2625],
4	not	RB	O	not	neg	5	SENT_93	[p5l247t2610r279b2625],
5	available	JJ	O	available	amod	3	SENT_93	[p5l285t2607r377b2625],
6	.	.	O	.	_	0	SENT_93	[p5l285t2607r377b2625],

1	*	NN	O	*	nsubjpass	6	SENT_94	[p5l384t2608r402b2624],
2	1	CD	NUMBER	1	num	4	SENT_94	[p5l384t2608r402b2624],
3	normal	JJ	O	normal	amod	4	SENT_94	[p5l412t2607r480b2625],
4	variants	NNS	O	variant	dep	1	SENT_94	[p5l487t2607r564b2625],
5	are	VBP	O	be	auxpass	6	SENT_94	[p5l571t2612r601b2625],
6	denoted	VBN	O	denote	_	0	SENT_94	[p5l607t2607r691b2625],
7	by	IN	O	by	_	0	SENT_94	[p5l699t2607r722b2629],
8	the	DT	O	the	det	11	SENT_94	[p5l727t2607r760b2625],
9	absence	NN	O	absence	nn	11	SENT_94	[p5l766t2607r848b2625],
10	ofvariant	JJ	O	ofvariant	amod	11	SENT_94	[p5l854t2607r947b2625],
11	SNPs	NNS	O	snp	agent	6	SENT_94	[p5l954t2607r1007b2625],
12	.	.	O	.	_	0	SENT_94	[p5l954t2607r1007b2625],

1	ABCB1	NN	O	abcb1	nn	3	SENT_95	[p5l91t2645r153b2662],
2	=	JJ	O	=	amod	3	SENT_95	[p5l167t2651r181b2657],
3	P	NN	O	p	_	0	SENT_95	[p5l195t2644r339b2667],
4	~	CD	NUMBER	~	num	5	SENT_95	[p5l195t2644r339b2667],
5	g	NN	O	g	dep	3	SENT_95	[p5l195t2644r339b2667],
6	|	NN	O	|	nn	8	SENT_95	[p5l195t2644r339b2667],
7	ycoprotein	NN	O	ycoprotein	nn	8	SENT_95	[p5l195t2644r339b2667],
8	gene	NN	O	gene	dep	5	SENT_95	[p5l350t2650r405b2667],
9	;	:	O	;	_	0	SENT_95	[p5l350t2650r405b2667],
10	ADP	NN	O	adp	dep	5	SENT_95	[p5l415t2645r457b2662],
11	=	JJ	O	=	amod	13	SENT_95	[p5l469t2651r484b2657],
12	adenosine	NN	O	adenosine	nn	13	SENT_95	[p5l496t2644r599b2662],
13	diphosphate	NN	O	diphosphate	dep	10	SENT_95	[p5l609t2644r740b2667],
14	;	:	O	;	_	0	SENT_95	[p5l609t2644r740b2667],
15	CES	NN	O	ce	dep	5	SENT_95	[p5l750t2645r786b2662],
16	=	JJ	O	=	amod	17	SENT_95	[p5l798t2651r813b2657],
17	carboxylesterase	NN	O	carboxylesterase	dep	15	SENT_95	[p5l825t2644r996b2667],
18	;	:	O	;	_	0	SENT_95	[p5l825t2644r996b2667],
19	CYP	NN	O	cyp	dep	5	SENT_95	[p5l1006t2645r1045b2662],
20	=	JJ	O	=	amod	22	SENT_95	[p5l1057t2651r1072b2657],
21	cytochrome	NN	O	cytochrome	nn	22	SENT_95	[p5l1084t2644r1203b2667],
22	P450	NN	O	p450	dep	19	SENT_95	[p5l1214t2645r1266b2665],
23	;	:	O	;	_	0	SENT_95	[p5l1214t2645r1266b2665],
24	db	NN	O	db	dep	5	SENT_95	[p5l1277t2644r1302b2662],
25	=	JJ	O	=	amod	26	SENT_95	[p5l1315t2651r1329b2657],
26	database	NN	O	database	dep	24	SENT_95	[p5l1342t2644r1437b2665],
27	;	:	O	;	_	0	SENT_95	[p5l1342t2644r1437b2665],
28	mRNA	NN	O	mrna	nn	30	SENT_95	[p5l1447t2645r1509b2662],
29	=	JJ	O	=	amod	30	SENT_95	[p5l1521t2651r1536b2657],
30	messenger	NN	O	messenger	dep	5	SENT_95	[p5l1549t2650r1657b2667],
31	ribonucleic	JJ	O	ribonucleic	amod	32	SENT_95	[p5l1667t2644r1776b2662],
32	acid	NN	O	acid	dep	30	SENT_95	[p5l1787t2644r1832b2665],
33	;	:	O	;	_	0	SENT_95	[p5l1787t2644r1832b2665],
34	SNP	NN	O	snp	dep	5	SENT_95	[p5l1842t2645r1881b2662],
35	=	JJ	O	=	amod	38	SENT_95	[p5l1893t2651r1908b2657],
36	single	JJ	O	single	amod	38	SENT_95	[p5l1920t2644r1978b2667],
37	nucleotide	NN	O	nucleotide	nn	38	SENT_95	[p5l1989t2644r2094b2662],
38	polymorphism	NN	O	polymorphism	dep	34	SENT_95	[p5l69t2682r219b2704],
39	.	.	O	.	_	0	SENT_95	[p5l69t2682r219b2704],

1	JACC	NN	O	jacc	_	0	SENT_96	[p5l6t2884r157b2915],
2	:	:	O	:	_	0	SENT_96	[p5l6t2884r157b2915],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_96	[p5l194t2884r696b2915],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_96	[p5l734t2884r1196b2920],
5	,	,	O	,	_	0	SENT_96	[p5l734t2884r1196b2920],
6	VOL	NNP	O	VOL	appos	4	SENT_96	[p5l1232t2884r1355b2915],
7	.	.	O	.	_	0	SENT_96	[p5l1232t2884r1355b2915],

1	1	CD	NUMBER	1	_	0	SENT_97	[p5l1394t2885r1435b2920],
2	,	,	O	,	_	0	SENT_97	[p5l1394t2885r1435b2920],
3	NO.	NNP	O	NO.	appos	1	SENT_97	[p5l1474t2884r1565b2915],
4	6	CD	NUMBER	6	num	3	SENT_97	[p5l1601t2885r1645b2919],
5	,	,	O	,	_	0	SENT_97	[p5l1601t2885r1645b2919],
6	2008	CD	DATE	2008	num	3	SENT_97	[p5l1683t2885r1809b2915],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_97	[p5l9t2949r295b2980],
8	2008:620	CD	NUMBER	2008:620	num	7	SENT_97	[p5l332t2950r655b2980],
9	—	CD	NUMBER	—	number	10	SENT_97	[p5l332t2950r655b2980],
10	7	CD	NUMBER	7	dep	7	SENT_97	[p5l332t2950r655b2980],

1	glnhibiltion	NN	O	glnhibiltion	_	0	SENT_98	[p6l77t462r163b865],
2	4	CD	NUMBER	4	num	3	SENT_98	[p6l77t395r141b437],
3	h	NN	O	h	dep	1	SENT_98	[p6l77t334r141b373],

1	.	.	O	.	_	0	SENT_99	[p6l77t965r141b1007],

1	:	:	O	:	_	0	SENT_100	[p6l77t965r141b1007],
2	r	NN	O	r	_	0	SENT_100	[p6l77t1033r141b1075, p6l93t1100r141b1142],
3	:	:	O	:	_	0	SENT_100	[p6l77t1033r141b1075, p6l93t1100r141b1142],
4	c	NN	O	c	nn	7	SENT_100	[p6l93t1153r141b1195],
5	E	NN	O	e	nn	7	SENT_100	[p6l77t1204r141b1269],
6	ﬂ	NN	O	ﬂ	nn	7	SENT_100	[p6l77t1278r141b1343],
7	J	NN	O	j	dep	2	SENT_100	[p6l77t1345r141b1394],
8	:	:	O	:	_	0	SENT_100	[p6l77t1345r141b1394],
9	E	NN	O	e	dep	7	SENT_100	[p6l77t1404r141b1469],

1	3	LS	NUMBER	3	dep	5	SENT_101	[p6l93t1530r158b1610],
2	-	:	O	-	_	0	SENT_101	[p6l77t1622r141b1662],
3	a	DT	O	a	det	4	SENT_101	[p6l77t1622r141b1662],
4	r	NN	O	r	nsubj	5	SENT_101	[p6l77t1681r141b1723],
5	-	:	O	-	_	0	SENT_101	[p6l77t1681r141b1723],
6	.	.	O	.	_	0	SENT_101	[p6l77t1681r141b1723],

1	.	.	O	.	_	0	SENT_102	[p6l77t1681r141b1723],

1	:	:	O	:	_	0	SENT_103	[p6l93t1745r141b1787],
2	o	NN	O	o	_	0	SENT_103	[p6l93t1797r141b1839],

1	:2	CD	NUMBER	:2	num	2	SENT_104	[p6l77t1922r141b1987],
2	g	NN	O	g	_	0	SENT_104	[p6l77t1996r141b2038],
3	5	CD	NUMBER	5	dep	2	SENT_104	[p6l77t2048r141b2112],

1	Inhibition	NN	O	inhibition	nn	4	SENT_105	[p6l235t2173r602b2238],
2	2	CD	NUMBER	2	num	4	SENT_105	[p6l627t2173r669b2238],
3	h	NN	O	h	nn	4	SENT_105	[p6l698t2173r740b2238],
4	o	NN	O	o	_	0	SENT_105	[p6l782t2126r813b2131],
5	a	DT	O	a	dep	4	SENT_105	[p6l782t2126r813b2131],
6	+	CC	O	+	_	0	SENT_105	[p6l782t2126r813b2131],
7	llnhilbitionl	NN	O	llnhilbitionl	nn	9	SENT_105	[p6l879t2173r1250b2238],
8	4	CD	NUMBER	4	num	9	SENT_105	[p6l1272t2173r1315b2238],
9	h	NN	O	h	conj_+	5	SENT_105	[p6l1343t2173r1385b2238],
10	`	``	O	`	_	0	SENT_105	[p6l1436t2130r1475b2131],
11	+	CC	O	+	cc	12	SENT_105	[p6l1436t2130r1475b2131],
12	Inhibition	NN	O	inhibition	dep	9	SENT_105	[p6l1524t2173r1891b2238],
13	7	CD	NUMBER	7	num	14	SENT_105	[p6l1914t2173r1959b2238],
14	h	NN	O	h	dep	4	SENT_105	[p6l1987t2173r2030b2238],

1	Figure	NN	O	figure	_	0	SENT_106	[p6l64t2382r232b2438],
2	2	CD	NUMBER	2	dep	1	SENT_106	[p6l257t2383r307b2426],
3	.	.	O	.	_	0	SENT_106	[p6l257t2383r307b2426],

1	Prediction	NN	O	prediction	_	0	SENT_107	[p6l335t2382r615b2427],
2	of	IN	O	of	_	0	SENT_107	[p6l640t2382r693b2427],
3	Late	JJ	O	late	amod	5	SENT_107	[p6l715t2383r833b2427],
4	Platelet	NN	O	platelet	nn	5	SENT_107	[p6l859t2383r1074b2427],
5	Inhibition	NN	O	inhibition	prep_of	1	SENT_107	[p6l1101t2382r1354b2427],
6	Based	VBN	O	base	partmod	5	SENT_107	[p6l1382t2383r1550b2427],
7	on	IN	O	on	_	0	SENT_107	[p6l1575t2393r1638b2427],
8	Platelet	NN	O	platelet	nn	9	SENT_107	[p6l1665t2383r1881b2427],
9	Inhibition	NN	O	inhibition	prep_on	6	SENT_107	[p6l1907t2382r2071b2427, p6l60t2463r165b2508],
10	at	IN	O	at	_	0	SENT_107	[p6l190t2465r245b2508],
11	Earlier	JJR	O	earlier	prep_at	6	SENT_107	[p6l271t2463r446b2508],
12	Time	NNP	O	Time	nn	13	SENT_107	[p6l467t2463r601b2508],
13	Intervals	NNPS	O	Intervals	dep	11	SENT_107	[p6l627t2463r864b2508],
14	After	IN	O	after	_	0	SENT_107	[p6l887t2463r1025b2508],
15	Clopidogrel	NNP	O	Clopidogrel	nn	16	SENT_107	[p6l1047t2463r1358b2518],
16	Dosing	NNP	O	Dosing	prep_after	6	SENT_107	[p6l1385t2463r1574b2518],

1	Pearson	NNP	PERSON	Pearson	nn	3	SENT_108	[p6l65t2598r265b2642],
2	correlation	NN	O	correlation	nn	3	SENT_108	[p6l292t2596r571b2642],
3	matrix	NN	O	matrix	_	0	SENT_108	[p6l599t2598r762b2642],
4	showing	VBG	O	show	partmod	3	SENT_108	[p6l786t2596r1004b2654],
5	the	DT	O	the	det	6	SENT_108	[p6l1029t2596r1114b2642],
6	relationship	NN	O	relationship	dobj	4	SENT_108	[p6l1140t2596r1445b2654],
7	between	IN	O	between	_	0	SENT_108	[p6l1472t2596r1696b2642],
8	platelet	NN	O	platelet	nn	10	SENT_108	[p6l1725t2596r1919b2654],
9	function	NN	O	function	nn	10	SENT_108	[p6l1941t2596r2074b2642, p6l61t2683r161b2727],
10	response	NN	O	response	prep_between	6	SENT_108	[p6l189t2695r421b2738],
11	at	IN	O	at	_	0	SENT_108	[p6l446t2688r494b2727],
12	different	JJ	O	different	amod	14	SENT_108	[p6l518t2680r739b2727],
13	time	NN	O	time	nn	14	SENT_108	[p6l763t2683r879b2726],
14	intervals	NNS	O	interval	prep_at	10	SENT_108	[p6l905t2681r1134b2727],
15	.	.	O	.	_	0	SENT_108	[p6l905t2681r1134b2727],

1	Platelet	NN	O	platelet	nn	2	SENT_109	[p6l1162t2681r1353b2726],
2	inhibition	NN	O	inhibition	nsubj	10	SENT_109	[p6l1379t2681r1625b2727],
3	of	IN	O	of	_	0	SENT_109	[p6l1652t2680r1705b2726],
4	<	JJR	O	<	prep_of	2	SENT_109	[p6l1728t2684r1856b2727],
5	2	CD	PERCENT	2	number	6	SENT_109	[p6l1728t2684r1856b2727],
6	%	NN	PERCENT	%	amod	4	SENT_109	[p6l1728t2684r1856b2727],
7	at	IN	O	at	_	0	SENT_109	[p6l1880t2688r1928b2727],
8	2	CD	NUMBER	2	num	9	SENT_109	[p6l1952t2684r1979b2726],
9	h	NN	O	h	prep_at	4	SENT_109	[p6l2007t2681r2033b2726],
10	predicted	VBD	O	predict	_	0	SENT_109	[p6l64t2766r309b2823],
11	nonresponse	JJ	O	nonresponse	acomp	10	SENT_109	[p6l338t2780r673b2823],
12	at	IN	O	at	_	0	SENT_109	[p6l698t2773r746b2812],
13	7	CD	NUMBER	7	num	16	SENT_109	[p6l771t2770r797b2811],
14	h	NN	O	h	nn	16	SENT_109	[p6l825t2766r851b2811],
15	(	NN	O	(	nn	16	SENT_109	[p6l880t2766r1144b2819],
16	inhibition	NN	O	inhibition	prep_at	11	SENT_109	[p6l880t2766r1144b2819],
17	<	JJR	O	<	amod	16	SENT_109	[p6l1174t2767r1363b2819],
18	lO	CD	PERCENT	lo	num	19	SENT_109	[p6l1174t2767r1363b2819],
19	%	NN	PERCENT	%	dep	17	SENT_109	[p6l1174t2767r1363b2819],
20	)	CD	NUMBER	)	tmod	10	SENT_109	[p6l1174t2767r1363b2819],
21	,	,	O	,	_	0	SENT_109	[p6l1174t2767r1363b2819],
22	with	IN	O	with	_	0	SENT_109	[p6l1387t2766r1498b2811],
23	a	DT	O	a	det	24	SENT_109	[p6l1525t2780r1550b2812],
24	sensitivity	NN	O	sensitivity	prep_with	10	SENT_109	[p6l1577t2768r1834b2824],
25	of	IN	O	of	_	0	SENT_109	[p6l1858t2766r1911b2812],
26	100	CD	PERCENT	100	num	27	SENT_109	[p6l1936t2769r2074b2812],
27	%	NN	PERCENT	%	prep_of	24	SENT_109	[p6l1936t2769r2074b2812],
28	and	CC	O	and	_	0	SENT_109	[p6l62t2851r156b2897],
29	a	DT	O	a	det	30	SENT_109	[p6l183t2865r208b2897],
30	speciﬁcity	NN	O	speciﬁcity	prep_with	10	SENT_109	[p6l235t2851r492b2910],
31	of	IN	O	of	_	0	SENT_109	[p6l515t2851r568b2897],
32	88	CD	PERCENT	88	num	33	SENT_109	[p6l589t2854r711b2897],
33	%	NN	PERCENT	%	prep_of	30	SENT_109	[p6l589t2854r711b2897],
34	.	.	O	.	_	0	SENT_109	[p6l589t2854r711b2897],

1	age	NN	O	age	nn	3	SENT_110	[p6l10t3156r124b3219],
2	platelet	NN	O	platelet	nn	3	SENT_110	[p6l151t3130r413b3219],
3	inhibition	NN	O	inhibition	nsubjpass	19	SENT_110	[p6l438t3130r792b3196],
4	at	IN	O	at	_	0	SENT_110	[p6l820t3147r883b3196],
5	2	CD	NUMBER	2	num	6	SENT_110	[p6l906t3133r948b3197],
6	h	NN	O	h	prep_at	3	SENT_110	[p6l976t3130r1041b3211],
7	,	,	O	,	_	0	SENT_110	[p6l976t3130r1041b3211],
8	compared	VBN	O	compare	_	0	SENT_110	[p6l1072t3130r1421b3219],
9	with	IN	O	with	prepc_compared_with	19	SENT_110	[p6l1443t3130r1605b3196],
10	the	DT	O	the	det	11	SENT_110	[p6l1632t3130r1742b3196],
11	percentage	NN	O	percentage	pobj	19	SENT_110	[p6l1769t3147r2151b3219],
12	at	IN	O	at	_	0	SENT_110	[p6l10t3239r74b3288],
13	7	CD	NUMBER	7	num	14	SENT_110	[p6l109t3224r149b3288],
14	h.	NN	O	h.	prep_at	11	SENT_110	[p6l184t3222r247b3288],
15	The	DT	O	the	det	17	SENT_110	[p6l283t3220r431b3288],
16	Kruskal-Wallis	NN	MISC	kruskal-walli	nn	17	SENT_110	[p6l470t3222r1008b3289],
17	test	NN	O	test	nsubjpass	19	SENT_110	[p6l1045t3239r1171b3288],
18	was	VBD	O	be	auxpass	19	SENT_110	[p6l1201t3248r1330b3288],
19	used	VBN	O	use	_	0	SENT_110	[p6l1367t3222r1526b3288],
20	to	TO	O	to	aux	21	SENT_110	[p6l1561t3239r1629b3288],
21	compare	VB	O	compare	xcomp	19	SENT_110	[p6l1667t3248r1968b3311],
22	3	CD	NUMBER	3	num	26	SENT_110	[p6l2005t3226r2041b3288],
23	or	CC	O	or	_	0	SENT_110	[p6l2082t3248r2154b3288],
24	more	JJR	O	more	conj_or	22	SENT_110	[p6l9t3357r190b3397],
25	genotype	NN	O	genotype	nn	26	SENT_110	[p6l224t3348r546b3420],
26	groups	NNS	O	group	dobj	21	SENT_110	[p6l580t3357r818b3420],
27	and	CC	O	and	_	0	SENT_110	[p6l855t3331r983b3397],
28	the	DT	O	the	det	29	SENT_110	[p6l1017t3331r1128b3397],
29	Mann	NNP	O	Mann	dobj	21	SENT_110	[p6l1161t3331r1740b3420],
30	.	.	O	.	_	0	SENT_110	[p6l1161t3331r1740b3420],

1	—	NN	O	—	_	0	SENT_111	[p6l1161t3331r1740b3420],
2	.	.	O	.	_	0	SENT_111	[p6l1161t3331r1740b3420],

1	Whitney	NNP	PERSON	Whitney	nn	3	SENT_112	[p6l1161t3331r1740b3420],
2	U	NNP	O	U	nn	3	SENT_112	[p6l1779t3335r1844b3397],
3	test	NN	O	test	nsubjpass	5	SENT_112	[p6l1866t3348r1992b3397],
4	was	VBD	O	be	auxpass	5	SENT_112	[p6l2021t3357r2151b3397],
5	used	VBN	O	use	_	0	SENT_112	[p6l7t3452r168b3518],
6	to	TO	O	to	aux	7	SENT_112	[p6l193t3469r261b3518],
7	compare	VB	O	compare	xcomp	5	SENT_112	[p6l289t3478r590b3542],
8	2	CD	NUMBER	2	num	10	SENT_112	[p6l615t3456r656b3519],
9	genotype	NN	O	genotype	nn	10	SENT_112	[p6l683t3469r1005b3542],
10	groups	NNS	O	group	dobj	7	SENT_112	[p6l1030t3478r1268b3542],
11	for	IN	O	for	_	0	SENT_112	[p6l1295t3452r1396b3518],
12	platelet	NN	O	platelet	nn	13	SENT_112	[p6l1420t3452r1682b3542],
13	inhibition	NN	O	inhibition	prep_for	10	SENT_112	[p6l1706t3452r2060b3518],
14	as	IN	O	as	_	0	SENT_112	[p6l2087t3479r2150b3518],
15	a	DT	O	a	det	16	SENT_112	[p7l10t49r45b89],
16	percentage	NN	O	percentage	nsubj	22	SENT_112	[p7l66t40r448b112],
17	of	IN	O	of	_	0	SENT_112	[p7l474t22r554b89],
18	the	DT	O	the	det	21	SENT_112	[p7l565t22r676b89],
19	baseline	NN	O	baseline	nn	21	SENT_112	[p7l699t22r982b89],
20	platelet	NN	O	platelet	nn	21	SENT_112	[p7l1006t23r1268b112],
21	activity	NN	O	activity	prep_of	16	SENT_112	[p7l1292t25r1548b112],
22	using	VBG	O	use	prepc_as	7	SENT_112	[p7l1568t25r1759b112],
23	GraphPad	NNP	O	GraphPad	nn	24	SENT_112	[p7l1783t22r2153b112],
24	Prism	NNP	O	Prism	nsubj	28	SENT_112	[p7l9t115r217b181],
25	4	CD	NUMBER	4	num	28	SENT_112	[p7l278t118r320b180],
26	(	CD	NUMBER	(	num	28	SENT_112	[p7l385t113r784b204],
27	GraphPad	NNP	O	GraphPad	nn	28	SENT_112	[p7l385t113r784b204],
28	Software	NNP	O	Software	xcomp	22	SENT_112	[p7l848t114r1178b195],
29	,	,	O	,	_	0	SENT_112	[p7l848t114r1178b195],
30	San	NNP	LOCATION	San	nn	31	SENT_112	[p7l1247t114r1375b181],
31	Diego	NNP	LOCATION	Diego	appos	28	SENT_112	[p7l1436t115r1675b204],
32	,	,	O	,	_	0	SENT_112	[p7l1436t115r1675b204],
33	California	NNP	LOCATION	California	nn	34	SENT_112	[p7l1742t113r2148b195],
34	)	NN	O	)	appos	31	SENT_112	[p7l1742t113r2148b195],
35	.	.	O	.	_	0	SENT_112	[p7l1742t113r2148b195],

1	Gladding	NNP	PERSON	Gladding	_	0	SENT_113	[p7l1434t219r1669b272],
2	et	FW	O	et	nn	3	SENT_113	[p7l1688t221r1740b262],
3	al.	FW	O	al.	dep	1	SENT_113	[p7l1757t219r1816b262],
4	623	CD	NUMBER	623	dep	1	SENT_113	[p7l2033t219r2138b262],

1	The	DT	O	the	det	2	SENT_114	[p7l887t302r982b344],
2	PRINC	NNP	O	PRINC	_	0	SENT_114	[p7l1006t301r1171b344],
3	Trial	NNP	O	Trial	nn	4	SENT_114	[p7l1190t302r1301b344],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	2	SENT_114	[p7l1327t302r1820b354],

1	Analysis	NN	O	analysis	nsubjpass	5	SENT_115	[p7l7t514r304b604],
2	of	IN	O	of	_	0	SENT_115	[p7l345t515r425b581],
3	covariance	NN	O	covariance	prep_of	1	SENT_115	[p7l452t518r818b582],
4	was	VBD	O	be	auxpass	5	SENT_115	[p7l853t542r982b582],
5	used	VBN	O	use	_	0	SENT_115	[p7l1021t515r1180b581],
6	to	TO	O	to	aux	7	SENT_115	[p7l1218t532r1286b581],
7	assess	VB	O	assess	xcomp	5	SENT_115	[p7l1327t542r1523b581],
8	the	DT	O	the	det	9	SENT_115	[p7l1563t515r1672b581],
9	inﬂuence	NN	O	inﬂuence	dobj	7	SENT_115	[p7l1712t515r2032b581],
10	of	IN	O	of	_	0	SENT_115	[p7l2072t515r2151b581],
11	genotyping	VBG	O	genotype	prepc_of	9	SENT_115	[p7l9t624r407b711],
12	for	IN	O	for	_	0	SENT_115	[p7l436t621r536b687],
13	CYPZCJ	NNP	O	CYPZCJ	prep_for	11	SENT_115	[p7l571t624r865b688],
14	9	CD	NUMBER	9	num	13	SENT_115	[p7l876t628r915b687],
15	and	CC	O	and	_	0	SENT_115	[p7l944t621r1072b687],
16	CYPZC9	NN	O	cypzc9	nn	17	SENT_115	[p7l1108t624r1407b688],
17	polymorphisms	NNS	O	polymorphism	conj_and	13	SENT_115	[p7l1434t621r1980b711],
18	and	CC	O	and	_	0	SENT_115	[p7l2013t621r2140b687],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_115	[p7l10t727r405b817],
20	dose	NN	O	dose	prep_for	11	SENT_115	[p7l441t727r596b793],
21	on	IN	O	on	_	0	SENT_115	[p7l634t754r721b793],
22	the	DT	O	the	det	23	SENT_115	[p7l758t727r868b793],
23	variance	NN	O	variance	prep_on	20	SENT_115	[p7l902t730r1191b794],
24	in	IN	O	in	_	0	SENT_115	[p7l1228t730r1296b793],
25	maximal	JJ	O	maximal	amod	27	SENT_115	[p7l1333t727r1635b793],
26	platelet	NN	O	platelet	nn	27	SENT_115	[p7l1669t727r1930b817],
27	inhibition	NN	O	inhibition	prep_in	23	SENT_115	[p7l1965t727r2137b793, p7l7t833r218b899],
28	using	VBG	O	use	xcomp	11	SENT_115	[p7l278t836r468b922],
29	SAS	NNP	O	SAS	dobj	28	SENT_115	[p7l531t832r684b900],
30	(	CD	NUMBER	(	num	29	SENT_115	[p7l751t831r1028b914],
31	Version	NNP	O	Version	nn	33	SENT_115	[p7l751t831r1028b914],
32	9.1	CD	NUMBER	9.1	num	33	SENT_115	[p7l1090t831r1222b914],
33	)	NN	O	)	dep	40	SENT_115	[p7l1090t831r1222b914],
34	and	CC	O	and	_	0	SENT_115	[p7l1288t833r1415b899],
35	R	NN	O	r	dep	40	SENT_115	[p7l1478t834r1537b899],
36	(	CD	NUMBER	(	num	37	SENT_115	[p7l1598t831r1875b914],
37	version	NN	O	version	dep	40	SENT_115	[p7l1598t831r1875b914],
38	2.1.1	CD	NUMBER	2.1.1	num	40	SENT_115	[p7l1933t831r2136b914],
39	)	NN	O	)	nn	40	SENT_115	[p7l1933t831r2136b914],
40	software	NN	O	software	dep	28	SENT_115	[p7l11t939r304b1006],
41	(	CD	NUMBER	(	num	49	SENT_115	[p7l343t937r526b1020],
42	SAS	NNP	ORGANIZATION	SAS	nn	49	SENT_115	[p7l343t937r526b1020],
43	Institute	NNP	ORGANIZATION	Institute	nn	49	SENT_115	[p7l563t940r883b1020],
44	,	,	O	,	_	0	SENT_115	[p7l563t940r883b1020],
45	Cary	NNP	PERSON	Cary	appos	49	SENT_115	[p7l923t939r1110b1028],
46	,	,	O	,	_	0	SENT_115	[p7l923t939r1110b1028],
47	North	NNP	LOCATION	North	appos	49	SENT_115	[p7l1148t939r1366b1005],
48	Carolina	NNP	LOCATION	Carolina	nn	49	SENT_115	[p7l1403t937r1756b1020],
49	)	NN	O	)	dep	40	SENT_115	[p7l1403t937r1756b1020],
50	.	.	O	.	_	0	SENT_115	[p7l1403t937r1756b1020],

1	Statistical	JJ	O	statistical	amod	2	SENT_116	[p7l1799t939r2140b1006],
2	adjustment	NN	O	adjustment	nsubjpass	9	SENT_116	[p7l11t1046r404b1135],
3	for	IN	O	for	_	0	SENT_116	[p7l435t1046r535b1112],
4	multiple	JJ	O	multiple	amod	6	SENT_116	[p7l568t1046r860b1136],
5	hypothesis	NN	O	hypothesis	nn	6	SENT_116	[p7l894t1046r1267b1136],
6	testing	NN	O	testing	prep_for	2	SENT_116	[p7l1302t1049r1540b1135],
7	was	VBD	O	be	auxpass	9	SENT_116	[p7l1568t1073r1697b1113],
8	not	RB	O	not	neg	9	SENT_116	[p7l1733t1063r1850b1112],
9	used	VBN	O	use	_	0	SENT_116	[p7l1880t1046r2057b1112],
10	.	.	O	.	_	0	SENT_116	[p7l1880t1046r2057b1112],

1	Results	NNS	O	result	_	0	SENT_117	[p7l11t1296r332b1358],

1	The	DT	O	the	det	2	SENT_118	[p7l7t1487r153b1555],
2	effect	NN	O	effect	nsubjpass	15	SENT_118	[p7l184t1489r369b1555],
3	of	IN	O	of	_	0	SENT_118	[p7l397t1489r477b1555],
4	different	JJ	O	different	amod	6	SENT_118	[p7l495t1489r791b1555],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_118	[p7l819t1489r1213b1578],
6	loading	NN	O	loading	prep_of	2	SENT_118	[p7l1240t1489r1505b1578],
7	and	CC	O	and	_	0	SENT_118	[p7l1533t1489r1661b1555],
8	maintenance	NN	O	maintenance	nn	10	SENT_118	[p7l1690t1492r2138b1555],
9	dose	NN	O	dose	nn	10	SENT_118	[p7l10t1596r165b1662],
10	regimens	NNS	O	regimen	conj_and	6	SENT_118	[p7l219t1599r538b1685],
11	on	IN	O	on	_	0	SENT_118	[p7l594t1622r681b1662],
12	platelet	NN	O	platelet	nn	13	SENT_118	[p7l733t1596r995b1685],
13	inhibition	NN	O	inhibition	prep_on	2	SENT_118	[p7l1046t1596r1398b1662],
14	is	VBZ	O	be	auxpass	15	SENT_118	[p7l1451t1599r1501b1662],
15	reported	VBN	O	report	_	0	SENT_118	[p7l1557t1596r1855b1685],
16	in	IN	O	in	_	0	SENT_118	[p7l1908t1599r1975b1661],
17	the	DT	O	the	det	19	SENT_118	[p7l2028t1596r2138b1662],
18	accompanying	VBG	O	accompany	amod	19	SENT_118	[p7l11t1740r518b1826],
19	report	NN	O	report	prep_in	15	SENT_118	[p7l550t1754r765b1826],
20	(	CD	NUMBER	(	num	22	SENT_118	[p7l799t1735r959b1817],
21	28	CD	NUMBER	28	num	22	SENT_118	[p7l799t1735r959b1817],
22	)	NN	O	)	dep	19	SENT_118	[p7l799t1735r959b1817],
23	.	.	O	.	_	0	SENT_118	[p7l799t1735r959b1817],

1	Prediction	NN	O	prediction	_	0	SENT_119	[p7l13t1849r373b1907],
2	of	IN	O	of	_	0	SENT_119	[p7l438t1848r510b1907],
3	response	NN	O	response	prep_of	1	SENT_119	[p7l569t1866r888b1922],
4	with	IN	O	with	_	0	SENT_119	[p7l948t1849r1101b1907],
5	phenotyping	NN	O	phenotyping	prep_with	1	SENT_119	[p7l1167t1849r1648b1924],
6	.	.	O	.	_	0	SENT_119	[p7l1167t1849r1648b1924],

1	A	DT	O	a	det	4	SENT_120	[p7l1696t1840r1763b1906],
2	receiveroperator	NN	O	receiveroperator	nn	4	SENT_120	[p7l1821t1845r2136b1907, p7l10t1965r307b2037],
3	characteristic	JJ	O	characteristic	amod	4	SENT_120	[p7l348t1948r812b2014],
4	analysis	NN	O	analysis	nsubj	5	SENT_120	[p7l854t1948r1119b2037],
5	found	VBD	O	find	_	0	SENT_120	[p7l1162t1948r1370b2014],
6	that	IN	O	that	complm	14	SENT_120	[p7l1411t1948r1552b2014],
7	lack	NN	O	lack	nsubj	14	SENT_120	[p7l1591t1948r1734b2014],
8	of	IN	O	of	_	0	SENT_120	[p7l1772t1948r1852b2014],
9	platelet	NN	O	platelet	nn	10	SENT_120	[p7l1881t1948r2141b2037],
10	inhibition	NN	O	inhibition	prep_of	7	SENT_120	[p7l9t2054r361b2120],
11	at	IN	O	at	_	0	SENT_120	[p7l388t2071r451b2120],
12	2	CD	NUMBER	2	num	13	SENT_120	[p7l472t2057r513b2121],
13	h	NN	O	h	prep_at	10	SENT_120	[p7l540t2054r584b2119],
14	predicted	VBD	O	predict	ccomp	5	SENT_120	[p7l608t2054r940b2143],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_120	[p7l965t2054r1360b2143],
16	resistance	NN	O	resistance	dobj	14	SENT_120	[p7l1383t2057r1722b2120],
17	at	IN	O	at	_	0	SENT_120	[p7l1750t2071r1813b2120],
18	7	CD	NUMBER	7	num	21	SENT_120	[p7l1838t2055r1878b2120],
19	h	NN	O	h	nn	21	SENT_120	[p7l1902t2054r1947b2119],
20	(	NN	O	(	nn	21	SENT_120	[p7l1975t2052r2042b2143],
21	p	NN	O	p	prep_at	14	SENT_120	[p7l1975t2052r2042b2143],
22	=	JJ	O	=	advmod	26	SENT_120	[p7l2077t2079r2131b2100],
23	0.02	CD	NUMBER	0.02	dep	22	SENT_120	[p7l10t2158r187b2240],
24	)	CD	NUMBER	)	number	25	SENT_120	[p7l10t2158r187b2240],
25	(	CD	NUMBER	(	num	26	SENT_120	[p7l247t2158r408b2249],
26	Fig	NN	O	fig	rcmod	21	SENT_120	[p7l247t2158r408b2249],
27	.	.	O	.	_	0	SENT_120	[p7l247t2158r408b2249],

1	2	CD	NUMBER	2	num	2	SENT_121	[p7l463t2158r554b2240],
2	)	CD	NUMBER	)	_	0	SENT_121	[p7l463t2158r554b2240],
3	.	.	O	.	_	0	SENT_121	[p7l463t2158r554b2240],

1	There	EX	O	there	expl	2	SENT_122	[p7l608t2158r823b2226],
2	were	VBD	O	be	_	0	SENT_122	[p7l873t2185r1040b2226],
3	fewer	JJR	O	fewer	amod	4	SENT_122	[p7l1093t2160r1286b2226],
4	nonresponders	NNS	O	nonresponder	iobj	2	SENT_122	[p7l1338t2160r1854b2249],
5	in	IN	O	in	_	0	SENT_122	[p7l1909t2163r1976b2225],
6	the	DT	O	the	det	10	SENT_122	[p7l2029t2160r2139b2226],
7	1,200	CD	NUMBER	1,200	number	8	SENT_122	[p7l14t2270r359b2356],
8	—	CD	NUMBER	—	num	10	SENT_122	[p7l14t2270r359b2356],
9	mg	NN	O	mg	nn	10	SENT_122	[p7l14t2270r359b2356],
10	group	NN	O	group	prep_in	4	SENT_122	[p7l389t2292r593b2356],
11	than	IN	O	than	dep	30	SENT_122	[p7l627t2267r786b2333],
12	in	IN	O	in	_	0	SENT_122	[p7l818t2270r886b2332],
13	the	DT	O	the	det	17	SENT_122	[p7l919t2267r1028b2333],
14	600	CD	NUMBER	600	number	15	SENT_122	[p7l1064t2270r1345b2356],
15	—	CD	NUMBER	—	num	17	SENT_122	[p7l1064t2270r1345b2356],
16	mg	NN	O	mg	nn	17	SENT_122	[p7l1064t2270r1345b2356],
17	group	NN	O	group	prep_in	11	SENT_122	[p7l1374t2292r1600b2356],
18	;	:	O	;	_	0	SENT_122	[p7l1374t2292r1600b2356],
19	2	CD	NUMBER	2	dep	17	SENT_122	[p7l1634t2270r1675b2334],
20	of	IN	O	of	_	0	SENT_122	[p7l1710t2267r1790b2333],
21	37	CD	NUMBER	37	prep_of	19	SENT_122	[p7l1812t2268r1896b2333],
22	in	IN	O	in	_	0	SENT_122	[p7l1929t2270r1996b2332],
23	the	DT	O	the	det	27	SENT_122	[p7l2029t2267r2139b2333],
24	high	JJ	O	high	amod	27	SENT_122	[p7l9t2373r364b2462],
25	—	NN	O	—	nn	27	SENT_122	[p7l9t2373r364b2462],
26	dose	NN	O	dose	nn	27	SENT_122	[p7l9t2373r364b2462],
27	group	NN	O	group	prep_in	19	SENT_122	[p7l422t2398r626b2462],
28	(	CD	PERCENT	(	number	29	SENT_122	[p7l689t2371r849b2453],
29	5	CD	PERCENT	5	num	30	SENT_122	[p7l689t2371r849b2453],
30	%	NN	PERCENT	%	dep	4	SENT_122	[p7l689t2371r849b2453],
31	)	CD	NUMBER	)	dep	4	SENT_122	[p7l689t2371r849b2453],
32	compared	VBN	O	compare	_	0	SENT_122	[p7l912t2373r1259b2462],
33	with	IN	O	with	prepc_compared_with	31	SENT_122	[p7l1313t2373r1474b2439],
34	6	CD	NUMBER	6	pobj	31	SENT_122	[p7l1534t2376r1572b2439],
35	of	IN	O	of	_	0	SENT_122	[p7l1633t2373r1713b2439],
36	26	CD	NUMBER	26	prep_of	34	SENT_122	[p7l1757t2376r1842b2440],
37	in	IN	O	in	_	0	SENT_122	[p7l1903t2376r1971b2438],
38	the	DT	O	the	det	42	SENT_122	[p7l2029t2373r2139b2439],
39	low	JJ	O	low	amod	42	SENT_122	[p7l8t2479r329b2545],
40	—	NN	O	—	nn	42	SENT_122	[p7l8t2479r329b2545],
41	dose	NN	O	dose	nn	42	SENT_122	[p7l8t2479r329b2545],
42	group	NN	O	group	prep_in	31	SENT_122	[p7l369t2504r574b2568],
43	(	CD	PERCENT	(	num	45	SENT_122	[p7l618t2477r822b2559],
44	26	CD	PERCENT	26	num	45	SENT_122	[p7l618t2477r822b2559],
45	%	NN	PERCENT	%	nsubj	47	SENT_122	[p7l618t2477r822b2559],
46	)	CD	NUMBER	)	dep	45	SENT_122	[p7l618t2477r822b2559],
47	had	VBD	O	have	rcmod	31	SENT_122	[p7l866t2479r996b2545],
48	7	CD	NUMBER	7	number	49	SENT_122	[p7l1037t2479r1160b2545],
49	—	CD	NUMBER	—	num	51	SENT_122	[p7l1037t2479r1160b2545],
50	h	NN	O	h	nn	51	SENT_122	[p7l1037t2479r1160b2545],
51	platelet	NN	O	platelet	dobj	47	SENT_122	[p7l1199t2479r1460b2568],
52	inhibition	NN	O	inhibition	npadvmod	53	SENT_122	[p7l1499t2479r1850b2545],
53	<	JJR	O	<	amod	51	SENT_122	[p7l1896t2482r2135b2545],
54	10	CD	PERCENT	10	num	55	SENT_122	[p7l1896t2482r2135b2545],
55	%	NN	PERCENT	%	dep	53	SENT_122	[p7l1896t2482r2135b2545],
56	.	.	O	.	_	0	SENT_122	[p7l1896t2482r2135b2545],

1	The	DT	O	the	det	2	SENT_123	[p7l7t2583r153b2651],
2	area	NN	O	area	nsubj	14	SENT_123	[p7l190t2611r330b2651],
3	under	IN	O	under	_	0	SENT_123	[p7l363t2585r569b2651],
4	the	DT	O	the	det	5	SENT_123	[p7l602t2585r712b2651],
5	curve	NN	O	curve	prep_under	2	SENT_123	[p7l749t2610r932b2651],
6	for	IN	O	for	_	0	SENT_123	[p7l967t2585r1067b2651],
7	these	DT	O	these	det	12	SENT_123	[p7l1100t2585r1280b2651],
8	receiVer	NN	O	receiver	nn	12	SENT_123	[p7l1315t2588r1922b2674],
9	—	NN	O	—	nn	12	SENT_123	[p7l1315t2588r1922b2674],
10	operator	NN	O	operator	nn	12	SENT_123	[p7l1315t2588r1922b2674],
11	characteristic	JJ	O	characteristic	amod	12	SENT_123	[p7l1956t2585r2137b2651, p7l11t2693r322b2755],
12	curves	NNS	O	curve	prep_for	5	SENT_123	[p7l347t2715r561b2755],
13	was	VBD	O	be	cop	14	SENT_123	[p7l584t2715r713b2755],
14	0.90	CD	NUMBER	0.90	_	0	SENT_123	[p7l741t2693r911b2755],
15	.	.	O	.	_	0	SENT_123	[p7l741t2693r911b2755],

1	Platelet	NN	O	platelet	nn	2	SENT_124	[p7l941t2690r1209b2755],
2	inhibition	NN	O	inhibition	nsubj	14	SENT_124	[p7l1232t2690r1584b2755],
3	of	IN	O	of	_	0	SENT_124	[p7l1610t2690r1690b2755],
4	less	JJR	O	less	mwe	5	SENT_124	[p7l1702t2690r1822b2755],
5	than	IN	O	than	quantmod	6	SENT_124	[p7l1848t2690r2007b2755],
6	2	CD	PERCENT	2	num	7	SENT_124	[p7l2030t2693r2139b2756],
7	%	NN	PERCENT	%	prep_of	2	SENT_124	[p7l2030t2693r2139b2756],
8	at	IN	O	at	_	0	SENT_124	[p7l11t2813r74b2862],
9	2	CD	NUMBER	2	num	10	SENT_124	[p7l114t2799r155b2863],
10	h	NN	O	h	prep_at	7	SENT_124	[p7l201t2796r245b2861],
11	was	VBD	O	be	cop	14	SENT_124	[p7l285t2822r415b2862],
12	the	DT	O	the	det	14	SENT_124	[p7l460t2796r570b2862],
13	best	JJS	O	best	amod	14	SENT_124	[p7l613t2796r755b2862],
14	predictor	NN	O	predictor	_	0	SENT_124	[p7l796t2796r1119b2885],
15	of	IN	O	of	_	0	SENT_124	[p7l1162t2796r1242b2862],
16	nonresponse	JJ	O	nonresponse	amod	18	SENT_124	[p7l1274t2822r1715b2885],
17	(	NN	O	(	nn	18	SENT_124	[p7l1762t2794r2140b2876],
18	inhibition	NN	O	inhibition	dep	19	SENT_124	[p7l1762t2794r2140b2876],
19	<	JJR	O	<	prep_of	14	SENT_124	[p7l14t2900r261b2982],
20	10	CD	PERCENT	10	number	21	SENT_124	[p7l14t2900r261b2982],
21	%	NN	PERCENT	%	amod	19	SENT_124	[p7l14t2900r261b2982],
22	)	CD	NUMBER	)	dep	19	SENT_124	[p7l14t2900r261b2982],
23	in	IN	O	in	_	0	SENT_124	[p7l296t2905r363b2967],
24	all	DT	O	all	det	25	SENT_124	[p7l395t2902r475b2968],
25	patients	NNS	O	patient	prep_in	22	SENT_124	[p7l503t2905r801b2991],
26	,	,	O	,	_	0	SENT_124	[p7l503t2905r801b2991],
27	regardless	RB	O	regardless	_	0	SENT_124	[p7l834t2902r1179b2991],
28	of	IN	O	of	_	0	SENT_124	[p7l1212t2902r1292b2968],
29	dose	NN	O	dose	prep_regardless_of	19	SENT_124	[p7l1311t2902r1487b2983],
30	,	,	O	,	_	0	SENT_124	[p7l1311t2902r1487b2983],
31	at	IN	O	at	advmod	35	SENT_124	[p7l1522t2919r1585b2968],
32	7	CD	NUMBER	7	num	33	SENT_124	[p7l1616t2903r1655b2968],
33	h	NN	O	h	pobj	31	SENT_124	[p7l1686t2902r1730b2967],
34	(	NN	O	(	nn	35	SENT_124	[p7l1764t2900r2144b2991],
35	sensitivity	NN	O	sensitivity	prep_regardless_of	19	SENT_124	[p7l1764t2900r2144b2991],
36	100	CD	PERCENT	100	number	37	SENT_124	[p7l14t3011r206b3074],
37	%	NN	PERCENT	%	amod	35	SENT_124	[p7l14t3011r206b3074],
38	and	CC	O	and	_	0	SENT_124	[p7l240t3008r368b3074],
39	speciﬁcity	NN	O	speciﬁcity	prep_regardless_of	19	SENT_124	[p7l401t3008r752b3097],
40	88	CD	PERCENT	88	num	41	SENT_124	[p7l784t3006r981b3088],
41	%	NN	PERCENT	%	dep	19	SENT_124	[p7l784t3006r981b3088],
42	)	CD	NUMBER	)	dep	41	SENT_124	[p7l784t3006r981b3088],
43	.	.	O	.	_	0	SENT_124	[p7l784t3006r981b3088],

1	Prediction	NN	O	prediction	_	0	SENT_125	[p7l13t3121r359b3180],
2	of	IN	O	of	_	0	SENT_125	[p7l400t3120r471b3180],
3	response	NN	O	response	prep_of	1	SENT_125	[p7l507t3138r815b3195],
4	with	IN	O	with	_	0	SENT_125	[p7l853t3121r1000b3180],
5	genotyping	NN	O	genotyping	prep_with	1	SENT_125	[p7l1042t3123r1461b3196],
6	.	.	O	.	_	0	SENT_125	[p7l1042t3123r1461b3196],

1	The	DT	O	the	det	2	SENT_126	[p7l1507t3112r1653b3180],
2	frequency	NN	O	frequency	nsubjpass	18	SENT_126	[p7l1691t3114r2038b3203],
3	of	IN	O	of	_	0	SENT_126	[p7l2072t3114r2152b3180],
4	the	DT	O	the	det	5	SENT_126	[p7l9t3221r119b3287],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_126	[p7l147t3238r498b3310],
6	tested	VBN	O	test	partmod	5	SENT_126	[p7l528t3221r736b3287],
7	in	IN	O	in	_	0	SENT_126	[p7l763t3224r831b3286],
8	our	PRP$	O	we	poss	10	SENT_126	[p7l860t3246r977b3287],
9	study	NN	O	study	nn	10	SENT_126	[p7l1005t3221r1194b3310],
10	population	NN	O	population	prep_in	6	SENT_126	[p7l1218t3221r1600b3310],
11	and	CC	O	and	_	0	SENT_126	[p7l1630t3221r1758b3287],
12	previously	RB	DATE	previously	advmod	13	SENT_126	[p7l1784t3221r2144b3310],
13	reported	VBN	O	report	amod	14	SENT_126	[p7l9t3327r308b3416],
14	frequencies	NNS	O	frequency	conj_and	5	SENT_126	[p7l337t3327r733b3416],
15	in	IN	O	in	_	0	SENT_126	[p7l766t3330r834b3392],
16	Caucasians	NNS	MISC	caucasian	prep_in	14	SENT_126	[p7l866t3327r1255b3393],
17	are	VBP	O	be	auxpass	18	SENT_126	[p7l1289t3352r1390b3393],
18	outlined	VBN	O	outline	_	0	SENT_126	[p7l1422t3327r1714b3393],
19	in	IN	O	in	_	0	SENT_126	[p7l1744t3330r1812b3392],
20	Table	NNP	O	Table	prep_in	18	SENT_126	[p7l1840t3325r2044b3393],
21	2	CD	NUMBER	2	num	20	SENT_126	[p7l2074t3330r2135b3394],
22	.	.	O	.	_	0	SENT_126	[p7l2074t3330r2135b3394],

1	CYP3A4/5	CD	NUMBER	cyp3a4/5	num	2	SENT_127	[p7l12t3451r302b3499],
2	POLYMORPHISMS	NNS	O	polymorphism	_	0	SENT_127	[p7l323t3448r965b3499],
3	.	.	O	.	_	0	SENT_127	[p7l323t3448r965b3499],

1	None	NN	O	none	nsubj	5	SENT_128	[p7l1015t3434r1211b3499],
2	of	IN	O	of	_	0	SENT_128	[p7l1237t3433r1317b3499],
3	the	DT	O	the	det	4	SENT_128	[p7l1328t3433r1439b3499],
4	patients	NNS	O	patient	prep_of	1	SENT_128	[p7l1463t3436r1739b3522],
5	carried	VBD	O	carry	_	0	SENT_128	[p7l1766t3433r2005b3499],
6	the	DT	O	the	det	9	SENT_128	[p7l2028t3433r2139b3499],
7	CYP3A4	NN	O	cyp3a4	nn	9	SENT_128	[p7l16t3542r451b3615],
8	*	CD	NUMBER	*	num	9	SENT_128	[p7l16t3542r451b3615],
9	JB	NN	O	jb	dobj	5	SENT_128	[p7l16t3542r451b3615],
10	,	,	O	,	_	0	SENT_128	[p7l16t3542r451b3615],
11	*	CD	NUMBER	*	number	12	SENT_128	[p7l494t3542r571b3615],
12	3	CD	NUMBER	3	appos	9	SENT_128	[p7l494t3542r571b3615],
13	,	,	O	,	_	0	SENT_128	[p7l494t3542r571b3615],
14	*	CD	NUMBER	*	number	15	SENT_128	[p7l614t3542r692b3615],
15	4	CD	NUMBER	4	conj_and	9	SENT_128	[p7l614t3542r692b3615],
16	,	,	O	,	_	0	SENT_128	[p7l614t3542r692b3615],
17	or	CC	O	or	_	0	SENT_128	[p7l730t3564r803b3604],
18	CYP3145	NN	O	cyp3145	nn	19	SENT_128	[p7l838t3542r1136b3605],
19	*	NN	O	*	conj_or	15	SENT_128	[p7l1140t3542r1203b3605],
20	2	CD	NUMBER	2	dep	19	SENT_128	[p7l1140t3542r1203b3605],
21	and	CC	O	and	_	0	SENT_128	[p7l1235t3539r1362b3604],
22	*	CD	NUMBER	*	num	25	SENT_128	[p7l1397t3542r1460b3604],
23	6	CD	NUMBER	6	num	25	SENT_128	[p7l1397t3542r1460b3604],
24	variant	JJ	O	variant	amod	25	SENT_128	[p7l1487t3542r1732b3604],
25	alleles	NNS	O	allele	dobj	5	SENT_128	[p7l1763t3539r1991b3619],
26	,	,	O	,	_	0	SENT_128	[p7l1763t3539r1991b3619],
27	but	CC	O	but	advmod	25	SENT_128	[p7l2023t3539r2141b3604],

1	3	CD	NUMBER	3	num	2	SENT_129	[p8l10t23r47b86],
2	patients	NNS	O	patient	nsubj	3	SENT_129	[p8l73t23r350b109],
3	had	VBD	O	have	_	0	SENT_129	[p8l375t20r505b86],
4	the	DT	O	the	det	10	SENT_129	[p8l527t20r638b86],
5	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	10	SENT_129	[p8l668t23r966b87],
6	*	NN	O	*	nn	10	SENT_129	[p8l971t23r1030b85],
7	1	CD	NUMBER	1	num	10	SENT_129	[p8l971t23r1030b85],
8	*	NN	O	*	nn	10	SENT_129	[p8l1041t23r1101b85],
9	1	CD	NUMBER	1	num	10	SENT_129	[p8l1041t23r1101b85],
10	genotype	NN	O	genotype	dobj	3	SENT_129	[p8l1127t37r1467b109],
11	,	,	O	,	_	0	SENT_129	[p8l1127t37r1467b109],
12	and	CC	O	and	_	0	SENT_129	[p8l1495t20r1622b86],
13	3	CD	NUMBER	3	num	14	SENT_129	[p8l1646t23r1682b86],
14	patients	NNS	O	patient	nsubj	15	SENT_129	[p8l1709t23r1986b109],
15	had	VBD	O	have	conj_and	3	SENT_129	[p8l2011t20r2140b86],
16	the	DT	O	the	det	22	SENT_129	[p8l9t126r119b192],
17	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	22	SENT_129	[p8l164t129r599b193],
18	*	CD	NUMBER	*	num	22	SENT_129	[p8l164t129r599b193],
19	]	CD	NUMBER	]	num	22	SENT_129	[p8l164t129r599b193],
20	*	NN	O	*	nn	22	SENT_129	[p8l164t129r599b193],
21	3	CD	NUMBER	3	num	22	SENT_129	[p8l164t129r599b193],
22	genotype	NN	O	genotype	dobj	15	SENT_129	[p8l635t143r974b215],
23	.	.	O	.	_	0	SENT_129	[p8l635t143r974b215],

1	However	RB	O	however	advmod	7	SENT_130	[p8l1016t127r1356b206],
2	,	,	O	,	_	0	SENT_130	[p8l1016t127r1356b206],
3	no	DT	O	no	det	5	SENT_130	[p8l1397t152r1482b192],
4	signiﬁcant	NN	O	signiﬁcant	nn	5	SENT_130	[p8l1522t126r1887b215],
5	difference	NN	O	difference	nsubjpass	7	SENT_130	[p8l1923t126r2137b192, p8l10t258r165b298],
6	was	VBD	O	be	auxpass	7	SENT_130	[p8l200t258r328b298],
7	observed	VBN	O	observe	_	0	SENT_130	[p8l369t232r677b298],
8	in	IN	O	in	_	0	SENT_130	[p8l714t235r782b297],
9	platelet	NN	O	platelet	nn	10	SENT_130	[p8l818t232r1079b321],
10	inhibition	NN	O	inhibition	prep_in	7	SENT_130	[p8l1115t232r1466b298],
11	in	IN	O	in	_	0	SENT_130	[p8l1504t235r1572b297],
12	those	DT	O	those	prep_in	7	SENT_130	[p8l1609t232r1795b298],
13	with	IN	O	with	_	0	SENT_130	[p8l1830t232r1991b298],
14	the	DT	O	the	det	16	SENT_130	[p8l2028t232r2138b298],
15	CYP3145	NN	O	cyp3145	nn	16	SENT_130	[p8l16t341r313b405],
16	genotype	NN	O	genotype	prep_with	12	SENT_130	[p8l342t355r662b427],
17	(	CD	NUMBER	(	num	18	SENT_130	[p8l698t336r873b418],
18	data	NNS	O	datum	npadvmod	19	SENT_130	[p8l698t336r873b418],
19	not	RB	O	not	neg	20	SENT_130	[p8l906t355r1023b404],
20	shown	VBN	O	show	partmod	16	SENT_130	[p8l1056t336r1331b418],
21	)	NN	O	)	dobj	20	SENT_130	[p8l1056t336r1331b418],
22	.	.	O	.	_	0	SENT_130	[p8l1056t336r1331b418],

1	Table	NNP	O	Table	_	0	SENT_131	[p8l67t518r137b538],
2	2	CD	NUMBER	2	dep	1	SENT_131	[p8l148t517r172b538],
3	.	.	O	.	_	0	SENT_131	[p8l148t517r172b538],

1	Frequency	NN	O	frequency	_	0	SENT_132	[p8l185t518r318b543],
2	of	IN	O	of	_	0	SENT_132	[p8l328t517r353b538],
3	Detectable	JJ	O	detectable	amod	5	SENT_132	[p8l363t518r505b538],
4	Variant	JJ	O	variant	amod	5	SENT_132	[p8l515t517r608b538],
5	Alleles	NNS	O	allele	prep_of	1	SENT_132	[p8l618t518r705b538],
6	in	IN	O	in	dep	1	SENT_132	[p8l716t517r737b538],
7	Our	PRP$	O	we	poss	9	SENT_132	[p8l749t517r793b538],
8	Study	NN	O	study	nn	9	SENT_132	[p8l803t517r877b543],
9	Population	NNP	O	Population	pobj	6	SENT_132	[p8l888t517r1024b543],
10	and	CC	O	and	_	0	SENT_132	[p8l1036t518r1081b538],
11	Those	DT	O	those	conj_and	9	SENT_132	[p8l1092t518r1169b538],
12	Reported	VBN	O	report	partmod	11	SENT_132	[p8l1181t518r1297b543],
13	in	IN	O	in	_	0	SENT_132	[p8l1310t517r1330b538],
14	Hapmap	NNP	O	Hapmap	nn	15	SENT_132	[p8l1343t518r1447b543],
15	Database	NNP	O	Database	prep_in	12	SENT_132	[p8l1459t518r1580b538],

1	SNP	NN	O	snp	nn	3	SENT_133	[p8l1355t585r1405b605],
2	Frequency	NN	O	frequency	nn	3	SENT_133	[p8l1416t586r1539b609],
3	cohort	NN	O	cohort	_	0	SENT_133	[p8l1549t586r1629b605],
4	Versus	NNP	O	Versus	nn	5	SENT_133	[p8l1639t586r1720b605],
5	Hapmap	NNP	O	Hapmap	dep	3	SENT_133	[p8l1731t586r1828b609],
6	(	CD	NUMBER	(	num	7	SENT_133	[p8l1838t586r1907b609],
7	CEU	NNP	O	CEU	dep	3	SENT_133	[p8l1838t586r1907b609],
8	)	CD	NUMBER	)	num	7	SENT_133	[p8l1838t586r1907b609],

1	Homozygotes	NNS	O	homozygote	nn	2	SENT_134	[p8l1280t668r1440b692],
2	Heterozygotes	NNS	O	heterozygote	_	0	SENT_134	[p8l1820t668r1991b692],
3	dbSNP	NN	O	dbsnp	dep	2	SENT_134	[p8l787t717r866b736],
4	Reference	NNP	O	Reference	dep	2	SENT_134	[p8l878t717r998b736],

1	Allele	NN	O	allele	dep	113	SENT_135	[p8l152t750r219b770],
2	SNP	NN	O	snp	dep	113	SENT_135	[p8l519t750r569b770],
3	Sequence	NN	O	sequence	dep	113	SENT_135	[p8l809t750r927b774],
4	No.	NN	O	no.	dep	113	SENT_135	[p8l938t750r975b770],
5	cohort	NN	O	cohort	dep	113	SENT_135	[p8l1183t750r1263b770],
6	Hapmap	NN	ORGANIZATION	hapmap	dep	113	SENT_135	[p8l1448t750r1544b774],
7	cohort	NN	O	cohort	dep	113	SENT_135	[p8l1728t750r1808b770],
8	Hapmap	NN	ORGANIZATION	hapmap	dep	113	SENT_135	[p8l1993t750r2090b774],
9	ABCB1	NN	O	abcb1	dep	113	SENT_135	[p8l66t821r163b840],
10	*	NN	O	*	dep	113	SENT_135	[p8l66t821r163b840],
11	2	CD	NUMBER	2	dep	113	SENT_135	[p8l66t821r163b840],
12	1236C	NN	O	1236c	dep	113	SENT_135	[p8l478t821r582b840],
13	>	JJR	O	>	dep	113	SENT_135	[p8l478t821r582b840],
14	T	NN	O	t	dep	113	SENT_135	[p8l478t821r582b840],
15	rs1128503	NN	O	rs1128503	dep	113	SENT_135	[p8l829t822r943b840],
16	0.13	CD	NUMBER	0.13	dep	113	SENT_135	[p8l1200t822r1245b840],
17	0.13	CD	NUMBER	0.13	dep	113	SENT_135	[p8l1473t822r1517b840],
18	0.62	CD	NUMBER	0.62	dep	113	SENT_135	[p8l1746t822r1791b840],
19	0.52	CD	NUMBER	0.52	dep	113	SENT_135	[p8l2018t822r2064b840],
20	3435C	NN	O	3435c	dep	113	SENT_135	[p8l476t869r582b888],
21	>	JJR	O	>	dep	113	SENT_135	[p8l476t869r582b888],
22	T	NN	O	t	dep	113	SENT_135	[p8l476t869r582b888],
23	rs1045642	NN	O	rs1045642	dep	113	SENT_135	[p8l829t870r943b888],
24	0.22	CD	NUMBER	0.22	dep	113	SENT_135	[p8l1200t870r1245b888],
25	0.24	CD	NUMBER	0.24	dep	113	SENT_135	[p8l1473t870r1519b888],
26	0.63	CD	NUMBER	0.63	dep	113	SENT_135	[p8l1746t870r1790b888],
27	0.60	CD	NUMBER	0.60	dep	113	SENT_135	[p8l2018t870r2064b888],
28	2677G	NN	O	2677g	dep	113	SENT_135	[p8l476t917r609b937],
29	>	JJR	O	>	dep	113	SENT_135	[p8l476t917r609b937],
30	T/A	NN	O	t/a	dep	113	SENT_135	[p8l476t917r609b937],
31	rs2032582	NN	O	rs2032582	dep	113	SENT_135	[p8l829t918r943b936],
32	0.12	CD	NUMBER	0.12	dep	113	SENT_135	[p8l1200t918r1245b936],
33	0.1	CD	NUMBER	0.1	dep	113	SENT_135	[p8l1473t918r1500b936],
34	1	CD	NUMBER	1	dep	113	SENT_135	[p8l1508t918r1514b936],
35	0.6	CD	NUMBER	0.6	dep	113	SENT_135	[p8l1746t918r1778b936],
36	0.56	CD	NUMBER	0.56	dep	113	SENT_135	[p8l2018t918r2064b936],
37	C	NN	O	c	dep	113	SENT_135	[p8l68t965r83b984],
38	YP3A5	NN	O	yp3a5	dep	113	SENT_135	[p8l85t965r176b984],
39	*	CD	NUMBER	*	dep	113	SENT_135	[p8l85t965r176b984],
40	3	CD	NUMBER	3	dep	113	SENT_135	[p8l85t965r176b984],
41	6986A	NN	O	6986a	dep	113	SENT_135	[p8l476t965r586b984],
42	>	JJR	O	>	dep	113	SENT_135	[p8l476t965r586b984],
43	G	NN	O	g	dep	113	SENT_135	[p8l476t965r586b984],
44	—	CD	NUMBER	—	dep	113	SENT_135	[p8l880t976r906b978],
45	0.92	CD	NUMBER	0.92	dep	113	SENT_135	[p8l1200t966r1245b984],
46	0.88	CD	NUMBER	0.88	dep	113	SENT_135	[p8l1473t966r1518b984],
47	0.05	CD	NUMBER	0.05	dep	113	SENT_135	[p8l1746t966r1790b984],
48	0.12	CD	NUMBER	0.12	dep	113	SENT_135	[p8l2018t966r2064b984],
49	CYP2C19	NN	O	cyp2c19	dep	113	SENT_135	[p8l68t1013r189b1032],
50	*	NN	O	*	dep	113	SENT_135	[p8l68t1013r189b1032],
51	2	CD	NUMBER	2	dep	113	SENT_135	[p8l68t1013r189b1032],
52	19154G	NN	O	19154g	dep	113	SENT_135	[p8l478t1013r600b1032],
53	>	JJR	O	>	dep	113	SENT_135	[p8l478t1013r600b1032],
54	A	DT	O	a	dep	113	SENT_135	[p8l478t1013r600b1032],
55	rs4244285	NN	O	rs4244285	dep	113	SENT_135	[p8l829t1014r943b1032],
56	o	NN	O	o	dep	113	SENT_135	[p8l1200t1014r1212b1032],
57	0.05	CD	NUMBER	0.05	dep	113	SENT_135	[p8l1473t1014r1518b1032],
58	0.27	CD	NUMBER	0.27	dep	113	SENT_135	[p8l1746t1014r1791b1032],
59	0.21	CD	NUMBER	0.21	dep	113	SENT_135	[p8l2018t1014r2060b1032],
60	C	NN	O	c	dep	113	SENT_135	[p8l68t1061r83b1080],
61	YPZC	NN	O	ypzc	dep	113	SENT_135	[p8l85t1061r139b1080],
62	19	CD	NUMBER	19	dep	113	SENT_135	[p8l143t1061r189b1080],
63	*	NN	O	*	dep	113	SENT_135	[p8l143t1061r189b1080],
64	4	CD	NUMBER	4	dep	113	SENT_135	[p8l143t1061r189b1080],
65	1A	NN	O	1a	dep	113	SENT_135	[p8l478t1061r544b1080],
66	>	JJR	O	>	dep	113	SENT_135	[p8l478t1061r544b1080],
67	G	NN	O	g	dep	113	SENT_135	[p8l478t1061r544b1080],
68	rs28399504	NN	O	rs28399504	dep	113	SENT_135	[p8l829t1062r958b1080],
69	o	NN	O	o	dep	113	SENT_135	[p8l1200t1062r1212b1080],
70	—	CD	NUMBER	—	dep	113	SENT_135	[p8l1483t1072r1509b1074],
71	0.05	CD	NUMBER	0.05	dep	113	SENT_135	[p8l1746t1062r1790b1080],
72	—	NN	O	—	dep	113	SENT_135	[p8l2028t1072r2054b1074],
73	C	NN	O	c	dep	113	SENT_135	[p8l68t1109r83b1128],
74	YP2C	NN	O	yp2c	dep	113	SENT_135	[p8l85t1109r139b1128],
75	19	CD	NUMBER	19	dep	113	SENT_135	[p8l143t1109r176b1128],
76	*	NN	O	*	dep	113	SENT_135	[p8l143t1109r176b1128],
77	77	CD	NUMBER	77	dep	113	SENT_135	[p8l181t1110r204b1128],
78	—	CD	NUMBER	—	dep	113	SENT_135	[p8l475t1109r582b1128],
79	806C	NN	O	806c	dep	113	SENT_135	[p8l475t1109r582b1128],
80	>	JJR	O	>	dep	113	SENT_135	[p8l475t1109r582b1128],
81	T	NN	O	t	dep	113	SENT_135	[p8l475t1109r582b1128],
82	rs12248560	NN	O	rs12248560	dep	113	SENT_135	[p8l829t1109r958b1128],
83	0.07	CD	NUMBER	0.07	dep	113	SENT_135	[p8l1200t1109r1245b1128],
84	0.02	CD	NUMBER	0.02	dep	113	SENT_135	[p8l1473t1109r1518b1128],
85	0.27	CD	NUMBER	0.27	dep	113	SENT_135	[p8l1746t1109r1791b1128],
86	0.40	CD	NUMBER	0.40	dep	113	SENT_135	[p8l2018t1109r2064b1128],
87	C	NN	O	c	dep	113	SENT_135	[p8l68t1157r83b1176],
88	YP2C9	NN	O	yp2c9	dep	113	SENT_135	[p8l85t1157r176b1176],
89	*	NN	O	*	dep	113	SENT_135	[p8l85t1157r176b1176],
90	2	CD	NUMBER	2	dep	113	SENT_135	[p8l85t1157r176b1176],
91	3608C	NN	O	3608c	dep	113	SENT_135	[p8l476t1157r583b1176],
92	>	JJR	O	>	dep	113	SENT_135	[p8l476t1157r583b1176],
93	T	NN	O	t	dep	113	SENT_135	[p8l476t1157r583b1176],
94	rs1799853	NN	O	rs1799853	dep	113	SENT_135	[p8l829t1157r943b1176],
95	0.02	CD	NUMBER	0.02	dep	113	SENT_135	[p8l1200t1157r1245b1176],
96	o	NN	O	o	dep	113	SENT_135	[p8l1473t1157r1485b1176],
97	0.25	CD	NUMBER	0.25	dep	113	SENT_135	[p8l1746t1157r1790b1176],
98	0.21	CD	NUMBER	0.21	dep	113	SENT_135	[p8l2019t1157r2060b1176],
99	CYP2C9	NN	O	cyp2c9	dep	113	SENT_135	[p8l68t1205r176b1224],
100	*	CD	NUMBER	*	dep	113	SENT_135	[p8l68t1205r176b1224],
101	3	CD	NUMBER	3	dep	113	SENT_135	[p8l68t1205r176b1224],
102	42614A	NN	O	42614a	dep	113	SENT_135	[p8l475t1205r598b1224],
103	>	JJR	O	>	dep	113	SENT_135	[p8l475t1205r598b1224],
104	C	NN	O	c	dep	113	SENT_135	[p8l475t1205r598b1224],
105	rs1057910	NN	O	rs1057910	dep	113	SENT_135	[p8l829t1205r944b1224],
106	o	NN	O	o	dep	113	SENT_135	[p8l1200t1205r1212b1224],
107	o	NN	O	o	dep	113	SENT_135	[p8l1473t1205r1485b1224],
108	0.05	CD	NUMBER	0.05	dep	113	SENT_135	[p8l1746t1205r1790b1224],
109	0.12	CD	NUMBER	0.12	dep	113	SENT_135	[p8l2019t1205r2064b1224],
110	P2Y12	NN	O	p2y12	dep	113	SENT_135	[p8l68t1253r135b1271],
111	H2	NN	O	h2	dep	113	SENT_135	[p8l146t1253r174b1271],
112	haplotype	NN	O	haplotype	dep	113	SENT_135	[p8l186t1252r299b1277],
113	i	FW	O	i	_	0	SENT_135	[p8l476t1252r560b1272],
114	.	.	O	.	_	0	SENT_135	[p8l476t1252r560b1272],

1	—	NN	O	—	_	0	SENT_136	[p8l476t1252r560b1272],
2	.	.	O	.	_	0	SENT_136	[p8l476t1252r560b1272],

1	T744C	NN	O	t744c	nn	2	SENT_137	[p8l476t1252r560b1272],
2	rs2046934	NN	O	rs2046934	nsubj	8	SENT_137	[p8l829t1253r944b1272],
3	0.03	CD	NUMBER	0.03	dep	2	SENT_137	[p8l1200t1253r1245b1272],
4	0.03	CD	NUMBER	0.03	num	5	SENT_137	[p8l1473t1253r1518b1272],
5	0.25	CD	NUMBER	0.25	dep	2	SENT_137	[p8l1746t1253r1790b1272],
6	0.38	CD	NUMBER	0.38	num	7	SENT_137	[p8l2019t1253r2064b1272],
7	Dash	NN	O	dash	dep	5	SENT_137	[p8l69t1313r116b1331],
8	denotes	VBZ	O	denote	_	0	SENT_137	[p8l123t1313r203b1331],
9	information	NN	O	information	dobj	8	SENT_137	[p8l210t1313r326b1331],
10	not	RB	O	not	neg	11	SENT_137	[p8l334t1316r367b1331],
11	available	JJ	O	available	amod	9	SENT_137	[p8l373t1313r465b1331],
12	.	.	O	.	_	0	SENT_137	[p8l373t1313r465b1331],

1	CEU	NN	O	ceu	_	0	SENT_138	[p8l92t1352r131b1369],
2	=	JJ	O	=	amod	3	SENT_138	[p8l140t1357r155b1363],
3	Caucasian	JJ	MISC	caucasian	amod	1	SENT_138	[p8l163t1352r268b1371],
4	;	:	O	;	_	0	SENT_138	[p8l163t1352r268b1371],
5	other	JJ	O	other	amod	6	SENT_138	[p8l274t1351r327b1369],
6	abbreviations	NNS	O	abbreviation	dep	1	SENT_138	[p8l333t1351r469b1369],
7	as	IN	O	as	prep	6	SENT_138	[p8l475t1356r495b1369],
8	in	IN	O	in	pcomp	7	SENT_138	[p8l502t1352r518b1368],
9	Table	NNP	O	Table	pobj	8	SENT_138	[p8l524t1351r579b1369],
10	1	CD	NUMBER	1	num	9	SENT_138	[p8l587t1352r601b1369],
11	.	.	O	.	_	0	SENT_138	[p8l587t1352r601b1369],

1	624	CD	NUMBER	624	num	2	SENT_139	[p8l9t1553r115b1596],
2	Gladding	NNP	O	Gladding	_	0	SENT_139	[p8l331t1553r567b1607],
3	et	FW	O	et	nn	4	SENT_139	[p8l587t1555r638b1596],
4	al.	FW	O	al.	dep	2	SENT_139	[p8l657t1553r715b1596],
5	.	.	O	.	_	0	SENT_139	[p8l657t1553r715b1596],

1	The	DT	O	the	det	2	SENT_140	[p8l328t1637r424b1680],
2	PRINC	NNP	O	PRINC	_	0	SENT_140	[p8l448t1636r614b1680],
3	Trial	NNP	O	Trial	nn	4	SENT_140	[p8l633t1637r745b1680],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	2	SENT_140	[p8l771t1637r1267b1690],

1	:2	NN	O	:2	_	0	SENT_141	[p9l64t754r119b816],
2	.	.	O	.	_	0	SENT_141	[p9l64t822r119b861],

1	:	:	O	:	_	0	SENT_142	[p9l64t822r119b861],
2	E	NN	O	e	_	0	SENT_142	[p9l64t867r119b927],
3	^	CD	NUMBER	^	num	4	SENT_142	[p9l61t956r122b1020],
4	*	NN	O	*	dep	2	SENT_142	[p9l61t956r122b1020],

1	Q	NNP	O	Q	_	0	SENT_143	[p9l77t1068r119b1094],
2	g	NN	O	g	nn	3	SENT_143	[p9l64t1100r119b1139],
3	N	NN	O	n	dep	1	SENT_143	[p9l64t1165r119b1203],

1	*	NN	O	*	nsubj	7	SENT_144	[p9l937t1390r1001b1442],
2	2	CD	NUMBER	2	num	1	SENT_144	[p9l937t1390r1001b1442],
3	or	CC	O	or	_	0	SENT_144	[p9l1025t1403r1093b1442],
4	*	CD	NUMBER	*	number	5	SENT_144	[p9l1115t1390r1179b1442],
5	4	CD	NUMBER	4	num	6	SENT_144	[p9l1115t1390r1179b1442],
6	carriers	NNS	O	carrier	nsubj	7	SENT_144	[p9l1199t1390r1456b1442],
7	*	VBP	O	*	_	0	SENT_144	[p9l1604t1390r1704b1442],
8	1	CD	NUMBER	1	dobj	7	SENT_144	[p9l1604t1390r1704b1442],
9	?	.	O	?	_	0	SENT_144	[p9l1604t1390r1704b1442],

1	’	NN	O	’	_	0	SENT_145	[p9l1604t1390r1704b1442],
2	r.	NN	O	r.	dep	1	SENT_145	[p9l1727t1357r1984b1442],
3	'	''	O	'	_	0	SENT_145	[p9l1727t1357r1984b1442],
4	:	:	O	:	_	0	SENT_145	[p9l1727t1357r1984b1442],
5	.	.	O	.	_	0	SENT_145	[p9l1727t1357r1984b1442],

1	arrier5	IN	O	arrier5	_	0	SENT_146	[p9l1727t1357r1984b1442],

1	C	NN	O	c	nn	2	SENT_147	[p9l866t1493r917b1551],
2	YPZC	NN	O	ypzc	_	0	SENT_147	[p9l927t1493r1112b1551],
3	1	CD	NUMBER	1	dep	2	SENT_147	[p9l1121t1493r1195b1551],
4	'	''	O	'	_	0	SENT_147	[p9l1121t1493r1195b1551],
5	9	CD	NUMBER	9	dep	3	SENT_147	[p9l1121t1493r1195b1551],
6	genotj/P6	NN	O	genotj/p6	dep	2	SENT_147	[p9l1215t1496r1530b1567],

1	Figure	NNP	O	Figure	_	0	SENT_148	[p9l64t1701r233b1757],
2	3	CD	NUMBER	3	dep	1	SENT_148	[p9l256t1701r307b1746],
3	.	.	O	.	_	0	SENT_148	[p9l256t1701r307b1746],

1	Platelet	NN	O	platelet	nn	2	SENT_149	[p9l335t1702r551b1746],
2	Inhibition	NN	O	inhibition	_	0	SENT_149	[p9l577t1701r831b1746],
3	(	CD	PERCENT	(	num	4	SENT_149	[p9l857t1702r922b1756],
4	%	NN	PERCENT	%	npadvmod	2	SENT_149	[p9l857t1702r922b1756],
5	of	IN	O	of	_	0	SENT_149	[p9l945t1701r997b1746],
6	Baseline	NN	O	baseline	nn	7	SENT_149	[p9l1020t1701r1276b1756],
7	)	NN	O	)	prep_of	2	SENT_149	[p9l1020t1701r1276b1756],
8	at	IN	O	at	_	0	SENT_149	[p9l1304t1703r1358b1746],
9	2	CD	NUMBER	2	num	10	SENT_149	[p9l1382t1701r1416b1746],
10	h	NN	O	h	prep_at	7	SENT_149	[p9l1441t1702r1469b1746],
11	After	IN	O	after	dep	2	SENT_149	[p9l1494t1701r1631b1746],
12	a	DT	O	a	det	16	SENT_149	[p9l1654t1712r1684b1746],
13	600-mg	JJ	O	600-mg	amod	16	SENT_149	[p9l1708t1701r1921b1757],
14	Clopidogrel	NNP	O	Clopidogrel	nn	16	SENT_149	[p9l1943t1701r2098b1756, p9l62t1783r231b1837],
15	Loading	NNP	O	Loading	nn	16	SENT_149	[p9l258t1782r473b1837],
16	Dose	NNP	O	Dose	pobj	11	SENT_149	[p9l497t1783r633b1827],
17	in	IN	O	in	dep	2	SENT_149	[p9l658t1782r702b1826],
18	CYP2C19	NNP	O	CYP2C19	nn	20	SENT_149	[p9l731t1782r1000b1827],
19	Genotype	NNP	O	Genotype	nn	20	SENT_149	[p9l1020t1782r1281b1837],
20	Groups	NNS	O	group	pobj	17	SENT_149	[p9l1305t1782r1497b1837],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_150	[p9l63t1917r393b1961],
2	*	NN	O	*	nsubj	7	SENT_150	[p9l63t1917r393b1961],
3	7	CD	NUMBER	7	num	6	SENT_150	[p9l63t1917r393b1961],
4	*	NN	O	*	nn	6	SENT_150	[p9l63t1917r393b1961],
5	1	CD	NUMBER	1	num	6	SENT_150	[p9l63t1917r393b1961],
6	carriers	NNS	O	carrier	dep	2	SENT_150	[p9l422t1917r608b1961],
7	have	VBP	O	have	_	0	SENT_150	[p9l636t1915r756b1961],
8	greater	JJR	O	greater	amod	10	SENT_150	[p9l781t1922r968b1973],
9	platelet	NN	O	platelet	nn	10	SENT_150	[p9l993t1915r1188b1973],
10	inhibition	NN	O	inhibition	dobj	7	SENT_150	[p9l1214t1915r1460b1961],
11	2	CD	NUMBER	2	num	12	SENT_150	[p9l1487t1918r1513b1960],
12	h	NN	O	h	npadvmod	7	SENT_150	[p9l1542t1915r1568b1960],
13	after	IN	O	after	_	0	SENT_150	[p9l1595t1915r1713b1961],
14	a	DT	O	a	det	18	SENT_150	[p9l1737t1929r1761b1961],
15	600	CD	NUMBER	600	number	16	SENT_150	[p9l1788t1918r1985b1973],
16	—	CD	NUMBER	—	num	18	SENT_150	[p9l1788t1918r1985b1973],
17	mg	NN	O	mg	nn	18	SENT_150	[p9l1788t1918r1985b1973],
18	dose	NN	O	dose	prep_after	7	SENT_150	[p9l62t2000r184b2046],
19	compared	VBN	O	compare	_	0	SENT_150	[p9l209t2000r470b2058],
20	with	IN	O	with	prepc_compared_with	18	SENT_150	[p9l496t2000r607b2046],
21	platelet	NN	O	platelet	nn	22	SENT_150	[p9l636t2000r831b2058],
22	inhibition	NN	O	inhibition	pobj	18	SENT_150	[p9l856t2000r1102b2046],
23	in	IN	O	in	_	0	SENT_150	[p9l1131t2003r1173b2045],
24	CYP2C19	NN	O	cyp2c19	nn	25	SENT_150	[p9l1200t2002r1479b2046],
25	*	NN	O	*	prep_in	22	SENT_150	[p9l1200t2002r1479b2046],
26	2	CD	NUMBER	2	number	29	SENT_150	[p9l1200t2002r1479b2046],
27	or	CC	O	or	_	0	SENT_150	[p9l1503t2014r1555b2046],
28	*	CD	NUMBER	*	conj_or	29	SENT_150	[p9l1581t2002r1632b2045],
29	4	CD	NUMBER	4	num	30	SENT_150	[p9l1581t2002r1632b2045],
30	carriers	NNS	O	carrier	dep	25	SENT_150	[p9l1657t2003r1843b2046],
31	and	CC	O	and	_	0	SENT_150	[p9l1867t2000r1962b2046],
32	CYP2C19	NN	O	cyp2c19	conj_and	25	SENT_150	[p9l63t2087r376b2131],
33	*	CD	NUMBER	*	number	34	SENT_150	[p9l63t2087r376b2131],
34	17	CD	NUMBER	17	num	35	SENT_150	[p9l63t2087r376b2131],
35	carriers	NNS	O	carrier	dep	32	SENT_150	[p9l397t2087r596b2131],
36	.	.	O	.	_	0	SENT_150	[p9l397t2087r596b2131],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_151	[p9l11t2358r281b2406],
2	AND	CC	O	and	_	0	SENT_151	[p9l296t2354r455b2405],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_151	[p9l480t2358r716b2406],
4	POLYMORPHISMS	NNS	O	polymorphism	conj_and	1	SENT_151	[p9l735t2355r1381b2405],
5	.	.	O	.	_	0	SENT_151	[p9l735t2355r1381b2405],

1	None	NN	O	none	nsubj	5	SENT_152	[p9l1432t2340r1629b2405],
2	of	IN	O	of	_	0	SENT_152	[p9l1652t2339r1732b2405],
3	the	DT	O	the	det	4	SENT_152	[p9l1741t2339r1851b2405],
4	patients	NNS	O	patient	prep_of	1	SENT_152	[p9l1872t2342r2151b2429],
5	carried	VBD	O	carry	_	0	SENT_152	[p9l9t2445r250b2511],
6	the	DT	O	the	det	10	SENT_152	[p9l320t2445r431b2511],
7	CYP2CJ9	NN	O	cyp2cj9	nn	10	SENT_152	[p9l509t2448r925b2512],
8	*	NN	O	*	nn	10	SENT_152	[p9l509t2448r925b2512],
9	3	CD	NUMBER	3	num	10	SENT_152	[p9l509t2448r925b2512],
10	allele	NN	O	allele	dobj	5	SENT_152	[p9l998t2445r1194b2511],
11	.	.	O	.	_	0	SENT_152	[p9l998t2445r1194b2511],

1	The	DT	O	the	det	2	SENT_153	[p9l1266t2444r1414b2511],
2	frequency	NN	O	frequency	nsubj	14	SENT_153	[p9l1485t2445r1834b2535],
3	of	IN	O	of	_	0	SENT_153	[p9l1902t2445r1982b2511],
4	the	DT	O	the	det	9	SENT_153	[p9l2041t2445r2152b2511],
5	CYP2	NN	O	cyp2	nn	9	SENT_153	[p9l15t2554r211b2618],
6	C1	NN	O	c1	nn	9	SENT_153	[p9l221t2554r311b2618],
7	9	CD	NUMBER	9	num	9	SENT_153	[p9l323t2554r428b2617],
8	*	NN	O	*	nn	9	SENT_153	[p9l323t2554r428b2617],
9	]	NN	O	]	prep_of	2	SENT_153	[p9l323t2554r428b2617],
10	7	CD	NUMBER	7	num	11	SENT_153	[p9l443t2556r481b2618],
11	allele	NN	O	allele	dep	9	SENT_153	[p9l505t2551r682b2617],
12	was	VBD	O	be	cop	14	SENT_153	[p9l707t2578r837b2618],
13	20	CD	PERCENT	20	num	14	SENT_153	[p9l865t2555r1019b2618],
14	%	NN	PERCENT	%	dep	31	SENT_153	[p9l865t2555r1019b2618],
15	in	IN	O	in	_	0	SENT_153	[p9l1047t2554r1115b2617],
16	our	PRP$	O	we	poss	18	SENT_153	[p9l1144t2577r1261b2617],
17	study	NN	O	study	nn	18	SENT_153	[p9l1289t2551r1479b2640],
18	population	NN	O	population	prep_in	14	SENT_153	[p9l1502t2551r1907b2641],
19	,	,	O	,	_	0	SENT_153	[p9l1502t2551r1907b2641],
20	which	WDT	O	which	nsubj	22	SENT_153	[p9l1934t2551r2152b2618],
21	is	VBZ	O	be	cop	22	SENT_153	[p9l8t2660r59b2723],
22	similar	JJ	O	similar	rcmod	18	SENT_153	[p9l86t2657r326b2723],
23	to	TO	O	to	_	0	SENT_153	[p9l348t2674r416b2723],
24	that	DT	O	that	prep_to	22	SENT_153	[p9l442t2657r584b2723],
25	reported	VBN	O	report	partmod	24	SENT_153	[p9l606t2657r906b2747],
26	in	IN	O	in	_	0	SENT_153	[p9l929t2660r997b2723],
27	Swedish	NNP	MISC	Swedish	prep_in	25	SENT_153	[p9l1025t2657r1317b2724],
28	and	CC	O	and	_	0	SENT_153	[p9l1342t2657r1470b2723],
29	Ethiopian	JJ	MISC	ethiopian	amod	30	SENT_153	[p9l1495t2657r1852b2747],
30	subjects	NNS	O	subject	prep_in	25	SENT_153	[p9l1878t2657r2150b2746],
31	(	VBP	O	(	_	0	SENT_153	[p9l11t2761r217b2844],
32	18	CD	PERCENT	18	num	33	SENT_153	[p9l11t2761r217b2844],
33	%	NN	PERCENT	%	dobj	31	SENT_153	[p9l11t2761r217b2844],
34	)	CD	NUMBER	)	dep	33	SENT_153	[p9l11t2761r217b2844],
35	and	CC	O	and	_	0	SENT_153	[p9l256t2763r384b2829],
36	higher	JJR	O	higher	dep	33	SENT_153	[p9l417t2763r647b2852],
37	than	IN	O	than	prep	31	SENT_153	[p9l679t2763r838b2829],
38	in	IN	O	in	pcomp	37	SENT_153	[p9l871t2766r939b2829],
39	a	DT	O	a	det	41	SENT_153	[p9l975t2790r1009b2829],
40	Chinese	JJ	LOCATION	chinese	amod	41	SENT_153	[p9l1043t2763r1332b2830],
41	population	NN	O	population	pobj	38	SENT_153	[p9l1365t2763r1750b2853],
42	(	CD	PERCENT	(	num	44	SENT_153	[p9l1787t2761r1947b2844],
43	4	CD	PERCENT	4	num	44	SENT_153	[p9l1787t2761r1947b2844],
44	%	NN	PERCENT	%	nsubj	31	SENT_153	[p9l1787t2761r1947b2844],
45	)	CD	NUMBER	)	number	46	SENT_153	[p9l1787t2761r1947b2844],
46	(	CD	NUMBER	(	dep	44	SENT_153	[p9l1987t2761r2148b2844],
47	19	CD	NUMBER	19	num	48	SENT_153	[p9l1987t2761r2148b2844],
48	)	NN	O	)	dep	46	SENT_153	[p9l1987t2761r2148b2844],
49	.	.	O	.	_	0	SENT_153	[p9l1987t2761r2148b2844],

1	Platelet	NN	O	platelet	nsubj	2	SENT_154	[p9l9t2869r279b2935],
2	inhibition	NN	O	inhibition	ccomp	73	SENT_154	[p9l313t2869r666b2935],
3	2	CD	NUMBER	2	num	4	SENT_154	[p9l701t2873r742b2937],
4	h	NN	O	h	dobj	2	SENT_154	[p9l780t2869r825b2935],
5	after	IN	O	after	mark	12	SENT_154	[p9l862t2869r1023b2935],
6	a	DT	O	a	det	10	SENT_154	[p9l1058t2896r1093b2935],
7	600	CD	NUMBER	600	number	8	SENT_154	[p9l1130t2873r1412b2958],
8	—	CD	NUMBER	—	num	10	SENT_154	[p9l1130t2873r1412b2958],
9	mg	NN	O	mg	nn	10	SENT_154	[p9l1130t2873r1412b2958],
10	dose	NN	O	dose	nsubj	12	SENT_154	[p9l1447t2869r1603b2936],
11	was	VBD	O	be	cop	12	SENT_154	[p9l1636t2896r1767b2936],
12	greater	JJR	O	greater	dep	4	SENT_154	[p9l1803t2886r2050b2958],
13	in	IN	O	in	_	0	SENT_154	[p9l2084t2872r2153b2935],
14	CYP2C19	NN	O	cyp2c19	prep_in	12	SENT_154	[p9l15t2978r499b3042],
15	*	CD	NUMBER	*	number	16	SENT_154	[p9l15t2978r499b3042],
16	1	CD	NUMBER	1	num	17	SENT_154	[p9l15t2978r499b3042],
17	*	NN	O	*	dep	4	SENT_154	[p9l15t2978r499b3042],
18	1	CD	NUMBER	1	num	19	SENT_154	[p9l15t2978r499b3042],
19	carriers	NNS	O	carrier	dep	4	SENT_154	[p9l550t2978r804b3042],
20	(	VBP	O	(	rcmod	19	SENT_154	[p9l855t2973r1163b3056],
21	median	NN	O	median	dobj	20	SENT_154	[p9l855t2973r1163b3056],
22	:	:	O	:	_	0	SENT_154	[p9l855t2973r1163b3056],
23	23	CD	PERCENT	23	num	24	SENT_154	[p9l1212t2979r1386b3056],
24	%	NN	PERCENT	%	dep	19	SENT_154	[p9l1212t2979r1386b3056],
25	,	,	O	,	_	0	SENT_154	[p9l1212t2979r1386b3056],
26	range	NN	O	range	appos	24	SENT_154	[p9l1436t3001r1648b3064],
27	:	:	O	:	_	0	SENT_154	[p9l1436t3001r1648b3064],
28	o	NN	PERCENT	o	nn	29	SENT_154	[p9l1700t2979r1807b3042],
29	%	NN	PERCENT	%	dobj	2	SENT_154	[p9l1700t2979r1807b3042],
30	to	TO	O	to	_	0	SENT_154	[p9l1853t2992r1922b3042],
31	66	CD	PERCENT	66	num	32	SENT_154	[p9l1971t2973r2149b3056],
32	%	NN	PERCENT	%	prep_to	29	SENT_154	[p9l1971t2973r2149b3056],
33	)	CD	NUMBER	)	npadvmod	34	SENT_154	[p9l1971t2973r2149b3056],
34	than	IN	O	than	advmod	32	SENT_154	[p9l8t3081r167b3147],
35	in	IN	O	in	_	0	SENT_154	[p9l206t3084r274b3147],
36	CYP2CJ9	NN	O	cyp2cj9	nn	37	SENT_154	[p9l319t3084r736b3148],
37	*	NN	O	*	prep_in	32	SENT_154	[p9l319t3084r736b3148],
38	2	CD	NUMBER	2	number	41	SENT_154	[p9l319t3084r736b3148],
39	or	CC	O	or	_	0	SENT_154	[p9l775t3107r847b3147],
40	*	CD	NUMBER	*	num	42	SENT_154	[p9l889t3084r957b3146],
41	4	CD	NUMBER	4	num	42	SENT_154	[p9l889t3084r957b3146],
42	carriers	NNS	O	carrier	nsubj	43	SENT_154	[p9l992t3084r1246b3147],
43	(	VBP	O	(	rcmod	29	SENT_154	[p9l1290t3079r1489b3162],
44	10	CD	PERCENT	10	num	45	SENT_154	[p9l1290t3079r1489b3162],
45	%	NN	PERCENT	%	dobj	43	SENT_154	[p9l1290t3079r1489b3162],
46	,	,	O	,	_	0	SENT_154	[p9l1290t3079r1489b3162],
47	o	NN	PERCENT	o	nn	48	SENT_154	[p9l1531t3085r1639b3148],
48	%	NN	PERCENT	%	appos	45	SENT_154	[p9l1531t3085r1639b3148],
49	to	TO	O	to	_	0	SENT_154	[p9l1677t3098r1745b3147],
50	56	CD	PERCENT	56	num	51	SENT_154	[p9l1786t3081r1958b3162],
51	%	NN	PERCENT	%	prep_to	48	SENT_154	[p9l1786t3081r1958b3162],
52	,	,	O	,	_	0	SENT_154	[p9l1786t3081r1958b3162],
53	p	NN	O	p	dep	54	SENT_154	[p9l1999t3108r2041b3171],
54	=	JJ	O	=	amod	45	SENT_154	[p9l2089t3107r2143b3127],
55	0.029	CD	NUMBER	0.029	num	56	SENT_154	[p9l9t3185r233b3268],
56	)	NN	O	)	dep	4	SENT_154	[p9l9t3185r233b3268],
57	and	CC	O	and	_	0	SENT_154	[p9l286t3187r414b3253],
58	CYP2CJ9	NN	O	cyp2cj9	conj_and	4	SENT_154	[p9l469t3190r934b3254],
59	*	CD	NUMBER	*	number	60	SENT_154	[p9l469t3190r934b3254],
60	17	CD	NUMBER	17	num	61	SENT_154	[p9l469t3190r934b3254],
61	carriers	NNS	O	carrier	nsubj	62	SENT_154	[p9l978t3190r1232b3253],
62	(	VBP	O	(	rcmod	58	SENT_154	[p9l1286t3185r1440b3268],
63	9	CD	PERCENT	9	num	64	SENT_154	[p9l1286t3185r1440b3268],
64	%	NN	PERCENT	%	dobj	62	SENT_154	[p9l1286t3185r1440b3268],
65	,	,	O	,	_	0	SENT_154	[p9l1286t3185r1440b3268],
66	o	NN	PERCENT	o	nn	67	SENT_154	[p9l1492t3191r1600b3254],
67	%	NN	PERCENT	%	nsubj	73	SENT_154	[p9l1492t3191r1600b3254],
68	to	TO	O	to	_	0	SENT_154	[p9l1648t3204r1716b3253],
69	98	CD	PERCENT	98	num	70	SENT_154	[p9l1768t3191r1939b3268],
70	%	NN	PERCENT	%	prep_to	67	SENT_154	[p9l1768t3191r1939b3268],
71	,	,	O	,	_	0	SENT_154	[p9l1768t3191r1939b3268],
72	p	NN	O	p	appos	70	SENT_154	[p9l1990t3214r2032b3277],
73	=	JJ	O	=	_	0	SENT_154	[p9l2090t3213r2143b3233],
74	0.026	CD	NUMBER	0.026	num	75	SENT_154	[p9l9t3291r233b3374],
75	)	CD	NUMBER	)	iobj	73	SENT_154	[p9l9t3291r233b3374],
76	(	CD	NUMBER	(	num	77	SENT_154	[p9l299t3291r461b3382],
77	Fig	NN	O	fig	dobj	73	SENT_154	[p9l299t3291r461b3382],
78	.	.	O	.	_	0	SENT_154	[p9l299t3291r461b3382],

1	3	CD	NUMBER	3	_	0	SENT_155	[p9l526t3291r615b3374],
2	)	NN	O	)	dep	1	SENT_155	[p9l526t3291r615b3374],
3	.	.	O	.	_	0	SENT_155	[p9l526t3291r615b3374],

1	The	DT	O	the	det	3	SENT_156	[p9l676t3291r824b3359],
2	platelet	NN	O	platelet	nn	3	SENT_156	[p9l884t3293r1146b3383],
3	inhibition	NN	O	inhibition	nsubj	6	SENT_156	[p9l1205t3293r1558b3359],
4	did	VBD	O	do	dep	6	SENT_156	[p9l1619t3293r1733b3359],
5	not	RB	O	not	neg	6	SENT_156	[p9l1793t3310r1911b3359],
6	difte	JJ	O	difte	_	0	SENT_156	[p9l1970t3293r2121b3359],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_156	[p9l10t3399r442b3488],
8	in	IN	O	in	_	0	SENT_156	[p9l486t3402r554b3465],
9	CYP2C19	NN	O	cyp2c19	nn	11	SENT_156	[p9l609t3402r1093b3466],
10	*	CD	NUMBER	*	num	11	SENT_156	[p9l609t3402r1093b3466],
11	J	NNP	O	J	prep_in	6	SENT_156	[p9l609t3402r1093b3466],
12	*	CD	NUMBER	*	number	13	SENT_156	[p9l609t3402r1093b3466],
13	]	CD	NUMBER	]	num	14	SENT_156	[p9l609t3402r1093b3466],
14	carriers	NNS	O	carrier	dep	11	SENT_156	[p9l1145t3402r1400b3466],
15	after	IN	O	after	_	0	SENT_156	[p9l1451t3399r1611b3466],
16	a	DT	O	a	det	18	SENT_156	[p9l1659t3426r1694b3466],
17	1,200	CD	NUMBER	1,200	num	18	SENT_156	[p9l1745t3403r1972b3480],
18	—	NN	O	—	prep_after	14	SENT_156	[p9l1745t3403r1972b3480],
19	and	CC	O	and	_	0	SENT_156	[p9l2025t3399r2153b3466],
20	600-mg	JJ	O	600-mg	amod	22	SENT_156	[p9l10t3509r293b3594],
21	loading	NN	O	loading	nn	22	SENT_156	[p9l314t3505r581b3594],
22	dose	NN	O	dose	conj_and	18	SENT_156	[p9l605t3505r761b3572],
23	at	IN	O	at	_	0	SENT_156	[p9l787t3522r851b3572],
24	4	CD	NUMBER	4	num	25	SENT_156	[p9l873t3509r915b3570],
25	h	NN	O	h	prep_at	18	SENT_156	[p9l940t3505r985b3571],
26	(	CD	PERCENT	(	number	28	SENT_156	[p9l1013t3503r1212b3586],
27	43	CD	PERCENT	43	number	28	SENT_156	[p9l1013t3503r1212b3586],
28	%	NN	PERCENT	%	amod	14	SENT_156	[p9l1013t3503r1212b3586],
29	,	,	O	,	_	0	SENT_156	[p9l1013t3503r1212b3586],
30	13	CD	PERCENT	13	number	31	SENT_156	[p9l1244t3509r1392b3572],
31	%	NN	PERCENT	%	num	34	SENT_156	[p9l1244t3509r1392b3572],
32	to	TO	O	to	dep	31	SENT_156	[p9l1417t3522r1485b3572],
33	97	CD	PERCENT	97	number	31	SENT_156	[p9l1513t3507r1665b3572],
34	%	NN	PERCENT	%	conj_and	14	SENT_156	[p9l1513t3507r1665b3572],
35	and	CC	O	and	_	0	SENT_156	[p9l1691t3505r1819b3572],
36	35	CD	PERCENT	35	num	37	SENT_156	[p9l1844t3505r2016b3586],
37	%	NN	PERCENT	%	conj_and	14	SENT_156	[p9l1844t3505r2016b3586],
38	,	,	O	,	_	0	SENT_156	[p9l1844t3505r2016b3586],
39	o	NN	PERCENT	o	nn	40	SENT_156	[p9l2043t3509r2151b3572],
40	%	NN	PERCENT	%	appos	37	SENT_156	[p9l2043t3509r2151b3572],
41	to	TO	O	to	_	0	SENT_156	[p9l8t3628r76b3677],
42	65	CD	PERCENT	65	num	43	SENT_156	[p9l105t3611r277b3692],
43	%	NN	PERCENT	%	prep_to	40	SENT_156	[p9l105t3611r277b3692],
44	,	,	O	,	_	0	SENT_156	[p9l105t3611r277b3692],
45	respectively	RB	O	respectively	advmod	37	SENT_156	[p9l304t3611r734b3701],
46	,	,	O	,	_	0	SENT_156	[p9l304t3611r734b3701],
47	p	NN	O	p	appos	11	SENT_156	[p9l761t3638r803b3701],
48	=	JJ	O	=	advmod	52	SENT_156	[p9l839t3637r892b3657],
49	0.3	CD	NUMBER	0.3	dep	48	SENT_156	[p9l927t3609r1061b3692],
50	)	CD	NUMBER	)	number	51	SENT_156	[p9l927t3609r1061b3692],
51	(	CD	NUMBER	(	num	52	SENT_156	[p9l1093t3609r1256b3700],
52	Fig	NN	O	fig	rcmod	47	SENT_156	[p9l1093t3609r1256b3700],
53	.	.	O	.	_	0	SENT_156	[p9l1093t3609r1256b3700],

1	4	CD	NUMBER	4	num	2	SENT_157	[p9l1285t3609r1352b3692],
2	)	NN	O	)	_	0	SENT_157	[p9l1285t3609r1352b3692],
3	and	CC	O	and	_	0	SENT_157	[p9l1383t3611r1511b3677],
4	7	CD	NUMBER	7	num	5	SENT_157	[p9l1538t3613r1578b3678],
5	h	NN	O	h	conj_and	2	SENT_157	[p9l1602t3611r1647b3677],
6	(	CD	PERCENT	(	number	7	SENT_157	[p9l1676t3609r1875b3692],
7	63	CD	PERCENT	63	num	8	SENT_157	[p9l1676t3609r1875b3692],
8	%	NN	PERCENT	%	dep	2	SENT_157	[p9l1676t3609r1875b3692],
9	,	,	O	,	_	0	SENT_157	[p9l1676t3609r1875b3692],
10	15	CD	PERCENT	15	number	11	SENT_157	[p9l1908t3611r2057b3678],
11	%	NN	PERCENT	%	num	14	SENT_157	[p9l1908t3611r2057b3678],
12	to	TO	O	to	dep	11	SENT_157	[p9l2082t3628r2150b3677],
13	98	CD	PERCENT	98	number	11	SENT_157	[p9l10t3721r161b3784],
14	%	NN	PERCENT	%	dep	2	SENT_157	[p9l10t3721r161b3784],
15	and	CC	O	and	_	0	SENT_157	[p9l192t3717r320b3783],
16	29	CD	PERCENT	29	num	17	SENT_157	[p9l346t3721r520b3798],
17	%	NN	PERCENT	%	dep	2	SENT_157	[p9l346t3721r520b3798],
18	,	,	O	,	_	0	SENT_157	[p9l346t3721r520b3798],
19	o	NN	PERCENT	o	nn	20	SENT_157	[p9l552t3721r661b3784],
20	%	NN	PERCENT	%	conj_and	20	SENT_157	[p9l552t3721r661b3784],
21	to	TO	O	to	_	0	SENT_157	[p9l689t3734r758b3783],
22	75	CD	PERCENT	75	num	23	SENT_157	[p9l789t3717r960b3798],
23	%	NN	PERCENT	%	prep_to	20	SENT_157	[p9l789t3717r960b3798],
24	,	,	O	,	_	0	SENT_157	[p9l789t3717r960b3798],
25	respectively	RB	O	respectively	advmod	23	SENT_157	[p9l992t3717r1421b3807],
26	,	,	O	,	_	0	SENT_157	[p9l992t3717r1421b3807],
27	p	NN	O	p	appos	23	SENT_157	[p9l1452t3744r1493b3807],
28	=	JJ	O	=	amod	30	SENT_157	[p9l1532t3743r1585b3763],
29	0.05	CD	NUMBER	0.05	tmod	28	SENT_157	[p9l1624t3715r1802b3798],
30	)	NN	O	)	dep	27	SENT_157	[p9l1624t3715r1802b3798],
31	and	CC	O	and	_	0	SENT_157	[p9l1836t3717r1965b3783],
32	after	IN	O	after	_	0	SENT_157	[p9l1994t3717r2154b3783],
33	a	DT	O	a	quantmod	34	SENT_157	[p10l10t43r44b83],
34	150	CD	NUMBER	150	prep_after	20	SENT_157	[p10l80t16r239b83],
35	-	:	O	-	_	0	SENT_157	[p10l80t16r239b83],
36	and	CC	O	and	_	0	SENT_157	[p10l275t16r403b83],
37	75	CD	NUMBER	75	number	38	SENT_157	[p10l437t16r674b105],
38	—	CD	NUMBER	—	num	39	SENT_157	[p10l437t16r674b105],
39	mg	NN	O	mg	conj_and	34	SENT_157	[p10l437t16r674b105],
40	daily	JJ	SET	daily	amod	42	SENT_157	[p10l706t16r876b105],
41	maintenance	NN	O	maintenance	nn	42	SENT_157	[p10l904t19r1356b83],
42	dosage	NN	O	dosage	dep	39	SENT_157	[p10l1390t16r1627b105],
43	(	CD	PERCENT	(	num	45	SENT_157	[p10l1663t14r1862b97],
44	46	CD	PERCENT	46	num	45	SENT_157	[p10l1663t14r1862b97],
45	%	NN	PERCENT	%	dep	34	SENT_157	[p10l1663t14r1862b97],
46	,	,	O	,	_	0	SENT_157	[p10l1663t14r1862b97],
47	18	CD	PERCENT	18	number	51	SENT_157	[p10l1902t20r2050b83],
48	%	NN	PERCENT	%	dep	51	SENT_157	[p10l1902t20r2050b83],
49	to	TO	O	to	dep	51	SENT_157	[p10l2082t33r2151b83],
50	97	CD	PERCENT	97	number	51	SENT_157	[p10l10t124r161b189],
51	%	NN	PERCENT	%	appos	45	SENT_157	[p10l10t124r161b189],
52	and	CC	O	and	_	0	SENT_157	[p10l194t122r322b189],
53	32	CD	PERCENT	32	num	54	SENT_157	[p10l353t126r525b203],
54	%	NN	PERCENT	%	conj_and	34	SENT_157	[p10l353t126r525b203],
55	,	,	O	,	_	0	SENT_157	[p10l353t126r525b203],
56	24	CD	PERCENT	24	number	60	SENT_157	[p10l557t126r712b190],
57	%	NN	PERCENT	%	dep	60	SENT_157	[p10l557t126r712b190],
58	to	TO	O	to	dep	60	SENT_157	[p10l743t139r811b188],
59	64	CD	PERCENT	64	number	60	SENT_157	[p10l845t126r1016b203],
60	%	NN	PERCENT	%	amod	64	SENT_157	[p10l845t126r1016b203],
61	,	,	O	,	_	0	SENT_157	[p10l845t126r1016b203],
62	respectively	RB	O	respectively	dep	60	SENT_157	[p10l1050t122r1480b212],
63	,	,	O	,	_	0	SENT_157	[p10l1050t122r1480b212],
64	p	NN	O	p	appos	54	SENT_157	[p10l1512t149r1554b212],
65	=	JJ	O	=	amod	64	SENT_157	[p10l1595t148r1649b168],
66	0.2	CD	NUMBER	0.2	tmod	65	SENT_157	[p10l1689t120r1824b203],
67	)	CD	NUMBER	)	number	68	SENT_157	[p10l1689t120r1824b203],
68	(	CD	NUMBER	(	num	69	SENT_157	[p10l1861t120r2023b211],
69	Fig	NN	O	fig	dep	20	SENT_157	[p10l1861t120r2023b211],
70	.	.	O	.	_	0	SENT_157	[p10l1861t120r2023b211],

1	4	CD	NUMBER	4	_	0	SENT_158	[p10l2058t120r2148b203],
2	)	NN	O	)	dep	1	SENT_158	[p10l2058t120r2148b203],
3	.	.	O	.	_	0	SENT_158	[p10l2058t120r2148b203],

1	In	IN	O	in	_	0	SENT_159	[p10l8t229r86b294],
2	contrast	NN	O	contrast	prep_in	11	SENT_159	[p10l125t245r427b309],
3	,	,	O	,	_	0	SENT_159	[p10l125t245r427b309],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_159	[p10l475t231r892b295],
5	*	NN	O	*	nsubj	11	SENT_159	[p10l475t231r892b295],
6	2	CD	NUMBER	2	dep	5	SENT_159	[p10l475t231r892b295],
7	or	CC	O	or	_	0	SENT_159	[p10l930t254r1003b294],
8	*	CD	NUMBER	*	number	9	SENT_159	[p10l1045t231r1112b293],
9	4	CD	NUMBER	4	num	10	SENT_159	[p10l1045t231r1112b293],
10	carriers	NNS	O	carrier	conj_or	5	SENT_159	[p10l1147t231r1402b294],
11	had	VBD	O	have	_	0	SENT_159	[p10l1441t228r1572b294],
12	greater	JJR	O	greater	amod	14	SENT_159	[p10l1609t245r1855b317],
13	platelet	NN	O	platelet	nn	14	SENT_159	[p10l1891t228r2154b318],
14	inhibition	NN	O	inhibition	dobj	11	SENT_159	[p10l8t334r362b400],
15	with	IN	O	with	_	0	SENT_159	[p10l384t334r546b401],
16	the	DT	O	the	det	20	SENT_159	[p10l571t334r681b400],
17	higher	JJR	O	higher	amod	20	SENT_159	[p10l708t334r938b423],
18	1,200-mg	JJ	O	1,200-mg	amod	20	SENT_159	[p10l966t338r1314b423],
19	loading	NN	O	loading	nn	20	SENT_159	[p10l1336t334r1602b423],
20	dose	NN	O	dose	prep_with	14	SENT_159	[p10l1627t334r1783b401],
21	than	IN	O	than	dep	11	SENT_159	[p10l1808t334r1968b401],
22	with	IN	O	with	_	0	SENT_159	[p10l1990t334r2152b401],
23	600	CD	NUMBER	600	num	24	SENT_159	[p10l10t444r138b507],
24	mg	NN	O	mg	prep_with	11	SENT_159	[p10l183t467r296b529],
25	at	IN	O	at	_	0	SENT_159	[p10l338t457r401b507],
26	4	CD	NUMBER	4	num	27	SENT_159	[p10l442t444r484b505],
27	h	NN	O	h	prep_at	24	SENT_159	[p10l527t440r572b506],
28	(	CD	PERCENT	(	number	29	SENT_159	[p10l618t438r817b521],
29	37	CD	PERCENT	37	num	30	SENT_159	[p10l618t438r817b521],
30	%	NN	PERCENT	%	dep	24	SENT_159	[p10l618t438r817b521],
31	,	,	O	,	_	0	SENT_159	[p10l618t438r817b521],
32	8	CD	PERCENT	8	number	33	SENT_159	[p10l866t444r971b507],
33	%	NN	PERCENT	%	num	36	SENT_159	[p10l866t444r971b507],
34	to	TO	O	to	dep	33	SENT_159	[p10l1014t457r1082b507],
35	87	CD	PERCENT	87	number	33	SENT_159	[p10l1129t442r1279b507],
36	%	NN	PERCENT	%	dep	24	SENT_159	[p10l1129t442r1279b507],
37	and	CC	O	and	_	0	SENT_159	[p10l1323t440r1452b507],
38	14	CD	PERCENT	14	num	39	SENT_159	[p10l1498t444r1667b521],
39	%	NN	PERCENT	%	conj_and	30	SENT_159	[p10l1498t444r1667b521],
40	,	,	O	,	_	0	SENT_159	[p10l1498t444r1667b521],
41	o	NN	PERCENT	o	nn	42	SENT_159	[p10l1713t444r1820b507],
42	%	NN	PERCENT	%	appos	39	SENT_159	[p10l1713t444r1820b507],
43	to	TO	O	to	_	0	SENT_159	[p10l1863t457r1932b507],
44	22	CD	PERCENT	22	num	45	SENT_159	[p10l1974t444r2149b521],
45	%	NN	PERCENT	%	prep_to	42	SENT_159	[p10l1974t444r2149b521],
46	,	,	O	,	_	0	SENT_159	[p10l1974t444r2149b521],
47	respectively	RB	O	respectively	advmod	24	SENT_159	[p10l8t546r437b636],
48	,	,	O	,	_	0	SENT_159	[p10l8t546r437b636],
49	p	NN	O	p	appos	24	SENT_159	[p10l486t573r528b636],
50	=	JJ	O	=	advmod	54	SENT_159	[p10l585t572r639b592],
51	0.002	CD	NUMBER	0.002	dep	50	SENT_159	[p10l696t544r920b627],
52	)	CD	NUMBER	)	number	53	SENT_159	[p10l696t544r920b627],
53	(	CD	NUMBER	(	num	54	SENT_159	[p10l973t544r1135b635],
54	Fig	NN	O	fig	rcmod	49	SENT_159	[p10l973t544r1135b635],
55	.	.	O	.	_	0	SENT_159	[p10l973t544r1135b635],

1	5	CD	NUMBER	5	nsubj	4	SENT_160	[p10l1187t544r1255b627],
2	)	NN	O	)	_	0	SENT_160	[p10l1187t544r1255b627],
3	and	CC	O	and	_	0	SENT_160	[p10l1307t546r1435b612],
4	tended	VBD	O	tend	conj_and	2	SENT_160	[p10l1481t546r1725b612],
5	to	TO	O	to	aux	6	SENT_160	[p10l1771t563r1839b612],
6	show	VB	O	show	xcomp	4	SENT_160	[p10l1890t546r2074b613],
7	a	DT	O	a	det	9	SENT_160	[p10l2119t573r2154b613],
8	similar	JJ	O	similar	amod	9	SENT_160	[p10l10t652r250b719],
9	trend	NN	O	trend	dobj	6	SENT_160	[p10l277t652r465b719],
10	at	IN	O	at	_	0	SENT_160	[p10l495t669r558b719],
11	7	CD	NUMBER	7	num	12	SENT_160	[p10l587t654r627b719],
12	h	NN	O	h	prep_at	9	SENT_160	[p10l655t652r700b718],
13	(	CD	PERCENT	(	number	14	SENT_160	[p10l731t650r931b733],
14	42	CD	PERCENT	42	num	15	SENT_160	[p10l731t650r931b733],
15	%	NN	PERCENT	%	dep	12	SENT_160	[p10l731t650r931b733],
16	,	,	O	,	_	0	SENT_160	[p10l731t650r931b733],
17	7	CD	PERCENT	7	num	18	SENT_160	[p10l964t654r1071b719],
18	%	NN	PERCENT	%	conj_and	12	SENT_160	[p10l964t654r1071b719],
19	to	TO	O	to	_	0	SENT_160	[p10l1099t669r1167b719],
20	94	CD	PERCENT	94	num	21	SENT_160	[p10l1199t656r1350b719],
21	%	NN	PERCENT	%	prep_to	18	SENT_160	[p10l1199t656r1350b719],
22	and	CC	O	and	_	0	SENT_160	[p10l1381t652r1509b719],
23	22	CD	PERCENT	22	num	24	SENT_160	[p10l1535t656r1710b733],
24	%	NN	PERCENT	%	conj_and	12	SENT_160	[p10l1535t656r1710b733],
25	,	,	O	,	_	0	SENT_160	[p10l1535t656r1710b733],
26	o	NN	PERCENT	o	nn	27	SENT_160	[p10l1742t656r1849b719],
27	%	NN	PERCENT	%	appos	24	SENT_160	[p10l1742t656r1849b719],
28	to	TO	O	to	_	0	SENT_160	[p10l1878t669r1946b719],
29	51	CD	PERCENT	51	num	30	SENT_160	[p10l1976t652r2149b734],
30	%	NN	PERCENT	%	prep_to	6	SENT_160	[p10l1976t652r2149b734],
31	,	,	O	,	_	0	SENT_160	[p10l1976t652r2149b734],
32	respectively	RB	O	respectively	advmod	6	SENT_160	[p10l8t759r437b849],
33	,	,	O	,	_	0	SENT_160	[p10l8t759r437b849],
34	p	NN	O	p	nsubj	37	SENT_160	[p10l483t786r525b849],
35	=	JJ	O	=	amod	37	SENT_160	[p10l579t785r633b805],
36	0.09	CD	NUMBER	0.09	num	37	SENT_160	[p10l687t757r888b840],
37	)	NN	O	)	xcomp	6	SENT_160	[p10l687t757r888b840],
38	.	.	O	.	_	0	SENT_160	[p10l687t757r888b840],

1	Similarly	RB	O	similarly	advmod	7	SENT_161	[p10l940t759r1275b848],
2	,	,	O	,	_	0	SENT_161	[p10l940t759r1275b848],
3	platelet	NN	O	platelet	nn	4	SENT_161	[p10l1321t759r1584b849],
4	inhibition	NN	O	inhibition	nsubj	7	SENT_161	[p10l1627t759r1980b825],
5	was	VBD	O	be	cop	7	SENT_161	[p10l2021t786r2151b826],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_161	[p10l10t865r441b954],
7	greater	JJR	O	greater	_	0	SENT_161	[p10l468t882r715b954],
8	with	IN	O	with	_	0	SENT_161	[p10l740t865r903b932],
9	the	DT	O	the	det	11	SENT_161	[p10l934t865r1045b931],
10	150-mg	JJ	O	150-mg	amod	11	SENT_161	[p10l1082t865r1362b954],
11	dose	NN	O	dose	prep_with	7	SENT_161	[p10l1392t865r1548b932],
12	than	IN	O	than	_	0	SENT_161	[p10l1580t865r1740b931],
13	the	DT	O	the	det	14	SENT_161	[p10l1771t865r1882b931],
14	75	CD	NUMBER	75	prep_than	11	SENT_161	[p10l1916t865r1997b932],
15	-	:	O	-	_	0	SENT_161	[p10l2006t892r2154b954],
16	mg	NN	O	mg	dep	11	SENT_161	[p10l2006t892r2154b954],
17	daily	JJ	SET	daily	amod	20	SENT_161	[p10l9t971r179b1060],
18	maintenance	NN	O	maintenance	nn	20	SENT_161	[p10l212t974r663b1038],
19	dosage	NN	O	dosage	nn	20	SENT_161	[p10l700t971r938b1060],
20	regimen	NN	O	regimen	dep	16	SENT_161	[p10l974t974r1264b1060],
21	(	CD	PERCENT	(	num	23	SENT_161	[p10l1303t969r1502b1052],
22	51	CD	PERCENT	51	num	23	SENT_161	[p10l1303t969r1502b1052],
23	%	NN	PERCENT	%	dep	11	SENT_161	[p10l1303t969r1502b1052],
24	,	,	O	,	_	0	SENT_161	[p10l1303t969r1502b1052],
25	15	CD	PERCENT	15	number	29	SENT_161	[p10l1545t971r1694b1038],
26	%	NN	PERCENT	%	dep	29	SENT_161	[p10l1545t971r1694b1038],
27	to	TO	O	to	dep	29	SENT_161	[p10l1729t988r1798b1038],
28	86	CD	PERCENT	86	number	29	SENT_161	[p10l1837t975r1988b1038],
29	%	NN	PERCENT	%	appos	23	SENT_161	[p10l1837t975r1988b1038],
30	and	CC	O	and	_	0	SENT_161	[p10l2025t971r2153b1038],
31	14	CD	PERCENT	14	num	32	SENT_161	[p10l12t1081r181b1158],
32	%	NN	PERCENT	%	conj_and	11	SENT_161	[p10l12t1081r181b1158],
33	,	,	O	,	_	0	SENT_161	[p10l12t1081r181b1158],
34	o	NN	PERCENT	o	nn	35	SENT_161	[p10l218t1081r326b1144],
35	%	NN	PERCENT	%	appos	32	SENT_161	[p10l218t1081r326b1144],
36	to	TO	O	to	_	0	SENT_161	[p10l359t1094r427b1143],
37	67	CD	PERCENT	67	num	38	SENT_161	[p10l463t1079r635b1158],
38	%	NN	PERCENT	%	prep_to	7	SENT_161	[p10l463t1079r635b1158],
39	,	,	O	,	_	0	SENT_161	[p10l463t1079r635b1158],
40	respectively	RB	O	respectively	advmod	7	SENT_161	[p10l670t1077r1100b1167],
41	,	,	O	,	_	0	SENT_161	[p10l670t1077r1100b1167],
42	p	NN	O	p	dep	43	SENT_161	[p10l1135t1104r1177b1167],
43	=	JJ	O	=	acomp	7	SENT_161	[p10l1220t1103r1274b1123],
44	0.042	CD	NUMBER	0.042	number	45	SENT_161	[p10l1316t1075r1540b1158],
45	)	CD	NUMBER	)	prep	43	SENT_161	[p10l1316t1075r1540b1158],
46	(	CD	NUMBER	(	num	47	SENT_161	[p10l1580t1075r1742b1166],
47	Fig	NN	O	fig	dep	45	SENT_161	[p10l1580t1075r1742b1166],
48	.	.	O	.	_	0	SENT_161	[p10l1580t1075r1742b1166],

1	5	CD	NUMBER	5	_	0	SENT_162	[p10l1780t1075r1869b1158],
2	)	NN	O	)	dep	1	SENT_162	[p10l1780t1075r1869b1158],
3	.	.	O	.	_	0	SENT_162	[p10l1780t1075r1869b1158],

1	The	DT	O	the	det	3	SENT_163	[p10l95t1182r243b1249],
2	CYPZC9	NN	O	cypzc9	nn	3	SENT_163	[p10l277t1186r578b1250],
3	genotype	NN	O	genotype	nsubj	4	SENT_163	[p10l602t1200r924b1273],
4	did	VBD	O	do	_	0	SENT_163	[p10l953t1183r1066b1249],
5	not	RB	O	not	neg	6	SENT_163	[p10l1093t1200r1211b1249],
6	signiﬁcantly	JJ	O	signiﬁcantly	amod	7	SENT_163	[p10l1237t1183r1669b1272],
7	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_163	[p10l1691t1183r2014b1249],
8	the	DT	O	the	det	10	SENT_163	[p10l2041t1183r2152b1249],
9	platelet	NN	O	platelet	nn	10	SENT_163	[p10l7t1289r270b1379],
10	response	NN	O	response	tmod	4	SENT_163	[p10l328t1315r652b1379],
11	,	,	O	,	_	0	SENT_163	[p10l328t1315r652b1379],
12	except	IN	O	except	_	0	SENT_163	[p10l716t1306r940b1379],
13	that	DT	O	that	det	16	SENT_163	[p10l998t1289r1140b1355],
14	CYP2C9	NN	O	cyp2c9	nn	16	SENT_163	[p10l1204t1292r1647b1356],
15	”‘	NN	O	”‘	nn	16	SENT_163	[p10l1204t1292r1647b1356],
16	J	NN	O	j	prep_except	10	SENT_163	[p10l1204t1292r1647b1356],
17	*	CD	NUMBER	*	number	18	SENT_163	[p10l1204t1292r1647b1356],
18	3	CD	NUMBER	3	num	19	SENT_163	[p10l1204t1292r1647b1356],
19	carriers	NNS	O	carrier	nsubj	21	SENT_163	[p10l1707t1292r1961b1355],
20	had	VBD	O	have	aux	21	SENT_163	[p10l2023t1289r2153b1355],
21	reduced	VBN	O	reduce	rcmod	16	SENT_163	[p10l8t1395r287b1461],
22	platelet	NN	O	platelet	nn	23	SENT_163	[p10l326t1395r588b1485],
23	inhibition	NN	O	inhibition	dobj	21	SENT_163	[p10l626t1395r980b1461],
24	compared	VBN	O	compare	_	0	SENT_163	[p10l1020t1395r1370b1485],
25	with	IN	O	with	prepc_compared_with	21	SENT_163	[p10l1405t1395r1568b1462],
26	platelet	NN	O	platelet	nn	27	SENT_163	[p10l1606t1395r1869b1485],
27	inhibition	NN	O	inhibition	pobj	21	SENT_163	[p10l1907t1395r2149b1461, p10l8t1504r150b1567],
28	in	IN	O	in	_	0	SENT_163	[p10l208t1504r276b1567],
29	CYP2C9	NN	O	cyp2c9	prep_in	27	SENT_163	[p10l341t1504r780b1568],
30	*	CD	NUMBER	*	number	31	SENT_163	[p10l341t1504r780b1568],
31	1	CD	NUMBER	1	dep	32	SENT_163	[p10l341t1504r780b1568],
32	*	NN	O	*	dep	29	SENT_163	[p10l341t1504r780b1568],
33	]	CD	NUMBER	]	num	34	SENT_163	[p10l341t1504r780b1568],
34	carriers	NNS	O	carrier	npadvmod	35	SENT_163	[p10l843t1504r1098b1567],
35	at	IN	O	at	advmod	29	SENT_163	[p10l1159t1518r1222b1567],
36	7	CD	NUMBER	7	number	37	SENT_163	[p10l1281t1503r1321b1568],
37	h	NN	O	h	amod	29	SENT_163	[p10l1379t1501r1424b1567],
38	with	IN	O	with	_	0	SENT_163	[p10l1479t1501r1641b1568],
39	the	DT	O	the	det	44	SENT_163	[p10l1699t1501r1810b1568],
40	600	CD	NUMBER	600	number	41	SENT_163	[p10l1871t1505r2153b1590],
41	—	CD	NUMBER	—	num	44	SENT_163	[p10l1871t1505r2153b1590],
42	mg	NN	O	mg	nn	44	SENT_163	[p10l1871t1505r2153b1590],
43	clopidogrel	NN	O	clopidogrel	nn	44	SENT_163	[p10l9t1607r406b1697],
44	dose	NN	O	dose	prep_with	37	SENT_163	[p10l450t1607r606b1673],
45	(	CD	PERCENT	(	number	47	SENT_163	[p10l653t1605r808b1688],
46	9	CD	PERCENT	9	number	47	SENT_163	[p10l653t1605r808b1688],
47	%	NN	PERCENT	%	amod	44	SENT_163	[p10l653t1605r808b1688],
48	,	,	O	,	_	0	SENT_163	[p10l653t1605r808b1688],
49	8	CD	PERCENT	8	number	50	SENT_163	[p10l858t1611r963b1674],
50	%	NN	PERCENT	%	num	53	SENT_163	[p10l858t1611r963b1674],
51	to	TO	O	to	dep	50	SENT_163	[p10l1007t1624r1075b1673],
52	11	CD	PERCENT	11	number	50	SENT_163	[p10l1125t1611r1274b1673],
53	%	NN	PERCENT	%	conj_and	44	SENT_163	[p10l1125t1611r1274b1673],
54	and	CC	O	and	_	0	SENT_163	[p10l1319t1607r1447b1673],
55	31	CD	PERCENT	31	num	56	SENT_163	[p10l1491t1611r1663b1688],
56	%	NN	PERCENT	%	conj_and	44	SENT_163	[p10l1491t1611r1663b1688],
57	,	,	O	,	_	0	SENT_163	[p10l1491t1611r1663b1688],
58	o	NN	PERCENT	o	nn	59	SENT_163	[p10l1711t1611r1818b1674],
59	%	NN	PERCENT	%	appos	56	SENT_163	[p10l1711t1611r1818b1674],
60	to	TO	O	to	_	0	SENT_163	[p10l1862t1624r1931b1673],
61	96	CD	PERCENT	96	num	62	SENT_163	[p10l1978t1611r2149b1688],
62	%	NN	PERCENT	%	prep_to	59	SENT_163	[p10l1978t1611r2149b1688],
63	,	,	O	,	_	0	SENT_163	[p10l1978t1611r2149b1688],
64	respectively	RB	O	respectively	advmod	56	SENT_163	[p10l8t1713r437b1803],
65	,	,	O	,	_	0	SENT_163	[p10l8t1713r437b1803],
66	p	NN	O	p	dep	67	SENT_163	[p10l472t1740r514b1803],
67	=	JJ	O	=	dep	37	SENT_163	[p10l558t1739r611b1759],
68	0.045	CD	NUMBER	0.045	num	69	SENT_163	[p10l654t1711r899b1794],
69	)	NN	O	)	dep	37	SENT_163	[p10l654t1711r899b1794],
70	.	.	O	.	_	0	SENT_163	[p10l654t1711r899b1794],

1	Individuals	NNS	O	individual	nsubjpass	3	SENT_164	[p10l97t1819r491b1886],
2	were	VBD	O	be	auxpass	3	SENT_164	[p10l525t1845r693b1886],
3	aggregated	VBN	O	aggregate	_	0	SENT_164	[p10l731t1819r1116b1908],
4	based	VBN	O	base	prep	3	SENT_164	[p10l1149t1819r1348b1885],
5	upon	IN	O	upon	pcomp	4	SENT_164	[p10l1382t1845r1564b1909],
6	their	PRP$	O	they	poss	7	SENT_164	[p10l1599t1819r1767b1885],
7	CYPZCJ	NNP	O	CYPZCJ	pobj	5	SENT_164	[p10l1808t1822r2105b1886],
8	9	CD	NUMBER	9	num	7	SENT_164	[p10l2115t1826r2154b1886],
9	and	CC	O	and	_	0	SENT_164	[p10l10t1925r138b1991],
10	CYP2	NN	O	cyp2	nn	13	SENT_164	[p10l168t1928r364b1992],
11	C9	NN	O	c9	nn	13	SENT_164	[p10l374t1928r470b1992],
12	genotype	NN	O	genotype	nn	13	SENT_164	[p10l491t1942r813b2015],
13	status	NN	O	status	pobj	5	SENT_164	[p10l840t1942r1037b1991],
14	as	IN	O	as	prep	13	SENT_164	[p10l1065t1951r1128b1991],
15	either	CC	O	either	dep	14	SENT_164	[p10l1155t1925r1360b1991],
16	predictive	JJ	O	predictive	conj	14	SENT_164	[p10l1381t1925r1729b2015],
17	of	IN	O	of	_	0	SENT_164	[p10l1755t1925r1835b1991],
18	response	NN	O	response	prep_of	14	SENT_164	[p10l1847t1951r2152b2015],

1	JACC	NN	O	jacc	_	0	SENT_165	[p10l349t2175r499b2206],
2	:	:	O	:	_	0	SENT_165	[p10l349t2175r499b2206],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_165	[p10l536t2175r1034b2206],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_165	[p10l1072t2175r1531b2210],
5	,	,	O	,	_	0	SENT_165	[p10l1072t2175r1531b2210],
6	VOL	NNP	O	VOL	appos	4	SENT_165	[p10l1567t2175r1689b2206],
7	.	.	O	.	_	0	SENT_165	[p10l1567t2175r1689b2206],

1	1	CD	NUMBER	1	_	0	SENT_166	[p10l1728t2176r1769b2210],
2	,	,	O	,	_	0	SENT_166	[p10l1728t2176r1769b2210],
3	NO.	NNP	O	NO.	appos	1	SENT_166	[p10l1807t2175r1897b2206],
4	6	CD	NUMBER	6	num	3	SENT_166	[p10l1934t2176r1977b2210],
5	,	,	O	,	_	0	SENT_166	[p10l1934t2176r1977b2210],
6	2008	CD	DATE	2008	num	3	SENT_166	[p10l2015t2176r2140b2206],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_166	[p10l1497t2240r1782b2271],
8	2008:620	CD	NUMBER	2008:620	num	7	SENT_166	[p10l1818t2241r2139b2271],
9	-7	CD	NUMBER	-7	dep	7	SENT_166	[p10l1818t2241r2139b2271],

1	P	NN	O	p	_	0	SENT_167	[p11l174t213r261b306],

1	C	NN	O	c	_	0	SENT_168	[p11l193t517r239b559],
2	.	.	O	.	_	0	SENT_168	[p11l808t427r907b517, p11l177t565r241b635],

1	E	NN	O	e	_	0	SENT_169	[p11l808t427r907b517, p11l177t565r241b635],
2	75	CD	NUMBER	75	number	3	SENT_169	[p11l331t558r411b616],
3	‘	CD	NUMBER	‘	dep	1	SENT_169	[p11l180t641r239b670],
4	II-5	NN	O	ii-5	dep	3	SENT_169	[p11l180t641r239b670],
5	.	.	O	.	_	0	SENT_169	[p11l1607t667r1609b669],

1	`	``	O	`	_	0	SENT_170	[p11l177t676r239b766],
2	U	NNP	O	U	nn	3	SENT_170	[p11l177t676r239b766],
3	(	NNP	O	(	_	0	SENT_170	[p11l177t676r239b766],
4	+	CC	O	+	_	0	SENT_170	[p11l177t676r239b766],
5	I	PRP	O	I	conj_+	3	SENT_170	[p11l808t699r847b738],
6	-	:	O	-	_	0	SENT_170	[p11l1510t667r1670b779],
7	:	:	O	:	_	0	SENT_170	[p11l1510t667r1670b779],
8	I	PRP	O	I	dep	3	SENT_170	[p11l1510t667r1670b779],
9	U	NNP	O	U	nn	10	SENT_170	[p11l177t773r239b891],
10	(	NNP	O	(	dep	8	SENT_170	[p11l177t773r239b891],
11	+	CC	O	+	_	0	SENT_170	[p11l177t773r239b891],
12	50	CD	NUMBER	50	conj_+	8	SENT_170	[p11l331t811r411b869],
13	'	''	O	'	_	0	SENT_170	[p11l808t770r847b808],
14	9	CD	NUMBER	9	dep	12	SENT_170	[p11l209t926r242b952],
15	:5	CD	NUMBER	:5	dep	12	SENT_170	[p11l571t891r1091b939],
16	.	.	O	.	_	0	SENT_170	[p11l571t891r1091b939],

1	-	:	O	-	_	0	SENT_171	[p11l571t891r1091b939],
2	I	PRP	O	I	_	0	SENT_171	[p11l571t891r1091b939],
3	?	.	O	?	_	0	SENT_171	[p11l571t891r1091b939],

1	’	NN	O	’	_	0	SENT_172	[p11l571t891r1091b939],
2	A	NN	O	a	rcmod	1	SENT_172	[p11l175t939r242b984],
3	‘	CD	NUMBER	‘	dep	2	SENT_172	[p11l175t939r242b984],
4	--	:	O	--	_	0	SENT_172	[p11l175t939r242b984],
5	.	.	O	.	_	0	SENT_172	[p11l175t939r242b984],

1	1	CD	NUMBER	1	_	0	SENT_173	[p11l177t965r239b1051],
2	!	.	O	!	_	0	SENT_173	[p11l686t1042r725b1083],

1	I	PRP	O	I	_	0	SENT_174	[p11l808t1013r907b1083],
2	!	.	O	!	_	0	SENT_174	[p11l808t1013r907b1083],

1	T	NN	O	t	_	0	SENT_175	[p11l1337t971r1846b1010],
2	.	.	O	.	_	0	SENT_175	[p11l177t1060r239b1099],

1	:	:	O	:	_	0	SENT_176	[p11l177t1060r239b1099],
2	25	CD	NUMBER	25	num	3	SENT_176	[p11l334t1064r411b1122],
3	I.	NN	O	i.	_	0	SENT_176	[p11l727t1064r847b1131],
4	I	PRP	O	I	nsubj	5	SENT_176	[p11l1571t1064r1609b1102],
5	«	VBP	O	«	rcmod	3	SENT_176	[p11l177t1131r239b1176, p11l808t1195r847b1234],
6	:1	CD	NUMBER	:1	nsubj	7	SENT_176	[p11l177t1131r239b1176, p11l808t1195r847b1234],
7	I	PRP	O	I	xcomp	5	SENT_176	[p11l177t1131r239b1176, p11l808t1195r847b1234],

1	I	PRP	O	I	_	0	SENT_177	[p11l1571t1214r1609b1253],

1	1200	CD	DATE	1200	num	2	SENT_178	[p11l683t1396r846b1454],
2	mg	NN	O	mg	_	0	SENT_178	[p11l872t1409r978b1467],
3	600	CD	NUMBER	600	num	4	SENT_178	[p11l1462t1396r1584b1454],
4	mg	NN	O	mg	dep	2	SENT_178	[p11l1612t1409r1718b1467],

1	CYP2Ci19	NN	O	cyp2ci19	_	0	SENT_179	[p11l773t1506r1292b1570],
2	*	CD	NUMBER	*	number	3	SENT_179	[p11l773t1506r1292b1570],
3	1	CD	NUMBER	1	num	4	SENT_179	[p11l773t1506r1292b1570],
4	*	NN	O	*	dep	1	SENT_179	[p11l773t1506r1292b1570],
5	1	CD	NUMBER	1	num	6	SENT_179	[p11l773t1506r1292b1570],
6	carriers	NNS	O	carrier	dep	4	SENT_179	[p11l1347t1509r1648b1570],

1	1uoo	NN	O	1uoo	_	0	SENT_180	[p11l290t1755r434b1813],
2	_	NN	O	_	dep	1	SENT_180	[p11l290t1755r434b1813],
3	.	.	O	.	_	0	SENT_180	[p11l741t1784r783b1823],

1	I	PRP	O	I	_	0	SENT_181	[p11l805t1886r843b1925],

1	g	NN	O	g	_	0	SENT_182	[p11l187t1967r235b2011],
2	i	FW	O	i	dep	1	SENT_182	[p11l187t2037r189b2040],
3	75	CD	PERCENT	75	number	4	SENT_182	[p11l328t2011r434b2066],
4	%	NN	PERCENT	%	amod	2	SENT_182	[p11l328t2011r434b2066],
5	I	CD	NUMBER	i	dep	2	SENT_182	[p11l805t2008r843b2046],
6	M	NN	O	m	dep	1	SENT_182	[p11l1568t2056r1602b2057],
7	'	''	O	'	_	0	SENT_182	[p11l171t2203r235b2242],

1	.	.	O	.	_	0	SENT_183	[p11l171t2203r235b2242],
2	'	''	O	'	_	0	SENT_183	[p11l171t2203r235b2242],

1	I	PRP	O	I	nsubj	4	SENT_184	[p11l805t2209r843b2248],
2	3	CD	PERCENT	3	num	3	SENT_184	[p11l171t2225r235b2341],
3	%	NN	PERCENT	%	npadvmod	4	SENT_184	[p11l171t2225r235b2341],
4	so	RB	O	so	_	0	SENT_184	[p11l328t2261r405b2319],
5	.	.	O	.	_	0	SENT_184	[p11l805t2312r843b2351],

1	E54	NN	O	e54	_	0	SENT_185	[p11l171t2379r238b2446],
2	i	FW	O	i	dep	1	SENT_185	[p11l744t2421r782b2462],
3	I	PRP	O	I	dep	2	SENT_185	[p11l865t2401r904b2443],
4	i	FW	O	i	dep	1	SENT_185	[p11l1506t2421r1545b2462],
5	5	CD	NUMBER	5	advmod	8	SENT_185	[p11l171t2472r235b2552],
6	25	CD	NUMBER	25	num	7	SENT_185	[p11l328t2516r427b2574],
7	~	NN	O	~	dep	5	SENT_185	[p11l328t2516r427b2574],
8	I	PRP	O	I	dep	4	SENT_185	[p11l805t2465r843b2504],
9	'	''	O	'	_	0	SENT_185	[p11l1328t2484r1846b2523],
10	.	.	O	.	_	0	SENT_185	[p11l1328t2484r1846b2523],

1	—	NN	O	—	_	0	SENT_186	[p11l1328t2484r1846b2523],
2	.	.	O	.	_	0	SENT_186	[p11l1328t2484r1846b2523],
3	"	''	O	"	dep	1	SENT_186	[p11l1328t2484r1846b2523],
4	"	''	O	"	punct	3	SENT_186	[p11l1328t2484r1846b2523],

1	-	:	O	-	_	0	SENT_187	[p11l1328t2484r1846b2523],
2	'	''	O	'	_	0	SENT_187	[p11l1328t2484r1846b2523],
3	_	NN	O	_	_	0	SENT_187	[p11l1328t2484r1846b2523],
4	.	.	O	.	_	0	SENT_187	[p11l174t2584r235b2626],

1	~	NN	O	~	_	0	SENT_188	[p11l174t2584r235b2626],
2	.	.	O	.	_	0	SENT_188	[p11l174t2584r235b2626],

1	.	.	O	.	_	0	SENT_189	[p11l174t2584r235b2626],

1	I	PRP	O	I	dep	2	SENT_190	[p11l344t2573r347b2574],
2	”	VBP	O	”	_	0	SENT_190	[p11l390t2563r405b2574],
3	I	PRP	O	I	nsubj	4	SENT_190	[p11l805t2625r843b2664],
4	I	PRP	O	I	xcomp	2	SENT_190	[p11l865t2574r904b2613],
5	I	PRP	O	I	dep	4	SENT_190	[p11l1506t2625r1545b2664],
6	I	PRP	O	I	nsubj	2	SENT_190	[p11l1567t2574r1606b2613],

1	1200	CD	DATE	1200	num	2	SENT_191	[p11l677t2843r840b2901],
2	mg	NN	O	mg	_	0	SENT_191	[p11l869t2859r971b2917],
3	500	CD	NUMBER	500	num	4	SENT_191	[p11l1458t2846r1580b2901],
4	mg	NN	O	mg	dep	2	SENT_191	[p11l1609t2859r1712b2920],

1	CYP2C19i	NN	O	cyp2c19us	_	0	SENT_192	[p11l776t2958r1296b3022],
2	*	CD	NUMBER	*	number	3	SENT_192	[p11l776t2958r1296b3022],
3	1	CD	NUMBER	1	num	4	SENT_192	[p11l776t2958r1296b3022],
4	*	NN	O	*	dep	1	SENT_192	[p11l776t2958r1296b3022],
5	1	CD	NUMBER	1	num	6	SENT_192	[p11l776t2958r1296b3022],
6	carriers	NNS	O	carrier	dep	4	SENT_192	[p11l1327t2958r1629b3022],

1	C	NN	O	c	_	0	SENT_193	[p11l171t3093r255b3189],

1	mu	NN	O	mu	_	0	SENT_194	[p11l290t3220r405b3278],
2	_	SYM	O	_	dep	1	SENT_194	[p11l805t3259r846b3298],

1	in	IN	O	in	_	0	SENT_195	[p11l171t3812r238b3834],
2	inhibition	NN	O	inhibition	pobj	1	SENT_195	[p11l171t3400r236b3775],

1	E	NN	O	e	nn	2	SENT_196	[p11l805t3585r846b3627],
2	D	NN	O	d	_	0	SENT_196	[p11l868t3585r907b3627],
3	I	PRP	O	I	dep	2	SENT_196	[p11l1631t3595r1670b3634],

1	so	RB	O	so	dep	2	SENT_197	[p11l328t3729r408b3787],
2	I	PRP	O	I	_	0	SENT_197	[p11l805t3729r846b3768],

1	150	CD	NUMBER	150	num	2	SENT_198	[p12l702t487r821b544],
2	mg	NN	O	mg	_	0	SENT_198	[p12l849t503r952b560],
3	75	CD	NUMBER	75	num	5	SENT_198	[p12l1484t487r1565b544],
4	mg	NN	O	mg	nn	5	SENT_198	[p12l1593t503r1696b560],
5	CYP2C19	NN	O	cyp2c19	dep	2	SENT_198	[p12l769t599r1133b663],
6	*	CD	NUMBER	*	number	7	SENT_198	[p12l1164t599r1315b663],
7	1	CD	NUMBER	1	num	8	SENT_198	[p12l1164t599r1315b663],
8	*	NN	O	*	dep	5	SENT_198	[p12l1164t599r1315b663],
9	1	CD	NUMBER	1	num	10	SENT_198	[p12l1164t599r1315b663],
10	carriers	NNS	O	carrier	dep	2	SENT_198	[p12l1347t599r1648b663],

1	Figure	NNP	O	Figure	_	0	SENT_199	[p12l64t803r232b857],
2	4	CD	NUMBER	4	dep	1	SENT_199	[p12l255t803r306b847],
3	.	.	O	.	_	0	SENT_199	[p12l255t803r306b847],

1	Platelet	NN	O	platelet	nn	2	SENT_200	[p12l334t803r549b847],
2	Inhibition	NN	O	inhibition	_	0	SENT_200	[p12l574t802r827b847],
3	(	CD	PERCENT	(	num	4	SENT_200	[p12l853t803r917b857],
4	%	NN	PERCENT	%	dep	2	SENT_200	[p12l853t803r917b857],
5	of	IN	O	of	_	0	SENT_200	[p12l940t803r992b847],
6	Baseline	NN	O	baseline	nn	7	SENT_200	[p12l1015t802r1269b857],
7	)	NN	O	)	prep_of	4	SENT_200	[p12l1015t802r1269b857],
8	at	IN	O	at	_	0	SENT_200	[p12l1296t805r1350b847],
9	4	CD	NUMBER	4	num	10	SENT_200	[p12l1373t803r1409b847],
10	h	NN	O	h	prep_at	7	SENT_200	[p12l1433t803r1479b856],
11	,	,	O	,	_	0	SENT_200	[p12l1433t803r1479b856],
12	7	CD	NUMBER	7	num	13	SENT_200	[p12l1508t803r1539b847],
13	h	NN	O	h	prep_at	7	SENT_200	[p12l1564t803r1610b856],
14	,	,	O	,	_	0	SENT_200	[p12l1564t803r1610b856],
15	and	CC	O	and	_	0	SENT_200	[p12l1636t803r1733b847],
16	7	CD	DURATION	7	num	17	SENT_200	[p12l1760t803r1791b847],
17	Days	NNS	DURATION	day	prep_at	7	SENT_200	[p12l1818t803r1948b857],
18	After	IN	O	after	dep	25	SENT_200	[p12l1971t803r2107b847],
19	Clopidogrel	NNP	O	Clopidogrel	nn	20	SENT_200	[p12l62t882r371b938],
20	Loading	NNP	O	Loading	pobj	18	SENT_200	[p12l398t882r612b938],
21	in	IN	O	in	_	0	SENT_200	[p12l635t883r679b927],
22	CYP2C19	NNP	O	CYP2C19	prep_in	20	SENT_200	[p12l708t883r1048b927],
23	*	CD	NUMBER	*	num	22	SENT_200	[p12l708t883r1048b927],
24	1	CD	NUMBER	1	num	25	SENT_200	[p12l708t883r1048b927],
25	*	NN	O	*	rcmod	17	SENT_200	[p12l1060t883r1123b927],
26	1	CD	NUMBER	1	num	27	SENT_200	[p12l1060t883r1123b927],
27	Carriers	NNS	O	carrier	dep	2	SENT_200	[p12l1145t882r1360b927],

1	CYP2C79	NN	O	cyp2c79	nsubj	7	SENT_201	[p12l63t1017r391b1060],
2	*	CD	NUMBER	*	num	6	SENT_201	[p12l63t1017r391b1060],
3	1	CD	NUMBER	1	num	6	SENT_201	[p12l63t1017r391b1060],
4	*	NN	O	*	nn	6	SENT_201	[p12l63t1017r391b1060],
5	1	CD	NUMBER	1	num	6	SENT_201	[p12l63t1017r391b1060],
6	carriers	NNS	O	carrier	dep	1	SENT_201	[p12l421t1017r606b1061],
7	had	VBD	O	have	_	0	SENT_201	[p12l633t1015r725b1060],
8	similar	JJ	O	similar	amod	10	SENT_201	[p12l752t1015r919b1060],
9	platelet	NN	O	platelet	nn	10	SENT_201	[p12l944t1015r1138b1072],
10	inhibition	NN	O	inhibition	dobj	7	SENT_201	[p12l1163t1015r1408b1061],
11	after	IN	O	after	_	0	SENT_201	[p12l1434t1015r1552b1061],
12	a	DT	O	a	quantmod	13	SENT_201	[p12l1575t1029r1600b1060],
13	1,200	CD	NUMBER	1,200	prep_after	10	SENT_201	[p12l1630t1018r1782b1067],
14	-	:	O	-	_	0	SENT_201	[p12l1630t1018r1782b1067],
15	and	CC	O	and	_	0	SENT_201	[p12l1806t1015r1900b1061],
16	600	CD	NUMBER	600	number	17	SENT_201	[p12l62t1103r258b1157],
17	—	CD	NUMBER	—	prep_after	10	SENT_201	[p12l62t1103r258b1157],
18	mg	NN	O	mg	nn	20	SENT_201	[p12l62t1103r258b1157],
19	loading	NN	O	loading	nn	20	SENT_201	[p12l287t1099r477b1157],
20	dose	NN	O	dose	dep	17	SENT_201	[p12l504t1099r625b1145],
21	at	IN	O	at	_	0	SENT_201	[p12l649t1107r696b1145],
22	4	CD	NUMBER	4	num	23	SENT_201	[p12l719t1103r750b1144],
23	h	NN	O	h	prep_at	13	SENT_201	[p12l776t1099r802b1144],
24	(	CD	NUMBER	(	dep	13	SENT_201	[p12l830t1101r917b1152],
25	A	DT	O	a	det	26	SENT_201	[p12l830t1101r917b1152],
26	)	NN	O	)	dep	24	SENT_201	[p12l830t1101r917b1152],
27	,	,	O	,	_	0	SENT_201	[p12l830t1101r917b1152],
28	7	CD	NUMBER	7	num	29	SENT_201	[p12l943t1103r969b1144],
29	h	NN	O	h	appos	26	SENT_201	[p12l997t1099r1023b1144],
30	(	NN	O	(	nn	32	SENT_201	[p12l1051t1101r1135b1152],
31	B	NN	O	b	nn	32	SENT_201	[p12l1051t1101r1135b1152],
32	)	NN	O	)	dep	29	SENT_201	[p12l1051t1101r1135b1152],
33	,	,	O	,	_	0	SENT_201	[p12l1051t1101r1135b1152],
34	and	CC	O	and	_	0	SENT_201	[p12l1160t1099r1254b1145],
35	after	IN	O	after	dep	13	SENT_201	[p12l1280t1099r1398b1145],
36	a	DT	O	a	det	46	SENT_201	[p12l1421t1113r1446b1145],
37	150	CD	NUMBER	150	num	40	SENT_201	[p12l1477t1103r1564b1145],
38	and	CC	O	and	_	0	SENT_201	[p12l1589t1099r1682b1145],
39	75	CD	NUMBER	75	num	40	SENT_201	[p12l1710t1103r1767b1145],
40	mg	NN	O	mg	npadvmod	41	SENT_201	[p12l1796t1113r1874b1157],
41	daily	JJ	SET	daily	amod	46	SENT_201	[p12l1901t1099r2022b1158],
42	maintenance	NN	O	maintenance	nn	46	SENT_201	[p12l65t1186r400b1229],
43	dosage	NN	O	dosage	nn	46	SENT_201	[p12l424t1184r610b1242],
44	(	NN	O	(	nn	46	SENT_201	[p12l636t1185r720b1236],
45	C	NN	O	c	nn	46	SENT_201	[p12l636t1185r720b1236],
46	)	NN	O	)	pobj	35	SENT_201	[p12l636t1185r720b1236],
47	.	.	O	.	_	0	SENT_201	[p12l636t1185r720b1236],

1	(	NN	O	(	nn	2	SENT_202	[p12l12t1464r455b1547],
2	CYP2CJ9	NN	O	cyp2cj9	_	0	SENT_202	[p12l12t1464r455b1547],
3	*	CD	NUMBER	*	number	4	SENT_202	[p12l12t1464r455b1547],
4	1	CD	NUMBER	1	nsubj	17	SENT_202	[p12l12t1464r455b1547],
5	*	NN	O	*	dep	4	SENT_202	[p12l467t1470r527b1532],
6	1	CD	NUMBER	1	num	5	SENT_202	[p12l467t1470r527b1532],
7	or	CC	O	or	_	0	SENT_202	[p12l553t1492r625b1532],
8	CYP2C9	CD	NUMBER	cyp2c9	num	9	SENT_202	[p12l653t1469r1090b1533],
9	*	NN	O	*	conj_or	4	SENT_202	[p12l653t1469r1090b1533],
10	1	CD	NUMBER	1	num	11	SENT_202	[p12l653t1469r1090b1533],
11	*	NN	O	*	dep	9	SENT_202	[p12l653t1469r1090b1533],
12	1	CD	NUMBER	1	number	15	SENT_202	[p12l653t1469r1090b1533],
13	or	CC	O	or	_	0	SENT_202	[p12l1117t1492r1189b1532],
14	*	CD	NUMBER	*	num	16	SENT_202	[p12l1215t1470r1279b1533],
15	2	CD	NUMBER	2	num	16	SENT_202	[p12l1215t1470r1279b1533],
16	carriers	NNS	O	carrier	dep	11	SENT_202	[p12l1302t1464r1582b1547],
17	)	VBP	O	)	rcmod	2	SENT_202	[p12l1302t1464r1582b1547],
18	or	CC	O	or	_	0	SENT_202	[p12l1609t1492r1681b1532],
19	predictive	JJ	O	predictive	nsubjpass	43	SENT_202	[p12l1702t1466r2047b1556],
20	of	IN	O	of	_	0	SENT_202	[p12l2072t1466r2152b1532],
21	poor	JJ	O	poor	amod	22	SENT_202	[p12l8t1598r172b1662],
22	response	NN	O	response	prep_of	19	SENT_202	[p12l206t1598r509b1662],
23	(	CD	NUMBER	(	num	25	SENT_202	[p12l552t1573r998b1656],
24	CYP2CJ9	NN	O	cyp2cj9	nn	25	SENT_202	[p12l552t1573r998b1656],
25	*	NN	O	*	dep	22	SENT_202	[p12l552t1573r998b1656],
26	2	CD	NUMBER	2	number	29	SENT_202	[p12l552t1573r998b1656],
27	or	CC	O	or	_	0	SENT_202	[p12l1034t1598r1107b1638],
28	*	CD	NUMBER	*	dep	25	SENT_202	[p12l1146t1575r1213b1637],
29	4	CD	NUMBER	4	dep	25	SENT_202	[p12l1146t1575r1213b1637],
30	or	CC	O	or	_	0	SENT_202	[p12l1246t1598r1318b1638],
31	*	CD	NUMBER	*	num	32	SENT_202	[p12l1358t1575r1470b1639],
32	]	NN	O	]	conj_or	22	SENT_202	[p12l1358t1575r1470b1639],
33	7	CD	NUMBER	7	number	37	SENT_202	[p12l1358t1575r1470b1639],
34	or	CC	O	or	_	0	SENT_202	[p12l1503t1598r1575b1638],
35	CYP2C9	CD	NUMBER	cyp2c9	num	38	SENT_202	[p12l1616t1570r2034b1653],
36	*	CD	NUMBER	*	number	37	SENT_202	[p12l1616t1570r2034b1653],
37	3	CD	NUMBER	3	num	38	SENT_202	[p12l1616t1570r2034b1653],
38	)	NN	O	)	rcmod	32	SENT_202	[p12l1616t1570r2034b1653],
39	,	,	O	,	_	0	SENT_202	[p12l1616t1570r2034b1653],
40	as	IN	O	as	advmod	38	SENT_202	[p12l2075t1599r2138b1638],
41	has	VBZ	O	have	aux	43	SENT_202	[p12l9t1678r122b1744],
42	been	VBN	O	be	auxpass	43	SENT_202	[p12l173t1678r340b1744],
43	described	VBN	O	describe	conj_or	17	SENT_202	[p12l392t1678r724b1745],
44	previously	RB	DATE	previously	advmod	43	SENT_202	[p12l774t1678r1134b1768],
45	߱	CD	NUMBER	߱	pobj	44	SENT_202	[p12l1185t1676r1300b1759],
46	"	``	O	"	punct	43	SENT_202	[p12l1185t1676r1300b1759],
47	]	NN	O	]	dobj	43	SENT_202	[p12l1185t1676r1300b1759],
48	+	CC	O	+	_	0	SENT_202	[p12l1185t1676r1300b1759],
49	Despite	IN	O	despite	_	0	SENT_202	[p12l1356t1679r1629b1768],
50	the	DT	O	the	det	53	SENT_202	[p12l1681t1678r1792b1744],
51	different	JJ	O	different	amod	53	SENT_202	[p12l1845t1678r2141b1744],
52	dosing	NN	O	dosing	nn	53	SENT_202	[p12l10t1785r244b1874],
53	regimens	NNS	O	regimen	prep_despite	58	SENT_202	[p12l265t1788r583b1874],
54	of	IN	O	of	_	0	SENT_202	[p12l609t1785r689b1851],
55	Clopidogrel	NNP	MISC	Clopidogrel	prep_of	53	SENT_202	[p12l700t1785r1113b1875],
56	,	,	O	,	_	0	SENT_202	[p12l700t1785r1113b1875],
57	platelet	NN	O	platelet	nn	58	SENT_202	[p12l1138t1785r1399b1875],
58	inhibition	NN	O	inhibition	conj_+	43	SENT_202	[p12l1420t1785r1772b1851],
59	at	IN	O	at	_	0	SENT_202	[p12l1796t1802r1860b1851],
60	7	CD	NUMBER	7	num	61	SENT_202	[p12l1883t1787r1922b1852],
61	h	NN	O	h	prep_at	58	SENT_202	[p12l1945t1785r1989b1851],
62	was	VBD	O	be	dep	2	SENT_202	[p12l2009t1812r2137b1852],

1	JACC	NN	O	jacc	_	0	SENT_203	[p12l8t2036r159b2067],
2	:	:	O	:	_	0	SENT_203	[p12l8t2036r159b2067],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_203	[p12l196t2036r697b2067],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_203	[p12l735t2036r1195b2071],
5	,	,	O	,	_	0	SENT_203	[p12l735t2036r1195b2071],
6	VOL	NNP	O	VOL	appos	4	SENT_203	[p12l1232t2036r1354b2067],
7	.	.	O	.	_	0	SENT_203	[p12l1232t2036r1354b2067],

1	1	LS	NUMBER	1	_	0	SENT_204	[p12l1394t2037r1435b2071],
2	.	.	O	.	_	0	SENT_204	[p12l1394t2037r1435b2071],

1	NO.	NNP	O	NO.	_	0	SENT_205	[p12l1474t2036r1564b2067],
2	6	CD	NUMBER	6	num	1	SENT_205	[p12l1600t2037r1644b2071],
3	,	,	O	,	_	0	SENT_205	[p12l1600t2037r1644b2071],
4	2008	CD	DATE	2008	num	1	SENT_205	[p12l1682t2037r1807b2067],
5	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_205	[p12l11t2101r297b2132],
6	2008:620	CD	NUMBER	2008:620	num	5	SENT_205	[p12l334t2102r656b2132],
7	—	CD	NUMBER	—	number	8	SENT_205	[p12l334t2102r656b2132],
8	7	CD	NUMBER	7	dep	5	SENT_205	[p12l334t2102r656b2132],

1	A	DT	O	a	det	2	SENT_206	[p13l170t213r257b307],
2	p	NN	O	p	_	0	SENT_206	[p13l1064t213r1251b307],
3	=	JJ	O	=	amod	4	SENT_206	[p13l1064t213r1251b307],
4	o.	NN	O	o.	dep	2	SENT_206	[p13l1064t213r1251b307],
5	002	CD	NUMBER	002	dep	2	SENT_206	[p13l1267t213r1431b288],

1	E	NN	O	e	_	0	SENT_207	[p13l167t756r231b794],
2	.	.	O	.	_	0	SENT_207	[p13l308t777r311b779],

1	+	CC	O	+	nsubj	3	SENT_208	[p13l166t795r231b885],
2	60	CD	NUMBER	60	num	3	SENT_208	[p13l285t763r366b821],
3	g	NN	O	g	_	0	SENT_208	[p13l398t799r399b802],
4	I	PRP	O	I	dobj	3	SENT_208	[p13l839t853r880b892],
5	.	.	O	.	_	0	SENT_208	[p13l166t895r231b937],

1	-	:	O	-	_	0	SENT_209	[p13l166t895r231b937],
2	=	JJ	O	=	amod	3	SENT_209	[p13l166t895r231b937],
3	50	CD	NUMBER	50	dep	8	SENT_209	[p13l285t876r366b937],
4	I	PRP	O	I	dep	5	SENT_209	[p13l777t885r816b927],
5	E	NN	O	e	dep	3	SENT_209	[p13l183t949r231b988],
6	E	NN	O	e	dep	8	SENT_209	[p13l166t1001r234b1107],
7	40	CD	NUMBER	40	num	6	SENT_209	[p13l282t994r366b1052],
8	I	PRP	O	I	dep	14	SENT_209	[p13l713t1001r755b1043],
9	I	PRP	O	I	dep	10	SENT_209	[p13l777t1014r818b1065],
10	P6	NN	O	p6	dep	8	SENT_209	[p13l839t1036r877b1043],
11	+	CC	O	+	_	0	SENT_209	[p13l839t1036r877b1043],
12	E	NN	O	e	conj_+	10	SENT_209	[p13l166t1094r231b1233],
13	30	CD	PERCENT	30	num	14	SENT_209	[p13l285t1110r366b1168],
14	%	NN	PERCENT	%	dep	16	SENT_209	[p13l398t1150r400b1152],
15	I	PRP	O	I	dep	14	SENT_209	[p13l713t1178r755b1217],
16	I	PRP	O	I	dep	18	SENT_209	[p13l777t1097r818b1136],
17	I	PRP	O	I	dep	16	SENT_209	[p13l841t1178r880b1217],
18	Q.	NNP	O	Q.	dep	23	SENT_209	[p13l167t1265r231b1311],
19	20	CD	NUMBER	20	num	18	SENT_209	[p13l285t1226r366b1285],
20	g	NN	O	g	dep	18	SENT_209	[p13l398t1267r400b1269],
21	'	''	O	'	_	0	SENT_209	[p13l777t1223r819b1266],
22	-	:	O	-	_	0	SENT_209	[p13l777t1223r819b1266],
23	I	PRP	O	I	_	0	SENT_209	[p13l1504t1249r1544b1288],
24	!	.	O	!	_	0	SENT_209	[p13l1566t1259r1608b1301],

1	I	PRP	O	I	_	0	SENT_210	[p13l1630t1249r1669b1288],
2	I	PRP	O	I	dep	1	SENT_210	[p13l1691t1213r1733b1253],

1	‘	NN	O	‘	_	0	SENT_211	[p13l286t1343r366b1401],
2	Io	NNP	O	Io	dep	1	SENT_211	[p13l286t1343r366b1401],
3	I	PRP	O	I	dep	1	SENT_211	[p13l1566t1352r1608b1394],

1	my	PRP$	O	my	_	0	SENT_212	[p13l324t1461r366b1520],
2	s	NNS	O	s	dep	1	SENT_212	[p13l1502t1468r1540b1540],
3	+	CC	O	+	_	0	SENT_212	[p13l1502t1468r1540b1540],
4	I	PRP	O	I	dep	1	SENT_212	[p13l1601t1468r1634b1470],

1	12100	CD	NUMBER	12100	num	2	SENT_213	[p13l646t1539r816b1600],
2	mg	NN	O	mg	_	0	SENT_213	[p13l845t1555r951b1613],
3	600	CD	NUMBER	600	num	4	SENT_213	[p13l1454t1539r1582b1600],
4	mg	NN	O	mg	dep	2	SENT_213	[p13l1611t1555r1717b1613],

1	CYP2	NN	O	cyp2	nn	4	SENT_214	[p13l690t1655r1151b1722],
2	‘	CD	NUMBER	‘	num	4	SENT_214	[p13l690t1655r1151b1722],
3	C19	NN	O	c19	nn	4	SENT_214	[p13l690t1655r1151b1722],
4	*	NN	O	*	_	0	SENT_214	[p13l690t1655r1151b1722],
5	2	CD	NUMBER	2	number	6	SENT_214	[p13l690t1655r1151b1722],
6	»	CD	NUMBER	»	num	8	SENT_214	[p13l1177t1655r1347b1722],
7	ar	NN	O	ar	nn	8	SENT_214	[p13l1177t1655r1347b1722],
8	*	NN	O	*	dep	4	SENT_214	[p13l1177t1655r1347b1722],
9	4	CD	NUMBER	4	num	10	SENT_214	[p13l1177t1655r1347b1722],
10	carriers	NNS	O	carrier	dep	8	SENT_214	[p13l1376t1657r1688b1722],

1	B.	NNP	O	B.	_	0	SENT_215	[p13l173t1818r250b1909],

1	100	CD	NUMBER	100	num	2	SENT_216	[p13l276t1915r392b1973],
2	V	NN	O	v	_	0	SENT_216	[p13l894t1989r896b1992],
3	d	NN	O	d	dep	2	SENT_216	[p13l794t2005r835b2046],
4	+	CC	O	+	_	0	SENT_216	[p13l794t2005r835b2046],
5	I	PRP	O	I	dep	2	SENT_216	[p13l855t1985r896b2024],

1	5	CD	NUMBER	5	_	0	SENT_217	[p13l186t2095r234b2191],
2	d	NN	O	d	dep	1	SENT_217	[p13l167t2198r234b2271],
3	+	CC	O	+	_	0	SENT_217	[p13l167t2198r234b2271],
4	75	CD	NUMBER	75	dep	1	SENT_217	[p13l315t2172r395b2230],

1	LE	NNP	O	LE	dep	8	SENT_218	[p13l167t2333r234b2400],
2	I	PRP	O	I	dep	1	SENT_218	[p13l732t2352r771b2391],
3	i	FW	O	i	dep	2	SENT_218	[p13l855t2342r896b2384],
4	E	NN	O	e	prep	3	SENT_218	[p13l167t2410r234b2480],
5	50	CD	NUMBER	50	dep	4	SENT_218	[p13l317t2426r392b2484],
6	'	''	O	'	_	0	SENT_218	[p13l794t2403r835b2442],
7	I	PRP	O	I	dep	8	SENT_218	[p13l1501t2423r1540b2464],
8	I	PRP	O	I	_	0	SENT_218	[p13l1562t2455r1601b2494],
9	35	CD	NUMBER	35	num	10	SENT_218	[p13l167t2519r234b2586],
10	jig	NN	O	jig	dep	8	SENT_218	[p13l555t2516r1077b2564],
11	1	CD	NUMBER	1	num	12	SENT_218	[p13l1562t2557r1601b2596],
12	3	CD	NUMBER	3	dep	10	SENT_218	[p13l167t2615r231b2699],
13	:	:	O	:	_	0	SENT_218	[p13l167t2615r231b2699],
14	I	PRP	O	I	dep	12	SENT_218	[p13l732t2648r771b2687],
15	+	CC	O	+	_	0	SENT_218	[p13l170t2728r234b2770],
16	25	CD	NUMBER	25	dep	12	SENT_218	[p13l317t2680r395b2738],
17	I	PRP	O	I	dep	18	SENT_218	[p13l794t2689r835b2731],
18	P	NN	O	p	dep	16	SENT_218	[p13l1562t2680r1602b2809],
19	+	CC	O	+	_	0	SENT_218	[p13l1562t2680r1602b2809],
20	I	PRP	O	I	conj_+	14	SENT_218	[p13l794t2872r835b2912],
21	I	PRP	O	I	dep	20	SENT_218	[p13l857t2811r893b2853],
22	I	PRP	O	I	dep	20	SENT_218	[p13l1501t2831r1540b2873],
23	W	NNP	O	W	nn	24	SENT_218	[p13l1562t2853r1601b2892],
24	O	NNP	O	O	dep	22	SENT_218	[p13l356t2937r392b2992],
25	,	,	O	,	_	0	SENT_218	[p13l816t2960r819b2961],
26	,	,	O	,	_	0	SENT_218	[p13l1605t2960r1608b2961],

1	1200	CD	DATE	1200	num	2	SENT_219	[p13l668t3014r832b3072],
2	mg	NN	O	mg	_	0	SENT_219	[p13l858t3027r964b3085],
3	600	CD	NUMBER	600	num	4	SENT_219	[p13l1453t3014r1576b3072],
4	mg	NN	O	mg	dep	2	SENT_219	[p13l1604t3027r1708b3085],
5	C	NN	O	c	nn	7	SENT_219	[p13l684t3126r742b3188],
6	YP2Cg19	NN	O	yp2cg19	nn	7	SENT_219	[p13l751t3126r1052b3188],
7	*	NN	O	*	dep	2	SENT_219	[p13l1081t3124r1158b3188],
8	2	CD	NUMBER	2	number	11	SENT_219	[p13l1081t3124r1158b3188],
9	or	CC	O	or	_	0	SENT_219	[p13l1183t3142r1273b3188],
10	*	CD	NUMBER	*	num	12	SENT_219	[p13l1299t3123r1373b3188],
11	4	CD	NUMBER	4	num	12	SENT_219	[p13l1299t3123r1373b3188],
12	carriers	NNS	O	carrier	dep	7	SENT_219	[p13l1402t3126r1704b3188],

1	C	NN	O	c	nn	2	SENT_220	[p13l170t3281r251b3375],
2	p	NN	O	p	nsubj	3	SENT_220	[p13l1031t3278r1402b3375],
3	=	JJ	O	=	_	0	SENT_220	[p13l1031t3278r1402b3375],
4	0	CD	NUMBER	0	dobj	3	SENT_220	[p13l1031t3278r1402b3375],
5	.	.	O	.	_	0	SENT_220	[p13l1031t3278r1402b3375],

1	D42	NN	O	d42	_	0	SENT_221	[p13l1031t3278r1402b3375],

1	I	PRP	O	I	_	0	SENT_222	[p13l787t3500r826b3542],
2	I	PRP	O	I	dep	1	SENT_222	[p13l1592t3382r1608b3575],

1	v	LS	O	v	_	0	SENT_223	[p13l192t3613r241b3655],
2	;	:	O	;	_	0	SENT_223	[p13l192t3613r241b3655],
3	.2	NN	NUMBER	.2	dep	1	SENT_223	[p13l176t3661r241b3732],
4	.	.	O	.	_	0	SENT_223	[p13l1572t3703r1611b3745],

1	:	:	O	:	_	0	SENT_224	[p13l176t3741r241b3787],
2	=	JJ	O	=	amod	3	SENT_224	[p13l176t3741r241b3787],
3	I	CD	NUMBER	i	_	0	SENT_224	[p13l787t3748r826b3790],
4	I	PRP	O	I	nsubj	5	SENT_224	[p13l1579t3743r1582b3745],
5	J51	VBP	O	j51	rcmod	3	SENT_224	[p13l176t3796r241b3834],

1	Day	NN	DURATION	day	_	0	SENT_225	[p14l176t376r260b525],
2	7	CD	PERCENT	7	num	3	SENT_225	[p14l176t305r241b348],
3	%	NN	PERCENT	%	dep	1	SENT_225	[p14l176t209r244b274],
4	ianhiil	NN	O	ianhiil	dep	1	SENT_225	[p14l176t6r241b171],

1	150	CD	NUMBER	150	num	2	SENT_226	[p14l678t723r803b782],
2	m	NN	O	m	_	0	SENT_226	[p14l832t737r938b798],
3	75	CD	NUMBER	75	num	6	SENT_226	[p14l1482t723r1566b782],
4	m	NN	O	m	nn	6	SENT_226	[p14l1595t739r1701b798],
5	CYP2C19	NN	O	cyp2c19	nn	6	SENT_226	[p14l690t839r1148b904],
6	*	NN	O	*	dep	2	SENT_226	[p14l690t839r1148b904],
7	2	CD	NUMBER	2	number	10	SENT_226	[p14l690t839r1148b904],
8	or	CC	O	or	_	0	SENT_226	[p14l1174t858r1267b904],
9	*	CD	NUMBER	*	num	11	SENT_226	[p14l1293t839r1370b904],
10	4	CD	NUMBER	4	num	11	SENT_226	[p14l1293t839r1370b904],
11	carriers	NNS	O	carrier	dep	6	SENT_226	[p14l1396t839r1708b904],

1	Figure	NNP	O	Figure	_	0	SENT_227	[p14l66t1038r234b1093],
2	5	CD	NUMBER	5	dep	1	SENT_227	[p14l260t1038r309b1082],
3	.	.	O	.	_	0	SENT_227	[p14l260t1038r309b1082],

1	Platelet	NN	O	platelet	nn	2	SENT_228	[p14l337t1038r552b1083],
2	Inhibition	NN	O	inhibition	_	0	SENT_228	[p14l578t1037r832b1083],
3	(	CD	PERCENT	(	num	4	SENT_228	[p14l857t1038r922b1092],
4	%	NN	PERCENT	%	dep	2	SENT_228	[p14l857t1038r922b1092],
5	of	IN	O	of	_	0	SENT_228	[p14l945t1038r997b1083],
6	Baseline	NN	O	baseline	nn	7	SENT_228	[p14l1020t1037r1276b1092],
7	)	NN	O	)	prep_of	2	SENT_228	[p14l1020t1037r1276b1092],
8	at	IN	O	at	dep	2	SENT_228	[p14l1303t1039r1357b1083],
9	4	CD	NUMBER	4	num	10	SENT_228	[p14l1381t1038r1416b1082],
10	h	NN	O	h	pobj	8	SENT_228	[p14l1441t1038r1487b1092],
11	,	,	O	,	_	0	SENT_228	[p14l1441t1038r1487b1092],
12	7	CD	NUMBER	7	num	13	SENT_228	[p14l1515t1038r1547b1082],
13	h	NN	O	h	conj_and	10	SENT_228	[p14l1572t1038r1618b1092],
14	,	,	O	,	_	0	SENT_228	[p14l1572t1038r1618b1092],
15	and	CC	O	and	_	0	SENT_228	[p14l1645t1038r1742b1083],
16	7	CD	DURATION	7	num	17	SENT_228	[p14l1769t1038r1800b1082],
17	Days	NNS	DURATION	day	conj_and	10	SENT_228	[p14l1827t1038r1958b1093],
18	After	IN	O	after	dep	2	SENT_228	[p14l1981t1038r2118b1083],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_228	[p14l64t1118r374b1174],
20	Loading	NN	O	loading	pobj	18	SENT_228	[p14l401t1118r616b1174],
21	in	IN	O	in	_	0	SENT_228	[p14l639t1118r683b1162],
22	CYP2C19	NN	O	cyp2c19	nn	28	SENT_228	[p14l712t1118r1051b1163],
23	*	NN	O	*	nn	28	SENT_228	[p14l712t1118r1051b1163],
24	2	CD	NUMBER	2	number	27	SENT_228	[p14l712t1118r1051b1163],
25	or	CC	O	or	_	0	SENT_228	[p14l1075t1129r1129b1163],
26	*	CD	NUMBER	*	conj_or	27	SENT_228	[p14l1162t1119r1227b1162],
27	4	CD	NUMBER	4	num	28	SENT_228	[p14l1162t1119r1227b1162],
28	Carriers	NNS	O	carrier	prep_in	20	SENT_228	[p14l1247t1118r1464b1163],

1	CYP2C79	NN	O	cyp2c79	nn	2	SENT_229	[p14l65t1253r343b1297],
2	*	NN	O	*	_	0	SENT_229	[p14l65t1253r343b1297],
3	2	CD	NUMBER	2	number	6	SENT_229	[p14l65t1253r343b1297],
4	or	CC	O	or	_	0	SENT_229	[p14l367t1265r419b1297],
5	*	CD	NUMBER	*	num	7	SENT_229	[p14l445t1253r496b1296],
6	4	CD	NUMBER	4	num	7	SENT_229	[p14l445t1253r496b1296],
7	carriers	NNS	O	carrier	nsubj	8	SENT_229	[p14l520t1254r706b1297],
8	had	VBD	O	have	rcmod	2	SENT_229	[p14l733t1251r825b1297],
9	greater	JJR	O	greater	amod	11	SENT_229	[p14l852t1258r1039b1309],
10	platelet	NN	O	platelet	nn	11	SENT_229	[p14l1064t1251r1258b1309],
11	inhibition	NN	O	inhibition	dobj	8	SENT_229	[p14l1284t1251r1544b1304],
12	,	,	O	,	_	0	SENT_229	[p14l1284t1251r1544b1304],
13	with	IN	O	with	_	0	SENT_229	[p14l1568t1251r1679b1297],
14	the	DT	O	the	det	15	SENT_229	[p14l1704t1251r1788b1297],
15	higher	JJR	O	higher	prep_with	11	SENT_229	[p14l1815t1251r1981b1309],
16	loading	VBG	O	load	partmod	15	SENT_229	[p14l66t1336r257b1394],
17	dose	NN	O	dose	dobj	16	SENT_229	[p14l283t1336r405b1382],
18	than	IN	O	than	advmod	16	SENT_229	[p14l429t1336r544b1382],
19	with	IN	O	with	_	0	SENT_229	[p14l570t1336r681b1382],
20	the	DT	O	the	det	22	SENT_229	[p14l707t1336r790b1382],
21	lower	JJR	O	lower	amod	22	SENT_229	[p14l818t1336r960b1382],
22	dose	NN	O	dose	prep_with	18	SENT_229	[p14l983t1336r1104b1382],
23	at	IN	O	at	_	0	SENT_229	[p14l1130t1343r1177b1382],
24	4	CD	NUMBER	4	num	25	SENT_229	[p14l1200t1340r1230b1381],
25	h	NN	O	h	prep_at	16	SENT_229	[p14l1256t1336r1282b1381],
26	(	CD	NUMBER	(	tmod	16	SENT_229	[p14l1311t1337r1384b1388],
27	A	DT	O	a	det	28	SENT_229	[p14l1311t1337r1384b1388],
28	)	NN	O	)	dep	26	SENT_229	[p14l1311t1337r1384b1388],
29	and	CC	O	and	_	0	SENT_229	[p14l1410t1336r1504b1382],
30	responded	VBD	O	respond	conj_and	8	SENT_229	[p14l1534t1336r1808b1393],
31	better	JJR	O	better	dobj	30	SENT_229	[p14l1837t1336r1992b1382],
32	with	IN	O	with	_	0	SENT_229	[p14l63t1421r174b1466],
33	the	DT	O	the	det	37	SENT_229	[p14l200t1421r284b1466],
34	higher	JJR	O	higher	amod	37	SENT_229	[p14l311t1421r476b1479],
35	maintenance	NN	O	maintenance	nn	37	SENT_229	[p14l502t1423r838b1466],
36	dosage	NN	O	dosage	nn	37	SENT_229	[p14l863t1421r1050b1479],
37	regimen	NN	O	regimen	prep_with	30	SENT_229	[p14l1077t1423r1288b1479],
38	(	NN	O	(	nn	40	SENT_229	[p14l1316t1422r1386b1473],
39	B	NN	O	b	nn	40	SENT_229	[p14l1316t1422r1386b1473],
40	)	NN	O	)	dep	2	SENT_229	[p14l1316t1422r1386b1473],
41	7	CD	NUMBER	7	num	42	SENT_229	[p14l1414t1425r1440b1466],
42	h	NN	O	h	dep	40	SENT_229	[p14l1468t1421r1509b1474],
43	;	:	O	;	_	0	SENT_229	[p14l1468t1421r1509b1474],
44	(	CD	NUMBER	(	num	46	SENT_229	[p14l1535t1422r1605b1473],
45	C	NN	O	c	nn	46	SENT_229	[p14l1535t1422r1605b1473],
46	)	NN	O	)	dep	2	SENT_229	[p14l1535t1422r1605b1473],
47	after	IN	O	after	_	0	SENT_229	[p14l1631t1420r1749b1466],
48	150	CD	NUMBER	150	prep_after	46	SENT_229	[p14l1777t1424r1865b1466],
49	and	CC	O	and	_	0	SENT_229	[p14l1890t1421r1984b1466],
50	75	CD	NUMBER	75	num	51	SENT_229	[p14l2012t1425r2069b1466],
51	mg	NN	O	mg	conj_and	46	SENT_229	[p14l66t1519r145b1564],
52	daily	JJ	SET	daily	amod	54	SENT_229	[p14l172t1506r294b1564],
53	maintenance	NN	O	maintenance	nn	54	SENT_229	[p14l319t1508r655b1551],
54	dose	NN	O	dose	dep	51	SENT_229	[p14l680t1506r815b1551],
55	.	.	O	.	_	0	SENT_229	[p14l680t1506r815b1551],

1	signiﬁcantly	RB	O	signiﬁcantly	advmod	2	SENT_230	[p14l12t1721r443b1810],
2	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_230	[p14l466t1721r835b1787],
3	by	IN	O	by	_	0	SENT_230	[p14l860t1721r947b1810],
4	having	VBG	O	have	prepc_by	2	SENT_230	[p14l970t1721r1208b1810],
5	a	DT	O	a	det	8	SENT_230	[p14l1235t1748r1270b1787],
6	poor	JJ	O	poor	amod	8	SENT_230	[p14l1295t1747r1801b1811],
7	—	NN	O	—	nn	8	SENT_230	[p14l1295t1747r1801b1811],
8	response	NN	O	response	dobj	4	SENT_230	[p14l1295t1747r1801b1811],
9	genotype	NN	O	genotype	nn	11	SENT_230	[p14l1828t1738r2149b1811],
10	(	NN	O	(	nn	11	SENT_230	[p14l13t1826r81b1918],
11	p	NN	O	p	nsubj	2	SENT_230	[p14l13t1826r81b1918],
12	=	JJ	O	=	amod	11	SENT_230	[p14l130t1854r183b1874],
13	0.04	CD	NUMBER	0.04	tmod	12	SENT_230	[p14l232t1832r404b1909],
14	,	,	O	,	_	0	SENT_230	[p14l232t1832r404b1909],
15	Mann-Whitney	NNP	O	Mann-Whitney	nn	18	SENT_230	[p14l445t1828r1022b1917],
16	U	NNP	O	U	nn	18	SENT_230	[p14l1066t1833r1131b1895],
17	test	NN	O	test	nn	18	SENT_230	[p14l1157t1826r1328b1909],
18	)	NN	O	)	appos	11	SENT_230	[p14l1157t1826r1328b1909],
19	.	.	O	.	_	0	SENT_230	[p14l1157t1826r1328b1909],

1	Two	CD	NUMBER	two	num	2	SENT_231	[p14l1369t1827r1536b1895],
2	individuals	NNS	O	individual	_	0	SENT_231	[p14l1576t1828r1959b1895],
3	who	WP	O	who	nsubj	6	SENT_231	[p14l1996t1828r2149b1895],
4	were	VBD	O	be	cop	6	SENT_231	[p14l7t1963r174b2004],
5	compound	JJ	O	compound	amod	6	SENT_231	[p14l218t1937r597b2027],
6	heterozygotes	NNS	O	heterozygote	dep	2	SENT_231	[p14l639t1937r1125b2026],
7	for	IN	O	for	_	0	SENT_231	[p14l1169t1937r1270b2003],
8	both	DT	O	both	det	11	SENT_231	[p14l1309t1937r1474b2003],
9	CYPZCJ	NNP	O	CYPZCJ	nn	11	SENT_231	[p14l1523t1940r1819b2004],
10	9	CD	NUMBER	9	num	11	SENT_231	[p14l1829t1944r1868b2003],
11	*	NN	O	*	prep_for	6	SENT_231	[p14l1908t1937r1977b2004],
12	2	CD	NUMBER	2	num	11	SENT_231	[p14l1908t1937r1977b2004],
13	and	CC	O	and	cc	6	SENT_231	[p14l2023t1937r2151b2003],

1	Gladding	NNP	PERSON	Gladding	_	0	SENT_232	[p14l1436t2186r1671b2239],
2	et	FW	O	et	nn	3	SENT_232	[p14l1690t2188r1741b2229],
3	al.	FW	O	al.	dep	1	SENT_232	[p14l1759t2186r1817b2229],
4	625	CD	NUMBER	625	dep	1	SENT_232	[p14l2035t2186r2140b2229],

1	The	DT	O	the	det	2	SENT_233	[p14l890t2269r985b2311],
2	PRINC	NNP	O	PRINC	_	0	SENT_233	[p14l1008t2268r1173b2311],
3	Trial	NNP	O	Trial	nn	4	SENT_233	[p14l1192t2269r1303b2311],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	2	SENT_233	[p14l1329t2269r1822b2321],

1	CYPZC9	NN	O	cypzc9	nsubj	5	SENT_234	[p14l21t2484r319b2547],
2	*	CD	NUMBER	*	num	1	SENT_234	[p14l347t2484r409b2547],
3	3	CD	NUMBER	3	num	4	SENT_234	[p14l347t2484r409b2547],
4	genotypes	NNS	O	genotype	dep	1	SENT_234	[p14l431t2498r781b2570],
5	had	VBD	O	have	_	0	SENT_234	[p14l807t2481r936b2547],
6	platelet	NN	O	platelet	nn	7	SENT_234	[p14l958t2481r1218b2570],
7	inhibition	NN	O	inhibition	dobj	5	SENT_234	[p14l1240t2481r1591b2547],
8	of	IN	O	of	_	0	SENT_234	[p14l1615t2481r1695b2547],
9	8	CD	PERCENT	8	num	10	SENT_234	[p14l1709t2485r1813b2547],
10	%	NN	PERCENT	%	prep_of	7	SENT_234	[p14l1709t2485r1813b2547],
11	and	CC	O	and	_	0	SENT_234	[p14l1839t2481r1966b2547],
12	11	CD	PERCENT	11	num	13	SENT_234	[p14l1993t2485r2140b2547],
13	%	NN	PERCENT	%	conj_and	10	SENT_234	[p14l1993t2485r2140b2547],
14	at	IN	O	at	_	0	SENT_234	[p14l15t2604r78b2653],
15	7	CD	NUMBER	7	num	16	SENT_234	[p14l111t2589r151b2653],
16	h	NN	O	h	prep_at	5	SENT_234	[p14l184t2587r248b2667],
17	,	,	O	,	_	0	SENT_234	[p14l184t2587r248b2667],
18	respectively	RB	O	respectively	advmod	5	SENT_234	[p14l283t2587r707b2676],
19	.	.	O	.	_	0	SENT_234	[p14l283t2587r707b2676],

1	Analysis	NN	O	analysis	nsubjpass	5	SENT_235	[p14l100t2692r397b2782],
2	of	IN	O	of	_	0	SENT_235	[p14l427t2693r507b2759],
3	covariance	NN	O	covariance	prep_of	1	SENT_235	[p14l524t2696r889b2760],
4	was	VBD	O	be	auxpass	5	SENT_235	[p14l914t2720r1043b2760],
5	used	VBN	O	use	dep	53	SENT_235	[p14l1071t2693r1230b2759],
6	to	TO	O	to	aux	7	SENT_235	[p14l1257t2710r1325b2759],
7	compare	VB	O	compare	xcomp	5	SENT_235	[p14l1355t2719r1654b2783],
8	the	DT	O	the	det	9	SENT_235	[p14l1682t2693r1792b2759],
9	inﬂuence	NN	O	inﬂuence	dobj	7	SENT_235	[p14l1821t2693r2140b2759],
10	of	IN	O	of	_	0	SENT_235	[p14l14t2798r94b2864],
11	genetics	NNS	O	genetics	prep_of	9	SENT_235	[p14l104t2801r407b2886],
12	,	,	O	,	_	0	SENT_235	[p14l104t2801r407b2886],
13	which	WDT	O	which	nsubj	14	SENT_235	[p14l430t2798r647b2864],
14	expressed	VBD	O	express	rcmod	11	SENT_235	[p14l671t2798r1005b2887],
15	as	IN	O	as	_	0	SENT_235	[p14l1029t2824r1091b2864],
16	number	NN	O	number	prep_as	14	SENT_235	[p14l1118t2798r1391b2864],
17	of	IN	O	of	_	0	SENT_235	[p14l1414t2798r1493b2864],
18	variants	NNS	O	variant	prep_of	16	SENT_235	[p14l1501t2801r1795b2878],
19	,	,	O	,	_	0	SENT_235	[p14l1501t2801r1795b2878],
20	with	IN	O	with	_	0	SENT_235	[p14l1818t2798r1979b2864],
21	that	DT	O	that	prep_with	14	SENT_235	[p14l2002t2798r2142b2864],
22	of	IN	O	of	_	0	SENT_235	[p14l14t2904r94b2970],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_235	[p14l128t2904r522b2994],
24	dose	NN	O	dose	prep_of	21	SENT_235	[p14l566t2904r721b2970],
25	on	IN	O	on	_	0	SENT_235	[p14l767t2931r854b2970],
26	platelet	NN	O	platelet	nn	27	SENT_235	[p14l898t2904r1158b2994],
27	inhibition	NN	O	inhibition	prep_on	7	SENT_235	[p14l1201t2904r1552b2970],
28	at	IN	O	at	_	0	SENT_235	[p14l1598t2921r1661b2970],
29	7	CD	NUMBER	7	num	30	SENT_235	[p14l1706t2906r1745b2971],
30	h.	NN	O	h.	prep_at	7	SENT_235	[p14l1790t2904r1853b2970],
31	The	DT	O	the	det	33	SENT_235	[p14l1898t2903r2045b2970],
32	F	NN	O	f	nn	33	SENT_235	[p14l2091t2905r2143b2970],
33	values	NNS	O	value	dep	43	SENT_235	[p14l10t3010r222b3076],
34	of	IN	O	of	_	0	SENT_235	[p14l260t3010r340b3076],
35	8.3	CD	NUMBER	8.3	prep_of	33	SENT_235	[p14l366t3014r467b3077],
36	for	IN	O	for	_	0	SENT_235	[p14l506t3010r607b3076],
37	clopidogrel	NN	O	clopidogrel	nn	38	SENT_235	[p14l642t3010r1035b3100],
38	dose	NN	O	dose	prep_for	35	SENT_235	[p14l1071t3010r1225b3076],
39	(	NN	O	(	nn	40	SENT_235	[p14l1265t3008r1331b3100],
40	p	NN	O	p	dep	43	SENT_235	[p14l1265t3008r1331b3100],
41	=	JJ	O	=	amod	43	SENT_235	[p14l1376t3036r1430b3056],
42	0.006	CD	NUMBER	0.006	number	43	SENT_235	[p14l1475t3008r1696b3091],
43	)	CD	NUMBER	)	dep	49	SENT_235	[p14l1475t3008r1696b3091],
44	and	CC	O	and	_	0	SENT_235	[p14l1737t3010r1864b3076],
45	5.9	CD	NUMBER	5.9	conj_and	43	SENT_235	[p14l1899t3010r2004b3077],
46	for	IN	O	for	_	0	SENT_235	[p14l2042t3010r2142b3076],
47	genetics	NNS	O	genetics	prep_for	45	SENT_235	[p14l13t3119r295b3205],
48	(	RB	O	(	advmod	45	SENT_235	[p14l331t3114r397b3206],
49	p	NN	O	p	dep	7	SENT_235	[p14l331t3114r397b3206],
50	=	JJ	O	=	advmod	53	SENT_235	[p14l439t3142r492b3162],
51	0.02	CD	NUMBER	0.02	num	52	SENT_235	[p14l533t3114r710b3197],
52	)	CD	NUMBER	)	dep	50	SENT_235	[p14l533t3114r710b3197],
53	indicate	VBP	O	indicate	_	0	SENT_235	[p14l745t3116r1022b3182],
54	that	IN	O	that	_	0	SENT_235	[p14l1054t3116r1195b3182],
55	both	CC	O	both	preconj	58	SENT_235	[p14l1222t3116r1386b3182],
56	the	DT	O	the	det	58	SENT_235	[p14l1417t3116r1527b3182],
57	clopidogrel	NN	O	clopidogrel	nn	58	SENT_235	[p14l1560t3116r1954b3206],
58	dose	NN	O	dose	prep_that	53	SENT_235	[p14l1985t3116r2139b3182],
59	and	CC	O	and	_	0	SENT_235	[p14l15t3223r142b3289],
60	genotype	NN	O	genotype	nn	61	SENT_235	[p14l189t3240r508b3312],
61	inﬂuence	NN	O	inﬂuence	prep_that	53	SENT_235	[p14l557t3223r876b3289],
62	the	DT	O	the	det	63	SENT_235	[p14l925t3223r1035b3289],
63	variance	NN	O	variance	nsubj	53	SENT_235	[p14l1081t3226r1370b3289],
64	in	IN	O	in	_	0	SENT_235	[p14l1418t3226r1486b3288],
65	maximal	JJ	O	maximal	amod	67	SENT_235	[p14l1535t3223r1836b3289],
66	platelet	NN	O	platelet	nn	67	SENT_235	[p14l1882t3223r2142b3312],
67	inhibition	NN	O	inhibition	prep_in	63	SENT_235	[p14l14t3328r383b3394],
68	.	.	O	.	_	0	SENT_235	[p14l14t3328r383b3394],

1	ABCB1	NN	O	abcb1	nn	2	SENT_236	[p14l6t3452r216b3499],
2	POLYMORPHISMS	NNS	O	polymorphism	_	0	SENT_236	[p14l247t3449r887b3499],
3	.	.	O	.	_	0	SENT_236	[p14l247t3449r887b3499],

1	No	DT	O	no	det	3	SENT_237	[p14l937t3434r1046b3499],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_237	[p14l1077t3433r1426b3521],
3	inﬂuence	NN	O	inﬂuence	nsubjpass	11	SENT_237	[p14l1452t3433r1759b3499],
4	of	IN	O	of	_	0	SENT_237	[p14l1789t3433r1867b3499],
5	ﬂBCB1	NN	O	ﬂbcb1	nn	6	SENT_237	[p14l1874t3436r2137b3499],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_237	[p14l13t3539r537b3628],
7	on	IN	O	on	_	0	SENT_237	[p14l568t3565r654b3605],
8	platelet	NN	O	platelet	nn	9	SENT_237	[p14l681t3539r930b3628],
9	response	NN	O	response	prep_on	6	SENT_237	[p14l957t3564r1247b3628],
10	was	VBD	O	be	auxpass	11	SENT_237	[p14l1273t3565r1398b3605],
11	observed	VBN	O	observe	_	0	SENT_237	[p14l1429t3539r1725b3605],
12	at	IN	O	at	_	0	SENT_237	[p14l1755t3556r1816b3605],
13	any	DT	O	any	det	15	SENT_237	[p14l1844t3565r1964b3627],
14	time	NN	O	time	nn	15	SENT_237	[p14l1989t3542r2140b3605],
15	interval	NN	O	interval	prep_at	11	SENT_237	[p14l14t3644r281b3710],
16	.	.	O	.	_	0	SENT_237	[p14l14t3644r281b3710],

1	P2Y12	NN	O	p2y12	_	0	SENT_238	[p15l11t45r192b92],
2	H2	NN	O	h2	nn	3	SENT_238	[p15l223t43r311b92],
3	HAPLOTYPE	NN	O	haplotype	dep	1	SENT_238	[p15l341t40r784b92],
4	.	.	O	.	_	0	SENT_238	[p15l341t40r784b92],

1	Patients	NNS	O	patient	nsubj	15	SENT_239	[p15l834t27r1118b92],
2	homozygous	JJ	O	homozygous	amod	1	SENT_239	[p15l1151t26r1594b114],
3	for	IN	O	for	_	0	SENT_239	[p15l1627t26r1727b92],
4	the	DT	O	the	det	7	SENT_239	[p15l1757t26r1866b92],
5	P2Y12	NN	O	p2y12	nn	7	SENT_239	[p15l1898t27r2139b93],
6	H2	NN	O	h2	nn	7	SENT_239	[p15l14t133r129b200],
7	haplotype	NN	O	haplotype	prep_for	2	SENT_239	[p15l167t132r511b222],
8	denoted	VBN	O	denote	partmod	7	SENT_239	[p15l549t132r833b198],
9	by	IN	O	by	_	0	SENT_239	[p15l867t132r953b221],
10	the	DT	O	the	det	13	SENT_239	[p15l985t132r1095b198],
11	insertion	NN	O	insertion	nn	13	SENT_239	[p15l1132t135r1443b198],
12	variation	NN	O	variation	nn	13	SENT_239	[p15l1475t135r1787b199],
13	i-T744C	NN	O	i-t744c	agent	8	SENT_239	[p15l1823t130r2139b199],
14	were	VBD	O	be	cop	15	SENT_239	[p15l10t262r176b303],
15	uncommon	JJ	O	uncommon	_	0	SENT_239	[p15l218t263r642b317],
16	;	:	O	;	_	0	SENT_239	[p15l218t263r642b317],
17	only	RB	O	only	quantmod	18	SENT_239	[p15l688t237r840b325],
18	2	CD	NUMBER	2	num	19	SENT_239	[p15l876t241r917b304],
19	subjects	NNS	O	subject	nsubj	22	SENT_239	[p15l962t237r1233b325],
20	were	VBD	O	be	cop	22	SENT_239	[p15l1272t262r1439b303],
21	CC	NN	O	cc	nn	22	SENT_239	[p15l1483t237r1608b303],
22	homozygotes	NNS	O	homozygote	parataxis	15	SENT_239	[p15l1652t237r2136b325],
23	.	.	O	.	_	0	SENT_239	[p15l1652t237r2136b325],

1	Although	IN	O	although	mark	3	SENT_240	[p15l11t342r355b432],
2	neither	DT	O	neither	nsubj	3	SENT_240	[p15l390t343r640b409],
3	had	VBD	O	have	csubj	20	SENT_240	[p15l673t343r802b409],
4	a	DT	O	a	det	6	SENT_240	[p15l837t370r871b409],
5	high	JJ	O	high	amod	6	SENT_240	[p15l904t343r1063b432],
6	baseline	NN	O	baseline	dobj	3	SENT_240	[p15l1095t343r1377b409],
7	peripheral	JJ	O	peripheral	amod	10	SENT_240	[p15l1411t343r1769b433],
8	resistance	NN	O	resistance	nn	10	SENT_240	[p15l1801t346r2140b409],
9	unit	NN	O	unit	nn	10	SENT_240	[p15l13t451r156b514],
10	value	NN	O	value	dep	6	SENT_240	[p15l184t448r385b528],
11	,	,	O	,	_	0	SENT_240	[p15l184t448r385b528],
12	platelet	NN	O	platelet	nn	13	SENT_240	[p15l419t448r679b537],
13	inhibition	NN	O	inhibition	appos	6	SENT_240	[p15l710t448r1061b514],
14	2	CD	NUMBER	2	num	15	SENT_240	[p15l1091t452r1133b515],
15	h	NN	O	h	dep	13	SENT_240	[p15l1167t448r1211b513],
16	after	IN	O	after	_	0	SENT_240	[p15l1245t448r1403b514],
17	600-mg	JJ	O	600-mg	amod	18	SENT_240	[p15l1436t452r1716b536],
18	clopidogrel	NN	O	clopidogrel	prep_after	3	SENT_240	[p15l1748t448r2141b537],
19	was	VBD	O	be	cop	20	SENT_240	[p15l10t579r139b619],
20	<	JJR	O	<	_	0	SENT_240	[p15l179t557r355b620],
21	2	CD	PERCENT	2	num	22	SENT_240	[p15l179t557r355b620],
22	%	NN	PERCENT	%	dep	23	SENT_240	[p15l179t557r355b620],
23	in	IN	O	in	prep	20	SENT_240	[p15l388t556r456b618],
24	both	CC	O	both	dep	23	SENT_240	[p15l486t553r650b619],
25	individuals	NNS	O	individual	conj	23	SENT_240	[p15l683t553r1084b619],
26	.	.	O	.	_	0	SENT_240	[p15l683t553r1084b619],

1	CES	NNP	O	CES	nn	2	SENT_241	[p15l17t678r138b726],
2	POLYMORPHISMS	NNPS	O	POLYMORPHISMS	_	0	SENT_241	[p15l175t675r817b725],
3	.	.	O	.	_	0	SENT_241	[p15l175t675r817b725],

1	The	DT	O	the	det	7	SENT_242	[p15l864t657r1010b725],
2	carboxylesterase	NN	O	carboxylesterase	nn	7	SENT_242	[p15l1052t659r1613b748],
3	intronic	JJ	O	intronic	amod	7	SENT_242	[p15l1654t662r1932b725],
4	SNP	NN	O	snp	nn	7	SENT_242	[p15l1975t659r2141b726],
5	(	CD	NUMBER	(	num	7	SENT_242	[p15l17t763r423b846],
6	IVSIO-88	NN	O	ivsio-88	nn	7	SENT_242	[p15l17t763r423b846],
7	)	NN	O	)	nsubj	10	SENT_242	[p15l17t763r423b846],
8	was	VBD	O	be	cop	10	SENT_242	[p15l456t792r584b832],
9	not	RB	O	not	neg	10	SENT_242	[p15l620t782r738b831],
10	present	JJ	DATE	present	_	0	SENT_242	[p15l767t782r1025b855],
11	in	IN	O	in	_	0	SENT_242	[p15l1057t768r1124b831],
12	this	DT	O	this	det	13	SENT_242	[p15l1157t765r1283b831],
13	cohort	NN	O	cohort	prep_in	10	SENT_242	[p15l1319t765r1564b831],
14	.	.	O	.	_	0	SENT_242	[p15l1319t765r1564b831],

1	Discussion	NN	O	discussion	_	0	SENT_243	[p15l16t994r472b1057],

1	Patients	NNS	O	patient	nsubj	17	SENT_244	[p15l14t1188r316b1253],
2	carrying	VBG	O	carry	partmod	1	SENT_244	[p15l387t1190r691b1275],
3	the	DT	O	the	det	5	SENT_244	[p15l757t1187r872b1253],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_244	[p15l947t1190r1399b1262],
5	*	NN	O	*	dobj	2	SENT_244	[p15l947t1190r1399b1262],
6	2	CD	NUMBER	2	dep	5	SENT_244	[p15l947t1190r1399b1262],
7	,	,	O	,	_	0	SENT_244	[p15l947t1190r1399b1262],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_244	[p15l1480t1190r1933b1263],
9	*	NN	O	*	conj_and	5	SENT_244	[p15l1480t1190r1933b1263],
10	4	CD	NUMBER	4	dep	9	SENT_244	[p15l1480t1190r1933b1263],
11	,	,	O	,	_	0	SENT_244	[p15l1480t1190r1933b1263],
12	and	CC	O	and	_	0	SENT_244	[p15l2009t1187r2141b1253],
13	CYP2C19	NN	O	cyp2c19	conj_and	5	SENT_244	[p15l21t1295r482b1358],
14	*	CD	NUMBER	*	number	15	SENT_244	[p15l21t1295r482b1358],
15	17	CD	NUMBER	17	num	16	SENT_244	[p15l21t1295r482b1358],
16	alleles	NNS	O	allele	dep	13	SENT_244	[p15l516t1292r723b1358],
17	have	VBP	O	have	_	0	SENT_244	[p15l762t1292r920b1358],
18	a	DT	O	a	det	21	SENT_244	[p15l960t1318r994b1358],
19	decreased	VBN	O	decrease	amod	21	SENT_244	[p15l1031t1292r1369b1358],
20	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_244	[p15l1408t1292r1803b1381],
21	response	NN	O	response	dobj	17	SENT_244	[p15l1838t1317r2140b1381],
22	to	TO	O	to	_	0	SENT_244	[p15l14t1414r82b1463],
23	clopidogrel	NN	O	clopidogrel	prep_to	21	SENT_244	[p15l111t1397r505b1486],
24	compared	VBN	O	compare	_	0	SENT_244	[p15l531t1397r878b1486],
25	with	IN	O	with	prepc_compared_with	21	SENT_244	[p15l900t1397r1061b1463],
26	the	DT	O	the	det	27	SENT_244	[p15l1088t1397r1198b1463],
27	response	NN	O	response	pobj	21	SENT_244	[p15l1225t1422r1528b1486],
28	of	IN	O	of	_	0	SENT_244	[p15l1556t1397r1636b1463],
29	CYP2C19	NN	O	cyp2c19	prep_of	27	SENT_244	[p15l1657t1400r2137b1463],
30	*	CD	NUMBER	*	number	31	SENT_244	[p15l1657t1400r2137b1463],
31	1	CD	NUMBER	1	num	32	SENT_244	[p15l1657t1400r2137b1463],
32	*	NN	O	*	dep	29	SENT_244	[p15l1657t1400r2137b1463],
33	1	CD	NUMBER	1	num	34	SENT_244	[p15l1657t1400r2137b1463],
34	carriers	NNS	O	carrier	dep	32	SENT_244	[p15l15t1505r287b1568],
35	.	.	O	.	_	0	SENT_244	[p15l15t1505r287b1568],

1	Patients	NNS	O	patient	nsubj	7	SENT_245	[p15l318t1503r601b1568],
2	carrying	VBG	O	carry	partmod	1	SENT_245	[p15l631t1505r916b1590],
3	any	DT	O	any	dobj	2	SENT_245	[p15l942t1528r1065b1590],
4	of	IN	O	of	_	0	SENT_245	[p15l1089t1502r1168b1568],
5	these	DT	O	these	det	6	SENT_245	[p15l1183t1502r1362b1568],
6	alleles	NNS	O	allele	prep_of	3	SENT_245	[p15l1391t1502r1597b1568],
7	displayed	VBD	O	display	_	0	SENT_245	[p15l1627t1502r1954b1591],
8	both	CC	O	both	prep	7	SENT_245	[p15l1977t1502r2141b1568],
9	a	DT	O	a	det	12	SENT_245	[p15l15t1634r50b1674],
10	reduced	VBN	O	reduce	amod	12	SENT_245	[p15l106t1608r383b1674],
11	early	JJ	O	early	amod	12	SENT_245	[p15l441t1608r608b1696],
12	response	NN	O	response	dep	8	SENT_245	[p15l662t1633r964b1697],
13	to	TO	O	to	_	0	SENT_245	[p15l1023t1625r1090b1674],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_245	[p15l1151t1608r1544b1697],
15	loading	NN	O	loading	prep_to	12	SENT_245	[p15l1599t1608r1864b1696],
16	and	CC	O	and	_	0	SENT_245	[p15l1922t1608r2049b1674],
17	a	DT	O	a	det	20	SENT_245	[p15l2108t1634r2142b1674],
18	reduced	VBN	O	reduce	amod	20	SENT_245	[p15l13t1713r291b1779],
19	sustained	JJ	O	sustained	amod	20	SENT_245	[p15l338t1713r663b1779],
20	response	NN	O	response	conj_and	12	SENT_245	[p15l710t1738r1012b1802],
21	after	IN	O	after	_	0	SENT_245	[p15l1061t1713r1219b1779],
22	1	CD	DURATION	1	num	23	SENT_245	[p15l1269t1717r1300b1778],
23	week	NN	NUMBER	week	prep_after	20	SENT_245	[p15l1349t1713r1533b1779],
24	of	IN	O	of	_	0	SENT_245	[p15l1577t1713r1656b1779],
25	maintenance	NN	O	maintenance	nn	26	SENT_245	[p15l1692t1716r2140b1779],
26	therapy	NN	O	therapy	prep_of	23	SENT_245	[p15l14t1818r295b1907],
27	.	.	O	.	_	0	SENT_245	[p15l14t1818r295b1907],

1	CYP2C19	NN	O	cyp2c19	nsubj	2	SENT_246	[p15l329t1818r700b1885],
2	appears	VBZ	O	appear	_	0	SENT_246	[p15l731t1843r991b1907],
3	to	TO	O	to	aux	5	SENT_246	[p15l1020t1835r1088b1884],
4	be	VB	O	be	cop	5	SENT_246	[p15l1115t1818r1195b1884],
5	important	JJ	O	important	xcomp	2	SENT_246	[p15l1223t1821r1579b1907],
6	in	IN	O	in	_	0	SENT_246	[p15l1605t1821r1672b1883],
7	the	DT	O	the	det	9	SENT_246	[p15l1700t1818r1810b1884],
8	first	JJ	ORDINAL	first	amod	9	SENT_246	[p15l1838t1818r1975b1884],
9	step	NN	O	step	prep_in	5	SENT_246	[p15l2002t1835r2139b1907],
10	in	IN	O	in	_	0	SENT_246	[p15l14t1926r82b1988],
11	biotransformation	NN	O	biotransformation	prep_in	9	SENT_246	[p15l130t1923r772b1989],
12	of	IN	O	of	_	0	SENT_246	[p15l823t1923r903b1989],
13	the	DT	O	the	det	15	SENT_246	[p15l941t1923r1051b1989],
14	parent	NN	O	parent	nn	15	SENT_246	[p15l1102t1940r1328b2012],
15	drug	NN	O	drug	prep_of	11	SENT_246	[p15l1378t1923r1540b2011],
16	into	IN	O	into	_	0	SENT_246	[p15l1589t1926r1728b1989],
17	the	DT	O	the	det	19	SENT_246	[p15l1780t1923r1890b1989],
18	active	JJ	O	active	amod	19	SENT_246	[p15l1943t1926r2140b1989],
19	metabolite	NN	O	metabolite	prep_into	5	SENT_246	[p15l15t2028r407b2108],
20	,	,	O	,	_	0	SENT_246	[p15l15t2028r407b2108],
21	and	CC	O	and	_	0	SENT_246	[p15l453t2028r580b2094],
22	a	DT	O	a	det	23	SENT_246	[p15l623t2054r657b2094],
23	loss	NN	O	loss	nsubj	30	SENT_246	[p15l697t2028r823b2094],
24	of	IN	O	of	_	0	SENT_246	[p15l868t2028r947b2094],
25	function	NN	O	function	prep_of	23	SENT_246	[p15l977t2028r1273b2094],
26	in	IN	O	in	_	0	SENT_246	[p15l1315t2031r1382b2093],
27	this	DT	O	this	det	29	SENT_246	[p15l1424t2028r1551b2094],
28	enzyme	NN	O	enzyme	nn	29	SENT_246	[p15l1596t2054r1862b2116],
29	system	NN	O	system	prep_in	25	SENT_246	[p15l1906t2045r2140b2116],
30	leads	VBZ	O	lead	conj_and	2	SENT_246	[p15l12t2133r185b2199],
31	to	TO	O	to	_	0	SENT_246	[p15l239t2150r307b2199],
32	a	DT	O	a	det	33	SENT_246	[p15l363t2159r397b2199],
33	reduction	NN	O	reduction	prep_to	30	SENT_246	[p15l448t2133r784b2199],
34	in	IN	O	in	_	0	SENT_246	[p15l837t2136r904b2198],
35	the	DT	O	the	det	37	SENT_246	[p15l957t2133r1067b2199],
36	plasma	NN	O	plasma	nn	37	SENT_246	[p15l1119t2133r1365b2222],
37	levels	NNS	O	level	prep_in	33	SENT_246	[p15l1415t2133r1602b2199],
38	of	IN	O	of	_	0	SENT_246	[p15l1658t2133r1737b2199],
39	the	DT	O	the	det	41	SENT_246	[p15l1778t2133r1887b2199],
40	active	JJ	O	active	amod	41	SENT_246	[p15l1943t2136r2139b2199],
41	metabolite	NN	O	metabolite	prep_of	37	SENT_246	[p15l14t2238r386b2304],
42	$	$	MONEY	$	dep	41	SENT_246	[p15l423t2236r538b2318],
43	*	CD	MONEY	*	num	41	SENT_246	[p15l423t2236r538b2318],

1	The	DT	O	the	det	2	SENT_247	[p15l100t2343r246b2410],
2	Cl/P3114	NN	O	cl/p3114	nsubj	6	SENT_247	[p15l282t2347r580b2411],
3	variant	JJ	O	variant	amod	4	SENT_247	[p15l600t2347r846b2411],
4	alleles	NNS	O	allele	dep	2	SENT_247	[p15l874t2344r1081b2410],
5	are	VBP	O	be	cop	6	SENT_247	[p15l1112t2370r1213b2410],
6	uncommon	JJ	O	uncommon	_	0	SENT_247	[p15l1241t2371r1645b2410],
7	in	IN	O	in	_	0	SENT_247	[p15l1674t2347r1742b2410],
8	a	DT	O	a	det	11	SENT_247	[p15l1772t2371r1806b2410],
9	predominantly	RB	O	predominantly	advmod	10	SENT_247	[p15l1831t2344r2138b2434, p15l14t2450r260b2539],
10	Caucasian	JJ	LOCATION	caucasian	amod	11	SENT_247	[p15l298t2450r656b2517],
11	population	NN	O	population	prep_in	6	SENT_247	[p15l695t2450r1095b2540],
12	.	.	O	.	_	0	SENT_247	[p15l695t2450r1095b2540],

1	As	IN	O	as	mark	4	SENT_248	[p15l1136t2449r1231b2516],
2	few	JJ	O	few	amod	3	SENT_248	[p15l1272t2450r1398b2517],
3	patients	NNS	O	patient	nsubj	4	SENT_248	[p15l1434t2453r1710b2540],
4	carried	VBD	O	carry	advcl	20	SENT_248	[p15l1752t2450r1991b2516],
5	the	DT	O	the	det	6	SENT_248	[p15l2030t2450r2140b2516],
6	variants	NNS	O	variant	dobj	4	SENT_248	[p15l10t2558r305b2635],
7	,	,	O	,	_	0	SENT_248	[p15l10t2558r305b2635],
8	the	DT	O	the	det	10	SENT_248	[p15l337t2555r447b2621],
9	potential	JJ	O	potential	amod	10	SENT_248	[p15l476t2555r791b2644],
10	inﬂuence	NN	O	inﬂuence	nsubjpass	20	SENT_248	[p15l819t2555r1138b2621],
11	of	IN	O	of	_	0	SENT_248	[p15l1170t2555r1249b2621],
12	CYP3ﬂ4	NN	O	cyp3ﬂ4	nn	13	SENT_248	[p15l1273t2558r1570b2621],
13	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_248	[p15l1594t2555r2139b2644],
14	on	IN	O	on	_	0	SENT_248	[p15l14t2686r102b2726],
15	clopidogrel	NN	O	clopidogrel	nn	16	SENT_248	[p15l129t2660r524b2749],
16	response	NN	O	response	prep_on	13	SENT_248	[p15l549t2685r851b2749],
17	could	MD	O	could	aux	20	SENT_248	[p15l879t2660r1070b2726],
18	not	RB	O	not	neg	20	SENT_248	[p15l1098t2677r1215b2726],
19	be	VB	O	be	auxpass	20	SENT_248	[p15l1238t2660r1318b2726],
20	assessed	VBN	O	assess	_	0	SENT_248	[p15l1347t2660r1646b2726],
21	.	.	O	.	_	0	SENT_248	[p15l1347t2660r1646b2726],

1	Moreover	RB	O	moreover	advmod	22	SENT_249	[p15l1676t2661r2044b2740],
2	,	,	O	,	_	0	SENT_249	[p15l1676t2661r2044b2740],
3	in	IN	O	in	_	0	SENT_249	[p15l2074t2663r2141b2725],
4	the	DT	O	the	det	6	SENT_249	[p15l13t2765r124b2831],
5	6	CD	NUMBER	6	num	6	SENT_249	[p15l158t2769r195b2831],
6	patients	NNS	O	patient	prep_in	22	SENT_249	[p15l228t2768r505b2854],
7	who	WP	O	who	nsubj	8	SENT_249	[p15l535t2765r687b2831],
8	carried	VBD	O	carry	rcmod	6	SENT_249	[p15l721t2765r960b2831],
9	the	DT	O	the	det	13	SENT_249	[p15l992t2765r1102b2831],
10	CYP3ﬂ5	NN	O	cyp3ﬂ5	nn	13	SENT_249	[p15l1141t2768r1438b2831],
11	*	NN	O	*	nn	13	SENT_249	[p15l1443t2768r1502b2830],
12	1	CD	NUMBER	1	num	13	SENT_249	[p15l1443t2768r1502b2830],
13	allele	NN	O	allele	dobj	8	SENT_249	[p15l1539t2765r1736b2845],
14	,	,	O	,	_	0	SENT_249	[p15l1539t2765r1736b2845],
15	no	DT	O	no	det	17	SENT_249	[p15l1772t2791r1857b2831],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_249	[p15l1892t2765r2138b2853, p15l15t2888r163b2937],
17	impact	NN	O	impact	nsubjpass	22	SENT_249	[p15l191t2874r433b2961],
18	of	IN	O	of	_	0	SENT_249	[p15l464t2871r543b2937],
19	CYP3A5	NN	O	cyp3a5	nn	20	SENT_249	[p15l564t2870r889b2938],
20	expression	NN	O	expression	prep_of	17	SENT_249	[p15l925t2874r1289b2961],
21	was	VBD	O	be	auxpass	22	SENT_249	[p15l1316t2898r1445b2938],
22	observed	VBN	O	observe	_	0	SENT_249	[p15l1479t2871r1787b2938],
23	on	IN	O	on	_	0	SENT_249	[p15l1817t2898r1905b2937],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_249	[p15l1937t2871r2138b2961, p15l15t2978r236b3066],
25	response	NN	O	response	prep_on	22	SENT_249	[p15l268t3003r589b3067],
26	.	.	O	.	_	0	SENT_249	[p15l268t3003r589b3067],

1	The	DT	O	the	det	2	SENT_250	[p15l100t3083r246b3150],
2	ﬁnding	NN	O	ﬁnding	nsubj	16	SENT_250	[p15l270t3084r525b3173],
3	of	IN	O	of	_	0	SENT_250	[p15l547t3084r627b3150],
4	reduced	VBN	O	reduce	amod	6	SENT_250	[p15l637t3084r915b3150],
5	platelet	NN	O	platelet	nn	6	SENT_250	[p15l937t3084r1197b3174],
6	inhibition	NN	O	inhibition	prep_of	2	SENT_250	[p15l1219t3084r1570b3150],
7	in	IN	O	in	_	0	SENT_250	[p15l1593t3087r1660b3150],
8	patients	NNS	O	patient	prep_in	6	SENT_250	[p15l1682t3087r1959b3174],
9	with	IN	O	with	_	0	SENT_250	[p15l1980t3084r2141b3151],
10	the	DT	O	the	det	14	SENT_250	[p15l14t3189r124b3255],
11	CYP2C19	NN	O	cyp2c19	nn	14	SENT_250	[p15l168t3192r629b3256],
12	*	NN	O	*	nn	14	SENT_250	[p15l168t3192r629b3256],
13	17	CD	NUMBER	17	num	14	SENT_250	[p15l168t3192r629b3256],
14	allele	NN	O	allele	prep_with	8	SENT_250	[p15l663t3189r839b3255],
15	is	VBZ	O	be	cop	16	SENT_250	[p15l876t3192r926b3255],
16	unexpected	JJ	O	unexpected	_	0	SENT_250	[p15l963t3189r1363b3278],
17	given	VBN	O	give	prep	16	SENT_250	[p15l1398t3192r1585b3277],
18	that	IN	O	that	complm	31	SENT_250	[p15l1621t3189r1762b3255],
19	*	NN	O	*	nsubj	31	SENT_250	[p15l1796t3189r1917b3255],
20	17	CD	NUMBER	17	num	21	SENT_250	[p15l1796t3189r1917b3255],
21	codes	NNS	O	code	advmod	31	SENT_250	[p15l1949t3189r2139b3255],
22	for	IN	O	for	_	0	SENT_250	[p15l14t3295r114b3361],
23	an	DT	O	a	det	24	SENT_250	[p15l139t3322r219b3361],
24	enzyme	NN	O	enzyme	prep_for	21	SENT_250	[p15l245t3322r512b3384],
25	with	IN	O	with	_	0	SENT_250	[p15l534t3295r695b3362],
26	higher	JJR	O	higher	amod	27	SENT_250	[p15l719t3295r949b3384],
27	activity	NN	O	activity	prep_with	21	SENT_250	[p15l973t3298r1228b3384],
28	than	IN	O	than	_	0	SENT_250	[p15l1249t3295r1407b3361],
29	*	CD	NUMBER	*	number	30	SENT_250	[p15l1437t3299r1496b3361],
30	1	CD	NUMBER	1	prep_than	27	SENT_250	[p15l1437t3299r1496b3361],
31	does	VBZ	O	do	pcomp	17	SENT_250	[p15l1525t3295r1679b3361],
32	(	CD	NUMBER	(	num	34	SENT_250	[p15l1709t3293r1868b3376],
33	19	CD	NUMBER	19	num	34	SENT_250	[p15l1709t3293r1868b3376],
34	)	NN	O	)	dobj	31	SENT_250	[p15l1709t3293r1868b3376],
35	.	.	O	.	_	0	SENT_250	[p15l1709t3293r1868b3376],

1	To	TO	O	to	_	0	SENT_251	[p15l1894t3294r1999b3361],
2	our	PRP$	O	we	poss	3	SENT_251	[p15l2026t3321r2143b3361],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_251	[p15l14t3400r414b3488],
4	,	,	O	,	_	0	SENT_251	[p15l14t3400r414b3488],
5	this	DT	O	this	nsubj	9	SENT_251	[p15l451t3400r577b3466],
6	is	VBZ	O	be	cop	9	SENT_251	[p15l613t3403r663b3466],
7	the	DT	O	the	det	9	SENT_251	[p15l699t3400r809b3466],
8	first	JJ	ORDINAL	first	amod	9	SENT_251	[p15l844t3400r981b3466],
9	study	NN	O	study	_	0	SENT_251	[p15l1015t3400r1203b3488],
10	to	TO	O	to	aux	11	SENT_251	[p15l1234t3417r1301b3466],
11	evaluate	VB	O	evaluate	infmod	9	SENT_251	[p15l1338t3400r1619b3466],
12	the	DT	O	the	det	13	SENT_251	[p15l1653t3400r1763b3466],
13	impact	NN	O	impact	dobj	11	SENT_251	[p15l1798t3403r2040b3489],
14	of	IN	O	of	_	0	SENT_251	[p15l2073t3400r2153b3466],
15	CYP2C19	NN	O	cyp2c19	prep_of	13	SENT_251	[p15l21t3508r438b3572],
16	*	CD	NUMBER	*	number	20	SENT_251	[p15l21t3508r438b3572],
17	4	CD	NUMBER	4	number	20	SENT_251	[p15l21t3508r438b3572],
18	and	CC	O	and	_	0	SENT_251	[p15l468t3505r595b3571],
19	*	CD	NUMBER	*	conj_and	20	SENT_251	[p15l632t3508r744b3571],
20	17	CD	NUMBER	17	num	15	SENT_251	[p15l632t3508r744b3571],
21	on	IN	O	on	_	0	SENT_251	[p15l773t3531r860b3571],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_251	[p15l894t3505r1288b3594],
23	response	NN	O	response	prep_on	11	SENT_251	[p15l1319t3530r1640b3594],
24	.	.	O	.	_	0	SENT_251	[p15l1319t3530r1640b3594],

1	Several	JJ	O	several	amod	3	SENT_252	[p15l106t3611r354b3678],
2	previous	JJ	O	previous	amod	3	SENT_252	[p15l400t3614r693b3701],
3	studies	NNS	O	study	nsubj	4	SENT_252	[p15l745t3611r982b3677],
4	(	VBP	O	(	_	0	SENT_252	[p15l1036t3609r1307b3692],
5	6,9,10	CD	NUMBER	6,9,10	num	6	SENT_252	[p15l1036t3609r1307b3692],
6	)	CD	NUMBER	)	nsubj	8	SENT_252	[p15l1036t3609r1307b3692],
7	have	VBP	O	have	aux	8	SENT_252	[p15l1359t3611r1516b3678],
8	shown	VBN	O	show	ccomp	4	SENT_252	[p15l1567t3611r1794b3678],
9	that	IN	O	that	complm	16	SENT_252	[p15l1843t3611r1984b3677],
10	the	DT	O	the	det	14	SENT_252	[p15l2030t3611r2140b3677],
11	CYP2C19	NN	O	cyp2c19	nn	14	SENT_252	[p15l21t3719r434b3783],
12	*	NN	O	*	nn	14	SENT_252	[p15l21t3719r434b3783],
13	2	CD	NUMBER	2	num	14	SENT_252	[p15l21t3719r434b3783],
14	allele	NN	O	allele	nsubjpass	16	SENT_252	[p15l472t3716r648b3782],
15	is	VBZ	O	be	auxpass	16	SENT_252	[p15l686t3719r737b3782],
16	associated	VBN	O	associate	ccomp	8	SENT_252	[p15l777t3716r1129b3782],
17	with	IN	O	with	_	0	SENT_252	[p15l1162t3716r1323b3782],
18	a	DT	O	a	det	21	SENT_252	[p15l1362t3742r1396b3782],
19	reduced	VBN	O	reduce	amod	21	SENT_252	[p15l1432t3716r1709b3782],
20	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_252	[p15l1747t3716r2142b3805],
21	response	NN	O	response	prep_with	16	SENT_252	[p16l14t42r316b106],
22	to	TO	O	to	_	0	SENT_252	[p16l347t33r415b82],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_252	[p16l448t16r842b106],
24	therapy	NN	O	therapy	prep_to	21	SENT_252	[p16l871t16r1152b106],
25	.	.	O	.	_	0	SENT_252	[p16l871t16r1152b106],

1	Hulot	NNP	PERSON	Hulot	nsubj	7	SENT_253	[p16l1188t16r1402b82],
2	et	FW	O	et	dep	1	SENT_253	[p16l1432t33r1495b82],
3	al.	FW	O	al.	nn	4	SENT_253	[p16l1526t16r1599b82],
4	(	FW	O	(	dep	1	SENT_253	[p16l1637t14r1730b97],
5	9	CD	NUMBER	9	num	6	SENT_253	[p16l1637t14r1730b97],
6	)	NN	O	)	dep	4	SENT_253	[p16l1637t14r1730b97],
7	found	VBD	O	find	_	0	SENT_253	[p16l1764t16r1972b83],
8	that	IN	O	that	complm	14	SENT_253	[p16l2002t16r2143b82],
9	heterozygote	NN	O	heterozygote	nn	11	SENT_253	[p16l14t121r466b209],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_253	[p16l500t124r913b187],
11	*	NN	O	*	nsubj	14	SENT_253	[p16l500t124r913b187],
12	2	CD	NUMBER	2	num	13	SENT_253	[p16l500t124r913b187],
13	subjects	NNS	O	subject	dep	11	SENT_253	[p16l939t121r1210b209],
14	had	VBD	O	have	ccomp	7	SENT_253	[p16l1237t121r1366b187],
15	no	DT	O	no	det	17	SENT_253	[p16l1392t147r1478b187],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_253	[p16l1506t121r1871b209],
17	change	NN	O	change	dobj	14	SENT_253	[p16l1895t121r2140b209],
18	in	IN	O	in	_	0	SENT_253	[p16l14t229r82b291],
19	platelet	NN	O	platelet	nn	20	SENT_253	[p16l111t226r372b315],
20	function	NN	O	function	prep_in	17	SENT_253	[p16l401t226r697b292],
21	after	IN	O	after	_	0	SENT_253	[p16l729t226r888b292],
22	7	CD	DURATION	7	num	23	SENT_253	[p16l919t228r958b292],
23	days	NNS	NUMBER	day	prep_after	14	SENT_253	[p16l990t226r1138b314],
24	of	IN	O	of	_	0	SENT_253	[p16l1172t226r1251b292],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_253	[p16l1271t226r1664b315],
26	75	CD	NUMBER	75	num	27	SENT_253	[p16l1696t226r1776b292],
27	mg	NN	O	mg	npadvmod	28	SENT_253	[p16l1811t252r1923b314],
28	daily	RB	SET	daily	advmod	14	SENT_253	[p16l1954t226r2138b314],
29	,	,	O	,	_	0	SENT_253	[p16l1954t226r2138b314],
30	as	IN	O	as	mark	31	SENT_253	[p16l15t357r78b397],
31	assessed	VBN	O	assess	advcl	14	SENT_253	[p16l113t331r395b397],
32	by	IN	O	by	_	0	SENT_253	[p16l423t331r509b419],
33	both	CC	O	both	preconj	37	SENT_253	[p16l534t331r698b397],
34	10	CD	NUMBER	10	number	35	SENT_253	[p16l733t331r1103b414],
35	—	CD	NUMBER	—	num	37	SENT_253	[p16l733t331r1103b414],
36	umol/l	NN	O	umol/l	nn	37	SENT_253	[p16l733t331r1103b414],
37	adenosine	NN	O	adenosine	prep_by	31	SENT_253	[p16l1135t331r1482b397],
38	diphosphate	NN	O	diphosphate	nn	41	SENT_253	[p16l1515t331r1947b420],
39	light	JJ	O	light	amod	41	SENT_253	[p16l1977t331r2143b419],
40	transmittance	JJ	O	transmittance	amod	41	SENT_253	[p16l13t440r509b503],
41	aggregometry	NN	O	aggregometry	dep	37	SENT_253	[p16l575t454r1072b525],
42	and	CC	O	and	_	0	SENT_253	[p16l1134t437r1263b503],
43	Vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	44	SENT_253	[p16l1323t437r2141b503],
44	phosphorylation	NN	O	phosphorylation	prep_by	31	SENT_253	[p16l13t542r635b631],
45	.	.	O	.	_	0	SENT_253	[p16l13t542r635b631],

1	In	IN	O	in	_	0	SENT_254	[p16l664t543r744b607],
2	another	DT	O	another	det	5	SENT_254	[p16l771t542r1052b608],
3	normal	JJ	O	normal	amod	4	SENT_254	[p16l1077t542r1337b608],
4	subject	JJ	O	subject	amod	5	SENT_254	[p16l1363t542r1616b630],
5	cohort	NN	O	cohort	pobj	1	SENT_254	[p16l1641t542r1898b622],
6	,	,	O	,	_	0	SENT_254	[p16l1641t542r1898b622],
7	plate626	NN	O	plate626	nn	8	SENT_254	[p16l1926t542r2138b631, p16l11t647r116b690],
8	Gladding	NNP	O	Gladding	appos	5	SENT_254	[p16l331t647r566b700],
9	et	FW	O	et	nn	10	SENT_254	[p16l585t649r636b690],
10	al.	FW	O	al.	dep	8	SENT_254	[p16l654t647r712b690],
11	.	.	O	.	_	0	SENT_254	[p16l654t647r712b690],

1	The	DT	O	the	det	4	SENT_255	[p16l328t730r423b772],
2	PRINC	NNP	O	PRINC	nn	4	SENT_255	[p16l447t729r612b772],
3	Trial	NNP	O	Trial	nn	4	SENT_255	[p16l631t730r742b772],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	nsubj	5	SENT_255	[p16l768t730r1261b782],
5	let	VBD	O	let	_	0	SENT_255	[p16l9t942r101b1008],
6	inhibition	NN	O	inhibition	dobj	5	SENT_255	[p16l141t942r508b1008],
7	after	IN	O	after	_	0	SENT_255	[p16l551t942r717b1008],
8	clopidogrel	NN	O	clopidogrel	prep_after	5	SENT_255	[p16l758t942r1170b1032],
9	75	CD	NUMBER	75	num	10	SENT_255	[p16l1212t942r1294b1009],
10	mg	NN	O	mg	npadvmod	11	SENT_255	[p16l1339t969r1453b1031],
11	daily	RB	SET	daily	advmod	5	SENT_255	[p16l1494t942r1670b1031],
12	for	IN	O	for	_	0	SENT_255	[p16l1707t942r1811b1008],
13	1	CD	DURATION	1	num	14	SENT_255	[p16l1855t946r1887b1007],
14	week	NN	NUMBER	week	prep_for	5	SENT_255	[p16l1930t942r2137b1023],
15	,	,	O	,	_	0	SENT_255	[p16l1930t942r2137b1023],
16	measured	VBN	O	measure	partmod	14	SENT_255	[p16l11t1049r359b1115],
17	by	IN	O	by	_	0	SENT_255	[p16l407t1049r495b1138],
18	20	CD	NUMBER	20	number	19	SENT_255	[p16l540t1053r628b1116],
19	p.	NN	O	p.	amod	23	SENT_255	[p16l683t1049r939b1133],
20	mol/l	NN	O	mol/l	nn	23	SENT_255	[p16l683t1049r939b1133],
21	adenosine	NN	O	adenosine	nn	23	SENT_255	[p16l990t1049r1352b1115],
22	diphosphate	NN	O	diphosphate	nn	23	SENT_255	[p16l1405t1049r1855b1139],
23	aggregometry	NN	O	aggregometry	agent	16	SENT_255	[p16l1909t1075r2138b1138, p16l9t1202r333b1274],
24	,	,	O	,	_	0	SENT_255	[p16l1909t1075r2138b1138, p16l9t1202r333b1274],

1	was	VBD	O	be	auxpass	3	SENT_256	[p16l381t1212r513b1252],
2	significantly	RB	O	significantly	advmod	3	SENT_256	[p16l564t1185r1012b1274],
3	reduced	VBN	O	reduce	_	0	SENT_256	[p16l1056t1185r1345b1251],
4	in	IN	O	in	_	0	SENT_256	[p16l1392t1188r1461b1251],
5	subjects	NNS	O	subject	prep_in	3	SENT_256	[p16l1511t1185r1794b1274],
6	carrying	VBG	O	carry	partmod	5	SENT_256	[p16l1845t1188r2142b1274],
7	the	DT	O	the	det	9	SENT_256	[p16l10t1290r124b1356],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_256	[p16l166t1293r594b1357],
9	”‘	NN	O	”‘	dobj	6	SENT_256	[p16l166t1293r594b1357],
10	2	CD	NUMBER	2	num	11	SENT_256	[p16l166t1293r594b1357],
11	allele	NN	O	allele	dep	9	SENT_256	[p16l629t1290r814b1356],
12	(	CD	NUMBER	(	number	13	SENT_256	[p16l853t1288r1019b1370],
13	10	CD	NUMBER	10	num	14	SENT_256	[p16l853t1288r1019b1370],
14	)	NN	O	)	dep	11	SENT_256	[p16l853t1288r1019b1370],
15	.	.	O	.	_	0	SENT_256	[p16l853t1288r1019b1370],

1	Brandt	NNP	PERSON	Brandt	dep	4	SENT_257	[p16l1058t1290r1314b1356],
2	et	FW	O	et	nn	4	SENT_257	[p16l1348t1307r1413b1356],
3	al.	FW	O	al.	nn	4	SENT_257	[p16l1447t1290r1525b1356],
4	(	FW	O	(	dep	7	SENT_257	[p16l1567t1288r1709b1370],
5	20	CD	NUMBER	20	num	6	SENT_257	[p16l1567t1288r1709b1370],
6	)	NN	O	)	nsubj	7	SENT_257	[p16l1567t1288r1709b1370],
7	found	VBD	O	find	_	0	SENT_257	[p16l1747t1290r1962b1356],
8	that	IN	O	that	_	0	SENT_257	[p16l1996t1290r2143b1356],
9	the	DT	O	the	det	11	SENT_257	[p16l10t1396r127b1462],
10	CYP2C9	NN	O	cyp2c9	nn	11	SENT_257	[p16l206t1399r600b1463],
11	*	NN	O	*	prep_that	7	SENT_257	[p16l206t1399r600b1463],
12	2	CD	NUMBER	2	number	15	SENT_257	[p16l206t1399r600b1463],
13	and	CC	O	and	_	0	SENT_257	[p16l671t1396r806b1462],
14	*	CD	NUMBER	*	num	16	SENT_257	[p16l881t1399r948b1462],
15	3	CD	NUMBER	3	num	16	SENT_257	[p16l881t1399r948b1462],
16	alleles	NNS	O	allele	dep	11	SENT_257	[p16l1019t1396r1273b1476],
17	,	,	O	,	_	0	SENT_257	[p16l1019t1396r1273b1476],
18	in	IN	O	in	_	0	SENT_257	[p16l1346t1399r1417b1461],
19	addition	NN	O	addition	_	0	SENT_257	[p16l1490t1396r1808b1462],
20	to	TO	O	to	_	0	SENT_257	[p16l1878t1413r1950b1462],
21	the	DT	O	the	det	25	SENT_257	[p16l2022t1396r2139b1462],
22	CYP2C	NN	O	cyp2c	nn	25	SENT_257	[p16l17t1505r445b1569],
23	]	CD	NUMBER	]	number	24	SENT_257	[p16l17t1505r445b1569],
24	9	CD	NUMBER	9	num	25	SENT_257	[p16l17t1505r445b1569],
25	*	NN	O	*	conj_in	11	SENT_257	[p16l17t1505r445b1569],
26	2	CD	NUMBER	2	num	27	SENT_257	[p16l17t1505r445b1569],
27	allele	NN	O	allele	dep	25	SENT_257	[p16l489t1502r696b1583],
28	,	,	O	,	_	0	SENT_257	[p16l489t1502r696b1583],
29	inﬂuence	NN	O	inﬂuence	conj_in	11	SENT_257	[p16l743t1502r1075b1568],
30	the	DT	O	the	det	32	SENT_257	[p16l1119t1502r1233b1568],
31	plasma	NN	O	plasma	nn	32	SENT_257	[p16l1276t1502r1531b1592],
32	levels	NNS	O	level	dep	29	SENT_257	[p16l1572t1502r1768b1569],
33	of	IN	O	of	_	0	SENT_257	[p16l1814t1502r1895b1568],
34	clopidogrel	NN	O	clopidogrel	nn	36	SENT_257	[p16l1928t1502r2138b1592, p16l11t1608r242b1697],
35	active	JJ	O	active	amod	36	SENT_257	[p16l307t1611r513b1675],
36	metabolite	NN	O	metabolite	prep_of	32	SENT_257	[p16l580t1608r968b1674],
37	as	IN	O	as	_	0	SENT_257	[p16l1035t1634r1100b1674],
38	Well	NNP	O	Well	prep_as	36	SENT_257	[p16l1163t1608r1314b1675],
39	as	IN	O	as	_	0	SENT_257	[p16l1379t1634r1444b1674],
40	the	DT	O	the	det	41	SENT_257	[p16l1510t1608r1624b1674],
41	response	NN	O	response	prep_as	7	SENT_257	[p16l1689t1634r2004b1698],
42	to	TO	O	to	_	0	SENT_257	[p16l2069t1625r2139b1674],
43	clopidogrel	NN	O	clopidogrel	prep_to	41	SENT_257	[p16l11t1715r442b1805],
44	.	.	O	.	_	0	SENT_257	[p16l11t1715r442b1805],

1	These	DT	O	these	det	2	SENT_258	[p16l477t1714r701b1781],
2	variants	NNS	O	variant	nsubj	3	SENT_258	[p16l731t1718r1017b1782],
3	are	VBP	O	be	_	0	SENT_258	[p16l1054t1741r1158b1781],
4	not	RB	O	not	neg	3	SENT_258	[p16l1194t1732r1314b1781],
5	in	IN	O	in	_	0	SENT_258	[p16l1346t1718r1415b1781],
6	linkage	NN	O	linkage	nn	7	SENT_258	[p16l1447t1715r1712b1804],
7	disequilibrium	NN	O	disequilibrium	prep_in	3	SENT_258	[p16l1747t1715r2138b1805, p16l10t1824r182b1887],
8	and	CC	O	and	cc	3	SENT_258	[p16l250t1821r402b1902],
9	,	,	O	,	_	0	SENT_258	[p16l250t1821r402b1902],
10	when	WRB	O	when	advmod	11	SENT_258	[p16l467t1821r666b1888],
11	considered	VBN	O	consider	advcl	15	SENT_258	[p16l733t1821r1128b1887],
12	together	RB	O	together	advmod	11	SENT_258	[p16l1192t1821r1521b1910],
13	,	,	O	,	_	0	SENT_258	[p16l1192t1821r1521b1910],
14	reportedly	RB	O	reportedly	advmod	15	SENT_258	[p16l1589t1821r1968b1911],
15	accounted	VBD	O	account	ccomp	3	SENT_258	[p16l2032t1847r2138b1887, p16l11t1927r304b1993],
16	for	IN	O	for	_	0	SENT_258	[p16l349t1927r453b1993],
17	two-thirds	NNS	O	two-third	prep_for	15	SENT_258	[p16l497t1927r886b1994],
18	of	IN	O	of	_	0	SENT_258	[p16l935t1927r1016b1993],
19	poor	JJ	O	poor	amod	20	SENT_258	[p16l1049t1953r1218b2017],
20	responders	NNS	O	responder	prep_of	17	SENT_258	[p16l1262t1927r1678b2017],
21	.	.	O	.	_	0	SENT_258	[p16l1262t1927r1678b2017],

1	The	DT	O	the	det	3	SENT_259	[p16l1725t1925r1876b1993],
2	thirdgeneration	NN	O	thirdgeneration	nn	3	SENT_259	[p16l1922t1927r2138b1993, p16l9t2037r401b2123],
3	thienopyridine	NN	O	thienopyridine	nsubj	24	SENT_259	[p16l432t2034r996b2124],
4	,	,	O	,	_	0	SENT_259	[p16l432t2034r996b2124],
5	prasugrel	NN	O	prasugrel	appos	3	SENT_259	[p16l1029t2034r1386b2124],
6	,	,	O	,	_	0	SENT_259	[p16l1029t2034r1386b2124],
7	is	VBZ	O	be	cop	24	SENT_259	[p16l1420t2037r1473b2100],
8	not	RB	O	not	neg	24	SENT_259	[p16l1506t2051r1627b2100],
9	as	IN	O	as	_	0	SENT_259	[p16l1658t2060r1722b2100],
10	dependent	JJ	O	dependent	amod	17	SENT_259	[p16l1756t2034r2143b2124],
11	on	IN	O	on	_	0	SENT_259	[p16l11t2167r101b2206],
12	either	CC	O	either	preconj	14	SENT_259	[p16l137t2140r350b2207],
13	the	DT	O	the	det	14	SENT_259	[p16l383t2140r497b2206],
14	CYPZC19	NN	O	cypzc19	prep_on	10	SENT_259	[p16l536t2140r918b2208],
15	or	CC	O	or	_	0	SENT_259	[p16l956t2166r1030b2206],
16	CYPZC9	NN	O	cypzc9	conj_or	14	SENT_259	[p16l1066t2140r1402b2208],
17	enzymes	NNS	O	enzyme	prep_as	8	SENT_259	[p16l1441t2166r1749b2229],
18	for	IN	O	for	_	0	SENT_259	[p16l1787t2140r1891b2206],
19	metabolic	JJ	O	metabolic	amod	20	SENT_259	[p16l1926t2157r2138b2206, p16l8t2245r187b2311],
20	activation	NN	O	activation	prep_for	17	SENT_259	[p16l224t2248r582b2311],
21	z	SYM	O	z	dep	17	SENT_259	[p16l621t2243r742b2325],
22	|	CD	NUMBER	|	num	24	SENT_259	[p16l621t2243r742b2325],
23	~	NN	O	~	nn	24	SENT_259	[p16l621t2243r742b2325],
24	b	NN	O	b	_	0	SENT_259	[p16l621t2243r742b2325],
25	+	CC	O	+	rcmod	24	SENT_259	[p16l621t2243r742b2325],

1	Patients	NNS	O	patient	nsubj	19	SENT_260	[p16l100t2352r384b2417],
2	given	VBN	O	give	partmod	1	SENT_260	[p16l416t2354r604b2440],
3	a	DT	O	a	det	4	SENT_260	[p16l638t2377r672b2417],
4	split	NN	O	split	iobj	2	SENT_260	[p16l705t2351r854b2441],
5	1,200	CD	NUMBER	1,200	number	6	SENT_260	[p16l888t2355r1234b2440],
6	—	CD	NUMBER	—	num	8	SENT_260	[p16l888t2355r1234b2440],
7	mg	NN	O	mg	nn	8	SENT_260	[p16l888t2355r1234b2440],
8	clopidogrel	NN	O	clopidogrel	dobj	2	SENT_260	[p16l1265t2351r1659b2441],
9	loading	VBG	O	load	partmod	8	SENT_260	[p16l1689t2351r1954b2440],
10	dose	NN	O	dose	dobj	9	SENT_260	[p16l1985t2351r2140b2417],
11	and	CC	O	and	_	0	SENT_260	[p16l12t2458r139b2524],
12	a	DT	O	a	det	15	SENT_260	[p16l166t2484r200b2524],
13	150	CD	NUMBER	150	number	14	SENT_260	[p16l228t2458r506b2547],
14	—	CD	NUMBER	—	num	15	SENT_260	[p16l228t2458r506b2547],
15	mg	NN	O	mg	dobj	9	SENT_260	[p16l228t2458r506b2547],
16	daily	JJ	SET	daily	amod	18	SENT_260	[p16l531t2458r700b2547],
17	maintenance	NN	O	maintenance	nn	18	SENT_260	[p16l723t2461r1171b2524],
18	dosage	NN	O	dosage	dep	15	SENT_260	[p16l1198t2458r1434b2547],
19	had	VBD	O	have	_	0	SENT_260	[p16l1461t2458r1590b2524],
20	greater	JJR	O	greater	amod	22	SENT_260	[p16l1614t2475r1859b2547],
21	platelet	NN	O	platelet	nn	22	SENT_260	[p16l1882t2458r2143b2548],
22	inhibition	NN	O	inhibition	dobj	19	SENT_260	[p16l10t2564r378b2630],
23	than	IN	O	than	_	0	SENT_260	[p16l419t2564r582b2630],
24	600	CD	NUMBER	600	num	25	SENT_260	[p16l625t2568r756b2631],
25	mg	NN	O	mg	prep_than	19	SENT_260	[p16l798t2590r913b2653],
26	and	CC	O	and	_	0	SENT_260	[p16l953t2564r1084b2630],
27	75	CD	NUMBER	75	num	28	SENT_260	[p16l1126t2564r1208b2631],
28	mg	NN	O	mg	prep_than	19	SENT_260	[p16l1254t2590r1387b2653],
29	,	,	O	,	_	0	SENT_260	[p16l1254t2590r1387b2653],
30	respectively	RB	O	respectively	advmod	19	SENT_260	[p16l1431t2564r1877b2654],
31	.	.	O	.	_	0	SENT_260	[p16l1431t2564r1877b2654],

1	Interestingly	RB	O	interestingly	advmod	11	SENT_261	[p16l1922t2565r2138b2630, p16l11t2671r314b2760],
2	,	,	O	,	_	0	SENT_261	[p16l1922t2565r2138b2630, p16l11t2671r314b2760],
3	the	DT	O	the	det	6	SENT_261	[p16l349t2671r462b2737],
4	higher	JJR	O	higher	amod	6	SENT_261	[p16l494t2671r733b2760],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_261	[p16l763t2671r1175b2761],
6	loading	NN	O	loading	nsubj	11	SENT_261	[p16l1205t2671r1480b2760],
7	and	CC	O	and	_	0	SENT_261	[p16l1511t2671r1642b2737],
8	maintenance	NN	O	maintenance	nn	10	SENT_261	[p16l1674t2674r2140b2737],
9	dose	NN	O	dose	nn	10	SENT_261	[p16l11t2806r170b2872],
10	regimens	NNS	O	regimen	conj_and	6	SENT_261	[p16l234t2809r561b2895],
11	achieved	VBD	O	achieve	_	0	SENT_261	[p16l628t2806r938b2873],
12	greater	JJR	O	greater	amod	14	SENT_261	[p16l1001t2823r1253b2895],
13	platelet	NN	O	platelet	nn	14	SENT_261	[p16l1314t2806r1583b2896],
14	inhibition	NN	O	inhibition	dobj	11	SENT_261	[p16l1645t2806r2007b2872],
15	in	IN	O	in	_	0	SENT_261	[p16l2071t2809r2140b2872],
16	CYPZCJ	NNP	O	CYPZCJ	nn	18	SENT_261	[p16l17t2915r311b2979],
17	9	CD	NUMBER	9	num	18	SENT_261	[p16l323t2915r431b2979],
18	*	NN	O	*	prep_in	11	SENT_261	[p16l323t2915r431b2979],
19	2	CD	NUMBER	2	number	22	SENT_261	[p16l323t2915r431b2979],
20	or	CC	O	or	_	0	SENT_261	[p16l456t2938r528b2978],
21	*	CD	NUMBER	*	num	23	SENT_261	[p16l556t2915r624b2977],
22	4	CD	NUMBER	4	num	23	SENT_261	[p16l556t2915r624b2977],
23	carriers	NNS	O	carrier	dep	11	SENT_261	[p16l645t2915r898b2978],
24	compared	VBN	O	compare	_	0	SENT_261	[p16l925t2912r1272b3002],
25	with	IN	O	with	prepc_compared_with	23	SENT_261	[p16l1292t2912r1454b2979],
26	inhibition	NN	O	inhibition	pobj	23	SENT_261	[p16l1479t2912r1830b2978],
27	in	IN	O	in	_	0	SENT_261	[p16l1855t2915r1923b2978],
28	lower	JJR	O	lower	amod	30	SENT_261	[p16l1946t2912r2142b2979],
29	dose	NN	O	dose	nn	30	SENT_261	[p16l11t3019r166b3085],
30	regimens	NNS	O	regimen	prep_in	26	SENT_261	[p16l196t3022r535b3108],
31	,	,	O	,	_	0	SENT_261	[p16l196t3022r535b3108],
32	whereas	IN	O	whereas	mark	40	SENT_261	[p16l564t3019r847b3086],
33	a	DT	O	a	det	35	SENT_261	[p16l878t3045r913b3085],
34	dose	NN	O	dose	nn	35	SENT_261	[p16l941t3019r1510b3109],
35	—	NN	O	—	npadvmod	36	SENT_261	[p16l941t3019r1510b3109],
36	dependent	JJ	O	dependent	amod	37	SENT_261	[p16l941t3019r1510b3109],
37	response	NN	O	response	nsubjpass	40	SENT_261	[p16l1536t3045r1839b3109],
38	was	VBD	O	be	auxpass	40	SENT_261	[p16l1865t3045r1994b3086],
39	not	RB	O	not	neg	40	SENT_261	[p16l2025t3036r2143b3085],
40	observed	VBN	O	observe	advcl	11	SENT_261	[p16l11t3125r320b3191],
41	in	IN	O	in	_	0	SENT_261	[p16l362t3128r430b3190],
42	CYPZCJ	NNP	ORGANIZATION	CYPZCJ	nn	44	SENT_261	[p16l480t3128r774b3192],
43	9	CD	NUMBER	9	num	44	SENT_261	[p16l785t3128r890b3191],
44	*	NN	O	*	prep_in	40	SENT_261	[p16l785t3128r890b3191],
45	]	CD	NUMBER	]	num	46	SENT_261	[p16l785t3128r890b3191],
46	*	NN	O	*	tmod	40	SENT_261	[p16l902t3128r961b3190],
47	1	CD	NUMBER	1	num	48	SENT_261	[p16l902t3128r961b3190],
48	carriers	NNS	O	carrier	dep	46	SENT_261	[p16l1008t3128r1281b3191],
49	.	.	O	.	_	0	SENT_261	[p16l1008t3128r1281b3191],

1	In	IN	O	in	_	0	SENT_262	[p16l1328t3126r1406b3190],
2	other	JJ	O	other	amod	3	SENT_262	[p16l1450t3125r1636b3191],
3	words	NNS	O	word	prep_in	14	SENT_262	[p16l1674t3125r1908b3206],
4	,	,	O	,	_	0	SENT_262	[p16l1674t3125r1908b3206],
5	those	DT	O	those	nsubj	14	SENT_262	[p16l1954t3125r2140b3191],
6	with	IN	O	with	_	0	SENT_262	[p17l7t20r168b87],
7	the	DT	O	the	det	11	SENT_262	[p17l214t20r323b86],
8	poor	JJ	O	poor	amod	11	SENT_262	[p17l368t46r872b110],
9	—	NN	O	—	nn	11	SENT_262	[p17l368t46r872b110],
10	response	NN	O	response	nn	11	SENT_262	[p17l368t46r872b110],
11	genotype	NN	O	genotype	prep_with	5	SENT_262	[p17l918t37r1238b110],
12	may	MD	O	may	aux	14	SENT_262	[p17l1285t46r1433b109],
13	speciﬁcally	RB	O	speciﬁcally	advmod	14	SENT_262	[p17l1476t20r1858b110],
14	beneﬁt	VB	O	beneﬁt	_	0	SENT_262	[p17l1898t20r2143b86],
15	from	IN	O	from	_	0	SENT_262	[p17l10t126r180b192],
16	a	DT	O	a	det	18	SENT_262	[p17l207t152r242b192],
17	higher	JJR	O	higher	amod	18	SENT_262	[p17l266t126r495b215],
18	dose	NN	O	dose	prep_from	14	SENT_262	[p17l520t126r675b192],
19	of	IN	O	of	_	0	SENT_262	[p17l701t126r782b192],
20	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_262	[p17l796t126r1207b216],
21	.	.	O	.	_	0	SENT_262	[p17l796t126r1207b216],

1	However	RB	O	however	advmod	9	SENT_263	[p17l1238t127r1578b207],
2	,	,	O	,	_	0	SENT_263	[p17l1238t127r1578b207],
3	the	DT	O	the	det	4	SENT_263	[p17l1607t126r1717b192],
4	numbers	NNS	O	number	nsubj	9	SENT_263	[p17l1744t126r2046b192],
5	in	IN	O	in	_	0	SENT_263	[p17l2073t129r2141b192],
6	this	DT	O	this	det	7	SENT_263	[p17l10t232r137b298],
7	study	NN	O	study	prep_in	4	SENT_263	[p17l165t232r353b321],
8	are	VBP	O	be	cop	9	SENT_263	[p17l375t258r475b298],
9	small	JJ	O	small	_	0	SENT_263	[p17l502t232r685b298],
10	and	CC	O	and	_	0	SENT_263	[p17l710t232r837b298],
11	this	DT	O	this	det	12	SENT_263	[p17l860t232r986b298],
12	ﬁnding	NN	O	ﬁnding	nsubj	13	SENT_263	[p17l1012t232r1267b321],
13	requires	VBZ	O	require	conj_and	9	SENT_263	[p17l1289t235r1566b322],
14	confirmation	NN	O	confirmation	dobj	13	SENT_263	[p17l1593t232r2049b298],
15	in	IN	O	in	_	0	SENT_263	[p17l2073t235r2141b298],
16	a	DT	O	a	det	19	SENT_263	[p17l12t365r47b405],
17	dose	NN	O	dose	nn	19	SENT_263	[p17l79t339r234b405],
18	escalation	NN	O	escalation	nn	19	SENT_263	[p17l268t339r613b405],
19	study	NN	O	study	prep_in	14	SENT_263	[p17l647t339r836b428],
20	with	IN	O	with	_	0	SENT_263	[p17l862t339r1023b406],
21	larger	JJR	O	larger	amod	23	SENT_263	[p17l1054t339r1256b428],
22	patient	NN	O	patient	nn	23	SENT_263	[p17l1287t342r1536b429],
23	numbers	NNS	O	number	prep_with	13	SENT_263	[p17l1567t339r1890b405],
24	.	.	O	.	_	0	SENT_263	[p17l1567t339r1890b405],

1	The	DT	O	the	det	5	SENT_264	[p17l96t444r243b511],
2	CYP2C19	NN	O	cyp2c19	nn	5	SENT_264	[p17l287t448r700b512],
3	*	NN	O	*	nn	5	SENT_264	[p17l287t448r700b512],
4	2	CD	NUMBER	2	num	5	SENT_264	[p17l287t448r700b512],
5	allele	NN	O	allele	nsubj	7	SENT_264	[p17l737t445r914b511],
6	is	VBZ	O	be	cop	7	SENT_264	[p17l950t448r1000b511],
7	present	JJ	DATE	present	_	0	SENT_264	[p17l1037t462r1296b535],
8	in	IN	O	in	_	0	SENT_264	[p17l1330t448r1397b511],
9	13	CD	PERCENT	13	num	10	SENT_264	[p17l1438t449r1585b512],
10	%	NN	PERCENT	%	prep_in	7	SENT_264	[p17l1438t449r1585b512],
11	of	IN	O	of	_	0	SENT_264	[p17l1622t445r1702b511],
12	Caucasians	NNPS	MISC	Caucasians	prep_of	10	SENT_264	[p17l1727t445r2138b526],
13	,	,	O	,	_	0	SENT_264	[p17l1727t445r2138b526],
14	18	CD	PERCENT	18	num	15	SENT_264	[p17l15t554r163b616],
15	%	NN	PERCENT	%	appos	12	SENT_264	[p17l15t554r163b616],
16	of	IN	O	of	_	0	SENT_264	[p17l201t550r280b616],
17	African	JJ	MISC	african	amod	18	SENT_264	[p17l303t549r572b616],
18	Americans	NNPS	MISC	Americans	prep_of	15	SENT_264	[p17l606t549r1008b631],
19	,	,	O	,	_	0	SENT_264	[p17l606t549r1008b631],
20	and	CC	O	and	_	0	SENT_264	[p17l1050t550r1177b616],
21	29	CD	PERCENT	29	num	22	SENT_264	[p17l1212t554r1366b617],
22	%	NN	PERCENT	%	conj_and	7	SENT_264	[p17l1212t554r1366b617],
23	of	IN	O	of	_	0	SENT_264	[p17l1404t550r1484b616],
24	East	NNP	MISC	East	nn	25	SENT_264	[p17l1511t551r1667b616],
25	Asians	NNPS	MISC	Asians	prep_of	22	SENT_264	[p17l1699t549r1935b616],
26	(	CD	NUMBER	(	number	27	SENT_264	[p17l1977t548r2136b630],
27	29	CD	NUMBER	29	num	28	SENT_264	[p17l1977t548r2136b630],
28	)	NN	O	)	dep	7	SENT_264	[p17l1977t548r2136b630],
29	.	.	O	.	_	0	SENT_264	[p17l1977t548r2136b630],

1	The	DT	O	the	det	3	SENT_265	[p17l8t655r154b722],
2	higher	JJR	O	higher	amod	3	SENT_265	[p17l190t656r420b745],
3	frequency	NN	O	frequency	nsubj	12	SENT_265	[p17l453t656r800b746],
4	of	IN	O	of	_	0	SENT_265	[p17l831t656r912b722],
5	the	DT	O	the	det	9	SENT_265	[p17l934t656r1044b722],
6	CYP2C19	NN	O	cyp2c19	nn	9	SENT_265	[p17l1087t659r1501b723],
7	*	NN	O	*	nn	9	SENT_265	[p17l1087t659r1501b723],
8	2	CD	NUMBER	2	num	9	SENT_265	[p17l1087t659r1501b723],
9	allele	NN	O	allele	prep_of	3	SENT_265	[p17l1536t656r1713b723],
10	in	IN	O	in	_	0	SENT_265	[p17l1749t659r1816b722],
11	Chinese	JJ	MISC	chinese	prep_in	9	SENT_265	[p17l1853t656r2140b723],
12	suggests	VBZ	O	suggest	_	0	SENT_265	[p17l12t779r298b851],
13	that	IN	O	that	complm	18	SENT_265	[p17l330t762r471b828],
14	there	EX	O	there	expl	18	SENT_265	[p17l500t762r678b828],
15	may	MD	O	may	aux	18	SENT_265	[p17l711t788r858b851],
16	be	VB	O	be	cop	18	SENT_265	[p17l883t762r964b828],
17	ethnic	JJ	O	ethnic	amod	18	SENT_265	[p17l996t762r1214b828],
18	differences	NNS	O	difference	ccomp	12	SENT_265	[p17l1245t762r1616b828],
19	in	IN	O	in	_	0	SENT_265	[p17l1648t765r1716b828],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_265	[p17l1747t762r2142b852],
21	response	NN	O	response	prep_in	18	SENT_265	[p17l10t895r332b959],
22	.	.	O	.	_	0	SENT_265	[p17l10t895r332b959],

1	Although	IN	O	although	mark	18	SENT_266	[p17l363t868r708b958],
2	an	DT	O	a	det	5	SENT_266	[p17l739t896r819b935],
3	ethnicity-based	JJ	O	ethnicity-based	amod	5	SENT_266	[p17l849t869r1393b958],
4	treatment	NN	O	treatment	nn	5	SENT_266	[p17l1421t886r1768b935],
5	approach	NN	O	approach	nsubj	18	SENT_266	[p17l1797t869r2138b959],
6	,	,	O	,	_	0	SENT_266	[p17l1797t869r2138b959],
7	such	JJ	O	such	_	0	SENT_266	[p17l12t975r168b1041],
8	as	IN	O	as	_	0	SENT_266	[p17l195t1002r258b1041],
9	targeting	VBG	O	target	prepc_such_as	5	SENT_266	[p17l285t978r604b1064],
10	the	DT	O	the	det	13	SENT_266	[p17l628t975r738b1041],
11	antihypertensive	JJ	O	antihypertensive	amod	13	SENT_266	[p17l766t975r1343b1065],
12	drug	NN	O	drug	nn	13	SENT_266	[p17l1371t975r1533b1064],
13	BiDil	NNP	MISC	BiDil	dobj	9	SENT_266	[p17l1557t975r1755b1041],
14	to	TO	MISC	to	_	0	SENT_266	[p17l1780t992r1848b1041],
15	African	NNP	MISC	African	nn	16	SENT_266	[p17l1872t974r2141b1041],
16	Americans	NNPS	MISC	Americans	prep_to	9	SENT_266	[p17l8t1080r409b1162],
17	,	,	O	,	_	0	SENT_266	[p17l8t1080r409b1162],
18	has	VBZ	O	have	advcl	38	SENT_266	[p17l457t1081r569b1147],
19	yet	RB	O	yet	advmod	18	SENT_266	[p17l612t1098r719b1170],
20	to	TO	O	to	aux	23	SENT_266	[p17l761t1098r829b1147],
21	be	VB	O	be	auxpass	23	SENT_266	[p17l872t1081r953b1147],
22	widely	RB	O	widely	advmod	23	SENT_266	[p17l994t1081r1229b1170],
23	accepted	VBN	O	accept	xcomp	18	SENT_266	[p17l1271t1081r1574b1171],
24	(	CD	NUMBER	(	number	25	SENT_266	[p17l1620t1079r1781b1162],
25	30	CD	NUMBER	30	num	26	SENT_266	[p17l1620t1079r1781b1162],
26	)	NN	O	)	dobj	23	SENT_266	[p17l1620t1079r1781b1162],
27	,	,	O	,	_	0	SENT_266	[p17l1620t1079r1781b1162],
28	potential	JJ	O	potential	amod	29	SENT_266	[p17l1827t1081r2142b1171],
29	differences	NNS	O	difference	nsubjpass	38	SENT_266	[p17l11t1188r382b1254],
30	among	IN	O	among	_	0	SENT_266	[p17l412t1214r653b1277],
31	ethnic	JJ	O	ethnic	amod	32	SENT_266	[p17l679t1188r898b1254],
32	groups	NNS	O	group	prep_among	29	SENT_266	[p17l922t1214r1158b1278],
33	in	IN	O	in	_	0	SENT_266	[p17l1187t1191r1255b1254],
34	drug	NN	O	drug	nn	35	SENT_266	[p17l1283t1188r1445b1277],
35	response	NN	O	response	prep_in	32	SENT_266	[p17l1470t1214r1772b1278],
36	should	MD	O	should	aux	38	SENT_266	[p17l1802t1188r2035b1254],
37	be	VB	O	be	auxpass	38	SENT_266	[p17l2060t1188r2140b1254],
38	considered	VBN	O	consider	_	0	SENT_266	[p17l11t1294r390b1360],
39	when	WRB	O	when	advmod	40	SENT_266	[p17l419t1294r613b1361],
40	evaluating	VBG	O	evaluate	advcl	38	SENT_266	[p17l647t1294r1007b1383],
41	trial	NN	O	trial	nn	42	SENT_266	[p17l1038t1294r1179b1360],
42	data	NNS	O	datum	dobj	40	SENT_266	[p17l1212t1294r1376b1360],
43	.	.	O	.	_	0	SENT_266	[p17l1212t1294r1376b1360],

1	Drugs	NNS	O	drug	nsubj	13	SENT_267	[p17l100t1401r316b1489],
2	that	WDT	O	that	nsubjpass	5	SENT_267	[p17l355t1400r496b1466],
3	are	VBP	O	be	auxpass	5	SENT_267	[p17l533t1426r633b1466],
4	competitively	RB	O	competitively	advmod	5	SENT_267	[p17l671t1400r1149b1490],
5	metabolized	VBN	O	metabolize	rcmod	1	SENT_267	[p17l1182t1400r1613b1466],
6	or	CC	O	or	_	0	SENT_267	[p17l1650t1426r1722b1466],
7	inhibit	VB	O	inhibit	rcmod	1	SENT_267	[p17l1757t1400r1995b1466],
8	the	DT	O	the	det	9	SENT_267	[p17l2030t1400r2140b1466],
9	activity	NN	O	activity	dobj	7	SENT_267	[p17l12t1509r267b1595],
10	of	IN	O	of	_	0	SENT_267	[p17l298t1506r378b1572],
11	CYPZC19	NN	O	cypzc19	prep_of	9	SENT_267	[p17l402t1506r773b1573],
12	also	RB	O	also	advmod	13	SENT_267	[p17l811t1506r941b1572],
13	have	VBP	O	have	_	0	SENT_267	[p17l977t1506r1135b1573],
14	the	DT	O	the	det	15	SENT_267	[p17l1170t1506r1280b1572],
15	potential	JJ	O	potential	dobj	13	SENT_267	[p17l1313t1506r1629b1596],
16	to	TO	O	to	aux	17	SENT_267	[p17l1661t1523r1730b1572],
17	reduce	VB	O	reduce	dep	15	SENT_267	[p17l1765t1506r1995b1572],
18	the	DT	O	the	det	19	SENT_267	[p17l2029t1506r2139b1572],
19	activity	NN	O	activity	dobj	17	SENT_267	[p17l12t1616r267b1702],
20	of	IN	O	of	_	0	SENT_267	[p17l306t1613r386b1679],
21	clopidogrel	NN	O	clopidogrel	prep_of	19	SENT_267	[p17l417t1613r828b1703],
22	.	.	O	.	_	0	SENT_267	[p17l417t1613r828b1703],

1	This	DT	O	this	det	3	SENT_268	[p17l872t1612r1036b1679],
2	drug	NN	O	drug	nn	3	SENT_268	[p17l1081t1613r1243b1702],
3	interaction	NN	O	interaction	nsubj	17	SENT_268	[p17l1283t1616r1666b1679],
4	has	VBZ	O	have	aux	7	SENT_268	[p17l1708t1613r1820b1679],
5	recently	RB	DATE	recently	advmod	7	SENT_268	[p17l1864t1613r2145b1702],
6	been	VBN	O	be	auxpass	7	SENT_268	[p17l8t1719r175b1785],
7	shown	VBN	O	show	_	0	SENT_268	[p17l208t1719r435b1786],
8	with	IN	O	with	_	0	SENT_268	[p17l463t1719r624b1786],
9	omeprazole	NN	O	omeprazole	prep_with	7	SENT_268	[p17l656t1719r1063b1809],
10	(	CD	NUMBER	(	number	11	SENT_268	[p17l1098t1717r1459b1800],
11	10,31,32	CD	NUMBER	10,31,32	num	12	SENT_268	[p17l1098t1717r1459b1800],
12	)	NN	O	)	dep	7	SENT_268	[p17l1098t1717r1459b1800],
13	and	CC	O	and	_	0	SENT_268	[p17l1495t1719r1622b1785],
14	may	MD	O	may	aux	17	SENT_268	[p17l1654t1746r1802b1808],
15	theoretically	RB	O	theoretically	advmod	17	SENT_268	[p17l1829t1719r2138b1785, p17l11t1825r170b1914],
16	also	RB	O	also	advmod	17	SENT_268	[p17l198t1825r328b1891],
17	occur	VB	O	occur	conj_and	7	SENT_268	[p17l361t1851r551b1891],
18	with	IN	O	with	_	0	SENT_268	[p17l577t1825r738b1892],
19	phenytoin	NN	O	phenytoin	prep_with	17	SENT_268	[p17l767t1825r1126b1915],
20	and	CC	O	and	_	0	SENT_268	[p17l1159t1825r1286b1891],
21	ﬂuoxetine	NN	O	ﬂuoxetine	conj_and	19	SENT_268	[p17l1316t1825r1682b1891],
22	.	.	O	.	_	0	SENT_268	[p17l1316t1825r1682b1891],

1	The	DT	O	the	det	3	SENT_269	[p17l1714t1824r1862b1891],
2	clinical	JJ	O	clinical	amod	3	SENT_269	[p17l1894t1825r2142b1891],
3	significance	NN	O	significance	nsubj	8	SENT_269	[p17l12t1931r421b2020],
4	of	IN	O	of	_	0	SENT_269	[p17l455t1931r535b1997],
5	this	DT	O	this	det	6	SENT_269	[p17l555t1931r682b1997],
6	interaction	NN	O	interaction	prep_of	3	SENT_269	[p17l717t1934r1099b1997],
7	remains	VBZ	O	remain	cop	8	SENT_269	[p17l1132t1934r1408b1997],
8	uncertain	JJ	O	uncertain	_	0	SENT_269	[p17l1441t1934r1791b1997],
9	.	.	O	.	_	0	SENT_269	[p17l1441t1934r1791b1997],

1	Study	NNP	O	Study	_	0	SENT_270	[p17l12t2045r210b2120],
2	limitations	NNS	O	limitation	dep	1	SENT_270	[p17l244t2045r626b2103],
3	.	.	O	.	_	0	SENT_270	[p17l244t2045r626b2103],

1	The	DT	O	the	det	3	SENT_271	[p17l672t2035r819b2104],
2	major	JJ	O	major	amod	3	SENT_271	[p17l853t2039r1056b2126],
3	limitation	NN	O	limitation	nsubj	10	SENT_271	[p17l1085t2037r1434b2104],
4	of	IN	O	of	_	0	SENT_271	[p17l1467t2037r1547b2103],
5	this	DT	O	this	det	6	SENT_271	[p17l1567t2037r1694b2104],
6	study	NN	O	study	prep_of	3	SENT_271	[p17l1729t2037r1918b2126],
7	is	VBZ	O	be	cop	10	SENT_271	[p17l1946t2040r1996b2104],
8	the	DT	O	the	det	10	SENT_271	[p17l2030t2037r2140b2104],
9	population	NN	O	population	nn	10	SENT_271	[p17l9t2143r392b2233],
10	size	NN	O	size	_	0	SENT_271	[p17l423t2146r570b2224],
11	,	,	O	,	_	0	SENT_271	[p17l423t2146r570b2224],
12	which	WDT	O	which	nsubj	14	SENT_271	[p17l599t2143r816b2210],
13	particularly	RB	O	particularly	advmod	14	SENT_271	[p17l845t2143r1246b2233],
14	affects	VBZ	O	affect	rcmod	10	SENT_271	[p17l1274t2143r1487b2209],
15	assessment	NN	O	assessment	dobj	14	SENT_271	[p17l1519t2160r1904b2209],
16	of	IN	O	of	_	0	SENT_271	[p17l1933t2143r2012b2209],
17	the	DT	O	the	det	18	SENT_271	[p17l2030t2143r2140b2209],
18	inﬂuence	NN	O	inﬂuence	prep_of	15	SENT_271	[p17l10t2250r330b2316],
19	of	IN	O	of	_	0	SENT_271	[p17l358t2250r438b2316],
20	the	DT	O	the	det	23	SENT_271	[p17l452t2250r562b2316],
21	less	JJR	O	less	amod	23	SENT_271	[p17l588t2250r708b2316],
22	common	JJ	O	common	amod	23	SENT_271	[p17l737t2277r1048b2316],
23	genotypes	NNS	O	genotype	prep_of	18	SENT_271	[p17l1073t2267r1444b2340],
24	.	.	O	.	_	0	SENT_271	[p17l1073t2267r1444b2340],

1	As	IN	O	as	mark	3	SENT_272	[p17l1472t2249r1568b2316],
2	there	EX	O	there	expl	3	SENT_272	[p17l1595t2250r1774b2316],
3	were	VBD	O	be	advcl	40	SENT_272	[p17l1797t2276r1964b2317],
4	only	RB	O	only	quantmod	5	SENT_272	[p17l1992t2250r2144b2339],
5	2	CD	NUMBER	2	num	6	SENT_272	[p17l9t2360r50b2424],
6	subjects	NNS	O	subject	nsubj	3	SENT_272	[p17l81t2356r352b2445],
7	with	IN	O	with	_	0	SENT_272	[p17l377t2356r539b2423],
8	compound	NN	O	compound	nn	9	SENT_272	[p17l567t2356r945b2446],
9	heterozygosity	NN	O	heterozygosity	prep_with	3	SENT_272	[p17l971t2356r1486b2445],
10	for	IN	O	for	_	0	SENT_272	[p17l1510t2356r1610b2422],
11	CYP2	NN	O	cyp2	nn	12	SENT_272	[p17l1643t2359r1837b2423],
12	C1	NN	O	c1	prep_for	9	SENT_272	[p17l1847t2359r1938b2423],
13	9	CD	NUMBER	9	num	12	SENT_272	[p17l1948t2363r1987b2423],
14	and	CC	O	and	_	0	SENT_272	[p17l2014t2356r2141b2422],
15	CYPZC9	NN	O	cypzc9	conj_and	9	SENT_272	[p17l17t2466r317b2530],
16	with	IN	O	with	_	0	SENT_272	[p17l336t2463r497b2530],
17	a	DT	O	a	det	19	SENT_272	[p17l524t2489r558b2529],
18	poor	JJ	O	poor	amod	19	SENT_272	[p17l581t2489r744b2553],
19	response	NN	O	response	prep_with	15	SENT_272	[p17l768t2489r1070b2553],
20	to	TO	O	to	_	0	SENT_272	[p17l1096t2480r1164b2529],
21	clopidogrel	NN	O	clopidogrel	prep_to	19	SENT_272	[p17l1191t2463r1604b2553],
22	,	,	O	,	_	0	SENT_272	[p17l1191t2463r1604b2553],
23	the	DT	O	the	det	24	SENT_272	[p17l1632t2463r1742b2529],
24	suggestion	NN	O	suggestion	nsubj	40	SENT_272	[p17l1769t2466r2140b2552],
25	that	IN	O	that	complm	33	SENT_272	[p17l10t2601r151b2667],
26	a	DT	O	a	det	27	SENT_272	[p17l181t2627r215b2667],
27	combination	NN	O	combination	nsubj	33	SENT_272	[p17l246t2601r691b2667],
28	of	IN	O	of	_	0	SENT_272	[p17l722t2601r802b2667],
29	genotypes	NNS	O	genotype	prep_of	27	SENT_272	[p17l819t2618r1169b2691],
30	may	MD	O	may	aux	33	SENT_272	[p17l1202t2627r1350b2690],
31	be	VB	O	be	cop	33	SENT_272	[p17l1374t2601r1455b2667],
32	more	RBR	O	more	advmod	33	SENT_272	[p17l1486t2627r1666b2667],
33	predictive	JJ	O	predictive	dep	24	SENT_272	[p17l1695t2601r2041b2691],
34	of	IN	O	of	_	0	SENT_272	[p17l2073t2601r2153b2667],
35	clopidogrel	NN	O	clopidogrel	nn	36	SENT_272	[p17l11t2738r406b2828],
36	response	NN	O	response	prep_of	33	SENT_272	[p17l437t2764r739b2828],
37	than	IN	O	than	_	0	SENT_272	[p17l773t2738r931b2804],
38	1	CD	NUMBER	1	num	39	SENT_272	[p17l968t2742r999b2804],
39	genotype	NN	O	genotype	prep_than	33	SENT_272	[p17l1036t2755r1356b2828],
40	remains	VBZ	O	remain	_	0	SENT_272	[p17l1389t2741r1665b2804],
41	a	DT	O	a	det	42	SENT_272	[p17l1701t2764r1735b2804],
42	hypothesis	NN	O	hypothesis	attr	40	SENT_272	[p17l1766t2738r2138b2828],
43	with	IN	O	with	_	0	SENT_272	[p17l7t2874r168b2941],
44	initial	JJ	O	initial	amod	46	SENT_272	[p17l199t2874r404b2940],
45	supportive	JJ	O	supportive	amod	46	SENT_272	[p17l435t2877r801b2964],
46	data	NNS	O	datum	prep_with	42	SENT_272	[p17l833t2874r997b2940],
47	.	.	O	.	_	0	SENT_272	[p17l833t2874r997b2940],

1	A	DT	O	a	det	3	SENT_273	[p17l1030t2873r1097b2940],
2	recent	JJ	O	recent	amod	3	SENT_273	[p17l1126t2891r1343b2940],
3	study	NN	O	study	nsubj	5	SENT_273	[p17l1373t2874r1562b2963],
4	has	VBZ	O	have	aux	5	SENT_273	[p17l1589t2874r1701b2940],
5	suggested	VBN	O	suggest	_	0	SENT_273	[p17l1736t2874r2076b2963],
6	a	DT	O	a	det	10	SENT_273	[p17l2108t2901r2142b2940],
7	gene	NN	O	gene	nn	10	SENT_273	[p17l9t3006r374b3069],
8	—	NN	O	—	nn	10	SENT_273	[p17l9t3006r374b3069],
9	gene	NN	O	gene	nn	10	SENT_273	[p17l9t3006r374b3069],
10	interaction	NN	O	interaction	dobj	5	SENT_273	[p17l399t2983r781b3046],
11	between	IN	O	between	_	0	SENT_273	[p17l803t2980r1096b3047],
12	the	DT	O	the	det	14	SENT_273	[p17l1120t2980r1230b3046],
13	PZYJZ	NNP	O	PZYJZ	nn	14	SENT_273	[p17l1254t2984r1486b3047],
14	haplotype	NN	O	haplotype	prep_between	10	SENT_273	[p17l1509t2980r1854b3070],
15	and	CC	O	and	_	0	SENT_273	[p17l1880t2980r2007b3046],
16	the	DT	O	the	det	21	SENT_273	[p17l2030t2980r2140b3046],
17	CYP2C19	NN	O	cyp2c19	nn	21	SENT_273	[p17l17t3089r431b3153],
18	*	NN	O	*	nn	21	SENT_273	[p17l17t3089r431b3153],
19	2	CD	NUMBER	2	num	21	SENT_273	[p17l17t3089r431b3153],
20	variant	JJ	O	variant	amod	21	SENT_273	[p17l483t3089r729b3153],
21	(	NN	O	(	conj_and	10	SENT_273	[p17l786t3084r946b3167],
22	33	CD	NUMBER	33	num	23	SENT_273	[p17l786t3084r946b3167],
23	)	NN	O	)	dep	21	SENT_273	[p17l786t3084r946b3167],
24	.	.	O	.	_	0	SENT_273	[p17l786t3084r946b3167],

1	Although	IN	O	although	mark	9	SENT_274	[p17l1004t3085r1348b3175],
2	a	DT	O	a	det	4	SENT_274	[p17l1405t3113r1440b3152],
3	poor	JJ	O	poor	amod	4	SENT_274	[p17l1494t3112r1657b3176],
4	response	NN	O	response	nsubjpass	9	SENT_274	[p17l1712t3112r2014b3176],
5	to	TO	O	to	_	0	SENT_274	[p17l2071t3103r2139b3152],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_274	[p17l11t3193r406b3283],
7	has	VBZ	O	have	aux	9	SENT_274	[p17l433t3193r546b3259],
8	been	VBN	O	be	auxpass	9	SENT_274	[p17l573t3193r740b3259],
9	associated	VBN	O	associate	advcl	25	SENT_274	[p17l770t3193r1122b3259],
10	with	IN	O	with	_	0	SENT_274	[p17l1146t3193r1307b3260],
11	an	DT	O	a	det	12	SENT_274	[p17l1337t3219r1418b3259],
12	increase	NN	O	increase	prep_with	9	SENT_274	[p17l1446t3196r1725b3259],
13	in	IN	O	in	_	0	SENT_274	[p17l1754t3196r1822b3259],
14	peripro	NN	O	peripro	nn	17	SENT_274	[p17l1849t3196r2138b3283],
15	—	NN	O	—	nn	17	SENT_274	[p17l1849t3196r2138b3283],
16	cedural	JJ	O	cedural	amod	17	SENT_274	[p17l11t3299r265b3366],
17	myonecrosis	NN	O	myonecrosis	prep_in	12	SENT_274	[p17l317t3302r749b3388],
18	during	IN	O	during	_	0	SENT_274	[p17l804t3299r1037b3388],
19	PCI	NNP	O	PCI	prep_during	9	SENT_274	[p17l1088t3299r1236b3366],
20	(	CD	NUMBER	(	num	19	SENT_274	[p17l1293t3297r1454b3380],
21	34	CD	NUMBER	34	num	22	SENT_274	[p17l1293t3297r1454b3380],
22	)	NN	O	)	dep	19	SENT_274	[p17l1293t3297r1454b3380],
23	,	,	O	,	_	0	SENT_274	[p17l1293t3297r1454b3380],
24	it	PRP	O	it	nsubj	25	SENT_274	[p17l1509t3302r1559b3366],
25	remains	VBZ	O	remain	_	0	SENT_274	[p17l1610t3302r1885b3366],
26	to	TO	O	to	aux	28	SENT_274	[p17l1939t3316r2007b3366],
27	be	VB	O	be	auxpass	28	SENT_274	[p17l2059t3299r2139b3366],
28	shown	VBN	O	show	xcomp	25	SENT_274	[p17l12t3406r239b3473],
29	whether	IN	O	whether	complm	33	SENT_274	[p17l280t3406r573b3473],
30	these	DT	O	these	det	31	SENT_274	[p17l616t3406r795b3472],
31	genotypes	NNS	O	genotype	nsubj	33	SENT_274	[p17l840t3423r1191b3496],
32	will	MD	O	will	aux	33	SENT_274	[p17l1233t3406r1365b3473],
33	predict	VB	O	predict	ccomp	28	SENT_274	[p17l1407t3406r1656b3496],
34	those	DT	O	those	dobj	33	SENT_274	[p17l1698t3406r1884b3472],
35	at	IN	O	at	_	0	SENT_274	[p17l1931t3423r1994b3472],
36	increased	VBN	O	increase	amod	37	SENT_274	[p17l2038t3409r2138b3472, p17l11t3512r266b3578],
37	risk	NN	O	risk	prep_at	33	SENT_274	[p17l317t3512r448b3578],
38	for	IN	O	for	_	0	SENT_274	[p17l495t3512r596b3578],
39	vascular	JJ	O	vascular	amod	41	SENT_274	[p17l642t3512r924b3579],
40	atherothrombotic	JJ	O	atherothrombotic	amod	41	SENT_274	[p17l976t3512r1599b3578],
41	complications	NNS	O	complication	prep_for	37	SENT_274	[p17l1650t3512r2138b3602],

1	JACC	NN	O	jacc	_	0	SENT_275	[p17l350t3762r500b3793],
2	:	:	O	:	_	0	SENT_275	[p17l350t3762r500b3793],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_275	[p17l537t3762r1036b3793],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_275	[p17l1074t3762r1533b3798],
5	,	,	O	,	_	0	SENT_275	[p17l1074t3762r1533b3798],
6	VOL	NNP	O	VOL	appos	4	SENT_275	[p17l1569t3762r1692b3793],
7	.	.	O	.	_	0	SENT_275	[p17l1569t3762r1692b3793],

1	1	CD	NUMBER	1	_	0	SENT_276	[p17l1731t3763r1772b3798],
2	,	,	O	,	_	0	SENT_276	[p17l1731t3763r1772b3798],
3	NO.	NNP	O	NO.	appos	1	SENT_276	[p17l1810t3762r1900b3793],
4	6	CD	NUMBER	6	num	3	SENT_276	[p17l1937t3763r1980b3797],
5	,	,	O	,	_	0	SENT_276	[p17l1937t3763r1980b3797],
6	2008	CD	DATE	2008	num	3	SENT_276	[p17l2018t3763r2143b3793],

1	DECEMBER	NNP	DATE	DECEMBER	_	0	SENT_277	[p18l1499t41r1784b72],
2	20082620-7	CD	NUMBER	20082620-7	dep	1	SENT_277	[p18l1821t42r2142b72],

1	while	IN	O	while	dep	9	SENT_278	[p18l6t232r199b299],
2	on	IN	O	on	pcomp	1	SENT_278	[p18l232t258r319b298],
3	clopidogrel	NN	O	clopidogrel	pobj	2	SENT_278	[p18l352t232r747b322],
4	and	CC	O	and	_	0	SENT_278	[p18l779t232r907b298],
5	whether	IN	O	whether	dep	6	SENT_278	[p18l934t232r1228b299],
6	some	DT	O	some	conj_and	1	SENT_278	[p18l1259t258r1439b298],
7	of	IN	O	of	_	0	SENT_278	[p18l1472t232r1553b298],
8	those	DT	O	those	prep_of	6	SENT_278	[p18l1572t232r1758b298],
9	complications	NNS	O	complication	nsubjpass	12	SENT_278	[p18l1792t232r2139b322, p18l9t341r180b404],
10	will	MD	O	will	aux	12	SENT_278	[p18l220t338r352b405],
11	be	VB	O	be	auxpass	12	SENT_278	[p18l391t338r472b404],
12	prevented	VBN	O	prevent	_	0	SENT_278	[p18l514t338r863b428],
13	by	IN	O	by	_	0	SENT_278	[p18l903t338r989b427],
14	an	DT	O	a	agent	12	SENT_278	[p18l1029t364r1109b404],
15	individualized	VBN	O	individualize	partmod	14	SENT_278	[p18l1152t338r1670b419],
16	,	,	O	,	_	0	SENT_278	[p18l1152t338r1670b419],
17	higher	JJR	O	higher	amod	20	SENT_278	[p18l1716t338r1945b427],
18	dose	NN	O	dose	nn	20	SENT_278	[p18l1987t338r2142b404],
19	treatment	NN	O	treatment	nn	20	SENT_278	[p18l9t461r356b510],
20	regimen	NN	O	regimen	conj_and	14	SENT_278	[p18l389t447r678b533],
21	targeting	VBG	O	target	partmod	20	SENT_278	[p18l712t447r1031b533],
22	carriers	NNS	O	carrier	dobj	21	SENT_278	[p18l1065t447r1318b510],
23	of	IN	O	of	_	0	SENT_278	[p18l1355t444r1435b510],
24	CYP2CJ9	NN	O	cyp2cj9	nn	25	SENT_278	[p18l1464t447r1878b511],
25	*	NN	O	*	prep_of	22	SENT_278	[p18l1464t447r1878b511],
26	2	CD	NUMBER	2	num	25	SENT_278	[p18l1464t447r1878b511],
27	and	CC	O	and	_	0	SENT_278	[p18l1914t444r2041b510],
28	*	CD	NUMBER	*	number	29	SENT_278	[p18l2080t447r2147b509],
29	4	CD	NUMBER	4	num	30	SENT_278	[p18l2080t447r2147b509],
30	genotypes	NNS	O	genotype	conj_and	14	SENT_278	[p18l8t568r379b641],
31	.	.	O	.	_	0	SENT_278	[p18l8t568r379b641],

1	A	DT	O	a	det	3	SENT_279	[p18l414t550r481b617],
2	recent	JJ	O	recent	amod	3	SENT_279	[p18l512t568r729b617],
3	study	NN	O	study	nsubj	9	SENT_279	[p18l761t551r951b640],
4	of	IN	O	of	_	0	SENT_279	[p18l981t551r1060b617],
5	797	CD	NUMBER	797	num	6	SENT_279	[p18l1083t553r1211b618],
6	patients	NNS	O	patient	prep_of	3	SENT_279	[p18l1243t554r1520b641],
7	undergoing	VBG	O	undergo	partmod	6	SENT_279	[p18l1554t551r1962b640],
8	PCI	NN	O	pcus	dobj	7	SENT_279	[p18l1993t551r2141b618],
9	failed	VBD	O	fail	_	0	SENT_279	[p18l9t657r203b723],
10	to	TO	O	to	aux	11	SENT_279	[p18l261t674r329b723],
11	show	VB	O	show	xcomp	9	SENT_279	[p18l391t657r574b724],
12	a	DT	O	a	det	13	SENT_279	[p18l632t683r666b723],
13	relationship	NN	O	relationship	dobj	11	SENT_279	[p18l724t657r1141b747],
14	between	IN	O	between	_	0	SENT_279	[p18l1199t657r1493b724],
15	the	DT	O	the	det	19	SENT_279	[p18l1552t657r1662b723],
16	CYP2C19	NN	O	cyp2c19	nn	19	SENT_279	[p18l1729t660r2143b724],
17	*	NN	O	*	nn	19	SENT_279	[p18l1729t660r2143b724],
18	2	CD	NUMBER	2	num	19	SENT_279	[p18l1729t660r2143b724],
19	genotype	NN	O	genotype	prep_between	13	SENT_279	[p18l8t780r329b853],
20	and	CC	O	and	_	0	SENT_279	[p18l384t763r512b829],
21	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_279	[p18l565t763r1063b830],
22	events	NNS	O	event	nsubj	23	SENT_279	[p18l1115t780r1331b830],
23	(	VBP	O	(	conj_and	9	SENT_279	[p18l1389t761r1548b844],
24	35	CD	NUMBER	35	num	25	SENT_279	[p18l1389t761r1548b844],
25	)	CD	NUMBER	)	dobj	23	SENT_279	[p18l1389t761r1548b844],
26	.	.	O	.	_	0	SENT_279	[p18l1389t761r1548b844],

1	Larger	JJR	O	larger	amod	3	SENT_280	[p18l1607t764r1843b852],
2	clinical	JJ	O	clinical	amod	3	SENT_280	[p18l1895t763r2144b829],
3	trials	NNS	O	trial	nsubjpass	6	SENT_280	[p18l9t869r179b935],
4	are	VBP	O	be	auxpass	6	SENT_280	[p18l216t895r317b935],
5	also	RB	O	also	advmod	6	SENT_280	[p18l353t869r484b935],
6	needed	VBN	O	need	_	0	SENT_280	[p18l520t869r770b935],
7	to	TO	O	to	aux	8	SENT_280	[p18l803t886r871b935],
8	conﬁrm	VB	O	conﬁrm	xcomp	6	SENT_280	[p18l907t869r1182b935],
9	the	DT	O	the	det	10	SENT_280	[p18l1216t869r1326b935],
10	merits	NNS	O	merit	dobj	8	SENT_280	[p18l1362t872r1580b935],
11	of	IN	O	of	_	0	SENT_280	[p18l1616t869r1696b935],
12	a	DT	O	a	det	15	SENT_280	[p18l1719t895r1754b935],
13	genotypefocused	JJ	O	genotypefocused	amod	15	SENT_280	[p18l1785t886r2140b959, p18l9t975r277b1041],
14	dosing	NN	O	dosing	nn	15	SENT_280	[p18l340t975r574b1064],
15	approach	NN	O	approach	prep_of	10	SENT_280	[p18l637t975r960b1065],
16	over	IN	O	over	_	0	SENT_280	[p18l1023t1001r1172b1042],
17	individualized	JJ	O	individualized	amod	18	SENT_280	[p18l1232t975r1734b1042],
18	treatment	NN	O	treatment	prep_over	15	SENT_280	[p18l1796t992r2144b1041],
19	based	VBN	O	base	_	0	SENT_280	[p18l7t1081r206b1147],
20	on	IN	O	on	prepc_based_on	8	SENT_280	[p18l233t1107r320b1147],
21	either	CC	O	either	preconj	22	SENT_280	[p18l349t1081r552b1147],
22	laboratory	NN	O	laboratory	pobj	8	SENT_280	[p18l576t1081r938b1170],
23	or	CC	O	or	_	0	SENT_280	[p18l962t1107r1035b1147],
24	point-of	JJ	O	point-of	amod	29	SENT_280	[p18l1059t1081r1532b1171],
25	—	NN	O	—	nn	29	SENT_280	[p18l1059t1081r1532b1171],
26	care	NN	O	care	nn	29	SENT_280	[p18l1059t1081r1532b1171],
27	platelet	NN	O	platelet	nn	29	SENT_280	[p18l1559t1081r1820b1171],
28	function	NN	O	function	nn	29	SENT_280	[p18l1845t1081r2143b1147],
29	analysis	NN	O	analysis	pobj	8	SENT_280	[p18l11t1188r296b1277],
30	.	.	O	.	_	0	SENT_280	[p18l11t1188r296b1277],

1	Conclusions	NNS	O	conclusion	_	0	SENT_281	[p18l9t1411r527b1474],

1	This	DT	O	this	det	2	SENT_282	[p18l7t1606r170b1674],
2	study	NN	O	study	nsubj	19	SENT_282	[p18l213t1608r402b1697],
3	provides	VBZ	O	provide	_	0	SENT_282	[p18l437t1608r732b1697],
4	evidence	NN	O	evidence	dobj	3	SENT_282	[p18l774t1608r1075b1674],
5	for	IN	O	for	_	0	SENT_282	[p18l1116t1608r1216b1674],
6	the	DT	O	the	det	7	SENT_282	[p18l1254t1608r1364b1674],
7	impact	NN	O	impact	prep_for	4	SENT_282	[p18l1405t1611r1647b1697],
8	of	IN	O	of	_	0	SENT_282	[p18l1686t1608r1766b1674],
9	CYP2CZ	NN	O	cyp2cz	nn	11	SENT_282	[p18l1800t1611r2095b1675],
10	9	CD	NUMBER	9	num	11	SENT_282	[p18l2106t1615r2145b1674],
11	genotype	NN	O	genotype	prep_of	7	SENT_282	[p18l8t1732r329b1804],
12	on	IN	O	on	_	0	SENT_282	[p18l361t1741r448b1781],
13	the	DT	O	the	det	15	SENT_282	[p18l479t1715r589b1781],
14	platelet	NN	O	platelet	nn	15	SENT_282	[p18l620t1715r881b1804],
15	response	NN	O	response	prep_on	11	SENT_282	[p18l910t1740r1213b1804],
16	to	TO	O	to	_	0	SENT_282	[p18l1245t1732r1312b1781],
17	clopidogrel	NN	O	clopidogrel	prep_to	3	SENT_282	[p18l1346t1715r1741b1804],
18	and	CC	O	and	_	0	SENT_282	[p18l1772t1715r1899b1781],
19	shows	VBZ	O	show	conj_and	3	SENT_282	[p18l1931t1715r2141b1781],
20	that	IN	O	that	complm	27	SENT_282	[p18l9t1836r150b1902],
21	higher	JJR	O	higher	nsubj	27	SENT_282	[p18l207t1836r630b1925],
22	—	CD	NUMBER	—	num	25	SENT_282	[p18l207t1836r630b1925],
23	dose	NN	O	dose	nn	25	SENT_282	[p18l207t1836r630b1925],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_282	[p18l689t1836r1084b1925],
25	regimens	NNS	O	regimen	dep	21	SENT_282	[p18l1140t1839r1459b1925],
26	can	MD	O	can	aux	27	SENT_282	[p18l1519t1862r1637b1902],
27	increase	VB	O	increase	ccomp	19	SENT_282	[p18l1695t1839r1974b1902],
28	the	DT	O	the	det	29	SENT_282	[p18l2032t1836r2142b1902],
29	degree	NN	O	degree	dobj	27	SENT_282	[p18l10t1957r239b2046],
30	of	IN	O	of	_	0	SENT_282	[p18l293t1957r373b2023],
31	platelet	NN	O	platelet	nn	32	SENT_282	[p18l413t1957r674b2046],
32	inhibition	NN	O	inhibition	prep_of	29	SENT_282	[p18l725t1957r1076b2023],
33	in	IN	O	in	_	0	SENT_282	[p18l1129t1960r1197b2022],
34	patients	NNS	O	patient	prep_in	27	SENT_282	[p18l1249t1960r1526b2046],
35	with	IN	O	with	_	0	SENT_282	[p18l1577t1957r1738b2023],
36	genotypes	NNS	O	genotype	prep_with	34	SENT_282	[p18l1790t1974r2141b2046],
37	predictive	JJ	O	predictive	amod	36	SENT_282	[p18l8t2078r355b2167],
38	of	IN	O	of	_	0	SENT_282	[p18l390t2078r470b2144],
39	poor	JJ	O	poor	amod	40	SENT_282	[p18l490t2103r654b2167],
40	response	NN	O	response	prep_of	36	SENT_282	[p18l685t2103r1007b2167],
41	.	.	O	.	_	0	SENT_282	[p18l685t2103r1007b2167],

1	Personalized	VBN	O	personalize	csubj	15	SENT_283	[p18l1046t2078r1496b2144],
2	therapy	NN	O	therapy	dobj	1	SENT_283	[p18l1528t2078r1796b2167],
3	targeting	VBG	O	target	partmod	2	SENT_283	[p18l1825t2081r2145b2167],
4	patients	NNS	O	patient	dobj	3	SENT_283	[p18l8t2170r286b2256],
5	who	WP	O	who	nsubj	6	SENT_283	[p18l312t2167r464b2233],
6	carry	VBP	O	carry	rcmod	4	SENT_283	[p18l495t2192r668b2256],
7	the	DT	O	the	det	9	SENT_283	[p18l693t2167r803b2233],
8	CYPZCI9	NN	O	cypzci9	nn	9	SENT_283	[p18l839t2170r1183b2234],
9	variants	NNS	O	variant	nsubj	10	SENT_283	[p18l1206t2170r1480b2233],
10	predictive	JJ	O	predictive	xcomp	6	SENT_283	[p18l1509t2167r1855b2256],
11	of	IN	O	of	_	0	SENT_283	[p18l1886t2167r1965b2233],
12	poor	JJ	O	poor	amod	13	SENT_283	[p18l1980t2192r2144b2256],
13	response	NN	O	response	prep_of	10	SENT_283	[p18l9t2299r312b2363],
14	may	MD	O	may	aux	15	SENT_283	[p18l358t2300r506b2363],
15	help	VB	O	help	_	0	SENT_283	[p18l546t2274r695b2363],
16	to	TO	O	to	aux	17	SENT_283	[p18l741t2291r809b2340],
17	improve	VB	O	improve	xcomp	15	SENT_283	[p18l854t2277r1142b2363],
18	clinical	JJ	O	clinical	amod	19	SENT_283	[p18l1188t2274r1437b2340],
19	outcomes	NNS	O	outcome	dobj	17	SENT_283	[p18l1480t2291r1814b2340],
20	and	CC	O	and	_	0	SENT_283	[p18l1861t2274r1989b2340],
21	the	DT	O	the	det	22	SENT_283	[p18l2032t2274r2142b2340],
22	cost-beneﬁt	NN	O	cost-beneﬁt	dobj	17	SENT_283	[p18l10t2364r449b2429],
23	of	IN	O	of	_	0	SENT_283	[p18l481t2364r561b2429],
24	treatment	NN	O	treatment	prep_of	22	SENT_283	[p18l582t2381r945b2429],
25	.	.	O	.	_	0	SENT_283	[p18l582t2381r945b2429],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_284	[p18l11t2574r271b2653],
2	requests	NNS	O	request	_	0	SENT_284	[p18l313t2588r588b2653],
3	and	CC	O	and	_	0	SENT_284	[p18l634t2572r757b2633],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_284	[p18l801t2572r1345b2653],
5	:	:	O	:	_	0	SENT_284	[p18l801t2572r1345b2653],
6	Dr.	NNP	O	Dr.	nn	8	SENT_284	[p18l1394t2574r1499b2633],
7	Patrick	NNP	PERSON	Patrick	nn	8	SENT_284	[p18l1548t2573r1778b2633],
8	Gladding	NNP	PERSON	Gladding	dep	2	SENT_284	[p18l1821t2573r2140b2653],
9	,	,	O	,	_	0	SENT_284	[p18l1821t2573r2140b2653],
10	Green	NNP	ORGANIZATION	Green	nn	13	SENT_284	[p18l11t2670r210b2729],
11	Lane	NNP	ORGANIZATION	Lane	nn	13	SENT_284	[p18l262t2671r422b2729],
12	Cardiovascular	NNP	ORGANIZATION	Cardiovascular	nn	13	SENT_284	[p18l475t2670r949b2729],
13	Service	NNP	ORGANIZATION	Service	appos	8	SENT_284	[p18l1002t2670r1242b2742],
14	,	,	O	,	_	0	SENT_284	[p18l1002t2670r1242b2742],
15	Auckland	NNP	LOCATION	Auckland	nn	17	SENT_284	[p18l1294t2669r1605b2729],
16	City	NNP	LOCATION	City	nn	17	SENT_284	[p18l1658t2670r1798b2750],
17	Hospital	NNP	LOCATION	Hospital	appos	8	SENT_284	[p18l1847t2670r2140b2750],
18	,	,	O	,	_	0	SENT_284	[p18l1847t2670r2140b2750],
19	Private	JJ	O	private	amod	20	SENT_284	[p18l10t2768r232b2827],
20	Bag	NN	O	bag	appos	8	SENT_284	[p18l284t2768r408b2847],
21	92	CD	NUMBER	92	number	22	SENT_284	[p18l459t2771r533b2828],
22	024	CD	NUMBER	024	dep	20	SENT_284	[p18l587t2771r721b2840],
23	,	,	O	,	_	0	SENT_284	[p18l587t2771r721b2840],
24	Auckland	NNP	LOCATION	Auckland	appos	8	SENT_284	[p18l773t2766r1084b2827],
25	1030	CD	DATE	1030	num	24	SENT_284	[p18l1139t2771r1310b2840],
26	,	,	O	,	_	0	SENT_284	[p18l1139t2771r1310b2840],
27	New	NNP	LOCATION	New	nn	28	SENT_284	[p18l1364t2768r1517b2827],
28	Zealand	NNP	LOCATION	Zealand	appos	24	SENT_284	[p18l1566t2767r1842b2827],
29	.	.	O	.	_	0	SENT_284	[p18l1566t2767r1842b2827],

1	E	NN	O	e	nn	3	SENT_285	[p18l1899t2768r2139b2827],
2	—	CD	NUMBER	—	num	3	SENT_285	[p18l1899t2768r2139b2827],
3	mail	NN	O	mail	_	0	SENT_285	[p18l1899t2768r2139b2827],
4	:	:	O	:	_	0	SENT_285	[p18l1899t2768r2139b2827],
5	patrickg@adhb.govt.nz	NN	O	patrickg@adhb.govt.nz	dep	3	SENT_285	[p18l8t2864r763b2944],
6	.	.	O	.	_	0	SENT_285	[p18l8t2864r763b2944],

1	REFERENCES	NNS	O	reference	_	0	SENT_286	[p18l10t3166r399b3210],

1	1	LS	NUMBER	1	_	0	SENT_287	[p19l48t63r92b113],
2	.	.	O	.	_	0	SENT_287	[p19l48t63r92b113],

1	Geiger	NNP	PERSON	Geiger	nn	2	SENT_288	[p19l118t60r312b132],
2	J	NNP	PERSON	J	_	0	SENT_288	[p19l326t61r370b128],
3	,	,	O	,	_	0	SENT_288	[p19l326t61r370b128],
4	Brich	NNP	O	Brich	nn	5	SENT_288	[p19l397t60r551b113],
5	J	NNP	O	J	appos	2	SENT_288	[p19l567t61r611b128],
6	,	,	O	,	_	0	SENT_288	[p19l567t61r611b128],
7	Honig	NNP	PERSON	Honig	appos	5	SENT_288	[p19l637t60r1004b132],
8	.	.	O	.	_	0	SENT_288	[p19l637t60r1004b132],

1	—	NN	O	—	_	0	SENT_289	[p19l637t60r1004b132],
2	.	.	O	.	_	0	SENT_289	[p19l637t60r1004b132],

1	Liedl	NN	O	liedl	nn	2	SENT_290	[p19l637t60r1004b132],
2	P	NN	O	p	_	0	SENT_290	[p19l1026t61r1082b125],
3	,	,	O	,	_	0	SENT_290	[p19l1026t61r1082b125],
4	et	FW	O	et	nn	5	SENT_290	[p19l1108t74r1159b113],
5	al.	FW	O	al.	appos	2	SENT_290	[p19l1183t60r1242b113],
6	.	.	O	.	_	0	SENT_290	[p19l1183t60r1242b113],

1	Speciﬁc	JJ	MISC	speciﬁc	amod	2	SENT_291	[p19l1272t60r1489b132],
2	impairment	NN	O	impairment	nsubj	8	SENT_291	[p19l1512t63r1845b132],
3	of	IN	O	of	_	0	SENT_291	[p19l1868t60r1932b113],
4	human	JJ	O	human	amod	6	SENT_291	[p19l1946t60r2143b113],
5	platelet	NN	O	platelet	nn	6	SENT_291	[p19l116t140r325b212],
6	P2Y	NN	O	p2y	prep_of	2	SENT_291	[p19l344t139r617b205],
7	(	CD	NUMBER	(	num	8	SENT_291	[p19l344t139r617b205],
8	AC	NN	ORGANIZATION	ac	_	0	SENT_291	[p19l344t139r617b205],
9	)	CD	NUMBER	)	num	10	SENT_291	[p19l344t139r617b205],
10	ADP	NN	ORGANIZATION	adp	dobj	8	SENT_291	[p19l639t139r792b193],
11	receptor-mediated	JJ	O	receptor-mediated	dep	12	SENT_291	[p19l813t140r1337b212],
12	signaling	NN	O	signaling	amod	10	SENT_291	[p19l1358t140r1613b212],
13	by	IN	O	by	_	0	SENT_291	[p19l1631t140r1699b212],
14	the	DT	O	the	det	17	SENT_291	[p19l1717t140r1805b193],
15	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_291	[p19l1827t140r2144b212],
16	drug	NN	O	drug	nn	17	SENT_291	[p19l117t220r247b292],
17	clopidogrel	NN	O	clopidogrel	prep_by	8	SENT_291	[p19l273t220r602b292],
18	.	.	O	.	_	0	SENT_291	[p19l273t220r602b292],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_292	[p19l631t219r968b273],
2	Thromb	NNP	O	Thromb	nn	4	SENT_292	[p19l990t219r1230b273],
3	Vasc	NNP	O	Vasc	nn	4	SENT_292	[p19l1258t221r1391b274],
4	Biol	NNP	O	Biol	_	0	SENT_292	[p19l1417t220r1535b273],
5	1999	CD	DATE	1999	num	4	SENT_292	[p19l1564t222r2071b285],
6	;	:	O	;	_	0	SENT_292	[p19l1564t222r2071b285],
7	19:2007	CD	DATE	19:2007	number	8	SENT_292	[p19l1564t222r2071b285],
8	-11	CD	DATE	-11	dep	4	SENT_292	[p19l1564t222r2071b285],
9	.	.	O	.	_	0	SENT_292	[p19l1564t222r2071b285],

1	2	LS	NUMBER	2	_	0	SENT_293	[p19l43t303r92b354],
2	.	.	O	.	_	0	SENT_293	[p19l43t303r92b354],

1	Serebruany	NNP	O	Serebruany	nn	2	SENT_294	[p19l119t300r437b372],
2	VL	NNP	O	VL	_	0	SENT_294	[p19l469t301r580b365],
3	,	,	O	,	_	0	SENT_294	[p19l469t301r580b365],
4	Steinhubl	NNP	O	Steinhubl	nn	5	SENT_294	[p19l620t300r893b354],
5	SR	NN	O	sr	appos	2	SENT_294	[p19l931t300r1029b365],
6	,	,	O	,	_	0	SENT_294	[p19l931t300r1029b365],
7	Berger	NNP	PERSON	Berger	nn	8	SENT_294	[p19l1068t301r1257b372],
8	PB	NN	O	pb	appos	2	SENT_294	[p19l1292t301r1395b365],
9	,	,	O	,	_	0	SENT_294	[p19l1292t301r1395b365],
10	Malinin	NNP	PERSON	Malinin	nn	11	SENT_294	[p19l1432t300r1662b353],
11	AI	NNP	O	AI	appos	2	SENT_294	[p19l1696t299r1790b365],
12	,	,	O	,	_	0	SENT_294	[p19l1696t299r1790b365],
13	Bhatt	NNP	PERSON	Bhatt	nn	14	SENT_294	[p19l1829t300r1988b353],
14	DL	NNP	O	DL	appos	2	SENT_294	[p19l2023t301r2140b365],
15	,	,	O	,	_	0	SENT_294	[p19l2023t301r2140b365],
16	Topol	NNP	PERSON	Topol	nn	18	SENT_294	[p19l114t380r290b453],
17	E	NNP	O	E	nn	18	SENT_294	[p19l320t382r403b449],
18	J	NNP	O	J	appos	2	SENT_294	[p19l320t382r403b449],
19	+	CC	O	+	_	0	SENT_294	[p19l320t382r403b449],
20	Variability	NN	O	variability	appos	2	SENT_294	[p19l435t381r736b453],
21	in	IN	O	in	_	0	SENT_294	[p19l762t384r816b434],
22	platelet	NN	O	platelet	nn	23	SENT_294	[p19l844t381r1053b453],
23	responsiveness	NN	O	responsiveness	prep_in	20	SENT_294	[p19l1080t384r1491b453],
24	to	TO	O	to	_	0	SENT_294	[p19l1521t395r1575b434],
25	clopidogrel	NN	O	clopidogrel	prep_to	23	SENT_294	[p19l1606t381r1922b453],
26	among	IN	O	among	_	0	SENT_294	[p19l1951t402r2145b453],
27	544	CD	NUMBER	544	num	28	SENT_294	[p19l117t461r221b514],
28	individuals	NNS	O	individual	prep_among	25	SENT_294	[p19l247t461r569b514],
29	.	.	O	.	_	0	SENT_294	[p19l247t461r569b514],

1	J	NNP	O	J	nn	4	SENT_295	[p19l591t462r620b528],
2	Am	NNP	O	Am	nn	4	SENT_295	[p19l644t460r753b513],
3	Coll	NNP	O	Coll	nn	4	SENT_295	[p19l782t461r903b514],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_295	[p19l931t461r1145b514],
5	2005	CD	DATE	2005	num	4	SENT_295	[p19l1169t461r1522b525],
6	;	:	O	;	_	0	SENT_295	[p19l1169t461r1522b525],
7	45:246	CD	NUMBER	45:246	number	8	SENT_295	[p19l1169t461r1522b525],
8	-51	CD	NUMBER	-51	dep	4	SENT_295	[p19l1533t461r1654b514],
9	.	.	O	.	_	0	SENT_295	[p19l1533t461r1654b514],

1	3	LS	NUMBER	3	_	0	SENT_296	[p19l45t543r92b594],
2	.	.	O	.	_	0	SENT_296	[p19l45t543r92b594],

1	Gurbel	NNP	ORGANIZATION	Gurbel	nn	2	SENT_297	[p19l118t540r318b594],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_297	[p19l351t539r460b605],
3	,	,	O	,	_	0	SENT_297	[p19l351t539r460b605],
4	Bliden	NNP	PERSON	Bliden	nn	5	SENT_297	[p19l496t540r683b593],
5	KP	NNP	O	KP	appos	2	SENT_297	[p19l719t541r824b605],
6	,	,	O	,	_	0	SENT_297	[p19l719t541r824b605],
7	Hiatt	NNP	PERSON	Hiatt	nn	8	SENT_297	[p19l861t541r1015b593],
8	BL	NN	O	bl	appos	2	SENT_297	[p19l1047t541r1154b605],
9	,	,	O	,	_	0	SENT_297	[p19l1047t541r1154b605],
10	O’Connor	NN	O	o’connor	nn	11	SENT_297	[p19l1192t540r1485b594],
11	CM	NN	O	cm	appos	2	SENT_297	[p19l1519t540r1653b594],
12	.	.	O	.	_	0	SENT_297	[p19l1519t540r1653b594],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_298	[p19l1692t540r2031b612],
2	for	IN	O	for	_	0	SENT_298	[p19l2064t540r2145b593],
3	coronary	JJ	O	coronary	amod	4	SENT_298	[p19l117t641r365b692],
4	stenting	NN	O	stenting	prep_for	1	SENT_298	[p19l383t623r625b692],
5	:	:	O	:	_	0	SENT_298	[p19l383t623r625b692],
6	response	NN	O	response	nn	7	SENT_298	[p19l648t641r891b692],
7	variability	NN	O	variability	conj_and	1	SENT_298	[p19l909t620r1206b692],
8	,	,	O	,	_	0	SENT_298	[p19l909t620r1206b692],
9	drug	NN	O	drug	nn	10	SENT_298	[p19l1229t620r1359b692],
10	resistance	NN	O	resistance	appos	7	SENT_298	[p19l1377t623r1666b685],
11	,	,	O	,	_	0	SENT_298	[p19l1377t623r1666b685],
12	and	CC	O	and	_	0	SENT_298	[p19l1689t620r1791b673],
13	the	DT	O	the	det	14	SENT_298	[p19l1811t620r1899b673],
14	effect	NN	O	effect	conj_and	1	SENT_298	[p19l1921t620r2069b673],
15	of	IN	O	of	_	0	SENT_298	[p19l2089t620r2153b673],
16	pretreatment	NN	O	pretreatment	nn	18	SENT_298	[p19l116t714r485b772],
17	platelet	NN	O	platelet	nn	18	SENT_298	[p19l509t700r718b772],
18	reactivity	NN	O	reactivity	prep_of	14	SENT_298	[p19l743t703r1015b772],
19	.	.	O	.	_	0	SENT_298	[p19l743t703r1015b772],

1	Circulation	NN	O	circulation	_	0	SENT_299	[p19l1046t700r1368b754],
2	2003	CD	DATE	2003	num	1	SENT_299	[p19l1393t701r1949b765],
3	;	:	O	;	_	0	SENT_299	[p19l1393t701r1949b765],
4	107:2908	CD	NUMBER	107:2908	number	5	SENT_299	[p19l1393t701r1949b765],
5	-13	CD	NUMBER	-13	dep	1	SENT_299	[p19l1393t701r1949b765],
6	.	.	O	.	_	0	SENT_299	[p19l1393t701r1949b765],

1	4	LS	NUMBER	4	_	0	SENT_300	[p19l44t783r92b833],
2	.	.	O	.	_	0	SENT_300	[p19l44t783r92b833],

1	Muller	NNP	PERSON	Muller	nn	2	SENT_301	[p19l115t780r312b833],
2	I	NNP	O	I	nsubj	28	SENT_301	[p19l348t781r388b845],
3	,	,	O	,	_	0	SENT_301	[p19l348t781r388b845],
4	Besta	NNP	O	Besta	nn	5	SENT_301	[p19l428t781r582b833],
5	F	NN	O	f	dep	2	SENT_301	[p19l619t781r674b845],
6	,	,	O	,	_	0	SENT_301	[p19l619t781r674b845],
7	Schulz	NNP	PERSON	Schulz	nn	8	SENT_301	[p19l717t780r905b834],
8	C	NNP	O	C	appos	5	SENT_301	[p19l942t780r1007b845],
9	,	,	O	,	_	0	SENT_301	[p19l942t780r1007b845],
10	Massberg	NNP	LOCATION	Massberg	nn	11	SENT_301	[p19l1046t780r1322b852],
11	S	NNP	LOCATION	S	appos	5	SENT_301	[p19l1361t780r1410b845],
12	,	,	O	,	_	0	SENT_301	[p19l1361t780r1410b845],
13	Schonig	NNP	O	Schonig	nn	14	SENT_301	[p19l1453t780r1682b852],
14	A	NNP	O	A	appos	5	SENT_301	[p19l1716t779r1784b845],
15	,	,	O	,	_	0	SENT_301	[p19l1716t779r1784b845],
16	Gawaz	NNP	PERSON	Gawaz	nn	18	SENT_301	[p19l1826t780r2022b834],
17	M.	NNP	PERSON	M.	nn	18	SENT_301	[p19l2057t781r2139b833],
18	Prevalence	NN	PERSON	prevalence	appos	5	SENT_301	[p19l117t861r418b915],
19	of	IN	O	of	_	0	SENT_301	[p19l449t861r513b914],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_301	[p19l534t861r850b933],
21	non-responders	NNS	O	non-responder	prep_of	18	SENT_301	[p19l879t861r1321b933],
22	among	IN	O	among	dep	5	SENT_301	[p19l1354t882r1547b933],
23	patients	NNS	O	patient	pobj	22	SENT_301	[p19l1574t864r1796b933],
24	With	IN	O	with	dep	5	SENT_301	[p19l1824t861r1953b915],
25	stable	JJ	O	stable	amod	27	SENT_301	[p19l1984t861r2142b914],
26	angina	NN	O	angina	nn	27	SENT_301	[p19l118t970r306b1039],
27	pectoris	NN	O	pectoris	pobj	24	SENT_301	[p19l354t970r576b1039],
28	scheduled	VBN	O	schedule	_	0	SENT_301	[p19l628t967r909b1020],
29	for	IN	O	for	_	0	SENT_301	[p19l959t967r1039b1020],
30	elective	JJ	O	elective	amod	33	SENT_301	[p19l1089t967r1298b1020],
31	coronary	JJ	O	coronary	amod	33	SENT_301	[p19l1349t988r1598b1039],
32	stent	NN	O	stent	nn	33	SENT_301	[p19l1646t981r1784b1020],
33	placement	NN	O	placement	prep_for	28	SENT_301	[p19l1831t967r2139b1039],
34	.	.	O	.	_	0	SENT_301	[p19l1831t967r2139b1039],

1	Thromb	NNP	O	Thromb	nn	2	SENT_302	[p19l114t1046r354b1100],
2	Haemost	NNP	O	Haemost	_	0	SENT_302	[p19l382t1048r643b1100],
3	2003	CD	DATE	2003	num	2	SENT_302	[p19l666t1049r1107b1111],
4	;	:	O	;	_	0	SENT_302	[p19l666t1049r1107b1111],
5	89:783	CD	NUMBER	89:783	num	6	SENT_302	[p19l666t1049r1107b1111],
6	—	NN	O	—	dep	2	SENT_302	[p19l666t1049r1107b1111],
7	7	CD	NUMBER	7	dep	6	SENT_302	[p19l666t1049r1107b1111],
8	.	.	O	.	_	0	SENT_302	[p19l666t1049r1107b1111],

1	5	CD	NUMBER	5	_	0	SENT_303	[p19l45t1126r92b1180],
2	.	.	O	.	_	0	SENT_303	[p19l45t1126r92b1180],

1	Clarke	NNP	PERSON	Clarke	nn	2	SENT_304	[p19l118t1126r305b1180],
2	TA	NNP	O	TA	_	0	SENT_304	[p19l322t1125r441b1191],
3	,	,	O	,	_	0	SENT_304	[p19l322t1125r441b1191],
4	Waskell	NNP	LOCATION	Waskell	nn	5	SENT_304	[p19l460t1126r693b1180],
5	LA.	NNP	LOCATION	LA.	appos	2	SENT_304	[p19l713t1125r823b1179],
6	.	.	O	.	_	0	SENT_304	[p19l713t1125r823b1179],

1	The	DT	O	the	det	2	SENT_305	[p19l844t1125r962b1179],
2	metabolism	NN	O	metabolism	nsubjpass	14	SENT_305	[p19l983t1126r1311b1179],
3	of	IN	O	of	_	0	SENT_305	[p19l1331t1126r1396b1179],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_305	[p19l1406t1126r1722b1198],
5	is	VBZ	O	be	auxpass	6	SENT_305	[p19l1740t1129r1781b1179],
6	catalyzed	VBN	O	catalyze	_	0	SENT_305	[p19l1802t1126r2060b1198],
7	by	IN	O	by	_	0	SENT_305	[p19l2077t1127r2146b1198],
8	human	JJ	O	human	amod	11	SENT_305	[p19l117t1206r314b1259],
9	cytochrome	NN	O	cytochrome	nn	11	SENT_305	[p19l348t1206r678b1278],
10	P450	NN	O	p450	nn	11	SENT_305	[p19l712t1206r859b1260],
11	3A	NN	O	3a	agent	6	SENT_305	[p19l894t1205r980b1260],
12	and	CC	O	and	_	0	SENT_305	[p19l1013t1206r1116b1259],
13	is	VBZ	O	be	auxpass	14	SENT_305	[p19l1149t1209r1189b1259],
14	inhibited	VBN	O	inhibit	conj_and	6	SENT_305	[p19l1224t1206r1481b1259],
15	by	IN	O	by	_	0	SENT_305	[p19l1513t1206r1582b1278],
16	atorvastatin	NN	O	atorvastatin	agent	14	SENT_305	[p19l1613t1209r1956b1259],
17	.	.	O	.	_	0	SENT_305	[p19l1613t1209r1956b1259],

1	Drug	NN	O	drug	nn	3	SENT_306	[p19l1994t1207r2145b1278],
2	Metab	NNP	O	Metab	nn	3	SENT_306	[p19l115t1286r301b1339],
3	Dispos	NNP	O	Dispos	_	0	SENT_306	[p19l330t1287r525b1358],
4	2003	CD	DATE	2003	num	3	SENT_306	[p19l552t1286r957b1351],
5	;	:	O	;	_	0	SENT_306	[p19l552t1286r957b1351],
6	31:53	CD	NUMBER	31:53	number	7	SENT_306	[p19l552t1286r957b1351],
7	-9	CD	NUMBER	-9	dep	3	SENT_306	[p19l552t1286r957b1351],
8	.	.	O	.	_	0	SENT_306	[p19l552t1286r957b1351],

1	6	CD	NUMBER	6	_	0	SENT_307	[p19l46t1369r92b1420],
2	.	.	O	.	_	0	SENT_307	[p19l46t1369r92b1420],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_308	[p19l117t1366r315b1419],
2	JT	NNP	O	JT	_	0	SENT_308	[p19l340t1365r434b1434],
3	,	,	O	,	_	0	SENT_308	[p19l340t1365r434b1434],
4	Close	NNP	O	Close	nn	5	SENT_308	[p19l472t1366r630b1420],
5	SL	NNP	O	SL	appos	2	SENT_308	[p19l667t1366r763b1431],
6	,	,	O	,	_	0	SENT_308	[p19l667t1366r763b1431],
7	Iturria	NNP	PERSON	Iturria	nn	8	SENT_308	[p19l799t1367r981b1419],
8	SJ	NNP	O	SJ	appos	2	SENT_308	[p19l1017t1366r1089b1434],
9	,	,	O	,	_	0	SENT_308	[p19l1017t1366r1089b1434],
10	et	FW	O	et	nn	11	SENT_308	[p19l1126t1380r1178b1419],
11	al.	FW	O	al.	appos	2	SENT_308	[p19l1211t1366r1271b1419],
12	.	.	O	.	_	0	SENT_308	[p19l1211t1366r1271b1419],

1	Common	JJ	O	common	amod	2	SENT_309	[p19l1310t1366r1582b1420],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_309	[p19l1615t1366r2053b1438],
3	of	IN	O	of	_	0	SENT_309	[p19l2089t1366r2152b1419],
4	CYPZC19	NN	O	cypzc19	prep_of	2	SENT_309	[p19l118t1446r415b1500],
5	and	CC	O	and	_	0	SENT_309	[p19l443t1446r545b1499],
6	CYPZC9	NN	O	cypzc9	prep_of	2	SENT_309	[p19l570t1446r832b1500],
7	affect	VBP	O	affect	_	0	SENT_309	[p19l859t1446r1007b1499],
8	the	DT	O	the	det	14	SENT_309	[p19l1030t1446r1118b1499],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_309	[p19l1142t1446r1616b1518],
10	and	CC	O	and	_	0	SENT_309	[p19l1641t1446r1743b1499],
11	pharmacody	JJ	O	pharmacody	conj_and	9	SENT_309	[p19l1766t1446r2141b1518],
12	—	NN	O	—	nn	14	SENT_309	[p19l1766t1446r2141b1518],
13	namic	JJ	O	namic	amod	14	SENT_309	[p19l117t1530r288b1580],
14	response	NN	O	response	dobj	7	SENT_309	[p19l317t1548r559b1599],
15	to	TO	O	to	_	0	SENT_309	[p19l589t1541r643b1580],
16	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_309	[p19l674t1527r990b1599],
17	but	CC	O	but	_	0	SENT_309	[p19l1016t1527r1111b1580],
18	not	RB	O	not	_	0	SENT_309	[p19l1140t1541r1233b1580],
19	prasugrel	NN	O	prasugrel	conj_negcc	14	SENT_309	[p19l1260t1527r1533b1599],
20	.	.	O	.	_	0	SENT_309	[p19l1260t1527r1533b1599],

1	J	NNP	O	J	nn	3	SENT_310	[p19l1558t1528r1587b1595],
2	Thromb	NNP	O	Thromb	nn	3	SENT_310	[p19l1613t1526r1853b1580],
3	Haemost	NNP	O	Haemost	_	0	SENT_310	[p19l1884t1528r2144b1580],
4	2007:5:2429	CD	NUMBER	2007:5:2429	num	3	SENT_310	[p19l115t1608r600b1661],
5	—	CD	NUMBER	—	number	6	SENT_310	[p19l115t1608r600b1661],
6	36	CD	NUMBER	36	num	3	SENT_310	[p19l115t1608r600b1661],
7	.	.	O	.	_	0	SENT_310	[p19l115t1608r600b1661],

1	7	CD	NUMBER	7	_	0	SENT_311	[p19l46t1689r92b1741],
2	.	.	O	.	_	0	SENT_311	[p19l46t1689r92b1741],

1	Suh	NNP	PERSON	Suh	nn	2	SENT_312	[p19l119t1687r227b1741],
2	JVV	NNP	O	JVV	_	0	SENT_312	[p19l242t1688r360b1755],
3	,	,	O	,	_	0	SENT_312	[p19l242t1688r360b1755],
4	Koo	NNP	LOCATION	Koo	nn	5	SENT_312	[p19l386t1688r502b1740],
5	BK	NNP	LOCATION	BK	appos	2	SENT_312	[p19l526t1688r636b1752],
6	,	,	O	,	_	0	SENT_312	[p19l526t1688r636b1752],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_312	[p19l662t1687r850b1759],
8	SY	NNP	PERSON	SY	appos	2	SENT_312	[p19l874t1687r970b1752],
9	,	,	O	,	_	0	SENT_312	[p19l874t1687r970b1752],
10	et	FW	O	et	nn	11	SENT_312	[p19l995t1701r1046b1740],
11	al.	FW	O	al.	appos	2	SENT_312	[p19l1068t1687r1127b1740],
12	.	.	O	.	_	0	SENT_312	[p19l1068t1687r1127b1740],

1	Increased	VBN	O	increase	amod	2	SENT_313	[p19l1152t1687r1422b1740],
2	risk	NN	O	risk	nsubj	6	SENT_313	[p19l1443t1687r1548b1740],
3	of	IN	O	of	_	0	SENT_313	[p19l1567t1687r1631b1740],
4	atherothrombotic	JJ	O	atherothrombotic	amod	5	SENT_313	[p19l1645t1687r2143b1740],
5	events	NNS	O	event	prep_of	2	SENT_313	[p19l117t1781r290b1820],
6	associated	VBN	O	associate	_	0	SENT_313	[p19l312t1767r594b1820],
7	with	IN	O	with	_	0	SENT_313	[p19l610t1767r739b1821],
8	cytochrome	NN	O	cytochrome	nn	11	SENT_313	[p19l759t1767r1088b1839],
9	P450	NN	O	p450	nn	11	SENT_313	[p19l1108t1767r1255b1821],
10	3A5	NN	O	3a5	nn	11	SENT_313	[p19l1276t1766r1394b1821],
11	polymorphism	NN	O	polymorphism	prep_with	6	SENT_313	[p19l1415t1767r1828b1839],
12	in	IN	O	in	_	0	SENT_313	[p19l1847t1770r1902b1820],
13	patients	NNS	O	patient	prep_in	6	SENT_313	[p19l1920t1770r2142b1839],
14	taking	VBG	O	take	partmod	13	SENT_313	[p19l116t1847r295b1919],
15	clopidogrel	NN	O	clopidogrel	dobj	14	SENT_313	[p19l321t1847r650b1919],
16	.	.	O	.	_	0	SENT_313	[p19l321t1847r650b1919],

1	CMAJ	NNP	O	CMAJ	_	0	SENT_314	[p19l682t1846r878b1915],
2	2006	CD	DATE	2006	num	1	SENT_314	[p19l902t1847r1450b1912],
3	;	:	O	;	_	0	SENT_314	[p19l902t1847r1450b1912],
4	174:1715	CD	NUMBER	174:1715	number	5	SENT_314	[p19l902t1847r1450b1912],
5	-22	CD	NUMBER	-22	dep	1	SENT_314	[p19l902t1847r1450b1912],
6	.	.	O	.	_	0	SENT_314	[p19l902t1847r1450b1912],

1	8	CD	NUMBER	8	_	0	SENT_315	[p19l47t1930r92b1981],
2	.	.	O	.	_	0	SENT_315	[p19l47t1930r92b1981],

1	Farid	NNP	PERSON	Farid	nn	2	SENT_316	[p19l117t1927r268b1980],
2	NA	NNP	O	NA	_	0	SENT_316	[p19l315t1926r438b1992],
3	,	,	O	,	_	0	SENT_316	[p19l315t1926r438b1992],
4	Payne	NNP	PERSON	Payne	nn	5	SENT_316	[p19l488t1928r658b1999],
5	CD	NNP	O	CD	appos	2	SENT_316	[p19l708t1927r830b1992],
6	,	,	O	,	_	0	SENT_316	[p19l708t1927r830b1992],
7	Small	NNP	O	Small	nn	8	SENT_316	[p19l883t1927r1042b1981],
8	DS	NN	O	d	appos	2	SENT_316	[p19l1089t1927r1199b1992],
9	,	,	O	,	_	0	SENT_316	[p19l1089t1927r1199b1992],
10	et	FW	O	et	nn	11	SENT_316	[p19l1250t1941r1301b1980],
11	al.	FW	O	al.	appos	2	SENT_316	[p19l1349t1927r1408b1980],
12	.	.	O	.	_	0	SENT_316	[p19l1349t1927r1408b1980],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_317	[p19l1461t1927r1814b1999],
2	P450	NN	O	p450	nn	4	SENT_317	[p19l1862t1927r2009b1981],
3	3A	NN	O	3a	nn	4	SENT_317	[p19l2058t1926r2144b1981],
4	inhibition	NN	O	inhibition	nsubj	7	SENT_317	[p19l117t2007r398b2060],
5	by	IN	O	by	_	0	SENT_317	[p19l418t2007r488b2079],
6	ketoconazole	NN	O	ketoconazole	prep_by	4	SENT_317	[p19l507t2007r875b2060],
7	affects	VBZ	O	affect	_	0	SENT_317	[p19l899t2007r1069b2060],
8	prasugrel	NN	O	prasugrel	nn	11	SENT_317	[p19l1092t2007r1351b2079],
9	and	CC	O	and	_	0	SENT_317	[p19l1373t2007r1475b2060],
10	clopidogrel	NN	O	clopidogrel	nn	11	SENT_317	[p19l1498t2007r1814b2079],
11	pharmacokinetics	NNS	O	pharmacokinetic	dobj	7	SENT_317	[p19l1834t2007r2141b2079, p19l117t2087r331b2140],
12	and	CC	O	and	_	0	SENT_317	[p19l382t2087r484b2140],
13	pharmacodynamics	NNS	O	pharmacodynamic	dobj	7	SENT_317	[p19l530t2087r1076b2159],
14	differently	RB	O	differently	advmod	7	SENT_317	[p19l1126t2087r1426b2159],
15	.	.	O	.	_	0	SENT_317	[p19l1126t2087r1426b2159],

1	Clin	NNP	O	Clin	nn	3	SENT_318	[p19l1479t2087r1603b2141],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_318	[p19l1651t2087r1956b2140],
3	Ther	NNP	O	Ther	_	0	SENT_318	[p19l2000t2086r2144b2140],
4	2007	CD	DATE	2007	num	3	SENT_318	[p19l115t2167r600b2232],
5	;	:	O	;	_	0	SENT_318	[p19l115t2167r600b2232],
6	81:735	CD	NUMBER	81:735	number	7	SENT_318	[p19l115t2167r600b2232],
7	—	CD	NUMBER	—	dep	3	SENT_318	[p19l115t2167r600b2232],
8	41	CD	NUMBER	41	dep	7	SENT_318	[p19l115t2167r600b2232],
9	.	.	O	.	_	0	SENT_318	[p19l115t2167r600b2232],

1	9	CD	NUMBER	9	_	0	SENT_319	[p19l46t2249r92b2300],
2	.	.	O	.	_	0	SENT_319	[p19l46t2249r92b2300],

1	Hulot	NNP	PERSON	Hulot	nn	2	SENT_320	[p19l117t2246r288b2299],
2	JS	NNP	O	JS	_	0	SENT_320	[p19l309t2246r392b2314],
3	,	,	O	,	_	0	SENT_320	[p19l309t2246r392b2314],
4	Bura	NNP	PERSON	Bura	nn	5	SENT_320	[p19l425t2247r560b2299],
5	A	NNP	O	A	appos	2	SENT_320	[p19l587t2245r655b2311],
6	,	,	O	,	_	0	SENT_320	[p19l587t2245r655b2311],
7	Villard	NNP	O	Villard	nn	8	SENT_320	[p19l687t2246r882b2300],
8	E	NNP	O	E	appos	2	SENT_320	[p19l912t2247r973b2311],
9	,	,	O	,	_	0	SENT_320	[p19l912t2247r973b2311],
10	et	FW	O	et	nn	11	SENT_320	[p19l1006t2260r1057b2299],
11	al.	FW	O	al.	appos	2	SENT_320	[p19l1086t2246r1145b2299],
12	.	.	O	.	_	0	SENT_320	[p19l1086t2246r1145b2299],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_321	[p19l1180t2246r1533b2318],
2	P450	NN	O	p450	nsubj	9	SENT_321	[p19l1563t2246r1709b2300],
3	ZC19	NN	O	zc19	nn	5	SENT_321	[p19l1738t2246r1895b2300],
4	lossoffunction	NN	O	lossoffunction	nn	5	SENT_321	[p19l1925t2246r2141b2299, p19l117t2327r354b2380],
5	polymorphism	NN	O	polymorphism	dep	2	SENT_321	[p19l380t2327r792b2399],
6	is	VBZ	O	be	cop	9	SENT_321	[p19l820t2330r860b2380],
7	a	DT	O	a	det	9	SENT_321	[p19l888t2348r916b2380],
8	major	JJ	O	major	amod	9	SENT_321	[p19l942t2329r1105b2399],
9	determinant	NN	O	determinant	_	0	SENT_321	[p19l1131t2327r1479b2380],
10	of	IN	O	of	_	0	SENT_321	[p19l1505t2327r1569b2380],
11	clopidogrel	NN	O	clopidogrel	nn	12	SENT_321	[p19l1586t2327r1902b2399],
12	responsiveness	NN	O	responsiveness	prep_of	9	SENT_321	[p19l1927t2348r2141b2399, p19l118t2410r337b2460],
13	in	IN	O	in	_	0	SENT_321	[p19l365t2410r419b2460],
14	healthy	JJ	O	healthy	amod	15	SENT_321	[p19l445t2407r655b2479],
15	subjects	NNS	O	subject	prep_in	12	SENT_321	[p19l680t2407r913b2479],
16	.	.	O	.	_	0	SENT_321	[p19l680t2407r913b2479],

1	Blood	NN	O	blood	_	0	SENT_322	[p19l943t2407r1114b2460],
2	2006	CD	DATE	2006	num	1	SENT_322	[p19l1138t2408r1659b2472],
3	;	:	O	;	_	0	SENT_322	[p19l1138t2408r1659b2472],
4	108:2244	CD	NUMBER	108:2244	number	5	SENT_322	[p19l1138t2408r1659b2472],
5	-7	CD	NUMBER	-7	dep	1	SENT_322	[p19l1138t2408r1659b2472],
6	.	.	O	.	_	0	SENT_322	[p19l1138t2408r1659b2472],

1	10	CD	NUMBER	10	_	0	SENT_323	[p19l13t2490r92b2540],
2	.	.	O	.	_	0	SENT_323	[p19l13t2490r92b2540],

1	Fontana	NNP	ORGANIZATION	Fontana	nn	2	SENT_324	[p19l117t2488r352b2540],
2	P	NN	ORGANIZATION	p	_	0	SENT_324	[p19l391t2488r447b2551],
3	,	,	O	,	_	0	SENT_324	[p19l391t2488r447b2551],
4	Hulot	NNP	PERSON	Hulot	nn	5	SENT_324	[p19l491t2487r662b2540],
5	JS	NNP	O	JS	appos	2	SENT_324	[p19l693t2487r776b2554],
6	,	,	O	,	_	0	SENT_324	[p19l693t2487r776b2554],
7	De	NNP	PERSON	De	nn	9	SENT_324	[p19l819t2488r903b2540],
8	Moerloose	NNP	PERSON	Moerloose	nn	9	SENT_324	[p19l943t2487r1245b2540],
9	P	NN	PERSON	p	appos	2	SENT_324	[p19l1286t2488r1342b2551],
10	,	,	O	,	_	0	SENT_324	[p19l1286t2488r1342b2551],
11	Gaussem	NNP	O	Gaussem	nn	13	SENT_324	[p19l1386t2487r1645b2540],
12	P.	NNP	O	P.	nn	13	SENT_324	[p19l1685t2488r1740b2540],
13	Inﬂuence	NNP	O	Inﬂuence	appos	2	SENT_324	[p19l1783t2487r2047b2540],
14	of	IN	O	of	_	0	SENT_324	[p19l2089t2487r2152b2540],
15	CYPZC19	NN	O	cypzc19	nn	19	SENT_324	[p19l118t2566r415b2620],
16	and	CC	O	and	_	0	SENT_324	[p19l445t2566r547b2619],
17	CYP3A4	NN	O	cyp3a4	nn	19	SENT_324	[p19l575t2565r839b2620],
18	gene	NN	O	gene	nn	19	SENT_324	[p19l865t2587r995b2638],
19	polymorphisms	NNS	O	polymorphism	prep_of	13	SENT_324	[p19l1022t2566r1459b2638],
20	on	IN	O	on	_	0	SENT_324	[p19l1488t2587r1558b2619],
21	clopidogrel	NN	O	clopidogrel	nn	22	SENT_324	[p19l1585t2566r1901b2638],
22	responsiveness	NN	O	responsiveness	prep_on	13	SENT_324	[p19l1927t2587r2140b2638, p19l118t2649r337b2699],
23	in	IN	O	in	_	0	SENT_324	[p19l365t2649r419b2699],
24	healthy	JJ	O	healthy	amod	25	SENT_324	[p19l445t2646r655b2718],
25	subjects	NNS	O	subject	prep_in	22	SENT_324	[p19l680t2646r913b2718],
26	.	.	O	.	_	0	SENT_324	[p19l680t2646r913b2718],

1	J	NNP	O	J	nn	3	SENT_325	[p19l935t2647r964b2714],
2	Thromb	NNP	O	Thromb	nn	3	SENT_325	[p19l988t2645r1227b2699],
3	Haemost	NNP	O	Haemost	_	0	SENT_325	[p19l1256t2647r1516b2699],
4	2007	CD	DATE	2007	num	3	SENT_325	[p19l1540t2646r1981b2711],
5	;	:	O	;	_	0	SENT_325	[p19l1540t2646r1981b2711],
6	5:2153	CD	NUMBER	5:2153	number	7	SENT_325	[p19l1540t2646r1981b2711],
7	—	CD	NUMBER	—	dep	3	SENT_325	[p19l1540t2646r1981b2711],
8	5	CD	NUMBER	5	dep	7	SENT_325	[p19l1540t2646r1981b2711],
9	.	.	O	.	_	0	SENT_325	[p19l1540t2646r1981b2711],

1	JACC	NN	O	jacc	_	0	SENT_326	[p19l7t2733r157b2764],
2	:	:	O	:	_	0	SENT_326	[p19l7t2733r157b2764],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_326	[p19l194t2733r694b2764],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_326	[p19l731t2733r1191b2769],
5	,	,	O	,	_	0	SENT_326	[p19l731t2733r1191b2769],
6	VOL	NNP	O	VOL	appos	4	SENT_326	[p19l1227t2733r1349b2764],
7	.	.	O	.	_	0	SENT_326	[p19l1227t2733r1349b2764],

1	1	CD	NUMBER	1	_	0	SENT_327	[p19l1388t2734r1429b2769],
2	,	,	O	,	_	0	SENT_327	[p19l1388t2734r1429b2769],
3	NO.	NNP	O	NO.	appos	1	SENT_327	[p19l1468t2733r1558b2764],
4	6	CD	NUMBER	6	num	3	SENT_327	[p19l1594t2734r1638b2768],
5	,	,	O	,	_	0	SENT_327	[p19l1594t2734r1638b2768],
6	2008	CD	DATE	2008	num	3	SENT_327	[p19l1675t2734r1801b2764],

1	DECEMBER	NN	DATE	december	_	0	SENT_328	[p19l10t2821r295b2852],
2	2008:620	CD	NUMBER	2008:620	num	3	SENT_328	[p19l332t2822r653b2852],
3	—	NN	O	—	dep	1	SENT_328	[p19l332t2822r653b2852],
4	7	CD	NUMBER	7	dep	1	SENT_328	[p19l332t2822r653b2852],

1	11	CD	NUMBER	11	_	0	SENT_329	[p19l12t3016r92b3066],
2	.	.	O	.	_	0	SENT_329	[p19l12t3016r92b3066],

1	Lau	NNP	PERSON	Lau	nn	2	SENT_330	[p19l117t3014r227b3066],
2	WC	NNP	O	WC	_	0	SENT_330	[p19l261t3013r404b3078],
3	,	,	O	,	_	0	SENT_330	[p19l261t3013r404b3078],
4	Gurbel	NNP	ORGANIZATION	Gurbel	nn	5	SENT_330	[p19l445t3013r644b3066],
5	PA	NN	ORGANIZATION	pa	appos	2	SENT_330	[p19l680t3012r789b3078],
6	,	,	O	,	_	0	SENT_330	[p19l680t3012r789b3078],
7	Watkins	NNP	ORGANIZATION	Watkins	nn	8	SENT_330	[p19l824t3013r1068b3066],
8	PB	NN	ORGANIZATION	pb	appos	2	SENT_330	[p19l1106t3014r1209b3078],
9	,	,	O	,	_	0	SENT_330	[p19l1106t3014r1209b3078],
10	et	FW	O	et	nn	11	SENT_330	[p19l1249t3027r1300b3066],
11	al.	FW	O	al.	appos	2	SENT_330	[p19l1336t3013r1395b3066],
12	.	.	O	.	_	0	SENT_330	[p19l1336t3013r1395b3066],

1	Contribution	NN	O	contribution	_	0	SENT_331	[p19l1437t3013r1812b3066],
2	of	IN	O	of	_	0	SENT_331	[p19l1849t3013r1913b3066],
3	hepatic	JJ	O	hepatic	amod	6	SENT_331	[p19l1939t3013r2144b3085],
4	cytochrome	NN	O	cytochrome	nn	6	SENT_331	[p19l117t3095r447b3167],
5	P450	NN	O	p450	nn	6	SENT_331	[p19l494t3095r641b3148],
6	3A4	NN	O	3a4	prep_of	1	SENT_331	[p19l689t3094r810b3148],
7	metabolic	JJ	O	metabolic	amod	8	SENT_331	[p19l857t3095r1133b3148],
8	activity	NN	O	activity	dep	1	SENT_331	[p19l1181t3097r1385b3167],
9	to	TO	O	to	_	0	SENT_331	[p19l1429t3109r1483b3148],
10	the	DT	O	the	det	11	SENT_331	[p19l1531t3095r1619b3148],
11	phenomenon	NN	O	phenomenon	prep_to	8	SENT_331	[p19l1666t3095r2041b3167],
12	of	IN	O	of	_	0	SENT_331	[p19l2089t3095r2153b3148],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_331	[p19l117t3177r433b3249],
14	resistance	NN	O	resistance	prep_of	11	SENT_331	[p19l459t3180r745b3230],
15	.	.	O	.	_	0	SENT_331	[p19l459t3180r745b3230],

1	Circulation	NN	O	circulation	_	0	SENT_332	[p19l777t3177r1098b3231],
2	2004	CD	DATE	2004	num	1	SENT_332	[p19l1123t3180r1512b3242],
3	;	:	O	;	_	0	SENT_332	[p19l1123t3180r1512b3242],
4	109:166	CD	NUMBER	109:166	number	5	SENT_332	[p19l1123t3180r1512b3242],
5	-71	CD	NUMBER	-71	dep	1	SENT_332	[p19l1524t3179r1644b3231],
6	.	.	O	.	_	0	SENT_332	[p19l1524t3179r1644b3231],

1	12	CD	NUMBER	12	_	0	SENT_333	[p19l12t3262r92b3314],
2	.	.	O	.	_	0	SENT_333	[p19l12t3262r92b3314],

1	Wang	NNP	PERSON	Wang	nn	2	SENT_334	[p19l114t3260r292b3331],
2	A	NNP	O	A	_	0	SENT_334	[p19l314t3259r382b3325],
3	,	,	O	,	_	0	SENT_334	[p19l314t3259r382b3325],
4	Yu	NNP	O	Yu	nn	5	SENT_334	[p19l406t3260r491b3313],
5	BN	NNP	O	BN	appos	2	SENT_334	[p19l516t3260r632b3325],
6	,	,	O	,	_	0	SENT_334	[p19l516t3260r632b3325],
7	Luo	NNP	PERSON	Luo	nn	8	SENT_334	[p19l661t3260r774b3313],
8	CH	NN	O	ch	appos	2	SENT_334	[p19l803t3260r928b3325],
9	,	,	O	,	_	0	SENT_334	[p19l803t3260r928b3325],
10	et	FW	O	et	nn	11	SENT_334	[p19l956t3274r1007b3313],
11	al.	FW	O	al.	appos	2	SENT_334	[p19l1032t3260r1091b3313],
12	.	.	O	.	_	0	SENT_334	[p19l1032t3260r1091b3313],

1	Ile118Val	JJ	O	ile118val	amod	3	SENT_335	[p19l1120t3260r1399b3313],
2	genetic	JJ	O	genetic	amod	3	SENT_335	[p19l1422t3262r1625b3331],
3	polymorphism	NN	O	polymorphism	_	0	SENT_335	[p19l1649t3260r2062b3332],
4	of	IN	O	of	_	0	SENT_335	[p19l2089t3260r2152b3313],
5	CYP3A4	NN	O	cyp3a4	prep_of	3	SENT_335	[p19l118t3340r382b3394],
6	and	CC	O	and	_	0	SENT_335	[p19l418t3341r520b3394],
7	its	PRP$	O	its	poss	8	SENT_335	[p19l555t3343r618b3394],
8	effects	NNS	O	effect	prep_of	3	SENT_335	[p19l655t3341r826b3394],
9	on	IN	O	on	_	0	SENT_335	[p19l863t3362r933b3394],
10	lipid-lowering	JJ	O	lipid-lowering	amod	11	SENT_335	[p19l967t3341r1374b3413],
11	eﬂicacy	NN	O	eﬂicacy	prep_on	3	SENT_335	[p19l1409t3341r1613b3412],
12	of	IN	O	of	_	0	SENT_335	[p19l1646t3341r1710b3394],
13	simvastatin	NN	O	simvastatin	prep_of	11	SENT_335	[p19l1737t3343r2054b3394],
14	in	IN	O	in	_	0	SENT_335	[p19l2089t3343r2143b3393],
15	Chinese	JJ	MISC	chinese	amod	17	SENT_335	[p19l118t3423r348b3476],
16	hyperlipidemic	JJ	O	hyperlipidemic	amod	17	SENT_335	[p19l395t3423r819b3495],
17	patients	NNS	O	patient	prep_in	3	SENT_335	[p19l864t3425r1102b3495],
18	.	.	O	.	_	0	SENT_335	[p19l864t3425r1102b3495],

1	Eur	NNP	MISC	Eur	nn	4	SENT_336	[p19l1153t3424r1260b3476],
2	J	NNP	O	J	nn	4	SENT_336	[p19l1298t3424r1326b3491],
3	Clin	NNP	O	Clin	nn	4	SENT_336	[p19l1374t3423r1498b3476],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_336	[p19l1545t3423r1850b3476],
5	2005	CD	DATE	2005	num	4	SENT_336	[p19l1894t3423r2139b3488],
6	;	:	O	;	_	0	SENT_336	[p19l1894t3423r2139b3488],
7	60	CD	NUMBER	60	num	9	SENT_336	[p19l1894t3423r2139b3488],
8	:	:	O	:	_	0	SENT_336	[p19l1894t3423r2139b3488],
9	843-8	CD	NUMBER	843-8	dep	4	SENT_336	[p19l119t3508r315b3558],
10	.	.	O	.	_	0	SENT_336	[p19l119t3508r315b3558],

1	13	CD	NUMBER	13	_	0	SENT_337	[p20l12t24r92b74],
2	.	.	O	.	_	0	SENT_337	[p20l12t24r92b74],

1	Hesselink	NNP	ORGANIZATION	Hesselink	nn	2	SENT_338	[p20l117t22r399b74],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_338	[p20l432t20r555b86],
3	,	,	O	,	_	0	SENT_338	[p20l432t20r555b86],
4	van	NNP	PERSON	van	nn	6	SENT_338	[p20l590t42r689b74],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_338	[p20l727t21r916b74],
6	RH	NNP	O	RH	appos	2	SENT_338	[p20l950t22r1072b86],
7	,	,	O	,	_	0	SENT_338	[p20l950t22r1072b86],
8	van	NNP	PERSON	van	nn	11	SENT_338	[p20l1107t42r1206b74],
9	der	NNP	PERSON	der	nn	11	SENT_338	[p20l1242t22r1331b74],
10	Heiden	NNP	PERSON	Heiden	nn	11	SENT_338	[p20l1366t22r1578b74],
11	IP	NNP	O	IP	appos	2	SENT_338	[p20l1612t22r1696b86],
12	,	,	O	,	_	0	SENT_338	[p20l1612t22r1696b86],
13	et	FW	O	et	nn	14	SENT_338	[p20l1734t35r1785b74],
14	al.	FW	O	al.	appos	2	SENT_338	[p20l1820t22r1879b74],
15	.	.	O	.	_	0	SENT_338	[p20l1820t22r1879b74],

1	Genetic	JJ	O	genetic	amod	2	SENT_339	[p20l1919t21r2144b74],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_339	[p20l116t103r553b174],
3	of	IN	O	of	_	0	SENT_339	[p20l590t103r654b156],
4	the	DT	O	the	det	7	SENT_339	[p20l679t103r767b156],
5	CYP3A4	NN	O	cyp3a4	nn	7	SENT_339	[p20l804t102r1083b168],
6	,	,	O	,	_	0	SENT_339	[p20l804t102r1083b168],
7	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_339	[p20l1122t102r1401b168],
8	,	,	O	,	_	0	SENT_339	[p20l1122t102r1401b168],
9	and	CC	O	and	_	0	SENT_339	[p20l1440t103r1541b156],
10	MDR	NN	O	mdr	nn	11	SENT_339	[p20l1575t103r1811b155],
11	—	NN	O	—	prep_of	2	SENT_339	[p20l1575t103r1811b155],
12	1	CD	NUMBER	1	num	13	SENT_339	[p20l1575t103r1811b155],
13	genes	NNS	O	gene	dep	2	SENT_339	[p20l1849t124r2004b174],
14	and	CC	O	and	_	0	SENT_339	[p20l2042t103r2144b156],
15	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_339	[p20l116t184r614b256],
16	of	IN	O	of	_	0	SENT_339	[p20l636t184r700b237],
17	the	DT	O	the	det	20	SENT_339	[p20l711t184r799b237],
18	calcineurin	NN	O	calcineurin	nn	20	SENT_339	[p20l821t184r1129b237],
19	inhibitors	NNS	O	inhibitor	nn	20	SENT_339	[p20l1150t184r1422b237],
20	cyclosporine	NN	O	cyclosporine	prep_of	13	SENT_339	[p20l1445t184r1793b256],
21	and	CC	O	and	_	0	SENT_339	[p20l1815t184r1917b237],
22	tacroli	JJ	O	tacroli	amod	24	SENT_339	[p20l1937t184r2140b237],
23	—	NN	O	—	nn	24	SENT_339	[p20l1937t184r2140b237],
24	mus	NN	O	mu	prep_of	13	SENT_339	[p20l117t287r247b319],
25	.	.	O	.	_	0	SENT_339	[p20l117t287r247b319],

1	Clin	NNP	O	Clin	nn	3	SENT_340	[p20l278t266r402b319],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_340	[p20l429t266r735b319],
3	Ther	NNP	O	Ther	_	0	SENT_340	[p20l758t265r901b319],
4	2003	CD	DATE	2003	num	3	SENT_340	[p20l925t266r1402b330],
5	;	:	O	;	_	0	SENT_340	[p20l925t266r1402b330],
6	74:245	CD	NUMBER	74:245	number	7	SENT_340	[p20l925t266r1402b330],
7	—	CD	NUMBER	—	dep	3	SENT_340	[p20l925t266r1402b330],
8	54	CD	NUMBER	54	dep	7	SENT_340	[p20l925t266r1402b330],
9	.	.	O	.	_	0	SENT_340	[p20l925t266r1402b330],

1	14	CD	NUMBER	14	_	0	SENT_341	[p20l12t350r92b400],
2	.	.	O	.	_	0	SENT_341	[p20l12t350r92b400],

1	Hesselink	NNP	ORGANIZATION	Hesselink	nn	2	SENT_342	[p20l117t347r399b400],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_342	[p20l439t346r563b412],
3	,	,	O	,	_	0	SENT_342	[p20l439t346r563b412],
4	van	NNP	PERSON	van	nn	6	SENT_342	[p20l605t368r704b401],
5	Gelder	NNP	PERSON	Gelder	nn	6	SENT_342	[p20l748t347r944b401],
6	T	NN	PERSON	t	appos	2	SENT_342	[p20l982t346r1048b412],
7	,	,	O	,	_	0	SENT_342	[p20l982t346r1048b412],
8	van	NN	PERSON	van	nn	10	SENT_342	[p20l1090t368r1189b401],
9	Schaik	NNP	PERSON	Schaik	nn	10	SENT_342	[p20l1234t347r1424b401],
10	RH	NNP	O	RH	appos	2	SENT_342	[p20l1465t348r1586b412],
11	,	,	O	,	_	0	SENT_342	[p20l1465t348r1586b412],
12	et	FW	O	et	nn	13	SENT_342	[p20l1632t361r1683b400],
13	al.	FW	O	al.	appos	2	SENT_342	[p20l1725t347r1785b400],
14	.	.	O	.	_	0	SENT_342	[p20l1725t347r1785b400],

1	Population	NNP	O	Population	_	0	SENT_343	[p20l1831t347r2143b419],
2	pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_343	[p20l116t431r614b502],
3	of	IN	O	of	_	0	SENT_343	[p20l639t430r703b484],
4	cyclosporine	NN	O	cyclosporine	prep_of	2	SENT_343	[p20l717t431r1065b502],
5	in	IN	O	in	_	0	SENT_343	[p20l1089t433r1143b483],
6	kidney	NN	O	kidney	nn	10	SENT_343	[p20l1167t430r1357b502],
7	and	CC	O	and	_	0	SENT_343	[p20l1379t431r1481b484],
8	heart	NN	O	heart	nn	10	SENT_343	[p20l1504t431r1649b484],
9	transplant	NN	O	transplant	nn	10	SENT_343	[p20l1670t430r1956b502],
10	recipients	NNS	O	recipient	prep_in	4	SENT_343	[p20l1977t433r2141b502, p20l117t541r248b592],

1	and	CC	O	and	_	0	SENT_344	[p20l276t539r378b592],
2	the	DT	O	the	det	3	SENT_344	[p20l403t539r491b592],
3	inﬂuence	NN	O	inﬂuence	_	0	SENT_344	[p20l518t539r774b592],
4	of	IN	O	of	_	0	SENT_344	[p20l802t539r865b592],
5	ethnicity	NN	O	ethnicity	prep_of	3	SENT_344	[p20l882t539r1132b610],
6	and	CC	O	and	_	0	SENT_344	[p20l1156t539r1258b592],
7	genetic	JJ	O	genetic	amod	8	SENT_344	[p20l1282t541r1485b610],
8	polymorphisms	NNS	O	polymorphism	conj_and	3	SENT_344	[p20l1510t539r1947b611],
9	in	IN	O	in	_	0	SENT_344	[p20l1974t541r2029b591],
10	the	DT	O	the	det	12	SENT_344	[p20l2054t539r2142b592],
11	MDR	NN	ORGANIZATION	mdr	nn	12	SENT_344	[p20l115t621r371b685],
12	—	NN	O	—	prep_in	8	SENT_344	[p20l115t621r371b685],
13	1	CD	NUMBER	1	dep	3	SENT_344	[p20l115t621r371b685],
14	,	,	O	,	_	0	SENT_344	[p20l115t621r371b685],
15	CYP3A4	NN	O	cyp3a4	dep	3	SENT_344	[p20l402t619r681b685],
16	,	,	O	,	_	0	SENT_344	[p20l402t619r681b685],
17	and	CC	O	and	_	0	SENT_344	[p20l712t620r814b673],
18	CYP3A5	NN	O	cyp3a5	nn	19	SENT_344	[p20l842t619r1103b673],
19	genes	NNS	O	gene	conj_and	13	SENT_344	[p20l1132t641r1303b691],
20	.	.	O	.	_	0	SENT_344	[p20l1132t641r1303b691],

1	Clin	NNP	O	Clin	nn	3	SENT_345	[p20l1336t620r1459b673],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_345	[p20l1486t620r1792b673],
3	Ther	NNP	O	Ther	_	0	SENT_345	[p20l1815t619r1960b673],
4	2004	CD	DATE	2004	num	3	SENT_345	[p20l1984t623r2140b685],
5	;	:	O	;	_	0	SENT_345	[p20l1984t623r2140b685],
6	762545-56	CD	NUMBER	762545-56	dep	3	SENT_345	[p20l118t703r431b756],
7	.	.	O	.	_	0	SENT_345	[p20l118t703r431b756],

1	15	CD	NUMBER	15	_	0	SENT_346	[p20l12t784r92b837],
2	.	.	O	.	_	0	SENT_346	[p20l12t784r92b837],

1	van	NN	PERSON	van	nn	3	SENT_347	[p20l114t805r213b837],
2	Schaik	NNP	PERSON	Schaik	nn	3	SENT_347	[p20l248t784r438b837],
3	RH	NNP	O	RH	dep	26	SENT_347	[p20l469t785r590b848],
4	,	,	O	,	_	0	SENT_347	[p20l469t785r590b848],
5	de	NNP	O	de	nn	7	SENT_347	[p20l626t784r690b837],
6	Wildt	NNP	O	Wildt	nn	7	SENT_347	[p20l720t784r894b837],
7	SN	NNP	O	SN	appos	3	SENT_347	[p20l928t784r1034b849],
8	,	,	O	,	_	0	SENT_347	[p20l928t784r1034b849],
9	Brosens	NNP	ORGANIZATION	Brosens	nn	10	SENT_347	[p20l1069t785r1290b837],
10	R	NNP	ORGANIZATION	R	appos	3	SENT_347	[p20l1326t785r1387b848],
11	,	,	O	,	_	0	SENT_347	[p20l1326t785r1387b848],
12	van	NNP	PERSON	van	nn	14	SENT_347	[p20l1420t805r1519b837],
13	Fessem	NNP	PERSON	Fessem	nn	14	SENT_347	[p20l1552t785r1760b837],
14	M	NN	PERSON	m	appos	3	SENT_347	[p20l1792t785r1876b848],
15	,	,	O	,	_	0	SENT_347	[p20l1792t785r1876b848],
16	van	NN	O	van	nn	17	SENT_347	[p20l1908t805r2008b837],
17	den	NN	O	den	appos	3	SENT_347	[p20l2041t784r2143b837],
18	Anker	NNP	ORGANIZATION	Anker	nn	19	SENT_347	[p20l115t864r296b919],
19	JN	NN	ORGANIZATION	jn	dep	17	SENT_347	[p20l315t866r415b933],
20	,	,	O	,	_	0	SENT_347	[p20l315t866r415b933],
21	Lindemans	NNP	PERSON	Lindemans	appos	3	SENT_347	[p20l446t866r764b919],
22	r	NN	O	r	dep	26	SENT_347	[p20l786t866r828b933],
23	*	CD	NUMBER	*	num	22	SENT_347	[p20l786t866r828b933],
24	The	DT	O	the	det	26	SENT_347	[p20l857t864r975b919],
25	CYP3A4	NN	O	cyp3a4	nn	26	SENT_347	[p20l1005t864r1324b919],
26	*	NN	O	*	dep	31	SENT_347	[p20l1005t864r1324b919],
27	3	CD	NUMBER	3	num	28	SENT_347	[p20l1005t864r1324b919],
28	allele	NN	O	allele	dep	26	SENT_347	[p20l1356t866r1512b919],
29	:	:	O	:	_	0	SENT_347	[p20l1356t866r1512b919],
30	is	VBZ	O	be	cop	31	SENT_347	[p20l1544t868r1584b919],
31	it	PRP	O	it	_	0	SENT_347	[p20l1613t868r1653b919],
32	really	RB	O	really	advmod	33	SENT_347	[p20l1679t865r1833b937],
33	rare	JJ	O	rare	amod	31	SENT_347	[p20l1857t868r1989b919],
34	?	.	O	?	_	0	SENT_347	[p20l1857t868r1989b919],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_348	[p20l2019t865r2143b919],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_348	[p20l118t948r292b1000],
3	2001	CD	DATE	2001	num	2	SENT_348	[p20l318t949r812b1012],
4	;	:	O	;	_	0	SENT_348	[p20l318t949r812b1012],
5	47:1104	CD	NUMBER	47:1104	number	6	SENT_348	[p20l318t949r812b1012],
6	-6	CD	NUMBER	-6	dep	2	SENT_348	[p20l318t949r812b1012],
7	.	.	O	.	_	0	SENT_348	[p20l318t949r812b1012],

1	16	CD	NUMBER	16	_	0	SENT_349	[p20l12t1031r92b1081],
2	.	.	O	.	_	0	SENT_349	[p20l12t1031r92b1081],

1	van	NN	PERSON	van	_	0	SENT_350	[p20l114t1049r213b1081],
2	Schaik	NNP	PERSON	Schaik	nn	3	SENT_350	[p20l241t1028r430b1081],
3	RH	NNP	O	RH	dep	1	SENT_350	[p20l454t1029r575b1093],
4	,	,	O	,	_	0	SENT_350	[p20l454t1029r575b1093],
5	de	NNP	PERSON	de	nn	7	SENT_350	[p20l604t1028r667b1081],
6	Wildt	NNP	PERSON	Wildt	nn	7	SENT_350	[p20l689t1028r863b1082],
7	SN	NNP	O	SN	appos	3	SENT_350	[p20l889t1028r995b1093],
8	,	,	O	,	_	0	SENT_350	[p20l889t1028r995b1093],
9	van	NNP	O	van	nn	11	SENT_350	[p20l1020t1049r1119b1081],
10	Iperen	NNP	ORGANIZATION	Iperen	nn	11	SENT_350	[p20l1144t1029r1327b1100],
11	NM	NNP	ORGANIZATION	NM	appos	3	SENT_350	[p20l1352t1029r1492b1093],
12	,	,	O	,	_	0	SENT_350	[p20l1352t1029r1492b1093],
13	Uitterlinden	NNP	ORGANIZATION	Uitterlinden	nn	14	SENT_350	[p20l1518t1028r1870b1081],
14	AG	NNP	ORGANIZATION	AG	appos	3	SENT_350	[p20l1893t1027r2019b1093],
15	,	,	O	,	_	0	SENT_350	[p20l1893t1027r2019b1093],
16	van	NNP	O	van	nn	18	SENT_350	[p20l2044t1049r2143b1081],
17	den	NN	O	den	nn	18	SENT_350	[p20l117t1110r219b1163],
18	Anker	NNP	ORGANIZATION	Anker	appos	3	SENT_350	[p20l243t1109r425b1163],
19	JN	NN	ORGANIZATION	jn	dep	18	SENT_350	[p20l442t1111r542b1178],
20	,	,	O	,	_	0	SENT_350	[p20l442t1111r542b1178],
21	Lindemans	NNP	O	Lindemans	nn	22	SENT_350	[p20l572t1110r889b1163],
22	CYP3A4	NNP	O	CYP3A4	appos	3	SENT_350	[p20l983t1109r1329b1164],
23	.	.	O	.	_	0	SENT_350	[p20l983t1109r1329b1164],

1	—	NN	O	—	_	0	SENT_351	[p20l983t1109r1329b1164],
2	.	.	O	.	_	0	SENT_351	[p20l983t1109r1329b1164],

1	V	NN	O	v	nn	3	SENT_352	[p20l983t1109r1329b1164],
2	polymorphism	NN	O	polymorphism	nn	3	SENT_352	[p20l1351t1110r1764b1182],
3	detection	NN	O	detection	_	0	SENT_352	[p20l1792t1110r2053b1163],
4	by	IN	O	by	_	0	SENT_352	[p20l2077t1110r2146b1182],
5	PCR-restriction	NN	O	pcr-restriction	nn	9	SENT_352	[p20l117t1192r579b1246],
6	fragment	NN	O	fragment	nn	9	SENT_352	[p20l603t1192r862b1264],
7	length	NN	O	length	nn	9	SENT_352	[p20l884t1192r1064b1264],
8	polymorphism	NN	O	polymorphism	nn	9	SENT_352	[p20l1088t1192r1501b1264],
9	analysis	NN	O	analysis	prep_by	3	SENT_352	[p20l1527t1192r1740b1264],
10	and	CC	O	and	_	0	SENT_352	[p20l1767t1192r1869b1245],
11	its	PRP$	O	its	poss	13	SENT_352	[p20l1893t1195r1956b1245],
12	allelic	JJ	O	allelic	amod	13	SENT_352	[p20l1983t1192r2143b1245],
13	frequency	NN	O	frequency	prep_by	3	SENT_352	[p20l116t1274r394b1346],
14	among	IN	O	among	_	0	SENT_352	[p20l413t1295r606b1346],
15	199	CD	NUMBER	199	num	17	SENT_352	[p20l628t1277r727b1328],
16	Dutch	JJ	MISC	dutch	amod	17	SENT_352	[p20l749t1275r931b1328],
17	Caucasians	NNPS	MISC	Caucasians	prep_among	3	SENT_352	[p20l953t1274r1280b1328],
18	.	.	O	.	_	0	SENT_352	[p20l953t1274r1280b1328],

1	Clin	NNP	ORGANIZATION	Clin	nn	2	SENT_353	[p20l1306t1274r1430b1328],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_353	[p20l1452t1274r1626b1328],
3	2000	CD	DATE	2000	num	2	SENT_353	[p20l1646t1277r2139b1340],
4	;	:	O	;	_	0	SENT_353	[p20l1646t1277r2139b1340],
5	46:1834	CD	NUMBER	46:1834	number	6	SENT_353	[p20l1646t1277r2139b1340],
6	—	CD	NUMBER	—	dep	2	SENT_353	[p20l1646t1277r2139b1340],
7	6	CD	NUMBER	6	dep	6	SENT_353	[p20l1646t1277r2139b1340],
8	.	.	O	.	_	0	SENT_353	[p20l1646t1277r2139b1340],

1	17	CD	NUMBER	17	_	0	SENT_354	[p20l12t1358r92b1410],
2	.	.	O	.	_	0	SENT_354	[p20l12t1358r92b1410],

1	Angiolillo	NN	O	angiolillo	nn	3	SENT_355	[p20l115t1356r401b1428],
2	D	NN	O	d	nn	3	SENT_355	[p20l427t1357r521b1425],
3	]	NN	O	]	_	0	SENT_355	[p20l427t1357r521b1425],
4	,	,	O	,	_	0	SENT_355	[p20l427t1357r521b1425],
5	Fernandez	NNP	PERSON	Fernandez	appos	3	SENT_355	[p20l548t1357r1033b1410],
6	.	.	O	.	_	0	SENT_355	[p20l548t1357r1033b1410],

1	—	NN	O	—	_	0	SENT_356	[p20l548t1357r1033b1410],
2	.	.	O	.	_	0	SENT_356	[p20l548t1357r1033b1410],

1	Ortiz	NNP	PERSON	Ortiz	nn	2	SENT_357	[p20l548t1357r1033b1410],
2	A	NNP	O	A	_	0	SENT_357	[p20l1053t1356r1121b1422],
3	,	,	O	,	_	0	SENT_357	[p20l1053t1356r1121b1422],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_357	[p20l1148t1357r1411b1410],
5	E	NNP	PERSON	E	appos	2	SENT_357	[p20l1437t1357r1498b1422],
6	,	,	O	,	_	0	SENT_357	[p20l1437t1357r1498b1422],
7	et	FW	O	et	nn	8	SENT_357	[p20l1526t1371r1576b1410],
8	al.	FW	O	al.	appos	5	SENT_357	[p20l1600t1357r1660b1410],
9	.	.	O	.	_	0	SENT_357	[p20l1600t1357r1660b1410],

1	Contribution	NN	O	contribution	_	0	SENT_358	[p20l1689t1357r2064b1410],
2	of	IN	O	of	_	0	SENT_358	[p20l2089t1357r2153b1410],
3	gene	NN	O	gene	nn	5	SENT_358	[p20l116t1459r246b1509],
4	sequence	NN	O	sequence	nn	5	SENT_358	[p20l271t1459r522b1510],
5	variations	NNS	O	variation	prep_of	1	SENT_358	[p20l543t1440r817b1491],
6	of	IN	O	of	_	0	SENT_358	[p20l843t1438r907b1491],
7	the	DT	O	the	det	12	SENT_358	[p20l920t1438r1008b1491],
8	hepatic	JJ	O	hepatic	amod	12	SENT_358	[p20l1032t1438r1236b1510],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_358	[p20l1260t1438r1589b1509],
10	P450	NN	O	p450	nn	12	SENT_358	[p20l1613t1438r1760b1491],
11	3A4	NN	O	3a4	nn	12	SENT_358	[p20l1784t1437r1905b1491],
12	enzyme	NN	O	enzyme	prep_of	1	SENT_358	[p20l1929t1459r2143b1509],
13	to	TO	O	to	_	0	SENT_358	[p20l116t1534r171b1573],
14	variability	NN	O	variability	prep_to	12	SENT_358	[p20l201t1520r485b1592],
15	in	IN	O	in	_	0	SENT_358	[p20l513t1523r568b1573],
16	individual	JJ	O	individual	amod	17	SENT_358	[p20l599t1520r882b1573],
17	responsiveness	NN	O	responsiveness	prep_in	1	SENT_358	[p20l913t1523r1323b1592],
18	to	TO	O	to	_	0	SENT_358	[p20l1356t1534r1411b1573],
19	clopidogrel	NN	O	clopidogrel	prep_to	17	SENT_358	[p20l1444t1520r1774b1592],
20	.	.	O	.	_	0	SENT_358	[p20l1444t1520r1774b1592],

1	Arterioscler	NN	O	arterioscler	_	0	SENT_359	[p20l1807t1519r2144b1573],

1	Thromb	NNP	O	Thromb	nn	3	SENT_360	[p20l114t1618r354b1672],
2	Vasc	NNP	O	Vasc	nn	3	SENT_360	[p20l382t1620r515b1672],
3	Biol	NNP	O	Biol	_	0	SENT_360	[p20l541t1619r659b1672],
4	2006	CD	DATE	2006	num	3	SENT_360	[p20l683t1619r1230b1683],
5	;	:	O	;	_	0	SENT_360	[p20l683t1619r1230b1683],
6	26:1895	CD	NUMBER	26:1895	num	7	SENT_360	[p20l683t1619r1230b1683],
7	—	NN	O	—	dep	3	SENT_360	[p20l683t1619r1230b1683],
8	900	CD	NUMBER	900	dep	7	SENT_360	[p20l683t1619r1230b1683],
9	.	.	O	.	_	0	SENT_360	[p20l683t1619r1230b1683],

1	18	CD	NUMBER	18	_	0	SENT_361	[p20l12t1703r92b1754],
2	.	.	O	.	_	0	SENT_361	[p20l12t1703r92b1754],

1	Kuehl	NNP	PERSON	Kuehl	nn	2	SENT_362	[p20l119t1701r288b1754],
2	P	NN	O	p	_	0	SENT_362	[p20l334t1701r390b1766],
3	,	,	O	,	_	0	SENT_362	[p20l334t1701r390b1766],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_362	[p20l439t1701r628b1772],
5	J	NNP	PERSON	J	appos	2	SENT_362	[p20l665t1701r709b1768],
6	,	,	O	,	_	0	SENT_362	[p20l665t1701r709b1768],
7	Lin	NNP	O	Lin	nn	8	SENT_362	[p20l758t1701r858b1753],
8	Y	NN	O	y	appos	2	SENT_362	[p20l901t1701r964b1765],
9	,	,	O	,	_	0	SENT_362	[p20l901t1701r964b1765],
10	et	FW	O	et	nn	11	SENT_362	[p20l1013t1714r1064b1754],
11	al.	FW	O	al.	appos	2	SENT_362	[p20l1110t1701r1169b1754],
12	.	.	O	.	_	0	SENT_362	[p20l1110t1701r1169b1754],

1	Sequence	NN	O	sequence	nn	2	SENT_363	[p20l1221t1700r1484b1772],
2	diversity	NN	O	diversity	_	0	SENT_363	[p20l1531t1700r1771b1772],
3	in	IN	O	in	_	0	SENT_363	[p20l1813t1703r1868b1753],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_363	[p20l1915t1699r2145b1754],
5	promoters	NNS	O	promoter	prep_in	2	SENT_363	[p20l116t1798r404b1856],
6	and	CC	O	and	_	0	SENT_363	[p20l443t1784r545b1837],
7	characterization	NN	O	characterization	prep_in	2	SENT_363	[p20l582t1784r1033b1837],
8	of	IN	O	of	_	0	SENT_363	[p20l1070t1784r1134b1837],
9	the	DT	O	the	det	11	SENT_363	[p20l1161t1784r1248b1837],
10	genetic	JJ	O	genetic	amod	11	SENT_363	[p20l1285t1786r1488b1855],
11	basis	NN	O	basis	prep_of	2	SENT_363	[p20l1522t1784r1655b1837],
12	of	IN	O	of	_	0	SENT_363	[p20l1694t1784r1758b1837],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_363	[p20l1783t1784r2144b1855],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_363	[p20l118t1864r379b1918],
15	expression	NN	O	expression	prep_of	11	SENT_363	[p20l409t1867r715b1937],
16	.	.	O	.	_	0	SENT_363	[p20l409t1867r715b1937],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_364	[p20l745t1866r854b1918],
2	Genet	NNP	PERSON	Genet	_	0	SENT_364	[p20l881t1865r1057b1918],
3	2001	CD	DATE	2001	num	2	SENT_364	[p20l1081t1866r1557b1930],
4	;	:	O	;	_	0	SENT_364	[p20l1081t1866r1557b1930],
5	27:383	CD	NUMBER	27:383	number	6	SENT_364	[p20l1081t1866r1557b1930],
6	—	CD	NUMBER	—	dep	2	SENT_364	[p20l1081t1866r1557b1930],
7	91	CD	NUMBER	91	dep	6	SENT_364	[p20l1081t1866r1557b1930],
8	.	.	O	.	_	0	SENT_364	[p20l1081t1866r1557b1930],

1	19	CD	NUMBER	19	_	0	SENT_365	[p20l12t1950r92b2000],
2	.	.	O	.	_	0	SENT_365	[p20l12t1950r92b2000],

1	Sim	NNP	PERSON	Sim	nn	2	SENT_366	[p20l119t1947r228b2000],
2	SC	NNP	O	SC	_	0	SENT_366	[p20l251t1947r353b2012],
3	,	,	O	,	_	0	SENT_366	[p20l251t1947r353b2012],
4	Risinger	NNP	PERSON	Risinger	nn	5	SENT_366	[p20l377t1948r614b2019],
5	C	NNP	O	C	appos	2	SENT_366	[p20l633t1947r697b2012],
6	,	,	O	,	_	0	SENT_366	[p20l633t1947r697b2012],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_366	[p20l719t1947r862b2000],
8	ML	NNP	O	ML	appos	2	SENT_366	[p20l879t1948r1010b2012],
9	,	,	O	,	_	0	SENT_366	[p20l879t1948r1010b2012],
10	et	FW	O	et	nn	11	SENT_366	[p20l1033t1961r1084b2000],
11	al.	FW	O	al.	appos	2	SENT_366	[p20l1103t1947r1162b2000],
12	.	.	O	.	_	0	SENT_366	[p20l1103t1947r1162b2000],

1	A	DT	O	a	det	5	SENT_367	[p20l1183t1946r1236b2000],
2	common	JJ	O	common	amod	5	SENT_367	[p20l1255t1968r1504b2000],
3	novel	JJ	O	novel	amod	5	SENT_367	[p20l1525t1947r1674b2000],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_367	[p20l1694t1947r1992b2001],
5	gene	NN	O	gene	_	0	SENT_367	[p20l2012t1968r2143b2019],
6	variant	JJ	O	variant	amod	7	SENT_367	[p20l114t2032r311b2083],
7	causes	NNS	O	cause	dep	5	SENT_367	[p20l346t2050r518b2082],
8	ultrarapid	JJ	O	ultrarapid	amod	10	SENT_367	[p20l555t2029r832b2101],
9	drug	NN	O	drug	nn	10	SENT_367	[p20l869t2029r998b2101],
10	metabolism	NN	O	metabolism	nsubj	17	SENT_367	[p20l1034t2029r1362b2082],
11	relevant	JJ	O	relevant	amod	10	SENT_367	[p20l1399t2029r1622b2082],
12	for	IN	O	for	_	0	SENT_367	[p20l1657t2029r1738b2082],
13	the	DT	O	the	det	15	SENT_367	[p20l1772t2029r1860b2082],
14	drug	NN	O	drug	nn	15	SENT_367	[p20l1898t2029r2028b2101],
15	response	NN	O	response	prep_for	11	SENT_367	[p20l2062t2050r2140b2082, p20l118t2133r304b2184],
16	to	TO	O	to	aux	17	SENT_367	[p20l326t2126r380b2166],
17	proton	VB	O	proton	infmod	5	SENT_367	[p20l402t2126r593b2184],
18	pump	NN	O	pump	nn	19	SENT_367	[p20l613t2133r776b2184],
19	inhibitors	NNS	O	inhibitor	dobj	17	SENT_367	[p20l799t2113r1072b2166],
20	and	CC	O	and	_	0	SENT_367	[p20l1096t2113r1198b2166],
21	antidepressants	NNS	O	antidepressant	dobj	17	SENT_367	[p20l1220t2113r1666b2184],
22	.	.	O	.	_	0	SENT_367	[p20l1220t2113r1666b2184],

1	Clin	NNP	O	Clin	nn	3	SENT_368	[p20l1693t2112r1817b2166],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_368	[p20l1839t2113r2144b2166],
3	Ther	NNP	O	Ther	_	0	SENT_368	[p20l114t2194r258b2248],
4	2006	CD	DATE	2006	num	3	SENT_368	[p20l281t2197r758b2260],
5	;	:	O	;	_	0	SENT_368	[p20l281t2197r758b2260],
6	79:103	CD	NUMBER	79:103	number	7	SENT_368	[p20l281t2197r758b2260],
7	—	CD	NUMBER	—	dep	3	SENT_368	[p20l281t2197r758b2260],
8	13	CD	NUMBER	13	dep	7	SENT_368	[p20l281t2197r758b2260],
9	.	.	O	.	_	0	SENT_368	[p20l281t2197r758b2260],

1	20	CD	NUMBER	20	_	0	SENT_369	[p20l8t2279r92b2330],
2	.	.	O	.	_	0	SENT_369	[p20l8t2279r92b2330],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_370	[p20l117t2276r315b2329],
2	JT	NNP	O	JT	_	0	SENT_370	[p20l340t2274r434b2344],
3	,	,	O	,	_	0	SENT_370	[p20l340t2274r434b2344],
4	Close	NNP	O	Close	nn	5	SENT_370	[p20l472t2276r629b2329],
5	SL	NNP	O	SL	appos	2	SENT_370	[p20l667t2276r763b2341],
6	,	,	O	,	_	0	SENT_370	[p20l667t2276r763b2341],
7	Iturria	NNP	PERSON	Iturria	nn	9	SENT_370	[p20l799t2277r980b2329],
8	S	NNP	O	S	nn	9	SENT_370	[p20l1017t2276r1089b2344],
9	]	NN	O	]	appos	2	SENT_370	[p20l1017t2276r1089b2344],
10	,	,	O	,	_	0	SENT_370	[p20l1017t2276r1089b2344],
11	et	FW	O	et	nn	12	SENT_370	[p20l1126t2290r1177b2329],
12	al.	FW	O	al.	appos	2	SENT_370	[p20l1211t2276r1271b2329],
13	.	.	O	.	_	0	SENT_370	[p20l1211t2276r1271b2329],

1	Common	JJ	O	common	amod	2	SENT_371	[p20l1310t2276r1582b2329],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_371	[p20l1615t2276r2053b2348],
3	of	IN	O	of	_	0	SENT_371	[p20l2089t2276r2152b2329],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_371	[p20l118t2358r415b2412],
5	and	CC	O	and	_	0	SENT_371	[p20l443t2358r545b2411],
6	CYP2C9	NN	O	cyp2c9	prep_of	2	SENT_371	[p20l570t2358r832b2412],
7	affect	VBP	O	affect	_	0	SENT_371	[p20l859t2358r1007b2411],
8	the	DT	O	the	det	14	SENT_371	[p20l1030t2358r1118b2411],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	14	SENT_371	[p20l1142t2358r1616b2430],
10	and	CC	O	and	_	0	SENT_371	[p20l1641t2358r1743b2411],
11	pharmacody	JJ	O	pharmacody	conj_and	9	SENT_371	[p20l1766t2358r2141b2430],
12	—	NN	O	—	nn	14	SENT_371	[p20l1766t2358r2141b2430],
13	namic	JJ	O	namic	amod	14	SENT_371	[p20l117t2444r288b2494],
14	response	NN	O	response	dobj	7	SENT_371	[p20l317t2462r559b2513],
15	to	TO	O	to	_	0	SENT_371	[p20l588t2455r643b2494],
16	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_371	[p20l674t2441r990b2513],
17	but	CC	O	but	_	0	SENT_371	[p20l1016t2441r1111b2494],
18	not	RB	O	not	_	0	SENT_371	[p20l1140t2455r1233b2494],
19	prasugrel	NN	O	prasugrel	conj_negcc	14	SENT_371	[p20l1260t2441r1533b2513],
20	.	.	O	.	_	0	SENT_371	[p20l1260t2441r1533b2513],

1	J	NNP	O	J	nn	3	SENT_372	[p20l1558t2442r1587b2509],
2	Thromb	NNP	O	Thromb	nn	3	SENT_372	[p20l1613t2440r1853b2494],
3	Haemost	NNP	O	Haemost	_	0	SENT_372	[p20l1884t2442r2144b2494],
4	2007	CD	DATE	2007	num	3	SENT_372	[p20l115t2525r600b2589],
5	;	:	O	;	_	0	SENT_372	[p20l115t2525r600b2589],
6	5:2429	CD	NUMBER	5:2429	number	7	SENT_372	[p20l115t2525r600b2589],
7	-36	CD	NUMBER	-36	dep	3	SENT_372	[p20l115t2525r600b2589],
8	.	.	O	.	_	0	SENT_372	[p20l115t2525r600b2589],

1	21	CD	NUMBER	21	_	0	SENT_373	[p20l8t2608r92b2660],
2	.	.	O	.	_	0	SENT_373	[p20l8t2608r92b2660],

1	von	NNP	PERSON	von	nn	3	SENT_374	[p20l114t2627r218b2659],
2	Beckerath	NNP	PERSON	Beckerath	nn	3	SENT_374	[p20l240t2606r524b2659],
3	N	NNP	PERSON	N	_	0	SENT_374	[p20l545t2606r616b2671],
4	,	,	O	,	_	0	SENT_374	[p20l545t2606r616b2671],
5	Taubert	NNP	PERSON	Taubert	nn	6	SENT_374	[p20l637t2604r868b2659],
6	D	NNP	O	D	appos	3	SENT_374	[p20l888t2606r959b2671],
7	,	,	O	,	_	0	SENT_374	[p20l888t2606r959b2671],
8	Pogatsa	NNP	LOCATION	Pogatsa	appos	6	SENT_374	[p20l983t2606r1449b2677],
9	.	.	O	.	_	0	SENT_374	[p20l983t2606r1449b2677],

1	—	NN	O	—	_	0	SENT_375	[p20l983t2606r1449b2677],
2	.	.	O	.	_	0	SENT_375	[p20l983t2606r1449b2677],

1	Murray	NNP	PERSON	Murray	nn	2	SENT_376	[p20l983t2606r1449b2677],
2	G	NNP	PERSON	G	_	0	SENT_376	[p20l1469t2606r1539b2671],
3	,	,	O	,	_	0	SENT_376	[p20l1469t2606r1539b2671],
4	Schomig	NNP	O	Schomig	nn	5	SENT_376	[p20l1566t2606r1815b2677],
5	E	NNP	O	E	conj_and	2	SENT_376	[p20l1836t2606r1897b2671],
6	,	,	O	,	_	0	SENT_376	[p20l1836t2606r1897b2671],
7	Kastrati	NNP	PERSON	Kastrati	nn	8	SENT_376	[p20l1922t2606r2143b2659],
8	A	NNP	O	A	conj_and	2	SENT_376	[p20l115t2686r182b2752],
9	,	,	O	,	_	0	SENT_376	[p20l115t2686r182b2752],
10	Schomig	NNP	O	Schomig	nn	12	SENT_376	[p20l214t2687r463b2758],
11	A.	NNP	O	A.	nn	12	SENT_376	[p20l485t2686r552b2740],
12	Absorption	NNP	O	Absorption	conj_and	2	SENT_376	[p20l580t2686r921b2759],
13	,	,	O	,	_	0	SENT_376	[p20l580t2686r921b2759],
14	metabolization	NN	O	metabolization	conj_and	2	SENT_376	[p20l950t2687r1388b2752],
15	,	,	O	,	_	0	SENT_376	[p20l950t2687r1388b2752],
16	and	CC	O	and	_	0	SENT_376	[p20l1418t2687r1520b2740],
17	antiplatelet	JJ	O	antiplatelet	amod	18	SENT_376	[p20l1547t2687r1864b2759],
18	effects	NNS	O	effect	conj_and	2	SENT_376	[p20l1890t2687r2061b2740],
19	of	IN	O	of	_	0	SENT_376	[p20l2089t2687r2153b2740],
20	300	CD	NUMBER	300	prep_of	18	SENT_376	[p20l117t2772r265b2834],
21	-	:	O	-	_	0	SENT_376	[p20l117t2772r265b2834],
22	,	,	O	,	_	0	SENT_376	[p20l117t2772r265b2834],
23	600	CD	NUMBER	600	appos	18	SENT_376	[p20l301t2772r448b2834],
24	-	:	O	-	_	0	SENT_376	[p20l301t2772r448b2834],
25	,	,	O	,	_	0	SENT_376	[p20l301t2772r448b2834],
26	and	CC	O	and	_	0	SENT_376	[p20l484t2769r586b2822],
27	900	CD	NUMBER	900	num	31	SENT_376	[p20l620t2772r845b2841],
28	—	CD	NUMBER	—	num	31	SENT_376	[p20l620t2772r845b2841],
29	mg	NN	O	mg	nn	31	SENT_376	[p20l620t2772r845b2841],
30	loading	NN	O	loading	nn	31	SENT_376	[p20l874t2769r1087b2841],
31	doses	NNS	O	dose	conj_and	2	SENT_376	[p20l1119t2769r1267b2822],
32	of	IN	O	of	_	0	SENT_376	[p20l1302t2769r1366b2822],
33	clopidogrel	NN	O	clopidogrel	prep_of	31	SENT_376	[p20l1389t2769r1718b2841],
34	:	:	O	:	_	0	SENT_376	[p20l1389t2769r1718b2841],
35	results	NNS	O	result	dep	2	SENT_376	[p20l1754t2769r1933b2822],
36	of	IN	O	of	_	0	SENT_376	[p20l1967t2769r2031b2822],
37	the	DT	O	the	det	41	SENT_376	[p20l2054t2769r2142b2822],
38	ISAR-CHOICE	NN	O	isar-choice	nn	41	SENT_376	[p20l116t2850r611b2905],
39	(	NN	O	(	nn	41	SENT_376	[p20l647t2850r1058b2923],
40	Intracoronary	JJ	O	intracoronary	amod	41	SENT_376	[p20l647t2850r1058b2923],
41	Stenting	NN	O	stenting	prep_of	35	SENT_376	[p20l1092t2851r1332b2923],
42	and	CC	O	and	_	0	SENT_376	[p20l1365t2851r1467b2904],
43	Antithrombotic	JJ	O	antithrombotic	amod	44	SENT_376	[p20l1498t2850r1950b2904],
44	Regimen	NN	O	regimen	conj_and	41	SENT_376	[p20l1985t2852r2140b2923, p20l117t2954r254b2987],
45	:	:	O	:	_	0	SENT_376	[p20l1985t2852r2140b2923, p20l117t2954r254b2987],
46	Choose	VB	O	choose	dep	2	SENT_376	[p20l283t2933r496b2987],
47	Between	IN	O	between	_	0	SENT_376	[p20l521t2934r765b2987],
48	3	CD	NUMBER	3	num	51	SENT_376	[p20l790t2936r819b2987],
49	High	JJ	O	high	amod	51	SENT_376	[p20l846t2934r996b3005],
50	Oral	JJ	O	oral	amod	51	SENT_376	[p20l1021t2933r1149b2987],
51	Doses	NNS	O	dose	prep_between	46	SENT_376	[p20l1172t2934r1343b2987],
52	for	IN	O	for	_	0	SENT_376	[p20l1368t2933r1448b2987],
53	Immediate	NNP	O	Immediate	nn	55	SENT_376	[p20l1470t2934r1779b2987],
54	Clopidogrel	NNP	O	Clopidogrel	nn	55	SENT_376	[p20l1805t2933r2144b3005],
55	Effect	NN	O	effect	prep_for	51	SENT_376	[p20l118t3014r304b3080],
56	)	CD	NUMBER	)	num	57	SENT_376	[p20l118t3014r304b3080],
57	Trial	NN	O	trial	nsubj	46	SENT_376	[p20l331t3014r487b3068],
58	.	.	O	.	_	0	SENT_376	[p20l331t3014r487b3068],

1	Circulation	NN	O	circulation	_	0	SENT_377	[p20l518t3016r839b3068],
2	2005	CD	DATE	2005	num	1	SENT_377	[p20l864t3016r1289b3080],
3	;	:	O	;	_	0	SENT_377	[p20l864t3016r1289b3080],
4	112:2946	CD	NUMBER	112:2946	number	5	SENT_377	[p20l864t3016r1289b3080],
5	-50	CD	NUMBER	-50	dep	1	SENT_377	[p20l1300t3016r1421b3068],
6	.	.	O	.	_	0	SENT_377	[p20l1300t3016r1421b3068],

1	22	CD	NUMBER	22	_	0	SENT_378	[p20l8t3099r92b3150],
2	.	.	O	.	_	0	SENT_378	[p20l8t3099r92b3150],

1	Taubert	NNP	PERSON	Taubert	nn	2	SENT_379	[p20l114t3094r345b3149],
2	D	NNP	PERSON	D	_	0	SENT_379	[p20l370t3097r441b3161],
3	,	,	O	,	_	0	SENT_379	[p20l370t3097r441b3161],
4	von	NNP	PERSON	von	nn	6	SENT_379	[p20l468t3117r572b3149],
5	Beckerath	NNP	PERSON	Beckerath	nn	6	SENT_379	[p20l600t3096r884b3149],
6	N	NNP	PERSON	N	appos	2	SENT_379	[p20l911t3097r981b3161],
7	,	,	O	,	_	0	SENT_379	[p20l911t3097r981b3161],
8	Grimberg	NNP	PERSON	Grimberg	nn	9	SENT_379	[p20l1012t3096r1293b3167],
9	G	NNP	PERSON	G	appos	2	SENT_379	[p20l1320t3096r1390b3161],
10	,	,	O	,	_	0	SENT_379	[p20l1320t3096r1390b3161],
11	et	FW	O	et	nn	12	SENT_379	[p20l1420t3110r1471b3149],
12	al.	FW	O	al.	appos	2	SENT_379	[p20l1498t3096r1557b3149],
13	.	.	O	.	_	0	SENT_379	[p20l1498t3096r1557b3149],

1	Impact	NN	O	impact	_	0	SENT_380	[p20l1587t3097r1789b3168],
2	of	IN	O	of	_	0	SENT_380	[p20l1815t3096r1879b3149],
3	P	NN	O	p	nn	5	SENT_380	[p20l1897t3096r2141b3167, p20l116t3180r320b3250],
4	—	CD	NUMBER	—	num	5	SENT_380	[p20l1897t3096r2141b3167, p20l116t3180r320b3250],
5	glycoprotein	NN	O	glycoprotein	prep_of	1	SENT_380	[p20l1897t3096r2141b3167, p20l116t3180r320b3250],
6	on	IN	O	on	_	0	SENT_380	[p20l342t3199r412b3231],
7	clopidogrel	NN	O	clopidogrel	nn	8	SENT_380	[p20l434t3178r750b3250],
8	absorption	NN	O	absorption	prep_on	1	SENT_380	[p20l772t3178r1085b3250],
9	.	.	O	.	_	0	SENT_380	[p20l772t3178r1085b3250],

1	Clin	NNP	O	Clin	nn	3	SENT_381	[p20l1112t3178r1236b3231],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_381	[p20l1258t3178r1563b3231],
3	Ther	NNP	O	Ther	_	0	SENT_381	[p20l1581t3177r1725b3231],
4	2006	CD	DATE	2006	num	3	SENT_381	[p20l1743t3181r2144b3243, p20l117t3260r235b3313],
5	;	:	O	;	_	0	SENT_381	[p20l1743t3181r2144b3243, p20l117t3260r235b3313],
6	80:486501	CD	NUMBER	80:486501	dep	3	SENT_381	[p20l1743t3181r2144b3243, p20l117t3260r235b3313],
7	.	.	O	.	_	0	SENT_381	[p20l1743t3181r2144b3243, p20l117t3260r235b3313],

1	23	CD	NUMBER	23	_	0	SENT_382	[p20l8t3344r92b3395],
2	.	.	O	.	_	0	SENT_382	[p20l8t3344r92b3395],

1	Fontana	NNP	PERSON	Fontana	nn	2	SENT_383	[p20l117t3342r352b3395],
2	P	NN	PERSON	p	_	0	SENT_383	[p20l387t3342r443b3407],
3	,	,	O	,	_	0	SENT_383	[p20l387t3342r443b3407],
4	Dupont	NNP	ORGANIZATION	Dupont	nn	5	SENT_383	[p20l481t3342r706b3413],
5	A	NNP	O	A	appos	2	SENT_383	[p20l739t3340r806b3406],
6	,	,	O	,	_	0	SENT_383	[p20l739t3340r806b3406],
7	Gandrille	NNP	LOCATION	Gandrille	nn	8	SENT_383	[p20l846t3341r1115b3395],
8	S	NNP	O	S	appos	2	SENT_383	[p20l1154t3341r1203b3407],
9	,	,	O	,	_	0	SENT_383	[p20l1154t3341r1203b3407],
10	et	FW	O	et	nn	11	SENT_383	[p20l1242t3355r1293b3395],
11	al.	FW	O	al.	appos	2	SENT_383	[p20l1329t3342r1388b3395],
12	.	.	O	.	_	0	SENT_383	[p20l1329t3342r1388b3395],

1	Adenosine	NN	LOCATION	adenosine	nn	3	SENT_384	[p20l1425t3340r1730b3395],
2	diphosphate	NN	O	diphosphate	nn	3	SENT_384	[p20l1767t3342r2140b3413],
3	—	NN	O	—	nsubj	4	SENT_384	[p20l1767t3342r2140b3413],
4	induced	VBD	O	induce	_	0	SENT_384	[p20l117t3424r341b3477],
5	platelet	NN	O	platelet	nn	6	SENT_384	[p20l369t3424r578b3495],
6	aggregation	NN	O	aggregation	nsubjpass	8	SENT_384	[p20l607t3426r938b3495],
7	is	VBZ	O	be	auxpass	8	SENT_384	[p20l967t3426r1007b3477],
8	associated	VBN	O	associate	ccomp	4	SENT_384	[p20l1039t3424r1321b3477],
9	With	IN	O	with	_	0	SENT_384	[p20l1347t3424r1477b3477],
10	P2Y12	NN	O	p2y12	nn	13	SENT_384	[p20l1506t3424r1699b3478],
11	gene	NN	O	gene	nn	13	SENT_384	[p20l1729t3444r1859b3495],
12	sequence	NN	O	sequence	nn	13	SENT_384	[p20l1891t3444r2142b3495],
13	variations	NNS	O	variation	prep_with	8	SENT_384	[p20l114t3507r388b3558],
14	in	IN	O	in	_	0	SENT_384	[p20l416t3507r470b3557],
15	healthy	JJ	O	healthy	amod	16	SENT_384	[p20l496t3505r706b3576],
16	subjects	NNS	O	subject	prep_in	8	SENT_384	[p20l731t3505r963b3576],
17	.	.	O	.	_	0	SENT_384	[p20l731t3505r963b3576],

1	Circulation	NN	O	circulation	_	0	SENT_385	[p20l995t3505r1317b3558],
2	2003	CD	DATE	2003	num	1	SENT_385	[p20l1341t3505r1862b3570],
3	;	:	O	;	_	0	SENT_385	[p20l1341t3505r1862b3570],
4	108:989	CD	NUMBER	108:989	number	5	SENT_385	[p20l1341t3505r1862b3570],
5	—	CD	NUMBER	—	dep	1	SENT_385	[p20l1341t3505r1862b3570],
6	95	CD	NUMBER	95	dep	5	SENT_385	[p20l1341t3505r1862b3570],
7	.	.	O	.	_	0	SENT_385	[p20l1341t3505r1862b3570],

1	Gladding	NNP	PERSON	Gladding	_	0	SENT_386	[p20l1436t3599r1671b3652],
2	et	FW	O	et	nn	3	SENT_386	[p20l1691t3601r1742b3642],
3	al.	FW	O	al.	dep	1	SENT_386	[p20l1760t3599r1819b3642],
4	627	CD	NUMBER	627	dep	1	SENT_386	[p20l2036t3599r2141b3642],

1	The	DT	O	the	det	2	SENT_387	[p20l888t3683r983b3725],
2	PRINC	NNP	O	PRINC	_	0	SENT_387	[p20l1007t3682r1173b3725],
3	Trial	NNP	O	Trial	nn	4	SENT_387	[p20l1191t3683r1303b3725],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	2	SENT_387	[p20l1329t3683r1823b3735],

1	24	CD	NUMBER	24	_	0	SENT_388	[p21l8t121r92b172],
2	.	.	O	.	_	0	SENT_388	[p21l8t121r92b172],

1	Fontana	NNP	ORGANIZATION	Fontana	nn	2	SENT_389	[p21l117t119r352b171],
2	P	NN	ORGANIZATION	p	_	0	SENT_389	[p21l370t119r426b183],
3	,	,	O	,	_	0	SENT_389	[p21l370t119r426b183],
4	Gaussem	NNP	O	Gaussem	nn	5	SENT_389	[p21l449t118r707b171],
5	P	NN	O	p	appos	2	SENT_389	[p21l727t119r783b183],
6	,	,	O	,	_	0	SENT_389	[p21l727t119r783b183],
7	Aiach	NNP	O	Aiach	nn	8	SENT_389	[p21l802t117r971b171],
8	M	NNP	O	M	appos	5	SENT_389	[p21l988t119r1072b183],
9	,	,	O	,	_	0	SENT_389	[p21l988t119r1072b183],
10	Fiessinger	NNP	O	Fiessinger	nn	11	SENT_389	[p21l1094t119r1381b189],
11	JN	NN	O	jn	appos	5	SENT_389	[p21l1391t119r1492b186],
12	,	,	O	,	_	0	SENT_389	[p21l1391t119r1492b186],
13	Emmerich	NNP	PERSON	Emmerich	nn	14	SENT_389	[p21l1514t118r1815b171],
14	J	NNP	O	J	appos	5	SENT_389	[p21l1827t119r1870b186],
15	,	,	O	,	_	0	SENT_389	[p21l1827t119r1870b186],
16	RenyJL	NNP	O	RenyJL	appos	5	SENT_389	[p21l1893t119r2139b189],
17	.	.	O	.	_	0	SENT_389	[p21l1893t119r2139b189],

1	P2Y12	NN	O	p2y12	nn	3	SENT_390	[p21l117t199r310b252],
2	H2	NN	O	h2	nn	3	SENT_390	[p21l343t199r435b252],
3	haplotype	NN	O	haplotype	nsubjpass	5	SENT_390	[p21l468t198r745b270],
4	is	VBZ	O	be	auxpass	5	SENT_390	[p21l777t200r818b251],
5	associated	VBN	O	associate	_	0	SENT_390	[p21l852t198r1134b251],
6	with	IN	O	with	_	0	SENT_390	[p21l1163t198r1292b251],
7	peripheral	JJ	O	peripheral	amod	9	SENT_390	[p21l1323t198r1610b270],
8	arterial	JJ	O	arterial	amod	9	SENT_390	[p21l1642t198r1839b251],
9	disease	NN	O	disease	prep_with	5	SENT_390	[p21l1871t198r2080b251],
10	:	:	O	:	_	0	SENT_390	[p21l1871t198r2080b251],
11	a	DT	O	a	det	13	SENT_390	[p21l2116t219r2144b251],
12	case-control	JJ	O	case-control	amod	13	SENT_390	[p21l117t278r462b331],
13	study	NN	O	study	dep	9	SENT_390	[p21l489t278r652b349],
14	.	.	O	.	_	0	SENT_390	[p21l489t278r652b349],

1	Circulation	NN	O	circulation	_	0	SENT_391	[p21l683t278r1004b331],
2	2003	CD	DATE	2003	num	1	SENT_391	[p21l1029t279r1542b343],
3	;	:	O	;	_	0	SENT_391	[p21l1029t279r1542b343],
4	108:2971	CD	NUMBER	108:2971	number	5	SENT_391	[p21l1029t279r1542b343],
5	—	CD	NUMBER	—	dep	1	SENT_391	[p21l1029t279r1542b343],
6	3	CD	NUMBER	3	dep	5	SENT_391	[p21l1029t279r1542b343],
7	.	.	O	.	_	0	SENT_391	[p21l1029t279r1542b343],

1	25	CD	NUMBER	25	_	0	SENT_392	[p21l8t358r92b412],
2	.	.	O	.	_	0	SENT_392	[p21l8t358r92b412],

1	von	NNP	PERSON	von	nn	3	SENT_393	[p21l114t379r218b411],
2	Beckerath	NNP	PERSON	Beckerath	nn	3	SENT_393	[p21l243t358r528b411],
3	N	NNP	PERSON	N	nsubj	32	SENT_393	[p21l553t359r623b423],
4	,	,	O	,	_	0	SENT_393	[p21l553t359r623b423],
5	von	NNP	PERSON	von	nn	7	SENT_393	[p21l648t379r752b411],
6	Beckerath	NNP	PERSON	Beckerath	nn	7	SENT_393	[p21l778t358r1063b411],
7	O	NNP	PERSON	O	appos	3	SENT_393	[p21l1089t358r1159b423],
8	,	,	O	,	_	0	SENT_393	[p21l1089t358r1159b423],
9	Koch	NNP	PERSON	Koch	nn	10	SENT_393	[p21l1189t358r1338b411],
10	W	NNP	O	W	appos	3	SENT_393	[p21l1360t359r1450b423],
11	,	,	O	,	_	0	SENT_393	[p21l1360t359r1450b423],
12	Eichinger	NNP	PERSON	Eichinger	nn	13	SENT_393	[p21l1479t358r1758b429],
13	M	NNP	O	M	appos	3	SENT_393	[p21l1781t359r1865b423],
14	,	,	O	,	_	0	SENT_393	[p21l1781t359r1865b423],
15	Schomig	NNP	O	Schomig	nn	16	SENT_393	[p21l1896t358r2145b429],
16	A	NNP	O	A	appos	3	SENT_393	[p21l115t437r182b503],
17	,	,	O	,	_	0	SENT_393	[p21l115t437r182b503],
18	Kastrati	NNP	PERSON	Kastrati	nn	23	SENT_393	[p21l229t439r450b491],
19	A.	NNP	O	A.	nn	23	SENT_393	[p21l491t437r558b491],
20	P2Y12	NNP	O	P2Y12	nn	23	SENT_393	[p21l604t439r798b492],
21	gene	NN	O	gene	nn	23	SENT_393	[p21l841t459r972b509],
22	H2	NN	O	h2	nn	23	SENT_393	[p21l1015t439r1107b492],
23	haplotype	NN	O	haplotype	nsubjpass	26	SENT_393	[p21l1151t438r1428b510],
24	is	VBZ	O	be	auxpass	26	SENT_393	[p21l1471t440r1511b491],
25	not	RB	O	not	neg	26	SENT_393	[p21l1556t452r1650b491],
26	associated	VBN	O	associate	parataxis	32	SENT_393	[p21l1692t438r1975b491],
27	with	IN	O	with	_	0	SENT_393	[p21l2014t438r2143b491],
28	increased	VBN	O	increase	amod	31	SENT_393	[p21l117t519r378b572],
29	adenosine	NN	O	adenosine	nn	31	SENT_393	[p21l422t519r701b572],
30	diphosphate	NN	O	diphosphate	nn	31	SENT_393	[p21l746t519r1349b591],
31	—	NN	O	—	prep_with	26	SENT_393	[p21l746t519r1349b591],
32	induced	VBD	O	induce	_	0	SENT_393	[p21l746t519r1349b591],
33	platelet	NN	O	platelet	nn	34	SENT_393	[p21l1390t519r1600b591],
34	aggregation	NN	O	aggregation	dobj	32	SENT_393	[p21l1642t521r1973b590],
35	after	IN	O	after	_	0	SENT_393	[p21l2017t519r2144b572],
36	initiation	NN	O	initiation	prep_after	32	SENT_393	[p21l117t601r377b652],
37	of	IN	O	of	_	0	SENT_393	[p21l419t599r483b652],
38	clopidogrel	NN	O	clopidogrel	nn	39	SENT_393	[p21l516t599r833b671],
39	therapy	NN	O	therapy	prep_of	36	SENT_393	[p21l874t599r1088b671],
40	with	IN	O	with	_	0	SENT_393	[p21l1124t599r1253b652],
41	a	DT	O	a	det	44	SENT_393	[p21l1296t620r1324b652],
42	high	JJ	O	high	amod	44	SENT_393	[p21l1365t599r1493b670],
43	loading	NN	O	loading	nn	44	SENT_393	[p21l1533t599r1746b670],
44	dose	NN	O	dose	prep_with	32	SENT_393	[p21l1787t599r1927b652],
45	.	.	O	.	_	0	SENT_393	[p21l1787t599r1927b652],

1	Blood	NNP	O	Blood	nn	3	SENT_394	[p21l1972t599r2143b652],
2	Coagul	NNP	O	Coagul	nn	3	SENT_394	[p21l118t679r322b750],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_394	[p21l348t679r677b750],
4	2005	CD	DATE	2005	num	3	SENT_394	[p21l703t679r1224b744],
5	;	:	O	;	_	0	SENT_394	[p21l703t679r1224b744],
6	16:199	CD	NUMBER	16:199	number	7	SENT_394	[p21l703t679r1224b744],
7	-204	CD	NUMBER	-204	dep	3	SENT_394	[p21l703t679r1224b744],
8	.	.	O	.	_	0	SENT_394	[p21l703t679r1224b744],

1	26	CD	NUMBER	26	_	0	SENT_395	[p21l8t761r92b812],
2	.	.	O	.	_	0	SENT_395	[p21l8t761r92b812],

1	Tang	NNP	PERSON	Tang	nn	2	SENT_396	[p21l114t756r268b829],
2	M	NNP	PERSON	M	_	0	SENT_396	[p21l290t759r375b823],
3	,	,	O	,	_	0	SENT_396	[p21l290t759r375b823],
4	Mukundan	NNP	PERSON	Mukundan	nn	5	SENT_396	[p21l401t758r720b811],
5	M	NNP	PERSON	M	appos	2	SENT_396	[p21l744t759r828b823],
6	,	,	O	,	_	0	SENT_396	[p21l744t759r828b823],
7	Yang	NNP	PERSON	Yang	nn	8	SENT_396	[p21l853t759r1004b829],
8	J	NNP	PERSON	J	appos	2	SENT_396	[p21l1021t759r1065b826],
9	,	,	O	,	_	0	SENT_396	[p21l1021t759r1065b826],
10	et	FW	O	et	nn	11	SENT_396	[p21l1093t772r1144b811],
11	al.	FW	O	al.	appos	2	SENT_396	[p21l1169t758r1228b811],
12	.	.	O	.	_	0	SENT_396	[p21l1169t758r1228b811],

1	Antiplatelet	JJ	O	antiplatelet	amod	3	SENT_397	[p21l1255t757r1598b830],
2	agents	NNS	O	agent	nn	3	SENT_397	[p21l1623t772r1799b829],
3	aspirin	NN	O	aspirin	nsubjpass	7	SENT_397	[p21l1826t760r2015b830],
4	and	CC	O	and	_	0	SENT_397	[p21l2041t758r2143b811],
5	clopidogrel	NN	O	clopidogrel	conj_and	3	SENT_397	[p21l117t838r433b910],
6	are	VBP	O	be	auxpass	7	SENT_397	[p21l452t858r532b891],
7	hydrolyzed	VBN	O	hydrolyze	_	0	SENT_397	[p21l551t838r863b909],
8	by	IN	O	by	_	0	SENT_397	[p21l879t838r948b909],
9	distinct	JJ	O	distinct	amod	10	SENT_397	[p21l964t838r1175b891],
10	carboxylesterases	NNS	O	carboxylesterase	agent	7	SENT_397	[p21l1193t838r1685b909],
11	,	,	O	,	_	0	SENT_397	[p21l1193t838r1685b909],
12	and	CC	O	and	_	0	SENT_397	[p21l1707t838r1809b891],
13	clopidogrel	NN	O	clopidogrel	nsubjpass	15	SENT_397	[p21l1828t838r2144b910],
14	is	VBZ	O	be	auxpass	15	SENT_397	[p21l117t920r157b971],
15	transesteriﬁcated	VBN	O	transesteriﬁcated	conj_and	7	SENT_397	[p21l185t918r664b971],
16	in	IN	O	in	_	0	SENT_397	[p21l691t920r745b970],
17	the	DT	O	the	det	18	SENT_397	[p21l772t918r860b971],
18	presence	NN	O	presence	prep_in	15	SENT_397	[p21l886t938r1128b990],
19	of	IN	O	of	_	0	SENT_397	[p21l1156t918r1220b971],
20	ethyl	NN	O	ethyl	nn	21	SENT_397	[p21l1238t918r1376b989],
21	alcohol	NN	O	alcohol	prep_of	18	SENT_397	[p21l1403t918r1619b971],
22	.	.	O	.	_	0	SENT_397	[p21l1403t918r1619b971],

1	J	NNP	O	J	nn	4	SENT_398	[p21l1643t919r1671b986],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_398	[p21l1698t918r2003b971],
3	Exp	NNP	O	Exp	nn	4	SENT_398	[p21l2030t919r2142b990],
4	Ther	NNP	O	Ther	_	0	SENT_398	[p21l114t996r258b1050],
5	2006	CD	DATE	2006	num	4	SENT_398	[p21l282t999r830b1062],
6	;	:	O	;	_	0	SENT_398	[p21l282t999r830b1062],
7	319:1467	CD	NUMBER	319:1467	number	8	SENT_398	[p21l282t999r830b1062],
8	-76	CD	NUMBER	-76	dep	4	SENT_398	[p21l282t999r830b1062],
9	.	.	O	.	_	0	SENT_398	[p21l282t999r830b1062],

1	27	CD	NUMBER	27	_	0	SENT_399	[p21l8t1078r92b1131],
2	.	.	O	.	_	0	SENT_399	[p21l8t1078r92b1131],

1	Marsh	NNP	PERSON	Marsh	nn	2	SENT_400	[p21l115t1077r302b1130],
2	S	NNP	O	S	_	0	SENT_400	[p21l349t1077r398b1142],
3	,	,	O	,	_	0	SENT_400	[p21l349t1077r398b1142],
4	Xiao	NNP	O	Xiao	nn	5	SENT_400	[p21l442t1078r575b1130],
5	M	NNP	O	M	appos	2	SENT_400	[p21l620t1078r704b1142],
6	,	,	O	,	_	0	SENT_400	[p21l620t1078r704b1142],
7	Yu	NNP	PERSON	Yu	nn	8	SENT_400	[p21l747t1078r832b1130],
8	J	NNP	PERSON	J	appos	2	SENT_400	[p21l868t1078r912b1145],
9	,	,	O	,	_	0	SENT_400	[p21l868t1078r912b1145],
10	et	FW	O	et	nn	11	SENT_400	[p21l960t1091r1010b1130],
11	al.	FW	O	al.	appos	2	SENT_400	[p21l1055t1077r1114b1130],
12	.	.	O	.	_	0	SENT_400	[p21l1055t1077r1114b1130],

1	Pharmacogenomic	JJ	O	pharmacogenomic	amod	2	SENT_401	[p21l1162t1077r1693b1148],
2	assessment	NN	O	assessment	_	0	SENT_401	[p21l1737t1091r2045b1130],
3	of	IN	O	of	_	0	SENT_401	[p21l2089t1077r2153b1130],
4	carboxylesterases	NNS	O	carboxylesterase	prep_of	2	SENT_401	[p21l117t1157r593b1228],
5	1	CD	NUMBER	1	num	4	SENT_401	[p21l624t1160r649b1209],
6	and	CC	O	and	_	0	SENT_401	[p21l681t1157r783b1210],
7	2	CD	NUMBER	2	conj_and	4	SENT_401	[p21l807t1160r856b1211],
8	.	.	O	.	_	0	SENT_401	[p21l807t1160r856b1211],

1	Genomics	NNS	O	genomic	_	0	SENT_402	[p21l888t1157r1175b1210],
2	2004	CD	DATE	2004	num	1	SENT_402	[p21l1201t1160r1651b1222],
3	;	:	O	;	_	0	SENT_402	[p21l1201t1160r1651b1222],
4	84:661	CD	NUMBER	84:661	number	5	SENT_402	[p21l1201t1160r1651b1222],
5	—	CD	NUMBER	—	dep	1	SENT_402	[p21l1201t1160r1651b1222],
6	8	CD	NUMBER	8	dep	5	SENT_402	[p21l1201t1160r1651b1222],
7	.	.	O	.	_	0	SENT_402	[p21l1201t1160r1651b1222],

1	28	CD	NUMBER	28	_	0	SENT_403	[p21l8t1240r92b1291],
2	.	.	O	.	_	0	SENT_403	[p21l8t1240r92b1291],

1	Gladding	VBG	PERSON	gladd	_	0	SENT_404	[p21l118t1237r388b1308],
2	P	NN	PERSON	p	dep	1	SENT_404	[p21l407t1238r463b1302],
3	,	,	O	,	_	0	SENT_404	[p21l407t1238r463b1302],
4	Webster	NNP	PERSON	Webster	nn	5	SENT_404	[p21l483t1237r728b1291],
5	M	NNP	O	M	appos	2	SENT_404	[p21l746t1238r830b1302],
6	,	,	O	,	_	0	SENT_404	[p21l746t1238r830b1302],
7	Zeng	NNP	O	Zeng	appos	2	SENT_404	[p21l855t1237r1005b1308],
8	I	PRP	O	I	dep	7	SENT_404	[p21l1024t1238r1064b1302],
9	,	,	O	,	_	0	SENT_404	[p21l1024t1238r1064b1302],
10	et	FW	O	et	nn	11	SENT_404	[p21l1087t1251r1138b1290],
11	al.	FW	O	al.	appos	2	SENT_404	[p21l1159t1237r1218b1290],
12	.	.	O	.	_	0	SENT_404	[p21l1159t1237r1218b1290],

1	The	DT	O	the	det	3	SENT_405	[p21l1240t1236r1357b1290],
2	antiplatelet	JJ	O	antiplatelet	amod	3	SENT_405	[p21l1380t1237r1697b1309],
3	effect	NN	O	effect	_	0	SENT_405	[p21l1717t1237r1865b1290],
4	of	IN	O	of	_	0	SENT_405	[p21l1886t1237r1949b1290],
5	higher	JJR	O	higher	amod	6	SENT_405	[p21l1960t1237r2144b1308],
6	loading	NN	O	loading	prep_of	3	SENT_405	[p21l116t1317r328b1388],
7	and	CC	O	and	_	0	SENT_405	[p21l361t1317r463b1370],
8	maintenance	NN	O	maintenance	nn	10	SENT_405	[p21l497t1319r856b1370],
9	dose	NN	O	dose	nn	10	SENT_405	[p21l891t1317r1015b1370],
10	regimens	NNS	O	regimen	prep_of	3	SENT_405	[p21l1049t1319r1304b1388],
11	of	IN	O	of	_	0	SENT_405	[p21l1340t1317r1403b1370],
12	clopidogrel	NN	O	clopidogrel	prep_of	6	SENT_405	[p21l1428t1317r1758b1389],
13	:	:	O	:	_	0	SENT_405	[p21l1428t1317r1758b1389],
14	the	DT	O	the	det	18	SENT_405	[p21l1794t1317r1883b1370],
15	PRINC	NNP	O	PRINC	nn	18	SENT_405	[p21l1917t1317r2141b1370],
16	(	CD	NUMBER	(	num	18	SENT_405	[p21l119t1394r311b1461],
17	Plavix	NNP	O	Plavix	nn	18	SENT_405	[p21l119t1394r311b1461],
18	Response	NN	O	response	dep	3	SENT_405	[p21l342t1397r608b1468],
19	in	IN	O	in	_	0	SENT_405	[p21l638t1398r692b1448],
20	Coronary	JJ	O	coronary	amod	23	SENT_405	[p21l724t1396r994b1467],
21	Intervention	NN	O	intervention	nn	23	SENT_405	[p21l1021t1394r1395b1460],
22	)	NN	O	)	nn	23	SENT_405	[p21l1021t1394r1395b1460],
23	trial	NN	O	trial	prep_in	18	SENT_405	[p21l1428t1396r1554b1449],
24	.	.	O	.	_	0	SENT_405	[p21l1428t1396r1554b1449],

1	J	NNP	O	J	nn	5	SENT_406	[p21l1580t1397r1608b1464],
2	Am	NNP	O	Am	nn	5	SENT_406	[p21l1636t1395r1745b1448],
3	Coll	NNP	O	Coll	nn	5	SENT_406	[p21l1777t1396r1899b1449],
4	Cardiol	NNP	O	Cardiol	nn	5	SENT_406	[p21l1930t1396r2144b1449],
5	Intv	NNP	O	Intv	_	0	SENT_406	[p21l116t1477r235b1528],
6	2008	CD	DATE	2008	num	5	SENT_406	[p21l257t1479r662b1540],
7	;	:	O	;	_	0	SENT_406	[p21l257t1479r662b1540],
8	1:612	CD	NUMBER	1:612	number	9	SENT_406	[p21l257t1479r662b1540],
9	—	CD	NUMBER	—	dep	5	SENT_406	[p21l257t1479r662b1540],
10	9	CD	NUMBER	9	dep	9	SENT_406	[p21l257t1479r662b1540],
11	.	.	O	.	_	0	SENT_406	[p21l257t1479r662b1540],

1	29	CD	NUMBER	29	_	0	SENT_407	[p21l8t1558r92b1609],
2	.	.	O	.	_	0	SENT_407	[p21l8t1558r92b1609],

1	Luo	NNP	PERSON	Luo	nn	2	SENT_408	[p21l117t1556r231b1608],
2	HR	NNP	DURATION	HR	_	0	SENT_408	[p21l264t1556r387b1620],
3	,	,	O	,	_	0	SENT_408	[p21l264t1556r387b1620],
4	Poland	NNP	LOCATION	Poland	nn	5	SENT_408	[p21l421t1555r621b1608],
5	RE	NNP	O	RE	appos	2	SENT_408	[p21l654t1556r764b1620],
6	,	,	O	,	_	0	SENT_408	[p21l654t1556r764b1620],
7	Lin	NNP	PERSON	Lin	nn	8	SENT_408	[p21l798t1556r899b1607],
8	KM	NNP	O	KM	appos	2	SENT_408	[p21l933t1556r1064b1620],
9	,	,	O	,	_	0	SENT_408	[p21l933t1556r1064b1620],
10	Wan	NNP	O	Wan	nn	12	SENT_408	[p21l1095t1556r1238b1608],
11	p	NN	O	p	nn	12	SENT_408	[p21l1266t1556r1352b1623],
12	uc	NN	O	uc	appos	2	SENT_408	[p21l1266t1556r1352b1623],
13	+	CC	O	+	_	0	SENT_408	[p21l1266t1556r1352b1623],
14	Genetic	JJ	O	genetic	amod	15	SENT_408	[p21l1389t1555r1613b1608],
15	polymorphism	NN	O	polymorphism	conj_+	2	SENT_408	[p21l1643t1555r2056b1627],
16	of	IN	O	of	_	0	SENT_408	[p21l2089t1555r2152b1608],
17	cytochrome	NN	O	cytochrome	nn	19	SENT_408	[p21l117t1635r447b1706],
18	P450	NN	O	p450	nn	19	SENT_408	[p21l479t1635r625b1688],
19	2C19	NN	O	2c19	prep_of	15	SENT_408	[p21l656t1635r813b1689],
20	in	IN	O	in	_	0	SENT_408	[p21l845t1637r900b1687],
21	Mexican	JJ	MISC	mexican	amod	22	SENT_408	[p21l930t1636r1177b1688],
22	Americans	NNPS	MISC	Americans	prep_in	19	SENT_408	[p21l1206t1634r1526b1688],
23	:	:	O	:	_	0	SENT_408	[p21l1206t1634r1526b1688],
24	a	DT	O	a	det	27	SENT_408	[p21l1562t1656r1590b1688],
25	cross-ethnic	JJ	O	cross-ethnic	amod	27	SENT_408	[p21l1621t1635r1964b1688],
26	comparative	JJ	O	comparative	amod	27	SENT_408	[p21l1996t1656r2141b1688, p21l116t1716r338b1786],
27	study	NN	O	study	dep	2	SENT_408	[p21l366t1714r529b1785],
28	.	.	O	.	_	0	SENT_408	[p21l366t1714r529b1785],

1	Clin	NNP	O	Clin	nn	3	SENT_409	[p21l560t1714r684b1767],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_409	[p21l711t1714r1016b1767],
3	Ther	NNP	O	Ther	_	0	SENT_409	[p21l1039t1712r1183b1767],
4	2006	CD	DATE	2006	num	3	SENT_409	[p21l1207t1717r1656b1779],
5	;	:	O	;	_	0	SENT_409	[p21l1207t1717r1656b1779],
6	80:33	CD	NUMBER	80:33	number	7	SENT_409	[p21l1207t1717r1656b1779],
7	—	CD	NUMBER	—	dep	3	SENT_409	[p21l1207t1717r1656b1779],
8	40	CD	NUMBER	40	dep	7	SENT_409	[p21l1207t1717r1656b1779],
9	.	.	O	.	_	0	SENT_409	[p21l1207t1717r1656b1779],

1	30	CD	NUMBER	30	_	0	SENT_410	[p21l10t1797r92b1847],
2	.	.	O	.	_	0	SENT_410	[p21l10t1797r92b1847],

1	Kahn	NNP	PERSON	Kahn	_	0	SENT_411	[p21l119t1794r271b1847],
2	p	NN	O	p	nn	4	SENT_411	[p21l291t1795r333b1862],
3	_	NN	O	_	nn	4	SENT_411	[p21l291t1795r333b1862],
4	c	NN	O	c	dep	1	SENT_411	[p21l291t1795r333b1862],
5	+	CC	O	+	_	0	SENT_411	[p21l291t1795r333b1862],
6	Race	NN	O	race	dep	1	SENT_411	[p21l366t1795r500b1847],
7	in	IN	O	in	_	0	SENT_411	[p21l528t1796r582b1846],
8	a	DT	O	a	det	9	SENT_411	[p21l610t1815r637b1847],
9	bottle	NN	O	bottle	prep_in	6	SENT_411	[p21l662t1794r841b1847],
10	.	.	O	.	_	0	SENT_411	[p21l662t1794r841b1847],

1	Drugmakers	NNS	O	drugmaker	nsubj	3	SENT_412	[p21l871t1794r1223b1865],
2	are	VBP	O	be	cop	3	SENT_412	[p21l1252t1814r1333b1847],
3	eager	JJ	O	eager	_	0	SENT_412	[p21l1361t1814r1509b1865],
4	to	TO	O	to	aux	5	SENT_412	[p21l1535t1808r1589b1847],
5	develop	VB	O	develop	xcomp	3	SENT_412	[p21l1618t1794r1832b1866],
6	medicines	NNS	O	medicine	dobj	5	SENT_412	[p21l1861t1794r2142b1847],
7	targeted	VBN	O	target	partmod	6	SENT_412	[p21l117t1875r347b1946],
8	at	IN	O	at	_	0	SENT_412	[p21l368t1889r419b1928],
9	ethnic	JJ	O	ethnic	amod	10	SENT_412	[p21l439t1875r614b1928],
10	groups	NNS	O	group	prep_at	7	SENT_412	[p21l633t1895r839b1947],
11	,	,	O	,	_	0	SENT_412	[p21l633t1895r839b1947],
12	but	CC	O	but	_	0	SENT_412	[p21l861t1875r956b1928],
13	so	RB	O	so	advmod	14	SENT_412	[p21l977t1896r1032b1928],
14	far	RB	O	far	advmod	17	SENT_412	[p21l1054t1875r1130b1928],
15	they	PRP	O	they	nsubj	17	SENT_412	[p21l1149t1875r1272b1946],
16	have	VBP	O	have	aux	17	SENT_412	[p21l1290t1875r1417b1928],
17	made	VBN	O	make	conj_but	3	SENT_412	[p21l1439t1875r1590b1928],
18	poor	JJ	O	poor	amod	19	SENT_412	[p21l1610t1895r1742b1947],
19	choices	NNS	O	choice	dobj	17	SENT_412	[p21l1762t1875r1964b1928],
20	based	VBN	O	base	_	0	SENT_412	[p21l1985t1875r2144b1928],
21	on	IN	O	on	prepc_based_on	17	SENT_412	[p21l117t1977r187b2008],
22	unsound	JJ	O	unsound	amod	23	SENT_412	[p21l213t1956r457b2008],
23	science	NN	O	science	pobj	17	SENT_412	[p21l484t1958r696b2008],
24	.	.	O	.	_	0	SENT_412	[p21l484t1958r696b2008],

1	Sci	NNP	O	Sci	nn	2	SENT_413	[p21l729t1956r811b2009],
2	Am	NNP	O	Am	_	0	SENT_413	[p21l835t1955r944b2008],
3	2007	CD	DATE	2007	num	2	SENT_413	[p21l970t1957r1324b2020],
4	;	:	O	;	_	0	SENT_413	[p21l970t1957r1324b2020],
5	297:40	CD	NUMBER	297:40	number	6	SENT_413	[p21l970t1957r1324b2020],
6	-5	CD	NUMBER	-5	dep	2	SENT_413	[p21l1335t1956r1419b2009],
7	.	.	O	.	_	0	SENT_413	[p21l1335t1956r1419b2009],

1	31	CD	NUMBER	31	_	0	SENT_414	[p21l10t2037r92b2087],
2	.	.	O	.	_	0	SENT_414	[p21l10t2037r92b2087],

1	Gilard	NNP	O	Gilard	nn	2	SENT_415	[p21l118t2034r302b2087],
2	M	NNP	O	M	nsubj	26	SENT_415	[p21l329t2035r413b2099],
3	,	,	O	,	_	0	SENT_415	[p21l329t2035r413b2099],
4	Arnaud	NNP	PERSON	Arnaud	nn	5	SENT_415	[p21l443t2033r661b2087],
5	B	NNP	PERSON	B	appos	2	SENT_415	[p21l689t2035r749b2099],
6	,	,	O	,	_	0	SENT_415	[p21l689t2035r749b2099],
7	Le	NNP	LOCATION	Le	nn	9	SENT_415	[p21l781t2035r855b2087],
8	Gal	NNP	LOCATION	Gal	nn	9	SENT_415	[p21l886t2034r990b2087],
9	G	NNP	LOCATION	G	appos	2	SENT_415	[p21l1019t2034r1089b2099],
10	,	,	O	,	_	0	SENT_415	[p21l1019t2034r1089b2099],
11	Abgrall	NNP	PERSON	Abgrall	nn	12	SENT_415	[p21l1119t2033r1333b2105],
12	JF	NNP	O	JF	appos	2	SENT_415	[p21l1354t2035r1441b2102],
13	,	,	O	,	_	0	SENT_415	[p21l1354t2035r1441b2102],
14	Boschat	NNP	O	Boschat	nn	15	SENT_415	[p21l1472t2034r1699b2087],
15	phc	NN	O	phc	appos	2	SENT_415	[p21l1719t2035r1762b2102],
16	+	CC	O	+	_	0	SENT_415	[p21l1719t2035r1762b2102],
17	Inﬂuence	NN	O	inﬂuence	appos	2	SENT_415	[p21l1795t2034r2059b2087],
18	of	IN	O	of	_	0	SENT_415	[p21l2089t2034r2153b2087],
19	omeprazol	NN	O	omeprazol	prep_of	17	SENT_415	[p21l117t2114r414b2186],
20	on	IN	O	on	_	0	SENT_415	[p21l432t2135r502b2167],
21	the	DT	O	the	det	23	SENT_415	[p21l520t2114r608b2167],
22	antiplatelet	JJ	O	antiplatelet	amod	23	SENT_415	[p21l629t2114r946b2186],
23	action	NN	O	action	prep_on	19	SENT_415	[p21l964t2116r1135b2167],
24	of	IN	O	of	_	0	SENT_415	[p21l1154t2114r1218b2167],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_415	[p21l1227t2114r1543b2186],
26	associated	VBN	O	associate	_	0	SENT_415	[p21l1562t2114r1843b2167],
27	to	TO	O	to	_	0	SENT_415	[p21l1861t2128r1916b2167],
28	aspirin	NN	O	aspirin	prep_to	26	SENT_415	[p21l1937t2116r2140b2186],
29	.	.	O	.	_	0	SENT_415	[p21l1937t2116r2140b2186],

1	J	NNP	O	J	nn	3	SENT_416	[p21l109t2195r138b2261],
2	Thromb	NNP	O	Thromb	nn	3	SENT_416	[p21l161t2192r401b2246],
3	Haemost	NNP	O	Haemost	_	0	SENT_416	[p21l430t2195r690b2246],
4	2006	CD	DATE	2006	num	3	SENT_416	[p21l714t2194r1163b2258],
5	;	:	O	;	_	0	SENT_416	[p21l714t2194r1163b2258],
6	4:2508	CD	NUMBER	4:2508	number	7	SENT_416	[p21l714t2194r1163b2258],
7	—	CD	NUMBER	—	dep	3	SENT_416	[p21l714t2194r1163b2258],
8	9	CD	NUMBER	9	dep	7	SENT_416	[p21l714t2194r1163b2258],
9	.	.	O	.	_	0	SENT_416	[p21l714t2194r1163b2258],

1	32	CD	NUMBER	32	_	0	SENT_417	[p21l10t2276r92b2327],
2	.	.	O	.	_	0	SENT_417	[p21l10t2276r92b2327],

1	Gilard	NNP	O	Gilard	nn	2	SENT_418	[p21l118t2273r302b2326],
2	M	NN	O	m	_	0	SENT_418	[p21l318t2274r402b2338],
3	,	,	O	,	_	0	SENT_418	[p21l318t2274r402b2338],
4	Arnaud	NN	PERSON	arnaud	nn	5	SENT_418	[p21l421t2272r639b2326],
5	B	NN	PERSON	b	appos	2	SENT_418	[p21l658t2274r717b2338],
6	,	,	O	,	_	0	SENT_418	[p21l658t2274r717b2338],
7	CornilyJ-C	NN	O	cornilyj-c	appos	2	SENT_418	[p21l740t2273r1092b2344],
8	,	,	O	,	_	0	SENT_418	[p21l740t2273r1092b2344],
9	et	FW	O	et	nn	10	SENT_418	[p21l1113t2287r1164b2326],
10	al.	FW	O	al.	appos	2	SENT_418	[p21l1183t2273r1242b2326],
11	.	.	O	.	_	0	SENT_418	[p21l1183t2273r1242b2326],

1	Inﬂuence	NN	O	inﬂuence	nsubj	10	SENT_419	[p21l1263t2273r1527b2326],
2	of	IN	O	of	_	0	SENT_419	[p21l1547t2273r1611b2326],
3	omeprazole	NN	O	omeprazole	prep_of	1	SENT_419	[p21l1620t2273r1946b2345],
4	on	IN	O	on	_	0	SENT_419	[p21l1966t2294r2036b2326],
5	the	DT	O	the	det	7	SENT_419	[p21l2054t2273r2142b2326],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_419	[p21l118t2353r434b2425],
7	action	NN	O	action	prep_on	3	SENT_419	[p21l461t2355r632b2406],
8	of	IN	O	of	_	0	SENT_419	[p21l659t2353r723b2406],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_419	[p21l741t2353r1057b2425],
10	associated	VBN	O	associate	_	0	SENT_419	[p21l1084t2353r1366b2406],
11	with	IN	O	with	_	0	SENT_419	[p21l1389t2353r1518b2406],
12	aspirin	NN	O	aspirin	prep_with	10	SENT_419	[p21l1546t2355r1749b2425],
13	:	:	O	:	_	0	SENT_419	[p21l1546t2355r1749b2425],
14	the	DT	O	the	nsubj	15	SENT_419	[p21l1779t2353r1867b2406],
15	randomized	VBN	O	randomize	parataxis	10	SENT_419	[p21l1894t2353r2141b2406, p21l117t2432r247b2497],
16	,	,	O	,	_	0	SENT_419	[p21l1894t2353r2141b2406, p21l117t2432r247b2497],
17	double-blind	JJ	O	double-blind	amod	18	SENT_419	[p21l278t2432r646b2485],
18	OCLA	NN	O	oclum	dep	24	SENT_419	[p21l676t2431r884b2485],
19	(	CD	NUMBER	(	num	24	SENT_419	[p21l914t2430r1284b2504],
20	Omeprazole	NNP	O	Omeprazole	nn	24	SENT_419	[p21l914t2430r1284b2504],
21	CLopidogrel	NNP	O	CLopidogrel	nn	24	SENT_419	[p21l1315t2432r1683b2504],
22	Aspirin	NNP	O	Aspirin	nn	24	SENT_419	[p21l1709t2430r1944b2504],
23	)	NN	O	)	nn	24	SENT_419	[p21l1709t2430r1944b2504],
24	study	NN	O	study	dep	15	SENT_419	[p21l1976t2432r2139b2503],
25	.	.	O	.	_	0	SENT_419	[p21l1976t2432r2139b2503],

1	J	NNP	O	J	nn	4	SENT_420	[p21l109t2513r138b2579],
2	Am	NNP	O	Am	nn	4	SENT_420	[p21l162t2511r271b2564],
3	Coll	NNP	O	Coll	nn	4	SENT_420	[p21l300t2512r421b2564],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_420	[p21l448t2512r662b2564],
5	2008	CD	DATE	2008	num	4	SENT_420	[p21l686t2512r1180b2576],
6	;	:	O	;	_	0	SENT_420	[p21l686t2512r1180b2576],
7	51:256	CD	NUMBER	51:256	number	8	SENT_420	[p21l686t2512r1180b2576],
8	-60	CD	NUMBER	-60	dep	4	SENT_420	[p21l686t2512r1180b2576],
9	.	.	O	.	_	0	SENT_420	[p21l686t2512r1180b2576],

1	33	CD	NUMBER	33	_	0	SENT_421	[p21l10t2594r92b2644],
2	.	.	O	.	_	0	SENT_421	[p21l10t2594r92b2644],

1	Malek	NNP	ORGANIZATION	Malek	nn	2	SENT_422	[p21l115t2591r301b2644],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_422	[p21l326t2590r438b2656],
3	,	,	O	,	_	0	SENT_422	[p21l326t2590r438b2656],
4	Kisiel	NNP	PERSON	Kisiel	nn	5	SENT_422	[p21l470t2591r629b2644],
5	B	NNP	O	B	appos	2	SENT_422	[p21l655t2592r715b2656],
6	,	,	O	,	_	0	SENT_422	[p21l655t2592r715b2656],
7	Spiewak	NNP	PERSON	Spiewak	nn	8	SENT_422	[p21l747t2591r985b2663],
8	M	NNP	O	M	appos	2	SENT_422	[p21l1007t2592r1091b2656],
9	,	,	O	,	_	0	SENT_422	[p21l1007t2592r1091b2656],
10	et	FW	O	et	nn	11	SENT_422	[p21l1122t2605r1173b2644],
11	al.	FW	O	al.	appos	2	SENT_422	[p21l1200t2591r1259b2644],
12	.	.	O	.	_	0	SENT_422	[p21l1200t2591r1259b2644],

1	Coexisting	VBG	O	coexist	amod	2	SENT_423	[p21l1291t2591r1597b2662],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_423	[p21l1622t2591r2059b2663],
3	of	IN	O	of	_	0	SENT_423	[p21l2089t2591r2152b2644],
4	P2Y12	NN	O	p2y12	nn	7	SENT_423	[p21l117t2672r310b2725],
5	and	CC	O	and	_	0	SENT_423	[p21l350t2671r451b2724],
6	CYP2C19	NN	O	cyp2c19	conj_and	4	SENT_423	[p21l490t2671r787b2725],
7	genes	NNS	O	gene	prep_of	2	SENT_423	[p21l825t2692r980b2742],
8	as	IN	O	as	_	0	SENT_423	[p21l1020t2692r1070b2724],
9	a	DT	O	a	det	11	SENT_423	[p21l1110t2692r1138b2724],
10	risk	NN	O	risk	nn	11	SENT_423	[p21l1173t2671r1278b2724],
11	factor	NN	O	factor	prep_as	7	SENT_423	[p21l1312t2671r1475b2724],
12	for	IN	O	for	_	0	SENT_423	[p21l1511t2671r1591b2724],
13	persistent	JJ	O	persistent	amod	15	SENT_423	[p21l1626t2673r1900b2743],
14	platelet	NN	O	platelet	nn	15	SENT_423	[p21l1935t2671r2144b2743],
15	activation	NN	O	activation	prep_for	11	SENT_423	[p21l118t2753r392b2804],
16	with	IN	O	with	_	0	SENT_423	[p21l415t2751r544b2804],
17	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_423	[p21l571t2751r901b2823],
18	.	.	O	.	_	0	SENT_423	[p21l571t2751r901b2823],

1	CircJ	NNP	O	CircJ	_	0	SENT_424	[p21l932t2751r1101b2819],
2	2008	CD	DATE	2008	num	1	SENT_424	[p21l1126t2751r1603b2816],
3	;	:	O	;	_	0	SENT_424	[p21l1126t2751r1603b2816],
4	72:1165	CD	NUMBER	72:1165	number	5	SENT_424	[p21l1126t2751r1603b2816],
5	—	CD	NUMBER	—	dep	1	SENT_424	[p21l1126t2751r1603b2816],
6	9	CD	NUMBER	9	dep	5	SENT_424	[p21l1126t2751r1603b2816],
7	.	.	O	.	_	0	SENT_424	[p21l1126t2751r1603b2816],

1	34	CD	NUMBER	34	_	0	SENT_425	[p21l10t2834r92b2884],
2	.	.	O	.	_	0	SENT_425	[p21l10t2834r92b2884],

1	Patti	NNP	PERSON	Patti	nn	2	SENT_426	[p21l117t2832r252b2884],
2	G	NNP	PERSON	G	_	0	SENT_426	[p21l273t2831r343b2896],
3	,	,	O	,	_	0	SENT_426	[p21l273t2831r343b2896],
4	Colonna	NNP	PERSON	Colonna	nn	5	SENT_426	[p21l366t2831r611b2884],
5	G	NNP	O	G	appos	2	SENT_426	[p21l632t2831r701b2896],
6	,	,	O	,	_	0	SENT_426	[p21l632t2831r701b2896],
7	Pasceri	NNP	O	Pasceri	nn	8	SENT_426	[p21l724t2832r922b2884],
8	V	NNP	O	V	appos	2	SENT_426	[p21l942t2832r1005b2896],
9	,	,	O	,	_	0	SENT_426	[p21l942t2832r1005b2896],
10	Pepe	NNP	PERSON	Pepe	nn	11	SENT_426	[p21l1028t2832r1164b2903],
11	LL	NNP	PERSON	LL	appos	2	SENT_426	[p21l1185t2832r1292b2896],
12	,	,	O	,	_	0	SENT_426	[p21l1185t2832r1292b2896],
13	Montinaro	NNP	O	Montinaro	nn	14	SENT_426	[p21l1312t2832r1623b2884],
14	A	NNP	O	A	appos	2	SENT_426	[p21l1641t2830r1710b2896],
15	,	,	O	,	_	0	SENT_426	[p21l1641t2830r1710b2896],
16	Di	NNP	PERSON	Di	nn	20	SENT_426	[p21l1732t2832r1806b2883],
17	Sciascio	NNP	PERSON	Sciascio	nn	20	SENT_426	[p21l1828t2831r2048b2884],
18	G.	NNP	PERSON	G.	nn	20	SENT_426	[p21l2071t2831r2139b2884],
19	Randomized	NNP	PERSON	Randomized	nn	20	SENT_426	[p21l118t2911r479b2964],
20	trial	NN	O	trial	appos	2	SENT_426	[p21l505t2911r618b2964],
21	of	IN	O	of	_	0	SENT_426	[p21l644t2911r708b2964],
22	high	JJ	O	high	prep_of	20	SENT_426	[p21l724t2911r851b2982],
23	loading	VBG	O	load	partmod	2	SENT_426	[p21l876t2911r1089b2982],
24	dose	NN	O	dose	dobj	23	SENT_426	[p21l1114t2911r1238b2964],
25	of	IN	O	of	_	0	SENT_426	[p21l1265t2911r1329b2964],
26	clopidogrel	NN	O	clopidogrel	prep_of	24	SENT_426	[p21l1346t2911r1663b2983],
27	for	IN	O	for	_	0	SENT_426	[p21l1687t2911r1768b2964],
28	reduction	NN	O	reduction	prep_for	23	SENT_426	[p21l1792t2911r2062b2964],
29	of	IN	O	of	_	0	SENT_426	[p21l2089t2911r2152b2964],
30	periprocedural	JJ	O	periprocedural	amod	32	SENT_426	[p21l116t2992r527b3064],
31	myocardial	JJ	O	myocardial	amod	32	SENT_426	[p21l557t2992r868b3063],
32	infarction	NN	O	infarction	prep_of	28	SENT_426	[p21l898t2992r1173b3045],
33	in	IN	O	in	_	0	SENT_426	[p21l1204t2994r1258b3044],
34	patients	NNS	O	patient	prep_in	32	SENT_426	[p21l1288t2994r1510b3064],
35	undergoing	VBG	O	undergo	xcomp	23	SENT_426	[p21l1542t2992r1868b3063],
36	coronary	JJ	O	coronary	amod	37	SENT_426	[p21l1899t3012r2146b3063],
37	intervention	NN	O	intervention	dobj	35	SENT_426	[p21l117t3073r476b3124],
38	:	:	O	:	_	0	SENT_426	[p21l117t3073r476b3124],
39	results	NNS	O	result	dep	2	SENT_426	[p21l510t3071r689b3124],
40	from	IN	O	from	_	0	SENT_426	[p21l720t3071r857b3124],
41	the	DT	O	the	det	45	SENT_426	[p21l887t3071r976b3124],
42	ARMYDA-2	NN	O	armyda-2	nn	45	SENT_426	[p21l1005t3070r1398b3125],
43	(	CD	NUMBER	(	num	45	SENT_426	[p21l1432t3069r1793b3143],
44	Antiplatelet	JJ	O	antiplatelet	amod	45	SENT_426	[p21l1432t3069r1793b3143],
45	therapy	NN	O	therapy	prep_from	39	SENT_426	[p21l1823t3071r2037b3143],
46	for	IN	O	for	_	0	SENT_426	[p21l2064t3071r2145b3124],
47	Reduction	NN	O	reduction	prep_for	45	SENT_426	[p21l118t3150r411b3203],
48	of	IN	O	of	_	0	SENT_426	[p21l439t3150r504b3203],
49	MYocardial	JJ	O	myocardial	amod	50	SENT_426	[p21l520t3150r861b3203],
50	Damage	NN	O	damage	prep_of	47	SENT_426	[p21l888t3151r1125b3221],
51	during	IN	O	during	_	0	SENT_426	[p21l1154t3150r1341b3221],
52	Angioplasty	NNP	O	Angioplasty	nn	54	SENT_426	[p21l1365t3148r1729b3222],
53	)	CD	NUMBER	)	num	54	SENT_426	[p21l1365t3148r1729b3222],
54	study	NN	O	study	prep_during	50	SENT_426	[p21l1761t3150r1924b3221],
55	.	.	O	.	_	0	SENT_426	[p21l1761t3150r1924b3221],

1	Circulation	NN	O	circulation	_	0	SENT_427	[p21l1957t3150r2140b3203, p21l116t3230r277b3282],
2	2005	CD	DATE	2005	num	1	SENT_427	[p21l303t3230r727b3294],
3	;	:	O	;	_	0	SENT_427	[p21l303t3230r727b3294],
4	111:2099	CD	NUMBER	111:2099	number	5	SENT_427	[p21l303t3230r727b3294],
5	-106	CD	NUMBER	-106	dep	1	SENT_427	[p21l739t3233r895b3283],
6	.	.	O	.	_	0	SENT_427	[p21l739t3233r895b3283],

1	35	CD	NUMBER	35	_	0	SENT_428	[p21l10t3309r92b3362],
2	.	.	O	.	_	0	SENT_428	[p21l10t3309r92b3362],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_429	[p21l114t3307r295b3362],
2	D	NN	O	d	_	0	SENT_429	[p21l315t3310r386b3374],
3	,	,	O	,	_	0	SENT_429	[p21l315t3310r386b3374],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_429	[p21l412t3309r752b3362],
5	W	NNP	PERSON	W	appos	2	SENT_429	[p21l771t3310r861b3374],
6	,	,	O	,	_	0	SENT_429	[p21l771t3310r861b3374],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_429	[p21l887t3310r1101b3362],
8	MF	NN	O	mf	appos	2	SENT_429	[p21l1123t3310r1250b3374],
9	,	,	O	,	_	0	SENT_429	[p21l1123t3310r1250b3374],
10	et	FW	O	et	nn	11	SENT_429	[p21l1277t3323r1327b3362],
11	al.	FW	O	al.	appos	2	SENT_429	[p21l1351t3309r1410b3362],
12	.	.	O	.	_	0	SENT_429	[p21l1351t3309r1410b3362],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_430	[p21l1438t3309r1791b3380],
2	P450	NN	O	p450	nn	4	SENT_430	[p21l1815t3309r1962b3362],
3	2C19	NN	O	2c19	nn	4	SENT_430	[p21l1984t3309r2141b3363],
4	681G	NN	O	681g	nsubj	13	SENT_430	[p21l118t3388r393b3442],
5	>	JJR	O	>	dep	4	SENT_430	[p21l118t3388r393b3442],
6	A	DT	O	a	det	7	SENT_430	[p21l118t3388r393b3442],
7	polymorphism	NN	O	polymorphism	dep	4	SENT_430	[p21l428t3389r841b3461],
8	and	CC	O	and	_	0	SENT_430	[p21l881t3389r982b3442],
9	high	JJ	O	high	amod	12	SENT_430	[p21l1020t3389r1148b3460],
10	on-clopidogrel	JJ	O	on-clopidogrel	amod	12	SENT_430	[p21l1186t3389r1604b3461],
11	platelet	NN	O	platelet	nn	12	SENT_430	[p21l1640t3389r1850b3461],
12	reactivity	NN	O	reactivity	dep	4	SENT_430	[p21l1886t3391r2146b3460],
13	associated	VBN	O	associate	_	0	SENT_430	[p21l118t3469r400b3522],
14	with	IN	O	with	_	0	SENT_430	[p21l416t3469r545b3522],
15	adverse	JJ	O	adverse	amod	18	SENT_430	[p21l566t3469r770b3522],
16	1-year	JJ	DURATION	1-year	amod	18	SENT_430	[p21l793t3472r969b3540],
17	clinical	JJ	O	clinical	amod	18	SENT_430	[p21l988t3469r1187b3522],
18	outcome	NN	O	outcome	prep_with	13	SENT_430	[p21l1206t3483r1449b3522],
19	of	IN	O	of	_	0	SENT_430	[p21l1469t3469r1533b3522],
20	elective	JJ	O	elective	amod	23	SENT_430	[p21l1544t3469r1751b3522],
21	percutaneous	JJ	O	percutaneous	amod	23	SENT_430	[p21l1770t3483r2142b3541],
22	coronary	JJ	O	coronary	amod	23	SENT_430	[p21l117t3569r365b3620],
23	intervention	NN	O	intervention	prep_of	18	SENT_430	[p21l397t3551r743b3602],
24	with	IN	O	with	_	0	SENT_430	[p21l775t3549r904b3602],
25	drug-eluting	NN	O	drug-eluting	nn	28	SENT_430	[p21l940t3549r1298b3620],
26	or	CC	O	or	_	0	SENT_430	[p21l1332t3569r1389b3602],
27	bare-metal	JJ	O	bare-metal	nn	28	SENT_430	[p21l1422t3549r1730b3602],
28	stents	NNS	O	stent	prep_with	13	SENT_430	[p21l1766t3563r1941b3602],
29	.	.	O	.	_	0	SENT_430	[p21l1766t3563r1941b3602],

1	J	NNP	O	J	nn	2	SENT_431	[p21l1972t3550r2001b3617],
2	Am	NNP	O	Am	_	0	SENT_431	[p21l2034t3548r2143b3601],

1	Coll	NNP	O	Coll	nn	2	SENT_432	[p22l118t19r240b72],
2	Cardiol	NNP	O	Cardiol	_	0	SENT_432	[p22l267t19r481b72],
3	2008	CD	DATE	2008	num	2	SENT_432	[p22l505t19r1018b83],
4	;	:	O	;	_	0	SENT_432	[p22l505t19r1018b83],
5	51:1925	CD	NUMBER	51:1925	number	6	SENT_432	[p22l505t19r1018b83],
6	—	CD	NUMBER	—	dep	2	SENT_432	[p22l505t19r1018b83],
7	34	CD	NUMBER	34	dep	6	SENT_432	[p22l505t19r1018b83],
8	.	.	O	.	_	0	SENT_432	[p22l505t19r1018b83],

1	36	CD	NUMBER	36	_	0	SENT_433	[p22l10t101r92b151],
2	.	.	O	.	_	0	SENT_433	[p22l10t101r92b151],

1	Romkes	NNS	MISC	romke	nn	2	SENT_434	[p22l118t98r346b151],
2	M	NN	O	m	_	0	SENT_434	[p22l371t99r455b163],
3	,	,	O	,	_	0	SENT_434	[p22l371t99r455b163],
4	Faletto	NNP	PERSON	Faletto	nn	5	SENT_434	[p22l483t98r681b151],
5	M	NNP	O	M	appos	2	SENT_434	[p22l706t99r790b163],
6	,	,	O	,	_	0	SENT_434	[p22l706t99r790b163],
7	Blaisdell	NNP	PERSON	Blaisdell	nn	8	SENT_434	[p22l818t98r1060b151],
8	J	NNP	PERSON	J	appos	2	SENT_434	[p22l1077t99r1120b166],
9	,	,	O	,	_	0	SENT_434	[p22l1077t99r1120b166],
10	Raucy	NNP	O	Raucy	nn	11	SENT_434	[p22l1150t99r1325b169],
11	J	NNP	O	J	appos	2	SENT_434	[p22l1340t99r1384b166],
12	,	,	O	,	_	0	SENT_434	[p22l1340t99r1384b166],
13	Goldstein	NNP	PERSON	Goldstein	nn	14	SENT_434	[p22l1413t98r1693b151],
14	o	NN	O	o	npadvmod	2	SENT_434	[p22l1711t99r1753b166],
15	e	SYM	O	e	dep	17	SENT_434	[p22l1711t99r1753b166],
16	*	CD	NUMBER	*	num	17	SENT_434	[p22l1711t99r1753b166],
17	Cloning	NN	O	cloning	dep	14	SENT_434	[p22l1783t98r2016b169],
18	and	CC	O	and	_	0	SENT_434	[p22l2042t98r2143b151],
19	expression	NN	O	expression	conj_and	17	SENT_434	[p22l117t180r410b250],
20	of	IN	O	of	_	0	SENT_434	[p22l452t178r516b231],
21	complementary	JJ	O	complementary	amod	22	SENT_434	[p22l548t178r989b250],
22	DNAS	NNS	O	dna	prep_of	2	SENT_434	[p22l1028t177r1216b231],
23	for	IN	O	for	_	0	SENT_434	[p22l1260t178r1340b231],
24	multiple	JJ	O	multiple	amod	25	SENT_434	[p22l1381t178r1616b250],
25	members	NNS	O	member	prep_for	22	SENT_434	[p22l1659t178r1915b231],
26	of	IN	O	of	_	0	SENT_434	[p22l1959t178r2023b231],
27	the	DT	O	the	det	31	SENT_434	[p22l2055t178r2142b231],
28	human	JJ	O	human	amod	31	SENT_434	[p22l117t258r314b311],
29	cytochrome	NN	O	cytochrome	nn	31	SENT_434	[p22l345t258r675b329],
30	P450lIC	NN	O	p450lic	nn	31	SENT_434	[p22l706t258r958b311],
31	subfamily	NN	O	subfamily	prep_of	25	SENT_434	[p22l991t258r1277b329],
32	.	.	O	.	_	0	SENT_434	[p22l991t258r1277b329],

1	Biochemistry	NNP	O	Biochemistry	_	0	SENT_435	[p22l1311t258r1690b329],
2	1991	CD	DATE	1991	num	1	SENT_435	[p22l1721t259r2145b323],
3	;	:	O	;	_	0	SENT_435	[p22l1721t259r2145b323],
4	30:3247	CD	NUMBER	30:3247	number	5	SENT_435	[p22l1721t259r2145b323],
5	—	CD	NUMBER	—	dep	1	SENT_435	[p22l1721t259r2145b323],
6	55	CD	NUMBER	55	dep	5	SENT_435	[p22l117t339r199b391],
7	.	.	O	.	_	0	SENT_435	[p22l117t339r199b391],

1	Key	NN	O	key	nn	2	SENT_436	[p22l12t519r155b607],
2	Words	NNS	O	word	_	0	SENT_436	[p22l180t517r456b585],
3	:	:	O	:	_	0	SENT_436	[p22l180t517r456b585],
4	clopidogrel	NN	O	clopidogrel	dep	2	SENT_436	[p22l493t518r870b607],
5	I	PRP	O	I	dep	6	SENT_436	[p22l900t530r945b575],
6	pharmacogenetics	NNS	O	pharmacogenetic	dep	4	SENT_436	[p22l975t518r1584b607],
7	I	PRP	O	I	dep	8	SENT_436	[p22l1616t530r1661b575],
8	antiplatelets	NNS	O	antiplatelet	dep	4	SENT_436	[p22l1693t518r2115b607],
9	.	.	O	.	_	0	SENT_436	[p22l1693t518r2115b607],

